
<html lang="en"     class="pb-page"  data-request-id="c64f8e9e-1c55-4f96-ab89-4aa3ce42d3f0"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.0c01735;website:website:acspubs;issue:issue:10.1021/jmcmar.2021.64.issue-1;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Synthesis, Tumor Specificity, and Photosensitizing Efficacy of Erlotinib-Conjugated Chlorins and Bacteriochlorins: Identification of a Highly Effective Candidate for Photodynamic Therapy of Cancer" /></meta><meta name="dc.Creator" content="Ravindra R.  Cheruku" /></meta><meta name="dc.Creator" content="Joseph  Cacaccio" /></meta><meta name="dc.Creator" content="Farukh A.  Durrani" /></meta><meta name="dc.Creator" content="Walter A.  Tabaczynski" /></meta><meta name="dc.Creator" content="Ramona  Watson" /></meta><meta name="dc.Creator" content="Kevin  Siters" /></meta><meta name="dc.Creator" content="Joseph R.  Missert" /></meta><meta name="dc.Creator" content="Erin C.  Tracy" /></meta><meta name="dc.Creator" content="Mykhaylo  Dukh" /></meta><meta name="dc.Creator" content="Khurshid  Guru" /></meta><meta name="dc.Creator" content="Richard C.  Koya" /></meta><meta name="dc.Creator" content="Pawel  Kalinski" /></meta><meta name="dc.Creator" content="Heinz  Baumann" /></meta><meta name="dc.Creator" content="Ravindra K.  Pandey" /></meta><meta name="dc.Description" content="Erlotinib was covalently linked to 3-(1′-hexyloxy)ethyl-3-devinylpyropheophorbide-a (HPPH) and structurally related chlorins and bacteriochlorins at different positions of the tetrapyrrole ring. Th..." /></meta><meta name="Description" content="Erlotinib was covalently linked to 3-(1′-hexyloxy)ethyl-3-devinylpyropheophorbide-a (HPPH) and structurally related chlorins and bacteriochlorins at different positions of the tetrapyrrole ring. Th..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 5, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01735" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01735" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01735" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01735" /></link>
        
    
    

<title>Synthesis, Tumor Specificity, and Photosensitizing Efficacy of Erlotinib-Conjugated Chlorins and Bacteriochlorins: Identification of a Highly Effective Candidate for Photodynamic Therapy of Cancer | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01735" /></meta><meta property="og:title" content="Synthesis, Tumor Specificity, and Photosensitizing Efficacy of Erlotinib-Conjugated Chlorins and Bacteriochlorins: Identification of a Highly Effective Candidate for Photodynamic Therapy of Cancer" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0023.jpeg" /></meta><meta property="og:description" content="Erlotinib was covalently linked to 3-(1′-hexyloxy)ethyl-3-devinylpyropheophorbide-a (HPPH) and structurally related chlorins and bacteriochlorins at different positions of the tetrapyrrole ring. The functional consequence of each modification was determined by quantifying the uptake and subcellular deposition of the erlotinib conjugates, cellular response to therapeutic light treatment in tissue cultures, and in eliminating of corresponding tumors grown as a xenograft in SCID mice. The experimental human cancer models the established cell lines UMUC3 (bladder), FaDu (hypopharynx), and primary cultures of head and neck tumor cells. The effectiveness of the compounds was compared to that of HPPH. Furthermore, specific functional contribution of the carboxylic acid side group at position 172 and the chiral methyl group at 3(1′) to the overall activity of the chimeric compounds was assessed. Among the conjugates investigated, the PS 10 was identified as the most effective candidate for achieving tumor cell-specific accumulation and yielding improved long-term tumor control." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01735"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01735">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-13/achre4.2021.54.issue-13/20210706/achre4.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-26/aamick.2021.13.issue-26/20210707/aamick.2021.13.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-13/accacs.2021.11.issue-13/20210702/accacs.2021.11.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-13/acncdm.2021.12.issue-13/20210707/acncdm.2021.12.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-27/acsodf.2021.6.issue-27/20210713/acsodf.2021.6.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-27/ascecg.2021.9.issue-27/20210712/ascecg.2021.9.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-27/ancham.2021.93.issue-27/20210713/ancham.2021.93.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-27/bichaw.2021.60.issue-27/20210713/bichaw.2021.60.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-13/cmatex.2021.33.issue-13/20210713/cmatex.2021.33.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-13/enfuem.2021.35.issue-13/20210701/enfuem.2021.35.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-13/esthag.2021.55.issue-13/20210706/esthag.2021.55.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-26/iecred.2021.60.issue-26/20210707/iecred.2021.60.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-13/inocaj.2021.60.issue-13/20210705/inocaj.2021.60.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-26/jafcau.2021.69.issue-26/20210707/jafcau.2021.69.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/jmcmar.2021.64.issue-13/20210708/jmcmar.2021.64.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-13/joceah.2021.86.issue-13/20210702/joceah.2021.86.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-26/jpcafh.2021.125.issue-26/20210708/jpcafh.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-26/jpcbfk.2021.125.issue-26/20210708/jpcbfk.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-26/jpccck.2021.125.issue-26/20210708/jpccck.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-26/jpclcd.2021.12.issue-26/20210708/jpclcd.2021.12.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-26/jacsat.2021.143.issue-26/20210707/jacsat.2021.143.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-27/langd5.2021.37.issue-27/20210713/langd5.2021.37.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-13/mamobx.2021.54.issue-13/20210713/mamobx.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-13/orlef7.2021.23.issue-13/20210702/orlef7.2021.23.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-13/orgnd7.2021.40.issue-13/20210712/orgnd7.2021.40.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01735&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01735&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01735&amp;href=/doi/10.1021/acs.jmedchem.0c01735" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 741-767</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01727" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01743" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis, Tumor Specificity, and Photosensitizing Efficacy of Erlotinib-Conjugated Chlorins and Bacteriochlorins: Identification of a Highly Effective Candidate for Photodynamic Therapy of Cancer</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Ravindra R. Cheruku</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ravindra R. Cheruku</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">PDT Center, Cell Stress Biology, Roswell Park Comprehensive Cancer Center Buffalo, Buffalo, New York 14223, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ravindra+R.++Cheruku">Ravindra R. Cheruku</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Joseph Cacaccio</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joseph Cacaccio</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">PDT Center, Cell Stress Biology, Roswell Park Comprehensive Cancer Center Buffalo, Buffalo, New York 14223, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joseph++Cacaccio">Joseph Cacaccio</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Farukh A. Durrani</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Farukh A. Durrani</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">PDT Center, Cell Stress Biology, Roswell Park Comprehensive Cancer Center Buffalo, Buffalo, New York 14223, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Farukh+A.++Durrani">Farukh A. Durrani</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Walter A. Tabaczynski</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Walter A. Tabaczynski</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">PDT Center, Cell Stress Biology, Roswell Park Comprehensive Cancer Center Buffalo, Buffalo, New York 14223, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Walter+A.++Tabaczynski">Walter A. Tabaczynski</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ramona Watson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ramona Watson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">PDT Center, Cell Stress Biology, Roswell Park Comprehensive Cancer Center Buffalo, Buffalo, New York 14223, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ramona++Watson">Ramona Watson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kevin Siters</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kevin Siters</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Photolitec, LLC, 73 High Street, Buffalo, New York 14223, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kevin++Siters">Kevin Siters</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Joseph R. Missert</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joseph R. Missert</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">PDT Center, Cell Stress Biology, Roswell Park Comprehensive Cancer Center Buffalo, Buffalo, New York 14223, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+R.++Missert">Joseph R. Missert</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Erin C. Tracy</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Erin C. Tracy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Molecular and Cellular Biology, Roswell Park Comprehensive Cancer Center Buffalo, Buffalo, New York 14263, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Erin+C.++Tracy">Erin C. Tracy</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mykhaylo Dukh</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mykhaylo Dukh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">PDT Center, Cell Stress Biology, Roswell Park Comprehensive Cancer Center Buffalo, Buffalo, New York 14223, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mykhaylo++Dukh">Mykhaylo Dukh</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Khurshid Guru</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Khurshid Guru</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Urology, Roswell Park Comprehensive Cancer Center Buffalo, Buffalo, New York 14263, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Khurshid++Guru">Khurshid Guru</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4551-4676" title="Orcid link">http://orcid.org/0000-0002-4551-4676</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Richard C. Koya</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Richard C. Koya</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Immunology, Roswell Park Comprehensive Cancer Center Buffalo, Buffalo, New York 14263, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Richard+C.++Koya">Richard C. Koya</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pawel Kalinski</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pawel Kalinski</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Immunology, Roswell Park Comprehensive Cancer Center Buffalo, Buffalo, New York 14263, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pawel++Kalinski">Pawel Kalinski</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Heinz Baumann</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Heinz Baumann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Molecular and Cellular Biology, Roswell Park Comprehensive Cancer Center Buffalo, Buffalo, New York 14263, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#014964686f7b2f6360746c606f6f41736e7276646d6d7160736a2f6e7366"><span class="__cf_email__" data-cfemail="79311c101703571b180c14181717390b160a0e1c151509180b1257160b1e">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Heinz++Baumann">Heinz Baumann</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Ravindra K. Pandey</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ravindra K. Pandey</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">PDT Center, Cell Stress Biology, Roswell Park Comprehensive Cancer Center Buffalo, Buffalo, New York 14223, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#037162756a6d6771622d73626d67667a43716c7074666f6f736271682d6c7164"><span class="__cf_email__" data-cfemail="9ceefdeaf5f2f8eefdb2ecfdf2f8f9e5dceef3efebf9f0f0ecfdeef7b2f3eefb">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ravindra+K.++Pandey">Ravindra K. Pandey</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9889-4860" title="Orcid link">http://orcid.org/0000-0002-9889-4860</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01735&amp;href=/doi/10.1021%2Facs.jmedchem.0c01735" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 741–767</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 5, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>2 October 2020</li><li><span class="item_label"><b>Published</b> online</span>5 January 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 January 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01735" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01735</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D741%26pageCount%3D27%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRavindra%2BR.%2BCheruku%252C%2BJoseph%2BCacaccio%252C%2BFarukh%2BA.%2BDurrani%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D1%26contentID%3Dacs.jmedchem.0c01735%26title%3DSynthesis%252C%2BTumor%2BSpecificity%252C%2Band%2BPhotosensitizing%2BEfficacy%2Bof%2BErlotinib-Conjugated%2BChlorins%2Band%2BBacteriochlorins%253A%2BIdentification%2Bof%2Ba%2BHighly%2BEffective%2BCandidate%2Bfor%2BPhotodynamic%2BTherapy%2Bof%2BCancer%26numPages%3D27%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D767%26publicationDate%3DJanuary%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01735"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">736</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">2</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01735" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis, Tumor Specificity, and Photosensitizing Efficacy of Erlotinib-Conjugated Chlorins and Bacteriochlorins: Identification of a Highly Effective Candidate for Photodynamic Therapy of Cancer&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ravindra&quot;,&quot;last_name&quot;:&quot;R. Cheruku&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;Cacaccio&quot;},{&quot;first_name&quot;:&quot;Farukh&quot;,&quot;last_name&quot;:&quot;A. Durrani&quot;},{&quot;first_name&quot;:&quot;Walter&quot;,&quot;last_name&quot;:&quot;A. Tabaczynski&quot;},{&quot;first_name&quot;:&quot;Ramona&quot;,&quot;last_name&quot;:&quot;Watson&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;Siters&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;R. Missert&quot;},{&quot;first_name&quot;:&quot;Erin&quot;,&quot;last_name&quot;:&quot;C. Tracy&quot;},{&quot;first_name&quot;:&quot;Mykhaylo&quot;,&quot;last_name&quot;:&quot;Dukh&quot;},{&quot;first_name&quot;:&quot;Khurshid&quot;,&quot;last_name&quot;:&quot;Guru&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;C. Koya&quot;},{&quot;first_name&quot;:&quot;Pawel&quot;,&quot;last_name&quot;:&quot;Kalinski&quot;},{&quot;first_name&quot;:&quot;Heinz&quot;,&quot;last_name&quot;:&quot;Baumann&quot;},{&quot;first_name&quot;:&quot;Ravindra&quot;,&quot;last_name&quot;:&quot;K. Pandey&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;05&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;741-767&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01735&quot;},&quot;abstract&quot;:&quot;Erlotinib was covalently linked to 3-(1′-hexyloxy)ethyl-3-devinylpyropheophorbide-a (HPPH) and structurally related chlorins and bacteriochlorins at different positions of the tetrapyrrole ring. The functional consequence of each modification was determined by quantifying the uptake and subcellular deposition of the erlotinib conjugates, cellular response to therapeutic light treatment in tissue cultures, and in eliminating of corresponding tumors grown as a xenograft in SCID mice. The experimental human cancer models the established cell lines UMUC3 (bladder), FaDu (hypopharynx), and primary cultures of head and neck tumor cells. The effectiveness of the compounds was compared to that of HPPH. Furthermore, specific functional contribution of the carboxylic acid side group at position 172 and the chiral methyl group at 3(1′) to the overall activity of the chimeric compounds was assessed. Among the conjugates investigated, the PS 10 was identified as the most effective candidate for achieving tumor cell-specif&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01735&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01735" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01735&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01735" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01735&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01735" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01735&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01735&amp;href=/doi/10.1021/acs.jmedchem.0c01735" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01735" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01735" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01735%26sid%3Dliteratum%253Aachs%26pmid%3D33400524%26genre%3Darticle%26aulast%3DCheruku%26date%3D2021%26atitle%3DSynthesis%252C%2BTumor%2BSpecificity%252C%2Band%2BPhotosensitizing%2BEfficacy%2Bof%2BErlotinib-Conjugated%2BChlorins%2Band%2BBacteriochlorins%253A%2BIdentification%2Bof%2Ba%2BHighly%2BEffective%2BCandidate%2Bfor%2BPhotodynamic%2BTherapy%2Bof%2BCancer%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D1%26spage%3D741%26epage%3D767%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a>,</li><li><a href="/action/doSearch?ConceptID=291290" title="Conjugate acid-base pairs">Conjugate acid-base pairs</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/jmcmar.2021.64.issue-1/20210114/jmcmar.2021.64.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0023.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Erlotinib was covalently linked to 3-(1′-hexyloxy)ethyl-3-devinylpyropheophorbide-a (HPPH) and structurally related chlorins and bacteriochlorins at different positions of the tetrapyrrole ring. The functional consequence of each modification was determined by quantifying the uptake and subcellular deposition of the erlotinib conjugates, cellular response to therapeutic light treatment in tissue cultures, and in eliminating of corresponding tumors grown as a xenograft in SCID mice. The experimental human cancer models the established cell lines UMUC3 (bladder), FaDu (hypopharynx), and primary cultures of head and neck tumor cells. The effectiveness of the compounds was compared to that of HPPH. Furthermore, specific functional contribution of the carboxylic acid side group at position 17<sup>2</sup> and the chiral methyl group at 3(1′) to the overall activity of the chimeric compounds was assessed. Among the conjugates investigated, the PS <b>10</b> was identified as the most effective candidate for achieving tumor cell-specific accumulation and yielding improved long-term tumor control.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12748" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12748" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Photodynamic therapy (PDT) is a non-invasive cancer treatment modality and is an alternative to surgery, chemotherapy, and radiotherapy.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Since the approval of Photofrin, a hematoporphyrin-based photosensitizer (PS) by various health organizations, different laboratories have investigated avenues to develop new PDT agents with photophysical properties at longer wavelengths, increased tumor cell specificity, and more favorable pharmacokinetic profile.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5">(2−5)</a> During the last 30 years, a large number of PDT agents with excitation light wavelengths ranging from 650 to 800 nm have been synthesized and evaluated.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> Tumor cells, in general, have a nonspecific affinity to porphyrins, and there has not been much success in improving the tumor selectivity and specificity of these agents<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8−10)</a></div><div class="NLM_p">Attempts have been made to direct PSs to cellular targets by conjugating with known tumor-targeting molecules.<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> The targeting molecules include cholesterol,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> chemotherapy agents,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> monoclonal antibodies,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> carbohydrates,<a onclick="showRef(event, 'ref16 ref17 ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19 ref20">(16−20)</a> and linear or cyclic peptide ligands.<a onclick="showRef(event, 'ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23">(21−23)</a> However, there is still a major challenge to gain a PS that is selectively taken up and is retained by malignant cells.</div><div class="NLM_p">One of the potential tumor cell targets appears to be an epidermal growth factor receptor (EGFR).<a onclick="showRef(event, 'ref24 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26 ref27">(24−27)</a> Mutations that lead to EGFR overexpression<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> or to dysregulation of its kinase activity<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> have been associated with a number of cancers, including squamous cell carcinoma of the bladder, head and neck (80–100%), lung (80%), anal cancers, and glioblastoma (50%).</div><div class="NLM_p">The separate approach to identify optimal PS structures is by structure–activity relationship (SAR) and quantitative structure–activity relationship (QSAR).<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30−32)</a> These studies indicated that, in asymmetrical PSs, such as chlorophyll-a derivatives, the presence of the substituents at variable positions of the macrocycle and the overall lipophilicity make a significant impact on tumor uptake and the pharmacokinetic profile. Such studies helped us in developing effective analogues, such as 3-(1′-hexyloxy)ethyl-3-devinylpyropheophorbide-a (HPPH),<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> which is currently in phase I/II human clinical trials of head and neck (H & N),<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> esophageal,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and lung cancer.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The 3-(1′-<i>m</i>-iodobenzyloxy)ethyl-3-devinylpyropheophorbide-a in radioactive (<sup>124</sup>I-, PET-ONCO) and no-radioactive (<sup>127</sup>I-) forms provide an opportunity to use a single agent for positron emission tomography (PET) imaging, fluorescence imaging, and photodynamic therapy of a variety of cancers, including head and neck, lung, and renal carcinoma.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> Among the near-infrared (NIR) PSs derived from bacteriochlorophyll-a, 3-(1′-butyloxy)ethyl-3-deacetyl-bacteriopurpurin-18-<i>N</i>-butylimide methyl ester (Photobac) showed potential for treating glioblastoma in SCID mice bearing U87 tumors.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36,37)</a></div><div class="NLM_p">We have recently shown that the iodinated PS discussed above on conjugating with an erlotinib moiety has applications in imaging (PET, fluorescence) and phototherapy (PDT) of bladder cancer.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Interestingly, the <i>in vivo</i> results indicated that the position of the erlotinib moiety at the peripheral position of the basic skeleton made a significant difference in long-term control.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Therefore, we sought to as follows: (i) to extend the SAR study in a variety of tetrapyrrolic systems derived from chlorophyll-a and bacteriochlorophyll-a and compare their <i>in vitro</i> and <i>in vivo</i> photosensitizing abilities in head and neck and bladder tumor cells and mice tumor models and (ii) to compare the biological efficacy of the best candidates with HPPH, a leading agent undergoing human clinical trials<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><div class="NLM_p last">Co-joining a porphyrin with erlotinib demands a reassessment of whether the distinct functionalities of each component are retained in the final product. Expected is that the lipophilic porphyrin contributes to the mode and specificity of cellular uptake and erlotinib the interaction with the cytoplasmic domain of the ATP binding site of the plasma membrane-resident EGFR. However, it is not yet known whether the close proximity of the porphyrin with its preference for membrane binding will negate the erlotinib interaction with the EGFR domain. To address the part of these questions, this study presents the syntheses of various porphyrin-erlotinib variants and tests these for as follows: (i) uptake, cellular deposition, and retention by cells with prominent EGFR expression; (ii) photoreaction <i>in vitro</i>; and (iii) <i>in vivo</i> localization and action in xenograft-bearing mice. A separate study will address the erlotinib-specific function of the chimeric compounds.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47615" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47615" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">For our study, a series of erlotinib–PS conjugates related to (a) pyropheophorbide-a λ<sub>max</sub>: 660 nm; (b) purpurinimide, λ<sub>max</sub>: 700 nm; (c) bacteriopurpurinimide, λ<sub>max</sub>: 782 nm; and (d) chlorin e<sub>6</sub>, λ<sub>max</sub>: 660 nm (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) were synthesized.<a onclick="showRef(event, 'ref31 ref39'); return false;" href="javascript:void(0);" class="ref ref31 ref39">(31,39)</a> These PSs were selected not only to determine the impact of the position of the erlotinib moiety but also to know the effects of inherent structural differences of these compounds in the photodynamic treatment of cancer as a consequence of cellular uptake and retention.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of the starting chlorins and bacteriochlorin used in present study retention.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i5" class="anchor-spacer"></div><h4 class="article-section__title" id="_i5"> Erlotinib Moiety Introduced at the Lower Half (Position 17<sup>2</sup>) of the Pyropheophorbide-a with Different Linkers</h4><div class="NLM_p">For the synthesis of the conjugate <b>5</b> containing a triazole alkyl linker, erlotinib <b>1</b> was first reacted with 1-azido-4-butyl amine <b>2</b>, the intermediate <b>3</b> was reacted with HPPH <b>4</b> in the presence of EDC/DMAP, and then the desired conjugate <b>5</b> was obtained. To investigate the impact of the linker joining the PS-erlotinib moieties, HPPH <b>4</b> was first reacted with 3-iodobenzylamine <b>6</b> and gave the corresponding iodobenzylamide analogue <b>7</b>, which on reacting with erlotinib under mild reaction conditions afforded the desired HPPH-erlotinib conjugate <b>8</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0013.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Erlotinib Moiety Conjugated at Position 17 of the Hexyl Ether Analogue of Pyropheophorbide-a</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i7" class="anchor-spacer"></div><h4 class="article-section__title" id="_i7"> Erlotinib Moiety Introduced at the Upper Half Position 3(1′) of the Pyropheophorbide-a and Bacteriopyropheophorbide-a</h4><div class="NLM_p">Methyl 3-(1′-<i>m</i>-iodo-benzyloxy)ethyl-3-devinylpyropheophorbide <b>9</b> obtained by reacting pyropheophorbide-a with HBr/AcOH, and <i>m</i>-iodobenzyl alcohol was reacted with erlotinib in the presence of the palladium catalyst and respective conjugate <b>10</b> as a methyl ester analogue was isolated. The methyl ester functionality was then converted into the corresponding carboxylic acid <b>11</b> by reacting with aqueous lithium hydroxide under mild conditions. Following a similar approach, the bacteriopyropheophorbide <b>12</b> in which rings “B & D” are reduced was also converted into the corresponding methyl ester and carboxylic acid analogues <b>13</b> and <b>14</b> respectively (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0014.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Erlotinib Moiety Conjugated at Position 3 of Pyropheophorbide-a and Bacteriopyropheophorbide-a</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9"> Erlotinib Conjugated at the <i>p</i>-Position of 3-(1′-<i>p</i>-Iodo-benzyloxy)ethyl- and 3-(-<i>m</i>-Iodobenzyloxy methyl) Pyropheophorbide-a</h4><div class="NLM_p">To investigate the impact of the position of the erlotinib moiety (<i>m-</i> vs <i>p-</i> of the phenyl group), the methyl ester and carboxylic acid analogues <b>16</b> and <b>17</b> were synthesized. For determining the necessity of the chiral center at position 3(1′-) in biological efficacy of <b>11</b>, PS <b>18</b> (without chiral center at position 3(1′) was synthesized by following our own methodology, which on conjugation with erlotinib gave the conjugate <b>19</b> as methyl ester (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0015.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Erlotinib Moiety Conjugated either at the <i>p-</i>Position of the Benzyloxy Group Having a Chiral Center at Position 3(1′) or at the <i>m-</i>Position without a Chiral Center at Position 3(1′) of the Conjugate</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> Erlotinib Moiety Conjugated at Position 20 of the Methyl Mesopyropheophorbide-a</h4><div class="NLM_p">For introducing erlotinib at position 20 of the PS, compound <b>20</b> containing a benzoic acid functionality <b>20</b> was prepared from 20-bromo-pyropheophorbide-a following the methodology developed in our laboratory.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> It was reacted with <i>p-</i>iodobenzyl amine, and the intermediate <b>22</b> was obtained in 66% yield. It was then reacted with erlotinib by following the methodology discussed for other compounds, and the desired erlotinib–PS conjugate <b>23</b> was obtained (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>).</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0016.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Erlotinib Moiety Conjugated at Position 20 of Methyl Meso-pyropheophorbide-a</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> HPPH Conjugated with Multiple Erlotinib Moieties at the Lower Half (Position 17<sup>2</sup>) of the PS</h4><div class="NLM_p">HPPH <b>4</b> was first reacted with triethyl ethyl amine <b>24</b>, and HPPH tricarboxylic analogue <b>25</b> was obtained. It was then reacted with erlotinib analogue <b>26</b> (BOP·Et<sub>3</sub>N), and the tri-erlotinib–PS conjugate <b>27</b> was obtained (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>).</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0017.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Hexyl Ether Analogue of Pyropheophorbide-a (HPPH) Conjugated with Three Erlotinib Moieties</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Erlotinib-<i>N</i>-imide-Substituted Purpurinimide and Bacteriopurpurinimides</h4><div class="NLM_p">To investigate the impact of the erlotinib moiety in biological efficacy, the purpurinimide <b>28</b> and bacteriopurpurinimide <b>30</b> containing <i>N</i>-3-iodobenzyl group at position 13<sup>2</sup> were reacted with erlotinib <b>1</b> by following the standard methodology as discussed for other conjugates and the corresponding conjugates <b>29</b> and <b>31</b> were obtained (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>).</div><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0018.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Erlotinib Moiety Conjugated to the Fused Imide Ring Systems of Purpurinimide and</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Bacteriopurpurinimide</div></div><div id="sec2_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Erlotinib Conjugated at Positions 13 and 15 of Chlorin e<sub>6</sub></h4><div class="NLM_p">Recently, Smith et al. prepared a series of peptide analogues of chlorin e<sub>6</sub> in which the peptides were attached either at position 13, 15, or 17 of chlorin e<sub>6</sub> moieties.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> In preliminary <i>in vitro</i> screening, the PSs conjugated at positions 13 and 15 were more effective than those conjugated at position 17. Therefore, to investigate the effect of the presence of the erlotinib moiety at these position on biological efficacy, methyl-3 devinyl-pheophorbide-a <b>32</b> and the corresponding 3-hexyloxy ethyl analogue methyl 3-(1′-hexyloxy)ethyl-pheophorbide-a <b>33</b> were individually reacted with 3-iodobenzyl amine <b>34</b>, and the respective iodobenzyl amide analogues <b>35</b> and <b>36</b> were isolated. Reaction of these intermediates with erlotinib moieties under similar reaction conditions as discussed for other compounds afforded the desired 13-substituted erlotinib analogues <b>37</b> and <b>38</b> (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>).</div><figure id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0019.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Erlotinib Moiety Conjugated at Position 13 of Chlorin e<sub>6</sub> with an Amide Linker</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To determine the impact of ethylene glycol with variable carbon units and also the nature of substituent at position 3 of chlorin e<sub>6</sub>, conjugates <b>43</b> and <b>50</b> with a variable glycol linker joining the PS at position 13 with erlotinib were synthesized (<a class="ref internalNav" href="#sch8" aria-label="Schemes 8">Schemes 8</a> and <a class="ref internalNav" href="#sch9" aria-label="9">9</a>).</div><figure id="sch8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0020.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Erlotinib Moiety Conjugated at Position 13 of Chlorin e<sub>6</sub> with an Ethylene Glycol Linker</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0021.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Erlotinib Moiety Conjugated at Position 13 of Chlorin by a Longer Ethylene Glycol Linker</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For the synthesis of the conjugate in which erlotinib was introduced at position 15 of the PS, chlorin e<sub>6</sub> tricarboxylic acid <b>51</b> was reacted with 3-iodo benzyl amine <b>6</b> gave the 15-substituted iodobenzyl analogue <b>52</b>, which on reacting with erlotinib <b>1</b> afforded the 15-erlotinib chlorin e<sub>6</sub> dimethyl ester <b>53</b> (<a class="ref internalNav" href="#sch10" aria-label="Scheme 10">Scheme 10</a>).</div><figure id="sch10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0022.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Erlotinib Moiety Conjugated at Position 15 of Chlorin e<sub>6</sub></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The structures of all intermediate and final products were confirmed by <sup>1</sup>H and <sup>13</sup>C NMR (1D and 2D). The NMR data are consistent with the proposed structures. In some cases, these data exhibited interesting features suggesting significant differences in molecular conformation, which depend on the location of the erlotinib linkage point in the molecule.</div><div class="NLM_p">Linkers joining the PS and erlotinib moiety through the position 17 of the macrocycle resulted in chemical shifts that differed substantially from those observed in other conjugates. Conjugates <b>5</b> and <b>8</b> exhibited shielding (relative to unconjugated compound <b>4</b>) of protons in the vicinity of the macrocycle’s C-ring. In conjugate <b>8</b>, the 10-H, 13<sup>2</sup>-CH<i>H</i>, and 12-CH<sub>3</sub> protons were observed at 8.97/8.95, 4.53, and 2.29/2.26 ppm, respectively. In unconjugated photosensitizer <b>4</b>,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> however, these protons appear at 9.45, 5.11, and 3.63 ppm, respectively. So, conjugation to erlotinib through the position 17 resulted in a significant shielding of each of these protons, which ranged from ∼0.5 to ∼1.4 ppm. In addition, the NMR spectra of <b>8</b> exhibited a marked deshielding of the quinazoline 5-H of erlotinib, which was observed at 7.853/7.850 ppm. This contrasts with the chemical shifts observed for the corresponding protons of conjugates linked through other positions, as well as that of an unconjugated erlotinib analogue (similar to <b>26</b>) observed in a nonpolar solvent. Under these conditions, the quinazoline 5-H typically resonates at ∼7.2 ppm. A deshielding of ∼0.7 ppm, therefore, resulted from conjugation to the photosensitizer’s position 17.</div><div class="NLM_p">Similar <sup>1</sup>H NMR chemical shifts were observed for <b>5</b>, which differs from <b>8</b> in the linker structure only. Here, the 10-H, 13<sup>2</sup>-CH<i>H</i>, and 12-CH<sub>3</sub> protons were observed at 8.80/8.78, 4.98, and 2.77 ppm, respectively. Compared with the shieldings observed for <b>8</b>, shieldings observed for <b>5</b> were larger for 10-H but smaller for 12-CH<sub>3</sub> and 13<sup>2</sup>-CH<i>H</i>. The difference in the linker structure is likely responsible for this. The quinazoline 5-H of <b>5</b> (7.77 ppm) was only slightly less deshielded than that observed in <b>8</b>.</div><div class="NLM_p">The chemical shifts observed for these specific protons of the PS and erlotinib moieties of <b>5</b> and <b>8</b> indicate significant differences in the electronic environment, relative to the other conjugates and precursors examined here. Conjugates <b>5</b> and <b>8</b> are both 17-linked. Furthermore, no other linkage point resulted in such pronounced shielding/deshielding effects for quinazoline 5-H or for protons near the macrocycle’s C-ring (relative to unconjugated PS of similar structure or the free erlotinib derivative).</div><div class="NLM_p">In <b>5</b> and <b>8</b>, the linkage point is reasonably close to the C-ring, and each linker consists of a flexible chain of several atoms that connect to the more rigid, aromatic portion of the erlotinib-containing substituent. This arrangement may allow the erlotinib moiety to interact with the atoms surrounding the C-ring. Stacking of the aromatic ring systems of the macrocycle and substituent might result in ring current-induced shielding/de-shielding, accounting for the observed chemical shifts, both for the protons (near the C-ring) of the macrocycle and quinazoline 5-H. π–π stacking interactions could help stabilize such a conformation. In the 3- and 20-linked conjugates, the erlotinib-containing substituent is much more distant from the C-ring. Moreover, the linkers are shorter and presumably much less flexible than those of <b>5</b> and <b>8</b>. Therefore, it is unlikely that these species can adopt conformations allowing a close approach of the C-ring and quinazoline moiety. This is consistent with the NMR observations. In conjugates with linkages at the 13-, 15-, or imide nitrogen position, the linkage point is certainly close enough to permit interactions between the C-ring and quinazoline moiety, but linker length and flexibility likely prevent this. In several of these conjugates (e.g., <b>23</b>, <b>29</b>, <b>31</b>, <b>37</b>, and <b>53</b>), the linker is too short and insufficiently flexible. In others (e.g., <b>43</b> and <b>47</b>), the linker is much too long, likely permitting too much motional freedom. Again, the NMR spectra are consistent with these hypotheses.</div><div class="NLM_p">Unlike <b>5</b> and <b>8</b>, conjugate <b>27</b> showed no shielding of the protons near the C-ring, despite being linked through the position 17. However, the substituent is much bulkier in <b>27</b>, containing three erlotinib moieties. Steric hindrance may prevent a close approach to the C-ring by this very bulky substituent, accounting for the observed (unshielded) delta values of protons near the C-ring. The quinazoline 5-H signal was actually moderately deshielded in <b>27</b>, but this likely resulted from the polar solvent used during observation. Similar to <b>27</b> and <b>37</b>, <b>17</b> also exhibited a moderate, solvent-induced (CDCl<sub>3</sub>/CD3OD (90:10)) deshielding of the quinazoline 5-H signal but no shielding in the vicinity of the C-ring. Similar deshielding (δ<sub>5-H</sub> = 7.65 ppm) was observed in <b>26</b>, which was examined in the CDCl<sub>3</sub>/CD<sub>3</sub>OD (80:20) solvent.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The polar solvent may induce a conformational change responsible for the deshielding. In a less polar solvent (i.e., CDCl<sub>3</sub>) in which most compounds reported here were observed, an erlotinib analogue similar to <b>26</b> showed no deshielding of the quinazoline 5-H signal.</div><div class="NLM_p last">The quinazoline 5-H protons of <b>23</b>, <b>31</b>, <b>43</b>, and <b>50</b> were each deshielded, but to a much lesser extent than observed in <b>5</b> or <b>8</b>. These conjugates, however, did not exhibit the wider effects demonstrated by <b>5</b> and <b>8</b>: the PS protons near the C-ring were not shielded. This suggests that the deshielding of 5-H in each of these four conjugates was not due to the interaction with the C-ring π system. Some other affect was likely responsible, perhaps a change in conformation within the erlotinib moiety itself. Although 10-H of <b>7</b> was shielded (δ = 9.07/9.05 ppm), neither its 12-CH<sub>3</sub> nor its 13<sup>2</sup>-CH<i>H</i> proton was significantly affected. This may be due to an interaction involving the aromatic ring of the iodobenzyl group, resulting from a conformation affecting only the proton at position 10.</div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Comparative <i>in Vitro</i> and <i>in Vivo</i> Efficacies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17667" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17667" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Uptake and Retention of the PS as a Function of the Tumor Cell Phenotype</h3><div class="NLM_p">The charge and position of hydrophobic residues critically influence the cell biological properties of porphyrins. Cultures of primary human head/neck tumor cells have been used to evaluate the structures that determines cell-type-specific uptake and PDT of the synthesized erlotinib–porphyrin compounds (<a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<a class="ref internalNav" href="#sch2" aria-label="2">2</a><a class="ref internalNav" href="#sch3" aria-label="3">3</a><a class="ref internalNav" href="#sch4" aria-label="4">4</a><a class="ref internalNav" href="#sch5" aria-label="5">5</a><a class="ref internalNav" href="#sch6" aria-label="6">6</a><a class="ref internalNav" href="#sch7" aria-label="7">7</a><a class="ref internalNav" href="#sch8" aria-label="8">8</a><a class="ref internalNav" href="#sch9" aria-label="9">9</a><a class="ref internalNav" href="#sch10" aria-label="10">10</a>). For facilitating comparison of activities, HPPH and HPPH methyl ester (HPPH-ME) were included in the analyses as a reference. A representative example is shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> in which tongue cancer-derived HNT1 cells were used to compare the uptake of HPPH with that of the erlotinib conjugates <b>10</b> and <b>11</b>. The analysis determined the effect of the substitution of the hexyl group at position 3(1′) by erlotinib (<b>10</b>) and the presence of a carboxyl group at position 17<sup>2</sup> (<b>11</b>). The results indicated a marked difference in the uptake and retention. As already noted previously by various investigators, uptake of the porphyrin-based PS was strongly moderated by the presence of serum proteins in the culture medium, which act as binding substrates. This property was also detected for the erlotinib conjugates by the difference in cellular loading when determined in cell cultures using a serum-free medium versus a medium containing 10% FBS (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, comparison of the two panels on the left). Retention was scored based on the kinetics by which the PS was detectable in the cells as a function of the time cultured in a PS-free medium but containing 10% FBS (termed “chase”). For instance, after a 24 h chase period, PS <b>10</b> exceeded that of HPPH and PS <b>11</b>, even though the latter two compounds were initially taken up by HNT1 cells at a much higher rate. An equivalent difference due to the presence of a carboxyl residue at position 17<sup>2</sup> was observed for conjugates <b>16</b> and <b>17</b> (data not shown). The quantitative comparison of all erlotinib–porphyrin compounds in separate preparations of head and neck cancer cell preparations carried out over the past 2 years indicated a consistent pattern of uptake and retention. Elevated retention over 48 h by cancer cells was identified for <b>5</b>, <b>8</b>, <b>10</b>, <b>16</b>, <b>17</b>, and <b>43</b>. In contrast, substantially lower uptake and retention level were determined for <b>13</b>, <b>14</b>, <b>19</b>, <b>22</b>, <b>23</b>, <b>27</b>, <b>29</b>, <b>36</b>, <b>38</b>, <b>49</b>, and <b>50</b> (data not shown, see also <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> below).<named-content content-type="anchor" rid="fig5" type="simple"></named-content><named-content content-type="anchor" rid="tbl1" type="simple"></named-content></div><figure id="fig2" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Uptake and retention by HNT1 cells (passage 116). Confluent cell cultures were incubated for 30 min in the serum-free medium containing 3.2 μM of the indicated PS. The cellular level and subcellular distribution of PS fluorescence indicates the binding to and mode of uptake by the cells. Subsequent treatment of the cells for 5 h with serum and the PS-containing medium determines the competing effect of serum proteins on uptake and steady-state accumulation of the PSs. Follow-up incubation for 15 h in the serum-containing medium but without PS provided an estimate for the rate of egress of PS from cells. PS fluorescence is recorded at 100× magnification by different-length exposure of the camera. Images allow digital quantification of the PS fluorescence level.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cell-type specific retention of erlotinib conjugates. Five-day-old co-cultures of FaDu-49 and CFSE-stained HN-121 T-Fb were incubated with the medium containing 10% FBS and 1.6 μM PS followed by a 48-h chase in medium without PS. Cell-associated fluorescence signals were recorded.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Five-day-old co-cultures of HN-143T-EC with HN-166T-Fb were incubated with the medium containing 10% FBS and 3 μM indicated PS for 5 h and then chased for 40 h with the medium without PS. Phase contrast images at 100× magnification (upper panel in each section) and corresponding fluorescent images of all cultures (500 ms exposure time) were taken at the indicated time points (lower panel in each section). Fluorescent pictures are shown in the monochrome format as photographed for optimal presentation of the fluorescent signals.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Microscopic images of the cells after short- and-long term treatment with erlotinib conjugates indicated that each compound, like HPPH, was taken up by transmembrane diffusion (internalization of the PS by cells incubated for 30 min at 4 to 20 °C, at temperatures which reduce or even prevent plasma membrane-dependent endocytosis). Most of the erlotinib conjugates accumulated in mitochondria and ER compartment (determined by co-localization using mitotracker green dye and transfection of the expression vector encoding ER-targeted green fluorescent protein. The only exception was compound <b>27</b>, which, probably due to the presence of the triple erlotinib side group, did not diffuse into the cells but was endocytosed and deposited in the lysosomal compartment (co-localized with lysotracker green dye).</div><div class="NLM_p">One of the goals of this study was to achieve a preferential retention of an erlotinib conjugate in tumor epithelial cells. Previous studies showed that certain forms of pheophorbides, including HPPH, were several-fold less effectively retained by tumor stromal cells (fibroblasts) than by the tumor epithelial cells.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> To identify this property for those erlotinib conjugates with appreciable uptake and retention activity, the compounds were tested on reconstituted co-cultures of tumor and stromal cells from head and neck cancer tissue. This culture system allowed a simultaneous assay of the cell type-specific retention by comparing PS fluorescence in each cell type as a function of culture period post PS incubation. A demonstration of this assay is shown by the example in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>. In this particular experiment, the detection of the stromal cells separate from the tumor cell clusters was enhanced by tagging these with CFSE prior to the addition to FaDu cells (subclonal line 49). The comparison of HPPH, <b>10</b>, and <b>19</b> demonstrated the difference in the magnitude of cellular retention. The PS level in the cells served not only as measure for cell type specificity of the PS but also as marker for the expected response to treatment with therapeutic light.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div><div class="NLM_p last">To rule out a modifying influence of the CFSE-tagging, nonmodified fibroblasts cultures combined with epithelial cells from different tumors were used to establish the level of cell-type specificity and pinpoint the potential optimal erlotinib conjugates. Despite quantitative variation in uptake and retention among separate tumor epithelial cell preparations, the most reproducible differential retention in epithelial cells was determined for <b>10</b>. Although conjugates <b>5</b> and <b>43</b> were taken-up and retained by most tumor epithelial at higher level than <b>10</b>, the similarly elevated retention of these PSs, including HPPH-ME, by fibroblasts did reduce the tumor cell specificity (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01735/suppl_file/jm0c01735_si_001.pdf" class="ext-link">Figure S1</a>), for higher magnification of the fluorescent image of co-culture in a separate experimental series). The comparative analyses also indicated that structural differences in the attachment of erlotinib to the porphyrin have an impact on uptake properties. The rigid linker of <b>8</b> lowered uptake when compared to <b>5</b> with the flexible linker. The same feature was observed by comparing uptake of <b>38</b> with <b>43</b>. The comparison of <b>10</b> and <b>16</b> highlighted the relevance of the position of erlotinib attachment to the benzyl ring at position 3. Substitution in the <i>meta</i> position (<b>10</b>) resulted in higher uptake than in the <i>para</i> position (<b>16</b>)</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>In Vitro</i> Photosensitizing Activity</h3><div class="NLM_p">The proportional relationship of quantified PS fluorescence signal with light-triggered photoreaction in cells has previously been demonstrated.<a onclick="showRef(event, 'ref45 ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref45 ref46 ref47">(45−47)</a> The PS-dependent photoreaction, through the production of singlet oxygen molecules, mediates intracellular oxidative reactions, including covalent cross-linking of proteins. The cross-linking of latent STAT3, a ubiquitous transcription factor present in essentially all vertebrate cells, has proven to be a particularly sensitive reaction. The conversion of monomeric STAT3 to covalently linked STAT3 homodimers is a quantitative read-out for the photoreaction triggered <i>in vitro</i> or <i>in vivo</i>. A second and less sensitive marker for the photoreaction in epithelial cells is PDT-dose-dependent degradation of EGFR protein.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> These markers have been used to assess the photoreaction mediated by the erlotinib conjugates. As shown in the representative example of head and neck tumor cells (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>), PS <b>10</b> mediates a dose-dependent PDT response that is highly comparable to that mediated by the nonconjugated PS-531-ME. The cellular level of PS <b>10</b>, expressed in fluorescent units (FU), correlates with the production of cross-linked STAT3 (complex 1) and the loss of viability. Due to the extremely high level of EGFR by HN-85 tumor cells, the PDT-dependent loss of this protein is less evident. This experimental setting also confirms the relationship of the specific uptake and retention of the PS type with the PDT response. Similar <i>in vitro</i> cell assays of the other erlotinib conjugates confirmed that the photoreaction by the porphyrin moieties been maintained and has not been measurably altered.</div><figure id="fig5" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. PS-dose dependent photoreaction in HN-85-1-3 T-EC. Level of PS taken up was quantified by fluorescence prior to 665 nm light treatment (3 J/cm<sup>2</sup>). (A) Immunoblot analysis of STAT3 and EGFR immediately after light treatment. (B) Duplicate cultures were incubated for 24 h after PDT, and then the percentage of surviving cells determined.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To relate the PDT response mediated by the erlotinib conjugates <i>in vitro</i> with that of the same cells grown as xenograft in mice, two separate established cell systems, UMUC3 and FaDu, were applied. Compared to HPPH, several erlotinib conjugates (e.g., <b>5</b>, <b>8</b>, <b>10</b>, <b>13</b>, <b>14</b>, <b>16</b>, <b>17</b>, <b>35</b>, <b>37</b>, <b>43</b>, <b>43</b>, and <b>49</b>) showed improved cytotoxicity in both UMUC3 and FaDu cell lines (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Comparative <i>in Vitro</i> Photosensitizing Efficacy (IC<sub>50</sub>) of PS–Erlotinib Conjugates with HPPH in UMUC3 (Bladder Cancer) and FaDu (Head and Neck Cancer) Cell Lines</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="9" align="center"><i>in vitro</i> PDT efficacy (IC<sub>50</sub>) of photosensitizers (concentration, nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound #</th><th class="colsep0 rowsep0" align="center" char=".">UMUC3</th><th class="colsep0 rowsep0" align="center" char=".">FaDu</th><th class="colsep0 rowsep0" align="center">compound #</th><th class="colsep0 rowsep0" align="center" char=".">UMUC3</th><th class="colsep0 rowsep0" align="center">FaDu</th><th class="colsep0 rowsep0" align="center">compound #</th><th class="colsep0 rowsep0" align="center" char=".">UMUC3</th><th class="colsep0 rowsep0" align="center" char=".">FaDu</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">20.25</td><td class="colsep0 rowsep0" align="char" char=".">17.6</td><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="char" char=".">34.4</td><td class="colsep0 rowsep0" align="left">59.6</td><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="char" char=".">6.8</td><td class="colsep0 rowsep0" align="char" char=".">15.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char=".">187.4</td><td class="colsep0 rowsep0" align="char" char=".">519.8</td><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="char" char=".">76.3</td><td class="colsep0 rowsep0" align="left">23.3</td><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="char" char=".">7.5</td><td class="colsep0 rowsep0" align="char" char=".">21.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="char" char=".">43.4</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="char" char=".">195.9</td><td class="colsep0 rowsep0" align="left">1246</td><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="char" char=".">26.4</td><td class="colsep0 rowsep0" align="char" char=".">19.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char=".">59.4</td><td class="colsep0 rowsep0" align="char" char=".">35.5</td><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">>10 μM</td><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="char" char=".">59.2</td><td class="colsep0 rowsep0" align="char" char=".">88.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char=".">54.8</td><td class="colsep0 rowsep0" align="char" char=".">31.8</td><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">6925</td><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="char" char=".">45.0</td><td class="colsep0 rowsep0" align="char" char=".">166.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="char" char=".">16.8</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="char" char=".">28.2*</td><td class="colsep0 rowsep0" align="left">13.8</td><td class="colsep0 rowsep0" align="left"><b>HPPH</b></td><td class="colsep0 rowsep0" align="char" char=".">68.4</td><td class="colsep0 rowsep0" align="char" char=".">43.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="char" char=".">*8.9</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="char" char=".">39.6</td><td class="colsep0 rowsep0" align="left">33.42</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="char" char=".">20.9</td><td class="colsep0 rowsep0" align="char" char=".">59.6</td><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="char" char=".">3.5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div></div><div class="NLM_p">Before selecting the best candidate for <i>in vivo</i> PDT efficacy, the PSs that showed higher tumor cell specificity were investigated for their uptake in tumor, liver, and skin at variable time points in SCID mice bearing UMUC3 and T24 tumors. PS <b>10</b> showed higher tumor uptake with a faster clearance from the liver and skin with time than HPPH and other erlotinib conjugates. Previous reports from our laboratory have shown that among the 3(1′) alkyl ether analogues of pyropheophorbide-a, HPPH containing a hexyl ether side chain at position 3 and the carboxylic acid group at position 17<sup>2</sup> show the best PDT efficacies. Replacing the carboxylic acid group at position 17<sup>2</sup> with methyl ester reduces its cell-selectivity and PDT efficacy in most of the tumor types. In addition, the presence and nature of chirality at position 3(1′) also seems to be important for higher efficacy. Therefore, to investigate the importance of these structural characteristics in erlotinib conjugate <b>10</b>, the corresponding methyl ester analogues <b>11</b> and <b>19</b> without chirality at position 3(1′) were investigated for comparative uptake and PDT efficacy (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>, see also uptake and cell specificity in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><figure id="fig6" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compounds selected to determine the impact of structural requirements for tumor uptake and <i>in vivo</i> PDT efficacy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Formulation of Photosensitizers</h3><div class="NLM_p last">PS–Erlotinib conjugates were insoluble in water and were formulated in 1% Tween80/5% dextrose solution. The concentration of the PS in the formulation was determined by using the Beer–Lambert equation, which states that there is a linear relationship between the concentration and absorbance of the solution.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Comparative Uptake and PDT Efficacy of HPPH with PS–Erlotinib Conjugates <b>10</b>, <b>11</b>, and <b>19</b> by UMUC3 Bladder Tumor</h3><div class="NLM_p">All PSs were initially evaluated for tumor uptake at variable time points at a dose of 0.47 μmole per kg bodyweight, a dose selected previously for HPPH to treat a variety of tumor types in animal models. Interestingly, compared to HPPH (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>F), which showed the highest uptake at 24 h post injection, PS <b>10</b> had maximal tumor accumulation at 6 h post injection (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A), which was half as that of HPPH at the same time point. As expected, PS <b>10</b> uptake by all organs was progressively reduced at lower doses, 0.25 and 0.125 μmole/kg, respectively (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B,C). In contrast, PS <b>11</b>, which is like HPPH bearing a carboxylic (−COOH) functionality at position 17<sup>2</sup> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>D) and PS <b>19</b> (achiral at position 3(1′)(<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>E), had significantly lower tumor uptake at all time points than <b>10</b>. In addition, compared to HPPH, the liver and skin uptake of PS <b>19</b> was higher at initial timepoints but cleared from the system significantly with time. Interestingly, the erlotinib conjugate <b>10</b> showed significantly improved long-term tumor control (74%, 17/23 mice were tumor free on day 60) than HPPH (30%, 3/10 mice were tumor free on day 30, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>G). At the reduced dose of 0.25 μmole/kg, PS <b>10</b> still yielded a long-term tumor cure significant (50%, 5/10 mice were tumor-free on day 60). HPPH at a dose of 0.47 μmole/kg. PS <b>19</b> at a dose of 0.47 μmole/kg and same light treatment parameters did not show any long-term tumor response (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>G). The promising antitumor activity of PS <b>10</b><i>in vivo</i> prompted us to compare its tumor uptake and PDT efficacy with HPPH in the FaDu head and neck cancer model.</div><figure id="fig7" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. <i>In vivo</i> uptake of PS <b>10</b> in tumor, liver, and skin of female SCID mice bearing UMUC3 tumor, at the doses of 0.47, 0.25, and 0.125 μmole/kg (A)–(C); <b>PS 11</b> at a dose of 0. 47 μmole/kg (D); and <b>PS 19</b> and <b>HPPH</b> at a dose of 0.47 μmol/kg (E, F). The comparative <i>in vivo</i> efficacies of <b>PS 10</b> at variable drug doses (0.47, 0.25, and 0.125 μmol/kg) and <b>PS 19</b> and <b>HPPH</b> at a dose of 0.47 μmole/kg are shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>G. All tumors were exposed with the same light dose (665 nm, 135 J/cm<sup>2</sup>, 75 mW/cm<sup>2</sup>), at the time of maximal tumor uptake of the PS. For PS-uptake study (tumor, liver, and skin), three female SCID mice bearing UMUC3 tumors were used (A)–(<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). For determining <i>in vivo</i> efficacy, the number of female SCID mice used in each study is indicated in (G). Statistical analysis; log rank (Mantel–Cox test), <i>p</i>-value:<0.0001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Comparative Uptake and PDT Efficacy of HPPH with PS <b>10</b> and <b>19</b> in Head and Neck Tumor</h3><div class="NLM_p">SCID mice bearing FaDu tumors (size: 4 to 5 mm diameter) were injected with HPPH or PS-Erlotinib conjugates <b>10</b> and <b>19</b> (PS dose: 0.47 μmol/kg), and the uptake of all the PSs was measured by fluorescence at various time points. HPPH and both erlotinib conjugates yielded the highest uptake at 24 h post injection. Unlike UMUC3 (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>), FaDu tumors after 24 h indicated a higher level of PS <b>10</b> accumulation than that of HPPH. Even at the reduced doses of 0.25 and 0.125 μmole/kg, PS <b>10</b> retained a similar biodistribution profile. In line with the results of the <i>in vitro</i> analysis (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>), PS <b>19</b> showed significantly lower uptake than PS <b>10</b> and HPPH. The PDT efficacy of PS <b>10</b> was compared to HPPH using a larger group of FaDu tumor bearing mice (25 mice: 5 mice/group/experiment). The results depicted in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>E shows that erlotinib–PS conjugate <b>10</b> at a dose of 0.47 μmol/kg is more effective (92% cure, 23/25 mice were tumor free on day 60); than HPPH (30%, 3/10 mice were tumor-free on day 60). Even at a lower dose of 0.25 μmole/kg (10 mice: 5 mice/group) PS <b>10</b> mediated a more effective PDT response than HPPH.</div><figure id="fig8" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. <i>In vivo</i> uptake of PS <b>10</b> at the dose of 0.47, 0.25, and 0.125 μmole/kg and <b>HPPH</b> in tumor, liver, and skin of female SCID mice bearing FaDu tumors (three mice/group), is shown in (A)–(D), respectively. The <i>in vivo</i> PDT efficacy (long-term tumor response) of PS <b>10</b> at variable doses: 0.47, 0.25, and 0.125 μmole/kg and <b>HPPH</b> at a dose of 0.47 μmole/kg, is shown in (E). Tumors were exposed to light (665 nm, 135 J/cm<sup>2</sup>, 75 mW/cm<sup>2</sup>) at 24 h post injection, and tumor growth was measured daily for 60 days. For the PS-uptake study (tumor, liver, and skin), three female SCID mice bearing FaDu tumors were used (A)–(D). For determining <i>in vivo</i> efficacy, the number of female SCID mice used in each study is indicated in (E). Statistical analysis; log rank (Mantel–Cox test), <i>p</i>-value:<0.0001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Impact of Positional Isomers (<b>10</b> vs <b>16</b>) in Biological Activity</h3><div class="NLM_p">As already observed in tissue culture analyses (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), changing the erlotinib moiety attachment from the meta to the para position of the 3-(1′-benzyloxy)ethyl side chain as shown for PS <b>10</b> and <b>16</b> (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>) reduces the uptake of the PS by tumor cells. This property attributed to PS was investigated my measuring PS <b>16</b> uptake by tumors, and the PDT efficacy in SCID mice bearing either UMUC3 or FaDu tumor mice was injected with PS <b>16</b> at a dose of 0.47 μmol/kg and the uptake by tumor, liver, skin was compared (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>). The maximum uptake of <b>16</b> was observed at 24 h post injection, and the PS concentration was almost 2-fold higher in FaDu than UMUC3 tumors. The ratio of PS uptake between the tumor to liver and skin were higher in mice bearing FaDu tumors than in those with UMUC3 tumors. The <i>in vivo</i> PDT efficacy is illustrated in <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>C,D and indicates a 60% long-term cure of mice bearing bladder tumors and 66% mice with FaDu tumors. Although PS <b>16</b> was appreciably taken up by both the tumor types, compare to <b>10</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a> and <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>), it was still less effective. These results suggest that the position of the erlotinib moiety at 3-(1′)-benzyloxyethyl side chain (<i>meta-</i> vs <i>para-</i>) makes a difference in directing uptake and intracellular retention resulting in a proportionally lower PDT efficacy.</div><figure id="fig9" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structure of the PS–Erlotinib conjugates in which the erlotinib moiety is attached either at <i>meta-</i> (PS <b>10</b>) or <i>para</i>-position (PS <b>16</b>) of the pyropheophorbide-a.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig10" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. <i>In vivo</i> uptake of PS <b>16</b> at a dose of 0.47μmole/kg in tumor, liver, and skin of female SCID mice bearing (A) UMUC3 and (B) FaDu tumors. The <i>in vivo</i> PDT efficacy (long-term tumor response) of PS <b>16</b> at a dose of 0.47 μmole/kg and PS <b>16</b> for UMUC 3 and FaDu tumors are shown (C) and (D), respectively. The tumors were exposed to light (665 nm, 135 J/cm<sup>2</sup>, 75 mW/cm<sup>2</sup>) at 24 h post injection of the PS. A direct correlation between the PS uptake and tumor response (cure) was observed (kg). Statistical analysis log rank (Mantel–Cox test), (C) UMUC3, <i>p</i>-value: <0.0001, and (D) FaDu tumors, <i>p</i>-value: 0.0019. For PS-uptake study (tumor, liver, and skin), three female SCID mice bearing either UMUC3 or FaDu tumors were used (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>A,B). For determining <i>in vivo</i> efficacy, the number of female SCID mice used in each study is indicated in <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>C,D.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Tumor Uptake and PDT Efficacy of Erlotinib Conjugate <b>5</b></h3><div class="NLM_p last">Among all conjugates, PS <b>5</b> showed the highest initial cellular uptake but on the expense of reduced tumor cell selectivity (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Therefore, before selecting the optimal PS–Erlotinib compound for future studies, the tumor uptake and PDT efficacy of PS <b>5</b> were also investigated in SCID mice bearing either UMUC3 or FaDu tumors (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>). In UMUC3 tumor, the maximal uptake of PS <b>5</b> was observed at 24 h post injection, whereas the maximum uptake in FaDu tumor was measured at 6 h post injection. Moreover, the PS <b>5</b> accumulation in FaDu tumors exceeded 2–3-fold than that of the liver, whereas the maximal PS <b>5</b> level in UMUC3 tumor relative to the liver was much lower and was 2–3-fold lower than that determined for FaDu tumors (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>A,B). This difference in uptake was similarly manifested in the difference in PDT efficacy (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>C,D).<figure id="fig11" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0012.jpeg" id="GRAPHIC-d7e2132-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. <i>In vivo</i> uptake of PS <b>5</b> at the dose of 0.47 mmol/kg in tumor, liver and skin of female SCID mice bearing (A) UMUC3 tumors and  (B) FaDu tumors. The in vivo PDT efficacy (long-term tumor response) of PS <b>5</b> at a dose of 0.47 μmole/kg for UMUC3 and FADU tumors is shown in  (C) and (D) respectively. The tumors were exposed to light (665 nm, 135 J/cm<sup>2</sup>, 75 mW/cm<sup>2</sup>) at 24 h post-injection of the PS. A direct correlation between the PS uptake and  tumor response (cure) was observed. For PS-uptake study (tumor, liver and skin), 3 female SCID mice bearing either UMUC3 or FaDu tumors were used (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>A,B). For determining <i>in vivo</i> efficacy, the number of female SCID mice used in each study are indicated in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>C,D. Statistical analysis log rank (Mantel−Cox test), (C): <i>p</i>-value: <0.0046 and (D): <i>p</i>-value: 0.0153.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Statistical Analysis</h3><div class="NLM_p last">The standard log-rank test (Mantel–Cox) was used for statistical analysis. It is a hypothesis test and compares the survival based on Kaplan Meier survival curve. It is a test of significance to detect difference between groups to confirm if one group has a risk of an event greater than the other. For analyzing the <i>in vivo</i> PDT/SDT efficacy (cure), the survival curves were plotted using the drug dose over tumor regrowth.</div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Ethical Approval for Using Animals</h3><div class="NLM_p last">The <i>in vivo</i> experiments discussed in this manuscript were performed in compliance with all state, local, federal laws, and the PHS Policy on the Human Care and use of Laboratory Animals. This study was conducted in an AAALAC accredited facility. The animal study was approved by the ethics committee of the institute.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10635" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10635" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A series of PSs derived from chlorophyll-a and bacteriochlorophyll-a were conjugated with the erlotinib moiety at different positions of the macrocycle. The structural difference of the PS, the presence of erlotinib at various positions, and the nature of linker joining the two moieties made a significant difference in tumor cell specificity and <i>in vitro</i> PDT efficacy. The additional key features are the presence of a chiral center at position 3(1′) and a fused five-membered ring (ring E), (c). The <i>in vivo</i> results suggest major tumor-specific differences in uptake and retention exist, and these differences can only in part be detected in tissue culture systems. This in turn implies that the <i>in vivo</i> environment affects the availability and bioactivity of the porphyrin–erlotinib compounds beyond what can be predicted from <i>ex vivo</i> SAR ad QSAR studies. The biology of the underlying processes responsible for <i>in vivo</i> fate of the compounds remains to be identified. Despite these unsolved questions, our study has allowed to identify in the example of the PS <b>10</b> most promising agent for further development.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03063" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03063" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All reactions were carried out in heat gun-dried glassware under an atmosphere of nitrogen and magnetic stirring. Thin-layer chromatography (TLC) was done on precoated silica gel sheets (layer thickness 0.2 mm). Column chromatography was performed either using silica gel 60 (70–230 mesh) or neutral alumina grade III. In some cases, preparative TLC was used for the purification of compounds. Purity of the compounds was ascertained by TLC and HPLC analyses. All compounds including the intermediates were >95% pure. UV–vis spectra were recorded on an FT UV–vis spectrophotometer using methanol as a solvent. Mass spectrometry analyses were performed at the Mass Spectrometry Facility, University of Buffalo, NY. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded at 28 °C on a Bruker Avance III HD spectrometer equipped with a 9.4T narrow-bore magnet, a 5-mm BBO Z-gradient probe, and Topspin 3.2 software. Observe frequencies were 400 MHz for <sup>1</sup>H and 100 MHz for <sup>13</sup>C. Chemical shifts are reported in parts per million (ppm) relative to tetramethylsilane (TMS) and were calibrated to the residual solvent peak. Coupling constants (<i>J</i>) are reported in Hertz (Hz). <sup>1</sup>H multiplicities are reported as follows: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, and br = broad. Compounds <b>10</b> and <b>11</b> are known compounds.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Synthesis of Conjugate (<b>5</b>)</h3><div class="NLM_p last">A mixture of erlotinib <b>1</b> (60 mg, 0.254 mmol), 4-azidobutylamine <b>2</b> (26.1 mg, 0.2286 mmol), CuSO<sub>4</sub>·5H<sub>2</sub>O (7.6 mg, 0.03 mmol), and sodium ascorbate (9 mg, 0.046 mmol) was dissolved in 8 mL of DMF, 4 mL of H<sub>2</sub>O, and 8 mL of <i>t</i>-BuOH and stirred at 40 °C under Ar for 8 h. The solvents were evaporated under reduced pressure; the residue was diluted with H<sub>2</sub>O, extracted with DCM, and dried over anhydrous sodium sulfate; and then the resulting reaction product was purified by an alumina grade III column, using 10% methanol in dichloromethane as an eluent. After evaporating the solvents, the erlotinib analogue <b>3</b> was obtained in 45% yield (77.3 mg). The erlotinib analogue <b>3</b> (47.82 mg, 0.0942 mmol) in 8 mL dichloromethane was reacted with HPPH <b>4</b> (30 mg, 0.0471 mmol) in the presence of 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC, 14.62 mg, 0.0942 mmol) and 4-(dimethylamino) pyridine (DMAP, 11.50 mg, 0.0942 mmol). The reaction mixture was stirred at room temperature under an N<sub>2</sub> atmosphere overnight. It was then diluted with dichloromethane (40 mL), washed with water (3 × 50 mL), dried over anhydrous sodium sulfate, and concentrated down to yield the crude product, which was purified by the preparative plate using 20% methanol in dichloromethane to obtain pure final product <b>5</b> with 52% yield (25.85 mg). HRMS (ESI): calcd. for C<sub>65</sub>H<sub>80</sub>N<sub>11</sub>O<sub>7</sub> (M + H<sup>+</sup>) 1126.6197; found, 1126.6199. UV–vis (CH<sub>3</sub>OH, λ<sub>max</sub>, nm (abs)): 662 (4.65 × 10<sup>4</sup>), 605 (8.77 × 10<sup>3</sup>), 539 (8.77 × 10<sup>3</sup>), 507 (8.77 × 10<sup>3</sup>), 409 (8.84 × 10<sup>3</sup>), 347 (4.78 × 10<sup>4</sup>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ ppm): 9.76/9.73 (1H, s, meso 5-H), 8.80/8.78 (1H, br s, meso 10-H), 8.67 (1H, br s, amine H), 8.66 (1H, s, pyrimidine H), 8.471/8.466 (1H, s, meso 20-H), 8.10 (1H, d, <i>J</i> = 7.0, phenyl H), 7.98 (1H, d, <i>J</i> = 7.0 Hz, phenyl H), 7.77 (1H, s, quinazoline 5-H), 7.22–7.38 (4H, m, 3 × phenyl H and quinazoline 8-H), 6.32 (1H, m, amide H), 5.90/5.87 (1H, q, <i>J</i> = 6.7 Hz, 3<sup>1</sup>-H), 5.28 (1H, d, <i>J</i> = 19.9 Hz, 13<sup>2</sup>-C<i>H</i>H), 4.98 (1H, d, <i>J</i> = 19.9 Hz, 13<sup>2</sup>-CH<i>H</i>), 4.47 (1H, dq, <i>J</i> = 7.3, 1.4 Hz, 18-H), 4.22–4.32 (5H, m, 17-H and 2 × −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 3.75–3.86 (4H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub> and > NC<i>H</i><sub>2</sub>(CH<sub>2</sub>)<sub>3</sub>NH−), 3.71 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.57–3.70 (2H, m, −OC<i>H</i><sub>2</sub>(CH<sub>2</sub>)<sub>4</sub>CH<sub>3</sub>), 3.35–3.57 (2H, m, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.45 (3H, s, −OCH<sub>3</sub>), 3.35/3.34 (3H, s, ring CH<sub>3</sub>), 3.310/3.306 (3H, s, −OCH<sub>3</sub>), 3.25/3.24 (3H, s, ring CH<sub>3</sub>), 3.02 (1H, m, >N(CH<sub>2</sub>)<sub>3</sub>C<i>H</i>HNH−), 2.89 (1H, m, >N(CH<sub>2</sub>)<sub>3</sub>CH<i>H</i>NH−), 2.77 (3H, br s, ring CH<sub>3</sub>), 2.69 (1H, m, 17-C<i>H</i>HCH<sub>2</sub>−), 2.50 (1H, m, 17-CH<i>H</i>CH<sub>2</sub>−), 2.36 (1H, m, 17-CH<sub>2</sub>C<i>H</i>H−), 2.11/2.10 (3H, d, <i>J</i> = 6.4 Hz, 3<sup>1</sup>-CH<sub>3</sub>), 2.06 (1H, m, 17-CH<sub>2</sub>CH<i>H</i>−), 1.67–1.81 (5H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>(CH<sub>2</sub>)<sub>3</sub>CH<sub>3</sub> and 18-CH<sub>3</sub>), 1.47–1.56 (5H, m, NCH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>N and 8-CH<sub>2</sub>C<i>H</i><sub>3</sub>), 1.33–1.47 (2H, m, −O(CH<sub>2</sub>)<sub>2</sub>C<i>H</i><sub>2</sub>(CH<sub>2</sub>)<sub>2</sub>CH<sub>3</sub>), 1.18–1.28 (4H, m, −O(CH<sub>2</sub>)<sub>3</sub>(C<i>H</i><sub>2</sub>)<sub>2</sub>CH<sub>3</sub>), 1.12 (2H, m, NCH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>N), 0.80/0.77 (3H, distorted t, <i>J</i> = 6.9 Hz −O(CH<sub>2</sub>)<sub>5</sub>C<i>H</i><sub>3</sub>), 0.41 (1H, br s, core NH), −1.59/–1.60 (1H, s, core NH); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>, δ ppm): 196.9, 173.03/173.01, 172.15/172.13, 160.4, 156.7, 155.5/155.4, 154.3, 153.5, 150.7, 149.0/148.9, 147.3, 147.12/147.08, 145.09/145.05, 141.6/141.5, 139.9, 139.82/139.80, 137.22/137.20, 136.09/136.06, 135.80/135.77, 132.5, 132.4, 131.1, 129.59/129.57, 129.3, 127.49/127.47, 121.6, 120.6, 119.58/119.56, 118.6, 109.6, 108.6, 105.9, 103.8/103.7, 102.9, 98.0/97.8, 92.6, 72.8, 70.8, 70.5, 69.7, 69.0, 68.4, 59.3, 59.2, 51.63/51.62, 50.0, 49.4, 48.1, 38.6, 33.04/32.98, 31.74/31.71, 30.6/30.5, 30.2, 27.2, 26.10/26.06, 25.78/25.75, 24.7/24.6, 22.94/22.93, 22.6/22.5, 19.2, 17.28/17.26, 14.0/13.9, 11.3, 11.2, 11.02/10.98. Note: Additional peaks, presumably due to grease impurity, were observed at 1.26 and 0.88 ppm in the <sup>1</sup>H spectrum and 29.7 ppm in the <sup>13</sup>C spectrum.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Synthesis of 17<sup>2</sup>-<i>m</i>-Iodo-benzylamine-3-(1′-hexyloxy)ethyl-pyropheophorbide-a (<b>7</b>)</h3><div class="NLM_p last">To a solution of <b>4</b> (50 mg, 0.0785 mmol) and 3-Iodobenzyl amine <b>6</b> (27.5 mg, 0.1178 mmol) in 10 mL of dry dichloromethane, 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride (EDCI, 30.0 mg, 0.1571 mmol) and 4-(dimethylamino)pyridine (DMAP, 19.2 mg, 0.158 mmol) were added. The reaction mixture was stirred at room temperature under an N<sub>2</sub> atmosphere for overnight. It was then diluted with dichloromethane (40 mL), washed with water (3 × 50 mL), dried over anhydrous sodium sulfate, and concentrated down to yield the crude product, which was purified by silica column by using 2% methanol in dichloromethane to obtain pure product <b>7</b> in 89% yield (59.52 mg). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ ppm): 9.82/9.81 (1H, s, meso 5-H), 9.07/9.05 (1H, s, meso 10-H), 8.53 (1H, s, meso 20-H), 7.35–7.42 (2H, m, 2 × phenyl H), 6.89 (1H, m, phenyl H), 6.79 (1H, t, <i>J</i> ∼7.7 Hz, phenyl H), 5.93/5.92 (1H, q, <i>J</i> = 6.6 Hz, 3<sup>1</sup>-H), 5.82/5.80 (1H, t, <i>J</i> = 5.9 Hz, amide H), 5.181/5.177 (1H, d, <i>J</i> = 19.7 Hz, 13<sup>2</sup>-C<i>H</i>H), 4.97/4.96 (1H, d, <i>J</i> = 19.7 Hz, 13<sup>2</sup>-CH<i>H</i>), 4.51/4.50 (1H, dq, <i>J</i> = 7.4, 1.7 Hz, 18-H), 4.30 (1H, m, 17-H), 4.10/4.09 (1H, dd, <i>J</i> = 5.7, 15.1 Hz, −NHC<i>H</i>H–phenyl−), 3.98/3.96 (1H, dd, <i>J</i> = 5.8, 15.1 Hz, −NHCH<i>H</i>–phenyl−), 3.46–3.74 (4H, m, −OC<i>H</i><sub>2</sub>(CH<sub>2</sub>)<sub>4</sub>CH<sub>3</sub> and 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.393/3.387 (3H, s, ring CH<sub>3</sub>), 3.30/3.29 (3H, s, ring CH<sub>3</sub>), 3.02/2.98 (3H, s, ring CH<sub>3</sub>), 2.63 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.45 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.25 (1H, ddd, <i>J</i> = 6.4, 9.8, 14.5 Hz, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.135/2.133 (3H, d, <i>J</i> = 6.7 Hz, 3<sup>1</sup>-CH<sub>3</sub>), 1.92 (1H, ddd, <i>J</i> = 5.1, 9.8, 14.5 Hz, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 1.788/1.785 (3H, d, <i>J</i> = 7.3 Hz, 18-CH<sub>3</sub>), 1.77 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>(CH<sub>2</sub>)<sub>3</sub>CH<sub>3</sub>), 1.61/1.60 (3H, t, <i>J</i> = 7.6 Hz, 8-CH<sub>2</sub>C<i>H</i><sub>3</sub>), 1.31–1.51 (2H, m, −O(CH<sub>2</sub>)<sub>2</sub>C<i>H</i><sub>2</sub>(CH<sub>2</sub>)<sub>2</sub>CH<sub>3</sub>), 1.19–1.32 (4H, m, −O(CH<sub>2</sub>)<sub>3</sub>(C<i>H</i><sub>2</sub>)<sub>2</sub>CH<sub>3</sub>), 0.82/0.80 (3H, distorted t, <i>J</i> ∼7.0 Hz, −O(CH<sub>2</sub>)<sub>5</sub>C<i>H</i><sub>3</sub>), 0.44 (1H, br s, core NH), −1.63 (1H, s, core NH); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>, δ ppm): 196.2, 172.22/172.20, 171.9/171.8, 160.18/160.16, 155.30/155.29, 150.7, 148.9, 145.04/145.03, 141.5/141.4, 140.52/140.51, 139.79/139.76, 137.5/137.4, 136.45/136.43, 136.24/136.23, 136.17/136.16, 135.7/135.6, 132.4/132.3, 130.1, 130.00/129.98, 127.9/127.8, 126.78/126.77, 105.94/105.93, 103.91/103.90, 98.03/97.96, 94.3, 92.5, 72.83/72.81, 69.7, 51.59/51.57, 50.0, 48.0, 42.6/42.5, 32.7, 31.74/31.72, 30.4, 30.2, 26.09/26.06, 24.72/24.66, 23.0, 22.58/22.55, 19.3, 17.35/17.33, 13.98/13.95, 11.51/11.48, 11.3, 11.04/11.03. Note: <sup>1</sup>H impurity peaks were observed at 0.91 ppm (probably grease CH<sub>3</sub>). Further <sup>1</sup>H impurity peaks (probably grease CH<sub>2</sub>) interfere with the hexyl group methylene protons observed at ∼1.25 ppm.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Synthesis of Conjugate (<b>8</b>)</h3><div class="NLM_p last">Triphenylarsine (8.62 mg, 0.0281 mmol) and Pd<sub>2</sub>dba<sub>3</sub> (12.89 mg, 0.014 mmol) were added to a stirred solution of compound <b>7</b> (30 mg, 0.0352 mmol) and erlotinib <b>1</b> (20.78 mg, 0.0528 mmol) in dry THF (20 mL) and Et<sub>3</sub>N (4 mL). The reaction mixture was stirred at room temperature under an argon atmosphere overnight. As per TLC, only 3/4 amount of starting material reacted to produce the desired product <b>8</b>. The remaining 1/4 of <b>7</b> remain unreacted even by increasing the catalyst quantity, temperature, and duration of the reaction. The desired conjugate <b>8</b> and remaining starting material <b>7</b> were purified by preparative TLC plates. Based on the starting material <b>7</b> recovered, the desired erlotinib conjugate <b>8</b> was isolated in 75% yield (29.51 mg). MS (ESI) <i>m</i>/<i>z</i>: 1117.58 (M + H<sup>+</sup>). HRMS (ESI): calcd. for C<sub>68</sub>H<sub>77</sub>N<sub>8</sub>O<sub>7</sub> (M + H<sup>+</sup>) 1117.5871; found, 1117.5897. UV–vis (CH<sub>3</sub>OH, λ<sub>max</sub>, nm (abs)): 662 (4.58 × 10<sup>4</sup>), 606 (8.84 × 10<sup>3</sup>), 538 (9.02 × 10<sup>3</sup>), 507 (8.66 × 10<sup>3</sup>), 409 (8.52 × 10<sup>4</sup>), 346 (5.06 × 10<sup>4</sup>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ ppm): 9.79/9.76 (1H, s, meso 5-H), 8.97/8.95 (1H, s, meso 10-H), ∼8.95 (1H, br s, amine NH), 8.68 (1H, s, pyrimidine H), 8.49 (1H, s, meso 20-H), 8.214/8.212 (1H, d, <i>J</i> = 8.1 Hz, phenyl H), 7.853/7.850 (1H, s, quinazoline 5-H), 7.64 (1H, m, phenyl H), 7.42 (1H, br s, phenyl H), 7.32 (1H, dd, <i>J</i> ∼8.0, 8.0 Hz, phenyl H), 7.303/7.301 (1H, d, <i>J</i> ∼7.5 Hz, phenyl H), 7.20–7.24 (2H, m, quinazoline 8-H and phenyl H), 7.17 (1H, br s, amide H), 7.02 (1H, ddd, <i>J</i> = 1.6, 7.6, 7.6 Hz, phenyl H), 6.91 (1H, d, <i>J</i> = 7.4 Hz, phenyl H), 5.91/5.90 (1H, q, <i>J</i> = 6.8 Hz, 3<sup>1</sup>-H), 5.07 (1H, d, <i>J</i> = 19.8, 13<sup>2</sup>-C<i>H</i>H), 4.53 (1H, d, <i>J</i> ∼19.6 Hz, 13<sup>2</sup>-CH<i>H</i>), 4.50 (1H, m, 18-H), 4.40 (1H, dd, <i>J</i> = 6.3, 14.8 Hz, −NHC<i>H</i>H–phenyl), 4.16–4.29 (5H, m, 17-H and 2 × −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 3.99 (1H, m, −NHCH<i>H</i>–phenyl), 3.81 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.67 (2H, m, −OC<i>H</i><sub>2</sub>(CH<sub>2</sub>)<sub>4</sub>CH<sub>3</sub>), 3.62 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.59 (m, 2H, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.44 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.372/3.365 (3H, s, ring CH<sub>3</sub>), 3.29 (3H, s, ring CH<sub>3</sub>), 3.234/3.232 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 2.82 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.67 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.30 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.29/2.26 (3H, s, ring CH<sub>3</sub>), 2.13/2.12 (3H, d, <i>J</i> = 6.7 Hz, 3<sup>1</sup>-CH<sub>3</sub>), 2.04 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 1.77 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>(CH<sub>2</sub>)<sub>3</sub>CH<sub>3</sub>), 1.75/1.74 (3H, d, <i>J</i> = 7.3 Hz, 18-CH<sub>3</sub>), 1.63/1.62 (3H, t, <i>J</i> = 7.6 Hz, 8-CH<sub>2</sub>C<i>H</i><sub>3</sub>), 1.43 (2H, m, −O(CH<sub>2</sub>)<sub>2</sub>C<i>H</i><sub>2</sub>(CH<sub>2</sub>)<sub>2</sub>CH<sub>3</sub>), 1.18–1.32 (4H, m, −O(CH<sub>2</sub>)<sub>3</sub>(C<i>H</i><sub>2</sub>)<sub>2</sub>CH<sub>3</sub>), 0.82/0.79 (3H, distorted t, <i>J</i> ∼7.1 Hz, −O(CH<sub>2</sub>)<sub>5</sub>C<i>H</i><sub>3</sub>), 0.62 (1H, br s, core NH), −1.48/–1.49 (1H, s, core NH); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>, δ ppm): 196.8, 172.93/172.92, 172.20/172.19, 160.09/160.07, 156.7, 155.68/155.67, 154.4, 153.6, 150.9, 149.1, 148.9, 147.4, 145.09/145.08, 141.8/141.7, 139.94/139.92, 139.4, 138.5, 137.5, 136.28/136.27, 136.0/135.9, 132.6/132.5, 130.7, 130.6, 129.49/129.48, 129.0, 128.5, 127.78, 127.76, 126.9, 124.3, 123.7, 123.5, 122.1, 109.7, 108.6, 105.8, 104.0, 103.0, 98.05/97.97, 92.5, 89.6, 89.0, 72.83/72.80, 70.7, 70.5, 69.7, 69.0, 68.3, 59.3, 59.1, 51.5, 49.8, 47.8, 43.2, 32.71/32.69, 31.75/31.73, 30.9, 30.2, 26.09/26.07, 24.71/24.66, 22.92/22.91, 22.59/22.56, 19.4, 17.41/17.40, 13.98/13.95, 11.3, 11.2/11.1, 11.02/11.00. Note: Minor <sup>1</sup>H impurity peaks appear at 7.65, 7.50, and 7.45 ppm. An additional <sup>13</sup>C peak, presumably due to grease impurity, was observed at 29.7 ppm.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Synthesis of Conjugate (<b>13</b>)</h3><div class="NLM_p last">Triphenylarsine (18.72 mg, 0.0611 mmol) and Pd<sub>2</sub>dba<sub>3</sub> (28.00 mg, 0.0305 mmol) were added to a stirred solution of compound <b>12</b> (60 mg, 0.07643 mmol) and erlotinib <b>1</b> (45.10 mg, 0.1146 mmol) in dry THF (30 mL) and Et<sub>3</sub>N (6 mL). The reaction mixture was stirred at room temperature under an argon atmosphere overnight. As per TLC, only 3/4 amount of starting material reacted to produce the desired product <b>13</b>. The remaining 1/4 unreacted <b>12</b> evens by increasing the catalyst quantity, temperature, and duration of the reaction. The product <b>13</b> and remaining starting material <b>12</b> were purified by preparative TLC plates. On the basis of the compound <b>12</b> recovered, the title compound <b>13</b> was obtained in 72% yield (57.79 mg). MS (ESI) <i>m</i>/<i>z</i>: 1050.50 (M + H<sup>+</sup>). HRMS (ESI): calcd. for C<sub>63</sub>H<sub>68</sub>N<sub>7</sub>O<sub>8</sub> (M + H<sup>+</sup>) 1050.5051; found, 1050.5049. UV–vis (CH<sub>3</sub>OH, λ<sub>max</sub>, nm (abs)): 714 (4.15 × 10<sup>4</sup>), 652 (1.74 × 10<sup>4</sup>), 517 (3.1 × 10<sup>4</sup>), 350 (1.4 × 10<sup>5</sup>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ ppm): 8.69/8.68 (1H, s, pyrimidine H), 8.55/8.47 (1H, s, meso 5-H), 8.19 (1H, s, meso 10-H), 8.03/8.02 (1H, s, meso 20-H), 7.94 (1H, m, phenyl H), 7.70 (1H, m, phenyl H), 7.68/7.67 (1H, br s, erlotinib NH), 7.50 (1H, m, phenyl H), 7.42 (1H, m, phenyl H), 7.35/7.34 (1H, s, phenyl H), 7.313/7.309 (1H, dd, <i>J</i> = 8.0, 8.0 Hz, phenyl H), 7.23–7.27 (3H, m, quinazoline 5-H, quinazoline 8-H and phenyl H), 7.20/7.19 (1H, ddd, <i>J</i> ∼7.7, 1.2, 1.2 Hz phenyl H), 5.72 (1H, q, <i>J</i> = 6.7 Hz, 3<sup>1</sup>-H), 4.96 (1H, d, <i>J</i> = 19.8 Hz, 13<sup>2</sup>-C<i>H</i>H), 4.79 (1H, d, <i>J</i> = 19.8 Hz, 13<sup>2</sup>-CH<i>H</i>), 4.67/4.64 (1H, d, <i>J</i> ∼12 Hz, −OC<i>H</i>H–phenyl−), 4.55/4.52 (1H, d, <i>J</i> = 12.2 Hz, −OCH<i>H</i>–phenyl−), 4.23–4.30 (4H, m, 2 × −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 4.14 (1H, q, <i>J</i> = 7.2 Hz, 18-H), 4.08 (1H, dq, <i>J</i> = 7.2, 3.1 Hz, 7-H), 3.98 (1H, m, 17-H), 3.81–3.89 (3H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub> and 8-H), 3.79 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.610/3.608 (3H, s, −COOCH<sub>3</sub>), 3.45 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.421/3.418 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.33 (3H, s, ring CH<sub>3</sub>), 3.15/3.14 (3H, s, ring CH<sub>3</sub>), 2.42–2.60 (2H, m, 17-C<i>H</i>HC<i>H</i>H−), 2.15–2.33 (3H, m, 8-C<i>H</i>HCH<sub>3</sub> and 17-CH<i>H</i>CH<i>H</i>−), 2.05/2.03 (3H, d, <i>J</i> = 6.7 Hz, 3<sup>1</sup>-CH<sub>3</sub>), ∼2.02 (1H, m, 8-CH<i>H</i>CH<sub>3</sub>), 1.74/∼1.67 (3H, d, <i>J</i> = 7.3 Hz, 7-CH<sub>3</sub>), ∼1.68/1.66 (3H, d, <i>J</i> = 7.3 Hz, 18-CH<sub>3</sub>), 1.38/1.37 (1H, s, core NH), 1.09/1.07 (3H, t, <i>J</i> ∼7.6 Hz, 8-CH<sub>2</sub>C<i>H</i><sub>3</sub>), −0.13/–0.14 (1H, s, core NH); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>, δ ppm): 195.6, 173.60/173.57, 171.1/171.0, 170.34/170.32, 161.53/161.51, 156.3, 155.2, 154.9, 153.3, 149.1, 147.92/147.90, 141.0/140.9, 138.71/138.69, 138.66/138.65, 138.61/138.56, 137.38/137.37, 136.3/136.2, 133.75/133.72, 131.2/131.1, 131.0/130.9, 129.0, 128.84/128.82, 128.5/128.4, 128.0/127.9, 127.4, 124.4, 124.0, 123.4/123.3, 121.7, 118.11/118.07, 109.0, 108.7, 108.5, 102.7, 99.24/99.22, 95.2/94.9, 93.82/93.77, 89.5, 89.24/89.20, 71.8/71.2, 71.0, 70.7/70.46, 70.49, 69.5, 68.4, 59.4, 59.3, 54.33/54.27, 51.67/51.66, 50.45/50.43, 49.9, 49.11/49.07, 47.4, 30.83/30.82, 30.2/30.1, 29.91/29.90, 24.1/23.9, 22.7/22.53, 22.53/22.52, 11.3, 10.9/10.83, 10.81/10.7. Note: Minor <sup>1</sup>H impurity peaks were observed at 7.77, 3.44, 3.43, 1.25 (likely grease CH<sub>2</sub>), and 0.88 (likely grease CH<sub>3</sub>) ppm. One <sup>13</sup>C signal is missing, presumably due to aggregation-induced line broadening. <sup>13</sup>C impurity peaks were observed at 131.7 and 128.3 ppm.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Synthesis of Conjugate (<b>14</b>, Carboxylic Analogue of <b>13</b>)</h3><div class="NLM_p last">Aqueous LiOH (36.02 mg in 3 mL of H<sub>2</sub>O) was added to a solution of compound <b>13</b> (30 mg) in dry THF/MeOH (4.5:3 mL), and the reaction mixture was stirred under argon at room temperature for 3 h. The reaction mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> (50 mL) and washed with 2% AcOH in H<sub>2</sub>O (18 mL) and then H<sub>2</sub>O (3 × 50 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated, and purified over a preparative TLC plate using 8% MeOH in CH<sub>2</sub>Cl<sub>2</sub> as an eluent to yield 26.93 mg (93%) of the desired product <b>14</b>. MS (ESI) <i>m</i>/<i>z</i>: 1034.48 (M + H<sup>+</sup>). HRMS (ESI): calcd. for C<sub>62</sub>H<sub>64</sub>N<sub>7</sub>O<sub>8</sub> (M + H<sup>+</sup>) 1034.4814; found, 1034.4821. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ ppm): 8.54/8.28 (1H, s, meso 5-H), 8.33/8.23 (1H, s, pyrimidine H), 8.10/8.08 (1H, s, meso 10-H), 8.00/7.96 (1H, s, meso 20-H), 7.79/7.73 (1H, s, phenyl H), 7.51 (1H, d, <i>J</i> ∼7 Hz, phenyl H), 7.27–7.39 (3H, m, 2 × phenyl H and quinazoline 5-H), 7.05–7.25 (4H, m, 3 × phenyl H and quinazoline 8-H), 7.00 (1H, m, phenyl H), 5.72/5.58 (1H, q, <i>J</i> = 6.7 Hz, 3<sup>1</sup>-H), 4.95 (1H, d, <i>J</i> = 19.7 Hz, 13<sup>2</sup>-C<i>H</i>H), 4.75 (1H, d, <i>J</i> = 19.7 Hz, 13<sup>2</sup>-CH<i>H</i>), 4.63/4.55 (1H, d, <i>J</i> = 12.2 Hz, −OC<i>H</i>H–phenyl−), 4.52/4.47 (1H, d, <i>J</i> = 12.2 Hz, −OCH<i>H</i>–phenyl−), 4.10–4.25 (5H, m, 2 × −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub> and 18-H), 4.06 (1H, m, 7-H), 3.97 (1H, d, <i>J</i> ∼7 Hz, 17-H), 3.72–3.83 (3H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub> and 8-H), 3.70 (2H, br s, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.40 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.34 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.23/3.22 (3H, s, ring CH<sub>3</sub>), 3.12/2.97 (3H, s, ring CH<sub>3</sub>), 2.40–2.55 (2H, m, 17-C<i>H</i>HC<i>H</i>H−), 2.15–2.34 (3H, m, 8-C<i>H</i>HCH<sub>3</sub> and 17-CH<i>H</i>CH<i>H</i>−), 2.01/1.99 (3H, d, <i>J</i> = 6.7 Hz, 3<sup>1</sup>-CH<sub>3</sub>), 1.98 (1H, m, 8-CH<i>H</i>CH<sub>3</sub>), 1.71/1.66 (3H, d, <i>J</i> = 7.2 Hz, 7-CH<sub>3</sub>), 1.632/1.628 (3H, d, <i>J</i> = 7.2 Hz, 18-CH<sub>3</sub>), 1.43/1.35 (1H, s, core NH), 1.07/1.05 (3H, t, <i>J</i> = 7.2 Hz, 8-CH<sub>2</sub>C<i>H</i><sub>3</sub>), −0.07/–0.13 (1H, br s, core NH); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>, δ ppm): 195.88/195.87, 176.84/176.75, 171.1/170.9, 170.8/170.7, 161.5/161.4, 156.5/156.4, 155.6/155.4, 154.9, 152.2/152.0, 148.9, 148.04/148.03, 145.2, 141.1/141.0, 139.0/138.6, 138.61/138.60, 138.29/138.27, 137.31/137.28, 136.3/136.2, 133.9, 131.6/131.5, 130.76/130.73, 128.72/128.71, 128.62/128.59, 128.41/128.38, 128.1/128.0, 127.34/127.28, 124.8/124.7, 123.7, 123.1/123.0, 121.81/121.76, 117.9/117.7, 108.7, 108.6/108.5, 107.0/106.7, 103.11/103.10, 99.02/98.99, 95.4/94.2, 94.0/93.9, 89.29/89.26, 89.22/89.16, 71.43/70.73, 70.80/70.49, 70.77, 70.4, 69.1/69.0, 68.4, 59.19, 59.17, 54.3/54.2, 50.6, 49.92/49.87, 49.1, 47.4, 31.5, 30.12/30.07, 30.0, 23.9/23.7, 22.64/22.50, 22.46/22.40, 11.2/11.1, 11.0/10.6, 10.88/10.86. Note: Two protons (one acid and one NH of erlotinib) are missing, presumably due to chemical exchange. Additional peaks, presumably due to grease impurity, were observed at 1.26 ppm in the <sup>1</sup>H spectrum and 29.7 ppm in the <sup>13</sup>C spectrum.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Synthesis of Conjugate (<b>16</b>)</h3><div class="NLM_p last">Triphenylarsine (25 mg, 0.082 mmol) and Pd<sub>2</sub>dba<sub>3</sub> (37.5 mg, 0.041 mmol) were added to a stirred solution of <b>15</b> (80 mg, 0.103) and erlotinib <b>1</b> (60.3 mg, 0.153) in dry THF (20 mL) and Et<sub>3</sub>N (4 mL). The reaction mixture was stirred at room temperature under an argon atmosphere overnight. As per TLC, only 3/4 amount of starting material reacted to produce the desired product. The product <b>16</b> and starting material <b>15</b> were purified by preparative TLC plates. On the basis of the starting material recovered, the title compound <b>15</b> was obtained in 75% yield (80.35 mg). MS (ESI) <i>m</i>/<i>z</i>: 1048.49 (M + H<sup>+</sup>). HRMS (ESI): calcd. for C<sub>63</sub>H<sub>66</sub>N<sub>7</sub>O<sub>8</sub> (M + H<sup>+</sup>) 1048.4928; found, 1048.4957. UV–vis (CH<sub>3</sub>OH, λ<sub>max</sub>, nm (ε)): 661 (4.66 × 10<sup>4</sup>), 606 (8.44 × 10<sup>3</sup>), 537 (9.2 × 10<sup>3</sup>), 506 (8.89 × 10<sup>3</sup>), 407 (8.97 × 10<sup>4</sup>), 334 (1.11 × 10<sup>5</sup>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ ppm): 9.75 (1H, s, meso 5-H), 9.52 (1H, s, meso 10-H), 8.70 (1H, s, pyrimidine H), 8.55 (1H, s, meso 20-H), 7.93 (1H, m, phenyl H), 7.74 (1H, d, <i>J</i> = 8.1 Hz phenyl H), ∼7.46 (1H, br s, erlotinib NH), 7.46 (2H, m, 2 × phenyl H), 7.37 (1H, dd, <i>J</i> ∼7.9, 7.9 Hz, phenyl H), 7.27–7.34 (4H, m, 3 × phenyl H and 1 × quinazoline 5-H), 7.25 (1H, s, quinazoline 8-H), 5.99 (1H, q, <i>J</i> = 6.7 Hz, 3<sup>1</sup>-H), 5.267/5.265 (1H, d, <i>J</i> = 19.9, 13<sup>2</sup>-C<i>H</i>H), 5.117/5.116 (1H, d, <i>J</i> ∼19.8 Hz, 13<sup>2</sup>-CH<i>H</i>), 4.75 (1H, d, <i>J</i> = 12.2 Hz, −OC<i>H</i>H–phenyl−), 4.61/4.60 (1H, d, <i>J</i> = 12.2 Hz, −OCH<i>H</i>–phenyl−), 4.49 (1H, qd, <i>J</i> = 7.3, 1.8 Hz, 18-H), 4.25–4.33 (5H, m, 2 × −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub> and 17-H), 3.84 (4H, m, 2 × −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.70 (2H, q, <i>J</i> = 7.7 Hz, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.67 (3H, s, ring CH<sub>3</sub>), 3.610/3.607 (3H, s, −COOCH<sub>3</sub>), 3.47 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.46 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.363/3.359 (3H, s, ring CH<sub>3</sub>), 3.20/3.19 (3H, s, ring CH<sub>3</sub>), 2.69 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.56 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.21–2.40 (2H, m, 2H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.17/2.16 (3H, d, <i>J</i> = 6.7 Hz, 3<sup>1</sup>-CH<sub>3</sub>), 1.83/1.82 (3H, d, <i>J</i> = 7.3 Hz, 18-CH<sub>3</sub>), 1.71 (3H, t, <i>J</i> = 7.7 Hz, 8-CH<sub>2</sub>C<i>H</i><sub>3</sub>), 0.43 (1H, br s, core NH), −1.71 (1H, s, core NH); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>, δ ppm): 196.3, 173.5, 171.4, 160.33/160.31, 156.3, 155.2, 154.7, 153.6, 151.0, 149.03, 148.99, 147.6, 145.0, 141.24/141.21, 138.9, 138.67/138.66, 138.61/138.59, 137.9, 136.4, 135.5/135.4, 132.73/132.67, 131.6 (2C), 130.5, 129.1, 128.4, 127.9 (2C), 127.3, 124.4, 124.0, 122.4, 121.7, 109.2, 108.9, 106.0, 104.2, 102.6, 97.9, 92.7, 89.5, 89.2, 71.8, 71.0, 70.7, 70.5, 69.4, 68.4, 59.34, 59.28, 51.7 (2C), 50.0, 48.1, 30.9, 29.9, 24.54/24.51, 23.2/23.1, 19.5, 17.4, 12.1, 11.2, 11.11/11.10. Note: The <sup>13</sup>C peak at 51.7 ppm is due to two overlapped signals (C17 and ester CH<sub>3</sub>). <sup>1</sup>H impurity peaks were observed at 1.27 (likely grease CH<sub>2</sub>), 0.89 (likely grease CH<sub>3</sub>), and 0.09 ppm (minor). Small <sup>13</sup>C impurity peaks were observed at 29.4, 22.7, 14.1 (probably grease CH<sub>3</sub>), and 1.0 ppm. A somewhat larger <sup>13</sup>C impurity peak, presumably CH<sub>2</sub> of grease, was observed at 29.7 ppm.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Synthesis of Conjugate (<b>17</b>, Carboxylic Acid Analogue of <b>16</b>)</h3><div class="NLM_p last">Aqueous LiOH (36.02 mg in 3 mL of H<sub>2</sub>O) was added to a solution of compound <b>8</b> (30 mg) in dry THF/MeOH (4.5:3 mL), and the reaction mixture was stirred under argon at room temperature for 3 h. It was then diluted with CH<sub>2</sub>Cl<sub>2</sub> (50 mL) and washed with 2% AcOH in H<sub>2</sub>O (18 mL) and with H<sub>2</sub>O (3 × 50 mL), and the organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated, and purified over a preparative TLC plate using 8% MeOH in CH<sub>2</sub>Cl<sub>2</sub> as an eluent to yield 26.93 mg (93%) of product <b>9</b>. MS (ESI) <i>m</i>/<i>z</i>: 1034.48 (M + H<sup>+</sup>). HRMS (ESI): calcd. for C<sub>62</sub>H<sub>64</sub>N<sub>7</sub>O<sub>8</sub> (M + H<sup>+</sup>) 1034.4814; found, 1034.4821. UV–vis (CH<sub>3</sub>OH, λmax, nm (ε)): 662 (4.66 × 10<sup>4</sup>), 604 (8.4 × 10<sup>3</sup>), 536 (8.89 × 10<sup>3</sup>), 505 (8.89 × 10<sup>3</sup>), 407 (8.9 × 10<sup>4</sup>). <sup>1</sup>H NMR (400 MHz, 90:10 CDCl<sub>3</sub>/CD<sub>3</sub>OD, δ ppm): 9.54 (1H, s, meso 5-H), 9.36 (1H, s, meso 10-H), 8.403/8.402 (1H, s, meso 20-H), 8.36 (1H, s, pyrimidine H), 7.76 (1H, m, phenyl H), 7.532/7.527 (1H, dd, <i>J</i> = 7.9, 1.3 Hz, phenyl H), 7.51 (1H, s, quinazoline 5-H), 7.34 (2H, m, 2 × phenyl H), 7.24 (1H, dd, <i>J</i> ∼7.9, 7.9 Hz, phenyl H), 7.15–7.21 (3H, m, 3 × phenyl H), 7.04 (1H, s, quinazoline 8-H), 5.851/5.849 (1H, q, <i>J</i> = 6.7 Hz, 3<sup>1</sup>-H), 5.13/5.12 (1H, d, <i>J</i> = 20.0, 13<sup>2</sup>-C<i>H</i>H), 4.96 (1H, d, <i>J</i> = 20.0 Hz, 13<sup>2</sup>-CH<i>H</i>), 4.62 (1H, d, <i>J</i> = 12.1 Hz, −OC<i>H</i>H–phenyl−), 4.50/4.49 (1H, d, <i>J</i> = 12.1 Hz, −OCH<i>H</i>–phenyl−), 4.35 (1H, qd, <i>J</i> = 7.3, 1.8 Hz, 18-H), 4.12–4.19 (5H, m, 2 × −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub> and 17-H), 3.73 (4H, m, 2 × −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.54 (2H, q, <i>J</i> = 7.6 Hz, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.50 (3H, s, ring CH<sub>3</sub>), 3.36 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.34 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.21/3.20 (3H, s, ring CH<sub>3</sub>), 3.024/3.018 (3H, s, ring CH<sub>3</sub>), 2.54 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.44 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.04–2.20 (2H, m, 2H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.02/2.01 (3H, d, <i>J</i> = 6.7 Hz, 3<sup>1</sup>-CH<sub>3</sub>), 1.67/1.66 (3H, d, <i>J</i> = 7.3 Hz, 18-CH<sub>3</sub>), 1.55 (3H, t, <i>J</i> = 7.6 Hz, 8-CH<sub>2</sub>C<i>H</i><sub>3</sub>); <sup>13</sup>C NMR (100 MHz, 90:10 CDCl<sub>3</sub>/CD<sub>3</sub>OD, δ ppm): 197.2, 175.5, 171.9, 160.6, 157.0, 155.4, 154.5, 152.7, 150.8, 148.9, 148.7, 146.2, 145.0, 141.2, 138.7, 138.4/138.3, 138.31/138.29, 137.3, 136.2, 135.4/135.3, 132.93/132.87, 131.4 (2C), 129.6, 128.6, 128.1, 127.8 (2C), 127.3, 125.3, 123.5, 122.5, 122.3, 109.3, 107.2, 105.5, 104.0, 103.4, 97.5/97.4, 92.7, 89.1, 89.0, 71.6, 70.6, 70.5, 70.3, 68.6, 68.1, 58.9, 58.8, 51.4, 49.9, 47.7, 30.8, 29.8, 24.03/23.99, 22.71/22.68, 19.1, 17.0, 11.5, 10.8, 10.67/10.65. Note: One acid and three NH protons were not observed, presumably due to chemical exchange. <sup>1</sup>H impurity peaks at 1.10 (likely grease CH<sub>2</sub>), 0.75 (likely grease CH<sub>3</sub>), and −0.08 ppm were observed. <sup>13</sup>C peaks at 131.4 and 127.8 ppm are each composed of two aromatic CH signals of the benzyl group. Low-intensity <sup>13</sup>C impurity peaks were observed at 31.6, 22.3, and 0.6 ppm. A somewhat larger <sup>13</sup>C impurity peak, presumably CH<sub>2</sub> of grease, was observed at 29.4 ppm.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Synthesis of Conjugate (<b>19</b>)</h3><div class="NLM_p last">Tryphenylarsine (6.37 mg, 0.0208 mmol) and Pd<sub>2</sub>dba<sub>3</sub> (28.06 mg, 0.0104 mmol) were added to a stirred solution of compound <b>18</b> (20 mg, 0.0260 mmol) and erlotinib <b>1</b> (15.35 mg, 0.0390 mmol) in dry THF (15 mL) and Et<sub>3</sub>N (2 mL). The reaction mixture was stirred at room temperature under an argon atmosphere overnight. As per TLC, only 3/43/4 amount of starting material reacted to produce the desired product. The remaining 1/4 unreacted evens by increasing the catalyst quantity, temperature, and duration of the reaction. The desired product <b>19</b> was purified by preparative TLC plates with 73% yield (19.64 mg). HRMS (ESI): calcd. for C<sub>62</sub>H<sub>64</sub>N<sub>7</sub>O<sub>8</sub> (M + H<sup>+</sup>) 1034.4772; found, 1034.4795. UV–vis (CH<sub>3</sub>OH, λ<sub>max</sub>, nm (abs)): 664 (4.6 × 10<sup>4</sup>), 606 (8.7 × 10<sup>3</sup>), 537 (9.1 × 10<sup>3</sup>), 507 (9.1 × 10<sup>3</sup>), 410 (8.8 × 10<sup>4</sup>), 347 (5.8 × 10<sup>4</sup>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ ppm): 9.45 (1H, s, meso10-H), 9.41 (1H, s, meso 5-H), 8.64 (1H, s, pyrimidine H), 8.55 (1H, s, meso 20-H), 7.75 (1H, m, phenyl H), 7.73 (1H, m, phenyl H), 7.66 (1H, s, phenyl H), 7.51 (1H, ddd, <i>J</i> = 7.5, ∼1.5, ∼1.5 Hz, phenyl H), 7.44 (1H, ddd, <i>J</i> = 7.5, ∼1.5, ∼1.5 Hz, phenyl H), 7.38 (1H, dd, <i>J</i> ∼7.5, ∼7.5 Hz, phenyl H), 7.33 (1H, dd, <i>J</i> ∼7.9, ∼7.9 Hz, phenyl H), 7.24 (1H, s, quinazoline 8-H), 7.21 (1H, ddd, <i>J</i> = 7.6, ∼1.3, ∼1.3 Hz, phenyl H), ∼7.20 (1H, br s, erlotinib NH), 7.05 (1H, s, quinazoline 5-H), 5.73 (2H, s, 3-C<i>H</i><sub>2</sub>O−), 5.26 (1H, d, <i>J</i> = 19.8 Hz, 13<sup>2</sup>-C<i>H</i>H), 5.11 (1H, d, <i>J</i> = 19.8 Hz, 13<sup>2</sup>-CH<i>H</i>), 4.83 (2H, s, −OC<i>H</i><sub>2</sub>–phenyl−), 4.48 (1H, qd, <i>J</i> = 7.3, 2.0 Hz, 18-H), 4.26–4.32 (3H, m, 17-H and −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 4.12 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 3.86 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.72 (2H, t, <i>J</i> = 4.7 Hz −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.61 (2H, q, <i>J</i> = 7.6 Hz, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.610 (3H, s, ring CH<sub>3</sub>), 3.608 (3H, s, −COOCH<sub>3</sub>), 3.48 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.41 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.36 (3H, s, ring CH<sub>3</sub>), 3.20 (3H, s, ring CH<sub>3</sub>), 2.70 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.56 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.24–2.36 (2H, m, 2H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 1.81 (3H, d, <i>J</i> = 7.3 Hz, 18-CH<sub>3</sub>), 1.63 (3H, t, <i>J</i> = 7.6 Hz, 8-CH<sub>2</sub>C<i>H</i><sub>3</sub>), 0.35 (1H, br s, core NH), −1.76 (1H, s, core NH); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>, δ ppm): 196.2, 173.5, 171.3, 160.3, 156.1, 155.2, 154.8, 153.4, 151.0, 149.0, 148.9, 145.0, 141.1, 138.7, 138.6, 137.9, 136.6, 136.3, 134.7, 133.9, 131.2, 131.0, 130.6, 129.0, 128.6, 128.4, 127.9, 127.2, 124.3, 123.9, 123.5, 121.5, 109.0, 108.7, 106.2, 104.0, 102.4, 97.2, 93.1, 89.5, 89.4, 71.8, 70.9, 70.5, 69.3, 68.4, 63.2, 59.3 (2C), 51.74, 51.68, 50.0, 48.1, 31.0, 29.9, 23.1, 19.4, 17.3, 12.0, 11.3 (2C). Note: <sup>1</sup>H impurity peaks at 1.27 and 0.88 ppm are likely due to grease CH<sub>2</sub> and CH<sub>3</sub>, respectively. One <sup>13</sup>C peak is missing, presumably due to aggregation-induced line broadening. The <sup>13</sup>C peak at 59.3 ppm is composed of two erlotinib −OCH<sub>3</sub> carbon signals. The <sup>13</sup>C peak at 11.3 ppm is composed of two photosensitizer ring CH<sub>3</sub> carbon signals. The <sup>13</sup>C impurity peak at 29.7 ppm is likely due to grease CH<sub>2</sub>.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Synthesis of Methyl-20-phenyl-<i>p</i>-iodobenzulamide-pyropheophorbide-a (<b>22</b>)</h3><div class="NLM_p last">The 20-benzoic acid analogue of methyl mesopyropheophorbide-a (44.6 mg (0.067 mmol)) <b>20</b>, synthesized using a previously established method, was dissolved in 10 mL of dichloromethane (DCM) dried over molecular sieves. To this, 73.5 mg (0.166 mmol) of (benzotriazol-1-yloxy)tris (dimethylamino) phosphonium hexafluorophosphate (BOP) and 250 μL (0.1806 g; 1.785 mmol) of triethylamine were added and the reaction mixture was allowed to stir for 30 min under Ar. To this reaction mixture, 35.6 mg (0.153 mmol) of 4-Iodobenzylamine HCl <b>21</b> was added. The reaction was allowed to stir overnight, protected from light, and under an Ar atmosphere. TLC in 3% methanol (MeOH) in DCM showed a disappearance of the starting material <b>20</b>. The reaction mixture was diluted with DCM and washed once with 1 M HCl, twice with DI H<sub>2</sub>O and once with brine (saturated aqueous sodium chloride). The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, concentrated using a rotorary evaporator, and dried under vacuum. The crude reaction mixture was purified using preparation TLC (3% MeOH in DCM). The desired product was collected with an <i>R<sub>f</sub></i> value of about 0.61 was then filtered over the silica gel using 50% MeOH in DCM. The organics were removed and concentrated using a rotary evaporator and dried to yield <b>22</b> in 84% yield (49.5 mg). HRMS (ESI) for C<sub>48</sub>H<sub>48</sub>IN<sub>5</sub>O<sub>4</sub> [MH<sup>+</sup>] calcd. for 886.28237; found: 886.28239. UV–vis (MeOH, λ<sub>max</sub>, nm): 270, 410, 510, 545, 610, 665. <sup>1</sup>H NMR (400 MHz, CD<sub>2</sub>Cl<sub>2</sub>, δ ppm): 9.57 (1H, s, meso 10-H), 9.43 (1H, s, meso 5-H), 8.17–8.23 (2H, m, 2 × phenyl H), 8.04 (1H, m, phenyl H), 7.75–7.79 (3H, m, 3 × phenyl H), 7.27 (2H, m, 2 × phenyl H), 6.84 (1H, t, <i>J</i> = 5.8 Hz, amide H), 5.18 (1H, d, <i>J</i> = 19.8 Hz, 13<sup>2</sup>-C<i>H</i>H), 5.15 (1H, d, <i>J</i> = 19.8 Hz, 13<sup>2</sup>-CH<i>H</i>), 4.72 (1H, dd, <i>J</i> = 5.8, 15.2 Hz, −NHC<i>H</i>H–phenyl−), 4.71 (1H, dd, <i>J</i> = 5.8, 15.2 Hz, −NHCH<i>H</i>–phenyl−), 4.24 (1H, q, <i>J</i> = 7.1 Hz, 18-H), 4.10 (1H, dd, <i>J</i> = 8.7, 3.4 Hz, 17-H), 3.81 (2H, q, <i>J</i> = 7.7 Hz, −C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.73 (2H, q, <i>J</i> = 7.6 Hz, −C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.66 (3H, s, ring CH<sub>3</sub>), 3.54 (3H, s, −COOCH<sub>3</sub>), 3.30 (3H, s, ring CH<sub>3</sub>), ∼2.55 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), ∼2.44 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.31 (3H, s, 2-CH<sub>3</sub>), 2.13–2.28 (2H, m, 2H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 1.73 (3H, t, <i>J</i> = 7.7 Hz, −CH<sub>2</sub>C<i>H</i><sub>3</sub>), 1.65 (3H, t, <i>J</i> = 7.6 Hz, −CH<sub>2</sub>C<i>H</i><sub>3</sub>), 1.04 (3H, d, <i>J</i> = 7.1 Hz, 18-CH<sub>3</sub>), −1.53 (1H, br s, core NH); <sup>13</sup>C NMR (100 MHz, CD<sub>2</sub>Cl<sub>2</sub>, δ ppm): 196.1, 173.7, 172.2, 167.4, 160.8, 153.7, 150.9, 148.8, 145.17, 145.16, 144.6, 140.8, 139.1, 139.0, 138.2 (2C), 136.7, 135.4, 135.1, 134.4, 133.0, 132.2, 131.6, 130.3 (2C), 129.1, 127.4, 126.8, 111.5, 107.0, 104.2, 97.3, 93.1, 52.6, 51.8, 49.0, 48.8, 44.0, 31.6, 30.2, 21.2, 19.83, 19.80, 17.6, 17.0, 14.3, 12.2, 11.4. Note: One core NH proton was not observed, presumably due to chemical exchange. <sup>1</sup>H impurity peaks were observed at: 5.33 (DCM), 1.27 (grease CH<sub>2</sub>), and 0.89 (grease CH<sub>3</sub>) ppm. <sup>13</sup>C peaks at 138.2 and 130.3 ppm are each composed of two aromatic CH carbon signals of the iodobenzyl group. The<sup>13</sup>C peak at 30.1 ppm is likely due to the CH<sub>2</sub> carbon of grease impurity.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Synthesis of Conjugate (<b>23</b>)</h3><div class="NLM_p last">Amounts of 20.0 mg (0.065 mmol) of triphenylarsine (AsPh<sub>3</sub>) and 22.0 mg (0.024 mmol) of tris(dibenzylideneacetone)dipalladium(0) [Pd<sub>2(</sub>dba)<sub>3</sub>] were added to a stirred solution of 49.5 mg (0.056 mmol) of <b>22</b>, 34.1 mg (0.087 mmol) of erlotinib <b>1</b>, and 4 mL (2.89 g; 28.56 mmol) of triethylamine in 30 mL of freshly distilled THF under an atmosphere of Ar. The reaction was allowed to stir overnight, protected from light, and under an Ar atmosphere. TLC in 5% methanol (MeOH) in DCM showed a disappearance of the starting material <b>1</b>. The reaction mixture was diluted with DCM and washed once with 1 M HCl, twice with DI H<sub>2</sub>O and once with brine (saturated sodium chloride). The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. The organic solution was filtered and concentrated using a rotorary evaporator and dried using a high-vacuum pump. The crude reaction mixture was purified using preparation TLC (4% MeOH in DCM). The desired product <b>10</b> was collected with an <i>R<sub>f</sub></i> value of about 0.24. The desired product was filtered off the silica gel using 50% MeOH in DCM. The organics were removed and concentrated using a rotary evaporator and dried using a high-vacuum pump. The title compound was obtained in 40% yield (25.7). HRMS (ESI) for C<sub>70</sub>H<sub>70</sub>N<sub>8</sub>O<sub>8</sub> [MH<sup>+</sup>] calcd. for 1151.53894; found: 1151.54308. UV–vis (MeOH, λ<sub>max</sub>, nm): 255, 335, 410, 510, 545, 610, 665. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ ppm) 9.48 (1H, s, meso 10-H), 9.34 (1H, s, meso 5-H), 8.54 (1H, s, pyrimidine H), ∼8.4 (1H, br s, erlotinib NH), 8.26 (1H, dd, <i>J</i> = 1.6, 7.9 Hz, phenyl H), 8.17 (1H, dd, <i>J</i> = 1.6, 7.9 Hz, phenyl H), 8.11 (1H, dd, <i>J</i> = 1.6, 7.9 Hz, phenyl H), 7.95 (1H, s, phenyl H), 7.76 (1H, d, <i>J</i> = 8.0 Hz, phenyl H), 7.72 (1H, dd, <i>J</i> = 1.6, 7.9 Hz, phenyl H), 7.56 (1H, br s, quinazoline 5-H), 7.46 (2H, d, <i>J</i> = 7.9 Hz, 2 × phenyl H), 7.38 (2H, d, <i>J</i> = 8.1 Hz, 2 × phenyl H), 7.34 (1H, t, <i>J</i> ∼7.8 Hz, phenyl H), 7.28 (1H, d, <i>J</i> = 7.7 Hz, phenyl H), 7.25 (1H, s, quinazoline 8-H), 7.16 (1H, br s, amide H), 5.15 (1H, d, <i>J</i> = 20.0 Hz, 13<sup>2</sup>-C<i>H</i>H), 5.12 (1H, d, <i>J</i> = 20.0 Hz, 13<sup>2</sup>-CH<i>H</i>), 4.77 (1H, dd, <i>J</i> ∼5.5, 15.2 Hz, −NHC<i>H</i>H–phenyl−), 4.76 (1H, dd, <i>J</i> ∼6.0, 15.2 Hz, −NHCH<i>H</i>–phenyl−), 4.36 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 4.25 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 4.17 (1H, q, <i>J</i> = 7.1 Hz, 18-H), 4.02 (1H, dd, <i>J</i> = 3.5, 8.2 Hz, 17-H), 3.83 (4H, m, 2 × −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.74 (2H, q, <i>J</i> = 7.7 Hz, −C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.69 (2H, q, <i>J</i> = 7.7 Hz, −C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.65 (3H, s, ring CH<sub>3</sub>), 3.52 (3H, s, −COOCH<sub>3</sub>), 3.459 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.456 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.26 (3H, s, ring CH<sub>3</sub>), ∼2.48 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), ∼2.38 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>), 2.27 (3H, s, 2-CH<sub>3</sub>), 2.09–2.21 (2H, m, 2H of 17-CH<sub>2</sub>CH<sub>2</sub>), 1.70 (3H, t, <i>J</i> = 7.7 Hz, −CH<sub>2</sub>C<i>H</i><sub>3</sub>), 1.61 (3H, t, <i>J</i> = 7.6 Hz, −CH<sub>2</sub>C<i>H</i><sub>3</sub>), 1.01 (3H, d, <i>J</i> = 7.0 Hz, 18-CH<sub>3</sub>), −1.47 (1H, s, core NH); <sup>13</sup>C NMR (100 MHz, 90:10 CDCl<sub>3</sub>/CD<sub>3</sub>OD, δ ppm): 196.8, 173.6, 171.7, 167.6, 159.6, 157.2, 155.2, 154.2, 151.4, 151.2, 149.2, 148.3, 144.8, 144.7, 144.1, 140.2, 138.7, 138.4, 138.3, 136.1, 135.0, 134.4, 133.6, 132.3, 131.8 (2C), 131.5, 130.4, 128.8, 128.4, 128.0, 127.8 (2C), 127.0, 126.5, 125.6, 123.7, 122.8, 122.2, 110.4, 108.7, 105.8, 105.7, 103.9, 103.8, 96.7, 89.24, 89.21, 70.8, 70.3, 69.0, 68.5, 59.2, 59.1, 51.9, 51.5, 48.4, 48.3, 43.7, 31.1, 29.7, 20.8, 19.3, 19.2, 17.2, 16.6, 13.9, 11.8, 11.1. Note: One of the core NH protons was not observed, presumably due to chemical exchange. <sup>1</sup>H impurity peaks were observed at: 5.30 (DCM), 3.35, 2.02, 1.26 (grease CH<sub>2</sub>), and 0.88 (grease CH<sub>3</sub>) ppm. One carbon peak is missing, presumably due to line broadening caused by aggregation. <sup>13</sup>C peaks at 131.8 and 127.8 ppm are each composed of two aromatic CH signals of the benzyl group. Very low-intensity <sup>13</sup>C impurity peaks were observed at the following chemical shifts: 113.8, 55.8, 31.8, 31.7, 29.2, and 22.5 ppm. The <sup>13</sup>C impurity peak at 29.6 ppm (likely due to grease CH<sub>2</sub>) is larger.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Synthesis of Conjugate (<b>27</b>)</h3><div class="NLM_p last">The compounds <b>25</b> and <b>26</b> were synthesized by using our published synthetic procedures.<sup>38,48</sup> To a stirred solution of compound <b>25</b> (30 mg, 0.035 mmol) and erlotinib analogue <b>26</b> (26 mg, 0.052 mmol) in dry THF (10 mL), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide HCl (EDCI, 40 mg, 0.21 mmol) and 4-dimethylaminopyridine (DMAP, 25 mg, 0.21 mmol) were added. The reaction mixture was stirred at room temperature under an argon atmosphere overnight. The solvents were evaporated and diluted with dichloromethane (20 mL), washed with water (3 × 20 mL), dried over anhydrous sodium sulfate, and concentrated to yield the crude product, which was purified by preparative TLC plates to yield <b>27</b> in 45% yield (36 mg). MS (ESI) <i>m</i>/<i>z</i>: 2307.24 (M + H<sup>+</sup>). HRMS (ESI): calcd. for C<sub>136</sub>H<sub>148</sub>N<sub>17</sub>O<sub>18</sub> (M + H<sup>+</sup>) 2307.2413; found, 2307.2419. λmax, nm (ε): 663 (4.5 × 10<sup>4</sup>), 607 (8.8 × 10<sup>3</sup>), 542 (8.8 × 103), 509 (8.4 × 10<sup>3</sup>), 413 (8.4 × 10<sup>4</sup>), 335 (9.2 × 10<sup>4</sup>). <sup>1</sup>H NMR (400 MHz, 90:10 CDCl<sub>3</sub>/CD<sub>3</sub>OD, δ ppm): 9.66/9.62 (1H, s, meso 5-H), 9.37/9.36 (1H, s, meso 10-H), 8.45 (3H, s, 3 × pyrimidine H), 8.371/8.365 (1H, s, meso 20-H), 7.67 (3H, m, 3 × phenyl H), 7.64 (3H, m, 3 × phenyl H), 7.514/7.512 (3H, s, 3 × quinazoline 5-H), 7.21 (3H, t, <i>J</i> ∼8 Hz, 3 × phenyl H), 7.18 (3H, d, <i>J</i> = 7.0 Hz, 3 × phenyl H), 7.09 (3H, m, 3 × phenyl H), 7.08 (3H, m, 3 × phenyl H), 7.063/7.059 (3H, s, 3 × quinazoline 8-H), 6.98/6.97 (3H, t, <i>J</i> = 7.6 Hz, 3 × phenyl H), 6.94 (3H, m, 3 × phenyl H), 5.83/5.80 (1H, q, <i>J</i> = 6.7 Hz, 3<sup>1</sup>-H), 5.14 (1H, d, <i>J</i> = 19.9 Hz, 13<sup>2</sup>-C<i>H</i>H), 4.91 (1H, d, <i>J</i> = 19.9 Hz, 13<sup>2</sup>-CH<i>H</i>), 4.38 (1H, dq, <i>J</i> = 7.4, 1.7 Hz, 18-H), 4.19 (6H, m, 3 × −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 4.11 (13H, m, 3 × −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub> and 3 × −NHC<i>H</i><sub>2</sub>–phenyl and 17-H), 3.77 (6H, m, 3 × −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.69 (6H, m, 3 × −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.50–3.64 (2H, m, −OC<i>H</i><sub>2</sub>(CH<sub>2</sub>)<sub>4</sub>CH<sub>3</sub>), ∼3.62 (2H, m, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.50 (3H, s, 12-CH<sub>3</sub>), 3.40 (9H, s, 3 × −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.364/3.361 (9H, s, 3 × −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.25/3.24 (3H, s, 2-CH<sub>3</sub>), 3.184/3.179 (3H, s, 7-CH<sub>3</sub>), 2.56 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.30 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.24 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.12 (6H, m, 3 × CH<sub>2</sub> of −CH<sub>2</sub>CH<sub>2</sub>C(═O)NH−), 2.05/2.04 (3H, d, <i>J</i> = 6.6 Hz, 3<sup>1</sup>-CH<sub>3</sub>), 2.02 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 1.94 (6H, m, 3 × CH<sub>2</sub> of −CH<sub>2</sub>CH<sub>2</sub>C(═O)NH−), 1.69/1.68 (3H, d, <i>J</i> = 7.1 Hz, 18-CH<sub>3</sub>), 1.68 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>(CH<sub>2</sub>)<sub>3</sub>CH<sub>3</sub>), 1.64 (3H, t, <i>J</i> = 7.6 Hz, 8-CH<sub>2</sub>C<i>H</i><sub>3</sub>), 1.23–1.40 (2H, m, −O(CH<sub>2</sub>)<sub>2</sub>C<i>H</i><sub>2</sub>(CH<sub>2</sub>)<sub>2</sub>CH<sub>3</sub>), 1.16 (4H, m, −O(CH<sub>2</sub>)<sub>3</sub>(C<i>H</i><sub>2</sub>)<sub>2</sub>CH<sub>3</sub>), 0.71/0.70 (3H, distorted t, <i>J</i> ∼6.9 Hz, −O(CH<sub>2</sub>)<sub>5</sub>C<i>H</i><sub>3</sub>); <sup>13</sup>C NMR (100 MHz, 90:10 CDCl<sub>3</sub>/CD<sub>3</sub>OD, δ ppm): 197.33/197.32, 174.08/174.06, 173.63/173.62, 172.2, 160.5, 157.0, 155.7, 154.6, 153.3, 150.9, 149.0, 148.8/148.7, 146.9, 145.22/145.20, 141.5/141.4, 139.6, 139.1, 138.39/138.37, 137.4, 136.35/136.32, 135.8/135.7, 132.7/132.6, 130.36/130.34, 130.26, 129.7, 128.8, 128.4, 128.1, 127.4, 127.2, 125.0, 123.5, 123.28/123.27, 122.5, 109.6, 107.7, 105.7, 104.2, 103.69/103.68, 97.9/97.7, 92.8, 89.37/89.36, 89.1, 72.9/72.8, 70.9, 70.6, 69.7, 68.9, 68.3, 59.19, 59.16, 57.9/57.8, 51.74/51.72, 50.1, 47.9, 42.9, 33.9, 31.7, 31.3, 31.0, 30.6, 30.2, 26.07/26.05, 24.6/24.5, 22.9, 22.57/22.55, 19.4, 17.4, 13.88/13.86, 11.8, 11.2, 10.90/10.86. Note: Two core NH, four amide NH, and three amine NH protons are missing, presumably due to chemical exchange. <sup>1</sup>H impurity peaks at 1.21 (likely grease CH<sub>2</sub>) and 0.83 ppm (likely grease CH<sub>3</sub>) were observed. The <sup>13</sup>C impurity peak at 29.7 ppm is likely due to grease CH<sub>2</sub>.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Synthesis of Conjugate (<b>29</b>)</h3><div class="NLM_p last">Triphenylarsine (9.25 mg, 0.0302 mmol) and Pd<sub>2</sub>dba<sub>3</sub> (13.84 mg, 0.0151 mmol) were added to a stirred solution of compound <b>28</b> (30 mg, 0.0377 mmol) and erlotinib <b>1</b> (22.30 mg, 0.0569 mmol) in dry THF (10 mL) and Et<sub>3</sub>N (2.5 mL). The reaction mixture was stirred at room temperature under an argon atmosphere overnight. As per TLC, only 50% amount of starting material reacted to produce the desired product. The desired conjugate <b>29</b> was purified by preparative TLC plates and obtained 68% yield (27.22 mg). MS (ESI) <i>m</i>/<i>z</i>: 1159.47 (M + H<sup>+</sup>). HRMS (ESI): calcd. for C<sub>63</sub>H<sub>63</sub>N<sub>8</sub>O<sub>8</sub> (M + H<sup>+</sup>) 1159.4724; found, 1159.4745. UV–vis (CH<sub>3</sub>OH, λ<sub>max</sub>, nm (abs)): 707 (4.4 × 10<sup>4</sup>), 652 (8.5 × 10<sup>3</sup>), 550 (2.3 × 10<sup>4</sup>), 513 (6.3 × 10<sup>3</sup>), 482 (4.8 × 10<sup>3</sup>), 416 (1.16 × 10<sup>5</sup>), 348 (6.7 × 10<sup>4</sup>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ ppm): 9.46 (1H, s, meso H), 9.24 (1H, s, meso H), 8.60 (1H, s, pyrimidine H), 8.54 (1H, s, meso 20-H), 7.89 (1H, br s, phenyl H), ∼7.85 (1H, br d, <i>J</i> ∼8.0 Hz, phenyl H), 7.82 (1H, dd, <i>J</i> = 17.9, 11.5 Hz, −C<i>H</i>═CH<sub>2</sub>), 7.72 (1H, br d, <i>J</i> = 7.7 Hz, phenyl H), 7.66 (1H, br s, amine NH), 7.59 (1H, br s, phenyl H), 7.38 (1H, br d, <i>J</i> = 7.7 Hz, phenyl H), 7.32 (1H, dd, <i>J</i> ∼7.7, 7.7 Hz, phenyl H), ∼7.26 (1H, m, phenyl H), 7.24 (1H, br s, quinazoline 5-H), 7.20 (1H, ddd, <i>J</i> = 7.7, ∼1.2, ∼1.2 Hz, phenyl H), 7.18 (1H, s, quinazoline 8-H), 6.24 (1H, dd, <i>J</i> = 17.9, 1.2 Hz, −CH═C<i>H</i>H), 6.11 (1H, dd, <i>J</i> = 11.6, 1.2 Hz, −CH═CH<i>H</i>), 5.72 (1H, d, <i>J</i> = 14.4 Hz, >NC<i>H</i>H–phenyl−), 5.61 (1H, d, <i>J</i> = 14.4 Hz, >NCH<i>H</i>–phenyl−), 5.40 (1H, m, 17-H), 4.34 (1H, q, <i>J</i> = 7.3 Hz, 18-H), 4.23 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 4.16 (2H, t, <i>J</i> = 4.7 Hz, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 3.82 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.75 (3H, s, ring CH<sub>3</sub>), 3.70 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.53 (2H, q, <i>J</i> = 7.6 Hz, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.52 (3H, s, −COOCH<sub>3</sub>), 3.45 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.36 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.31 (3H, s, ring CH<sub>3</sub>), 3.07 (3H, s, ring CH<sub>3</sub>), ∼2.75 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.35–2.52 (2H, m, 2H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.01 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 1.77 (3H, d, <i>J</i> = 7.3 Hz, 18-CH<sub>3</sub>), 1.60 (3H, t, <i>J</i> = 7.6 Hz, 8-CH<sub>2</sub>C<i>H</i><sub>3</sub>), −0.06 (1H, s, core NH), −0.17 (1H, s, core NH); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>, δ ppm): 176.8, 175.0, 174.2, 167.5, 163.3, 156.2, 155.4, 154.4, 153.5, 149.8, 148.8, 147.3, 145.4, 143.0, 139.6, 139.0, 138.9, 137.6, 137.0, 136.3, 136.0, 131.8, 131.7, 131.1, 130.3, 128.89, 128.87, 128.6, 128.5, 126.9, 124.2, 123.9, 123.2, 123.0, 121.4, 115.6, 109.2, 108.7, 106.9, 102.6, 102.4, 97.3, 94.7, 89.8, 89.0, 70.8, 70.5, 69.1, 68.3, 59.3, 59.2, 54.7, 51.6, 49.1, 43.1, 32.5, 31.5, 24.0, 19.3, 17.4, 12.5, 11.9, 11.0. Note: <sup>1</sup>H impurity peaks at 1.27 and 0.89 ppm are likely due to grease CH<sub>2</sub> and CH<sub>3</sub>, respectively.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> Synthesis of Conjugate (<b>31</b>)</h3><div class="NLM_p last">Triphenylarsine (8.44 mg, 0.0275 mmol) and Pd<sub>2</sub>dba<sub>3</sub> (12.63 mg, 0.0137 mmol) were added to a stirred solution of compound <b>30</b> (30 mg, 0.0344 mmol) and erlotinib <b>1</b> (20.34 mg, 0.0517 mmol) in dry THF (10 mL) and Et<sub>3</sub>N (2.5 mL). The reaction mixture was stirred at room temperature under an argon atmosphere overnight. The product <b>11</b> was purified by preparative TLC plates and obtained in 75% yield (29.36 mg). MS (ESI) <i>m</i>/<i>z</i>: 1135.56 (M + H<sup>+</sup>). HRMS (ESI): calcd. for C<sub>67</sub>H<sub>75</sub>N<sub>8</sub>O<sub>9</sub> (M + H<sup>+</sup>) 1135.5612; found, 1135.5635. UV–vis (CH<sub>3</sub>OH, λ<sub>max</sub>, nm (abs)): 783 (4.15 × 10<sup>4</sup>), 538 (3.98 × 10<sup>4</sup>), 415 (4.37 × 10<sup>4</sup>), 366 (1.07 × 10<sup>5</sup>), 342 (7.5 × 10<sup>4</sup>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ ppm): 9.46 (1H, s, meso H), 9.24 (1H, s, meso H), 8.60 (1H, s, pyrimidine H), 8.54 (1H, s, meso 20-H), 7.89 (1H, br s, phenyl H), ∼7.85 (1H, br d, <i>J</i> ∼8.0 Hz, phenyl H), 7.82 (1H, dd, <i>J</i> = 17.9, 11.5 Hz, −C<i>H</i>═CH<sub>2</sub>), 7.72 (1H, br d, <i>J</i> = 7.7 Hz, phenyl H), 7.66 (1H, br s, amine NH), 7.59 (1H, br s, phenyl H), 7.38 (1H, br d, <i>J</i> = 7.7 Hz, phenyl H), 7.32 (1H, dd, <i>J</i> ∼7.7, 7.7 Hz, phenyl H), ∼7.26 (1H, m, phenyl H), 7.24 (1H, br s, quinazoline 5-H), 7.20 (1H, ddd, <i>J</i> = 7.7, ∼1.2, ∼1.2 Hz, phenyl H), 7.18 (1H, s, quinazoline 8-H), 6.24 (1H, dd, <i>J</i> = 17.9, 1.2 Hz, −CH═C<i>H</i>H), 6.11 (1H, dd, <i>J</i> = 11.6, 1.2 Hz, −CH═CH<i>H</i>), 5.72 (1H, d, <i>J</i> = 14.4 Hz, >NC<i>H</i>H–phenyl−), 5.61 (1H, d, <i>J</i> = 14.4 Hz, >NCH<i>H</i>–phenyl−), 5.40 (1H, m, 17-H), 4.34 (1H, q, <i>J</i> = 7.3 Hz, 18-H), 4.23 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 4.16 (2H, t, <i>J</i> = 4.7 Hz, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 3.82 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.75 (3H, s, ring CH<sub>3</sub>), 3.70 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.53 (2H, q, <i>J</i> = 7.6 Hz, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.52 (3H, s, −COOCH<sub>3</sub>), 3.45 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.36 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.31 (3H, s, ring CH<sub>3</sub>), 3.07 (3H, s, ring CH<sub>3</sub>), ∼2.75 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.35–2.52 (2H, m, 2H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.01 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 1.77 (3H, d, <i>J</i> = 7.3 Hz, 18-CH<sub>3</sub>), 1.60 (3H, t, <i>J</i> = 7.6 Hz, 8-CH<sub>2</sub>C<i>H</i><sub>3</sub>), −0.06 (1H, s, core NH), −0.17 (1H, s, core NH); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>, δ ppm): 176.8, 175.0, 174.2, 167.5, 163.3, 156.2, 155.4, 154.4, 153.5, 149.8, 148.8, 147.3, 145.4, 143.0, 139.6, 139.0, 138.9, 137.6, 137.0, 136.3, 136.0, 131.8, 131.7, 131.1, 130.3, 128.89, 128.87, 128.6, 128.5, 126.9, 124.2, 123.9, 123.2, 123.0, 121.4, 115.6, 109.2, 108.7, 106.9, 102.6, 102.4, 97.3, 94.7, 89.8, 89.0, 70.8, 70.5, 69.1, 68.3, 59.3, 59.2, 54.7, 51.6, 49.1, 43.1, 32.5, 31.5, 24.0, 19.3, 17.4, 12.5, 11.9, 11.0. Note: <sup>1</sup>H impurity peaks at 1.27 and 0.89 ppm are likely due to grease CH<sub>2</sub> and CH<sub>3</sub>, respectively.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Synthesis of Conjugate (<b>37</b>)</h3><div class="NLM_p">Methyl pheophorbide-a <b>32</b> (50 mg, 0.0825 mmol) and 3-iodonenzlamine <b>34</b> (96 mg, 0.413 mmol) were dissolved in 10 mL of dry THF. The reaction mixture was stirred at room temperature under an argon atmosphere overnight. The solvent was evaporated, and the crude product was purified by a silica column by using 3% methanol in dichloromethane to obtain pure product <b>35</b> with 91% yield (69.2 mg). MS (ESI) <i>m</i>/<i>z</i>: 840.2617 (M + H<sup>+</sup>). HRMS (ESI): calcd. for C<sub>43</sub>H<sub>47</sub>N<sub>5</sub>O<sub>5</sub>I (M + H<sup>+</sup>) 840.2617; found, 840.2616. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ ppm): 9.66 (1H, s, meso H), 9.62 (1H, s, meso H), 8.80 (1H, s, meso 20-H), 8.07 (1H, dd, <i>J</i> = 17.9, 11.5 Hz, −C<i>H</i>═CH<sub>2</sub>), 7.91 (1H, t, <i>J</i> ∼1.6 Hz, phenyl H), 7.67 (1H, ddd, <i>J</i> = 7.9, ∼1.4, ∼1.2 Hz, phenyl H), 7.49 (1H, br d, <i>J</i> = 7.7 Hz, phenyl H), 7.12 (1H, t, <i>J</i> = 7.8 Hz, phenyl H), 6.70 (1H, br t, <i>J</i> ∼5.8 Hz, amide NH), 6.34 (1H, dd, <i>J</i> = 17.9, 1.5 Hz, −CH═C<i>H</i>H), 6.13 (1H, dd, <i>J</i> = 11.5, 1.5 Hz, −CH═CH<i>H</i>), 5.50 (1H, d, <i>J</i> = 18.8 Hz, 15-C<i>H</i>H−), 5.24 (1H, d, <i>J</i> = 18.8 Hz, 15-CH<i>H</i>−), 4.96 (1H, dd, <i>J</i> = 14.6, 6.4 Hz, −NHC<i>H</i>H–phenyl−), 4.64 (1H, dd, <i>J</i> = 14.6, 5.3 Hz, −NHCH<i>H</i>–phenyl−), 4.47 (1H, q, <i>J</i> = 7.2 Hz, 18-H), 4.38 (1H, m, 17-H), 3.77 (2H, q, <i>J</i> = 7.7 Hz, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.72 (3H, s, −COOCH<sub>3</sub>), 3.61 (3H, s, −COOCH<sub>3</sub>), 3.51 (3H, s, ring CH<sub>3</sub>), 3.48 (3H, s, ring CH<sub>3</sub>), 3.31 (3H, s, ring CH<sub>3</sub>), ∼2.55 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.12–2.27 (2H, m, 2H of 17-CH<sub>2</sub>CH<sub>2</sub>−), ∼1.82 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 1.72 (3H, d, <i>J</i> = 7.2 Hz, 18-CH<sub>3</sub>), 1.71 (3H, t, <i>J</i> = 7.7 Hz, 8-CH<sub>2</sub>C<i>H</i><sub>3</sub>), −1.56 (1H, br s, core NH), −1.76 (1H, s, core NH); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>, δ ppm): 173.9, 173.5, 169.3, 169.0, 166.7, 154.3, 149.0, 144.8, 140.4, 139.0, 137.1, 136.8, 136.1, 135.0, 134.93, 134.91, 134.6, 130.6, 130.3, 129.8, 129.4, 127.6, 127.4, 121.7, 102.1, 101.5, 98.8, 94.6, 93.7, 53.1, 52.2, 51.6, 49.3, 43.9, 38.0, 31.1, 29.7, 23.0, 19.7, 17.7, 12.1, 12.0, 11.3. Note: <sup>1</sup>H impurity peaks at 1.27 and 0.89 ppm are likely due to grease.</div><div class="NLM_p last">Triphenylarsine (11.67 mg, 0.038 mmol) and Pd<sub>2</sub>dba<sub>3</sub> (17.45 mg, 0.02 mmol) were added to a stirred solution of compound <b>35</b> (40 mg, 0.048 mmol) and erlotinib <b>1</b> (28 mg, 0.0715 mmol) in dry THF (20 mL) and Et<sub>3</sub>N (3 mL). The reaction mixture was stirred at room temperature under an argon atmosphere overnight. After completion of the reaction, the reaction mixture was evaporated. The crude was diluted with DCM and washed with water. The organic layer was removed and concentrated using a rotary evaporator and dried using a high-vacuum pump. The desired conjugate <b>37</b> was purified by preparative TLC plates with 79% yield (41.52 mg). MS (ESI) <i>m</i>/<i>z</i>: 1103.54 (M + H<sup>+</sup>). HRMS (ESI): calcd. for C<sub>67</sub>H<sub>71</sub>N<sub>6</sub>O<sub>9</sub> (M + H<sup>+</sup>) 1103.5441; found, 1103.5446. UV–vis (CH<sub>3</sub>OH, λ<sub>max</sub>, nm (abs)): 660 (5.1 × 10<sup>4</sup>), 501 (1.4 × 10<sup>4</sup>), 397 (1.6 × 10<sup>5</sup>), 349 (5.5 × 10<sup>4</sup>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ ppm): 9.59 (2H, s, meso 5-H and meso 10-H), 8.78 (1H, s, meso 20-H), 8.57 (1H, br s, pyrimidine H), 8.04 (1H, dd, <i>J</i> = 17.4, 11.6 Hz, −C<i>H</i>═CH<sub>2</sub>), 7.80 (1H, s, phenyl H), 7.66–7.74 (2H, m, 2 × phenyl H), ∼7.50 (1H, br s, amine NH), 7.43–7.52 (2H, m, 2 × phenyl H), 7.37 (1H, t, <i>J</i> = 7.6 Hz, phenyl H), 7.22–7.32 (3H, m, 2 × phenyl H and quinazoline 5-H), 7.16 (1H, s, quinazoline 8-H), 6.83 (1H, br s, amide NH), 6.31 (1H, d, <i>J</i> = 17.7 Hz, −CH═C<i>H</i>H), 6.10 (1H, d, <i>J</i> = 11.4 Hz, −CH═CH<i>H</i>), 5.49 (1H, d, <i>J</i> = 18.8 Hz, 15-C<i>H</i>H−), 5.25 (1H, d, <i>J</i> = 18.8 Hz, 15-CH<i>H</i>−), 4.95 (1H, dd, <i>J</i> ∼14, 5 Hz, −NHC<i>H</i>H–phenyl−), 4.72 (1H, dd, <i>J</i> = 14.3, 4.3 Hz, −NHCH<i>H</i>–phenyl−), 4.45 (1H, q, <i>J</i> = 7.2 Hz, 18-H), 4.37 (1H, m, 17-H), 4.18 (4H, m, 2 × −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 3.76 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), ∼3.72 (2H, m, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.71 (3H, s, −COOCH<sub>3</sub>), 3.66 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.59 (3H, s, −COOCH<sub>3</sub>), 3.45 (6H, br s, 2 × ring CH<sub>3</sub>), 3.41 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.34 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.27 (3H, s, ring CH<sub>3</sub>), ∼2.54 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.10–2.27 (2H, m, 2H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 1.81 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 1.69 (3H, d, <i>J</i> = 7.1 Hz, 18-CH<sub>3</sub>), 1.67 (3H, t, <i>J</i> = 7.5 Hz, 8-CH<sub>2</sub>C<i>H</i><sub>3</sub>), −1.59 (1H, br s, core NH), −1.82 (1H, s, core NH); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>, δ ppm): 173.9, 173.6, 169.5, 168.9, 166.6, 156.3, 154.7, 154.3, 153.3, 149.05, 149.01, 144.8, 139.0, 138.7, 138.2, 136.1, 134.91, 134.90, 134.6, 131.4, 130.9, 130.2, 129.8, 129.4, 128.95, 128.94, 128.2, 127.6, 127.3, 124.6, 123.8, 123.7, 122.0, 121.6, 109.0, 108.6, 102.7, 102.1, 101.4, 98.8, 93.7, 89.6, 89.2, 70.8, 70.4, 69.3, 68.3, 59.24, 59.20, 53.1, 52.2, 51.6, 49.2, 44.4, 38.0, 31.2, 29.7, 23.0, 19.6, 17.7, 12.1, 12.0, 11.3. Note: <sup>1</sup>H impurity peaks at 1.27 (likely grease CH<sub>2</sub>), 0.89 (likely grease CH<sub>3</sub>), and 0.08 ppm were observed. Two carbon peaks are missing, presumably due to line broadening caused by aggregation.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Synthesis of Conjugate (<b>38</b>)</h3><div class="NLM_p">Methylpheophorbide-a <b>32</b> (100.0 mg, 0.165 mmol) was dissolved in 12 mL of DCM, HBr gas was bubbled for 5 min, and the reaction mixture was stirred for 1 h at room temperature. The solvent was evaporated under high vacuum, the resulting crude was dried, and the entire crude was dissolved in dry CH<sub>2</sub>Cl<sub>2</sub> (10 mL). A 100 mg of portion of dry K<sub>2</sub>CO<sub>3</sub> was added to this mixture, followed by the addition of 1-hexanol (0.62 mL, 4.95 mmol). The resulting reaction mixture was stirred for 1 h at room temperature and then worked up. The crude mixture was purified by flash column chromatography (silica gel, 40% ethyl acetate in hexane). Evaporation of the appropriate elutes gave the desired compound <b>33</b>, 55% (64.26 mg). Compound <b>33</b> (50 mg, 0.053 mmol) was then reacted with <b>34</b> (61.9 mg, 0.266 mmol) and dissolved in 10 mL of dry THF. The reaction mixture was stirred at room temperature under an argon atmosphere overnight. The solvent was evaporated, and the crude product was purified by silica column by using 3% methanol in dichloromethane to obtain pure product <b>36</b> in 89% yield (59.13 mg). MS (ESI) <i>m</i>/<i>z</i>: 942.36 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ ppm): 9.93 (1H, s, meso 5-H), 9.71 (1H, s, meso 10-H), 8.77 (1H, s, meso 20-H), 7.94 (1H, s, phenyl H), 7.69 (1H, d, <i>J</i> = 7.8 Hz, phenyl H), 7.54 (1H, d, <i>J</i> = 7.7 Hz, phenyl H), 7.16 (1H, t, <i>J</i> = 7.8 Hz, phenyl H), 6.76 (1H, br t, <i>J</i> ∼5.6 Hz, amide NH), 5.96 (1H, q, <i>J</i> = 6.7 Hz, 3<sup>1</sup>-H), 5.51 (1H, d, <i>J</i> = 18.7 Hz, 15-C<i>H</i>H−), 5.26/5.25 (1H, d, <i>J</i> = 18.8 Hz, 15-CH<i>H</i>−), 5.02/5.00 (1H, dd, <i>J</i> = 14.5, 6.2 Hz, −NHC<i>H</i>H–phenyl−), 4.70/4.69 (1H, dd, <i>J</i> = 14.5, 4.6 Hz, −NHCH<i>H</i>–phenyl−), 4.46 (1H, q, <i>J</i> = 7.1 Hz, 18-H), 4.39 (1H, d, <i>J</i> = 9.5 Hz, 17-H), 3.81 (2H, q, <i>J</i> = 7.5 Hz, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.74/3.73 (3H, s, −COOCH<sub>3</sub>), 3.59–3.70 (2H, m, −OC<i>H</i><sub>2</sub>(CH<sub>2</sub>)<sub>4</sub>CH<sub>3</sub>), 3.60 (3H, s, −COOCH<sub>3</sub>), 3.56 (3H, s, ring CH<sub>3</sub>), 3.46/3.45 (3H, s, ring CH<sub>3</sub>), 3.34 (3H, s, ring CH<sub>3</sub>), 2.53 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), ∼2.21 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.133/2.125 (3H, d, <i>J</i> = 6.6 Hz, 3<sup>1</sup>-CH<sub>3</sub>), ∼2.12 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), ∼1.81 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), ∼1.75 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>(CH<sub>2</sub>)<sub>3</sub>CH<sub>3</sub>), 1.72 (3H, t, <i>J</i> = 7.6 Hz, 8-CH<sub>2</sub>C<i>H</i><sub>3</sub>), 1.71 (3H, d, <i>J</i> = 7.1 Hz, 18-CH<sub>3</sub>), 1.29–1.47 (2H, m, −O(CH<sub>2</sub>)<sub>2</sub>C<i>H</i><sub>2</sub>(CH<sub>2</sub>)<sub>2</sub>CH<sub>3</sub>), 1.23 (4H, m, −O(CH<sub>2</sub>)<sub>3</sub>(C<i>H</i><sub>2</sub>)<sub>2</sub>CH<sub>3</sub>), 0.79/0.78 (3H, distorted t, <i>J</i> ∼6.9 Hz, −O(CH<sub>2</sub>)<sub>5</sub>C<i>H</i><sub>3</sub>), −1.59 (1H, br s, core NH), −1.78 (1H, s, core NH); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>, δ ppm): 173.9, 173.5, 169.4, 169.0, 166.4, 154.3, 149.0, 144.8, 140.4, 139.0, 137.20/137.19, 136.9, 136.2, 134.8, 134.5/134.3, 130.9, 130.6, 129.7, 127.52/127.51, 102.00/101.98, 101.5, 99.63/99.59, 94.7, 93.3/93.2, 72.9/72.8, 69.72/69.69, 53.0, 52.2, 51.6, 49.35/49.33, 44.0, 38.0, 31.8, 31.12/31.11, 30.24/30.22, 29.7, 26.1, 25.0/24.9, 23.02/23.00, 22.58/22.57, 19.7, 17.7, 14.0, 12.0, 11.40/11.39, 11.13/11.10. Note: <sup>1</sup>H impurity peaks at 1.27 and 0.89 ppm are likely due to grease CH<sub>2</sub> and CH<sub>3</sub>, respectively. An additional minor <sup>1</sup>H impurity peak is observed at 0.09 ppm. Three carbon peaks are missing, presumably due to line broadening caused by aggregation. Very low-intensity <sup>13</sup>C impurity peaks were observed at the following chemical shifts: 31.9, 29.4, 22.7, and 14.1 (likely grease CH<sub>3</sub>) ppm.</div><div class="NLM_p last">Compound <b>36</b> (40 mg, 0.043 mmol) was reacted with erlotinib <b>1</b> (25 mg, 0.0637 mmol) in dry THF (20 mL), triethylamine (3 mL), triphenylarsine (10.40 mg, 0.034 mmol), and Pd<sub>2</sub>dba<sub>3</sub> (15.56 mg, 0.017 mmol). The reaction mixture was stirred at room temperature under an argon atmosphere overnight. After completion of the reaction, the reaction mixture was evaporated. The crude was diluted with DCM and washed with water. The organic layer was removed and concentrated using a rotary evaporator and dried using a high-vacuum pump. The product <b>15</b> was purified by preparative TLC plates with 79% yield (41.52 mg). MS (ESI) <i>m</i>/<i>z</i>: 1205.66 (M + H<sup>+</sup>). HRMS (ESI): calcd. for C<sub>73</sub>H<sub>84</sub>N<sub>6</sub>O<sub>10</sub> (M + H<sup>+</sup>) 1205.6634; found, 1205.6641. UV–vis (CH<sub>3</sub>OH, λ<sub>max</sub>, nm (abs)): 653 (5.7 × 10<sup>4</sup>), 599 (5.4 × 10<sup>3</sup>), 495 (1.4 × 10<sup>4</sup>), 394 (1.7 × 10<sup>5</sup>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ ppm): 9.92/9.91 (1H, s, meso 5-H), 9.67 (1H, s, meso 10-H), 8.76/8.75 (1H, s, meso 20-H), 8.65 (1H, s, pyrimidine H), 7.85 (1H, br s, phenyl H), 7.71–7.76 (2H, m, 2 × phenyl H), 7.54 (1H, d, <i>J</i> = 7.6 Hz, phenyl H), 7.51 (1H, d, <i>J</i> = 7.7 Hz, phenyl H), ∼7.50 (1H, br s, amine NH), 7.40 (1H, dd, <i>J</i> ∼7.7, 7.7 Hz, phenyl H), 7.30 (1H, dd, <i>J</i> ∼7.6 Hz, phenyl H), 7.28 (1H, d, <i>J</i> ∼8 Hz, phenyl H), 7.26 (1H, s, quinazoline 5-H), 7.19 (1H, s, quinazoline 8-H), 6.89 (1H, br t, <i>J</i> ∼5.6 Hz, amide NH), 5.95 (1H, q, <i>J</i> = 6.7 Hz, 3<sup>1</sup>-H), 5.52 (1H, d, <i>J</i> = 18.7 Hz, 15-C<i>H</i>H), 5.27/5.26 (1H, d, <i>J</i> = 18.7 Hz, 15-CH<i>H</i>), 5.024/5.020 (1H, dd, <i>J</i> = 14.4, 5.9 Hz, −NHC<i>H</i>H–phenyl−), 4.79/4.78 (1H, dd, <i>J</i> = 14.4, ∼4.6 Hz, −NHCH<i>H</i>–phenyl−), 4.44 (1H, q, <i>J</i> = 7.2 Hz, 18-H), 4.38/4.37 (1H, m, 17-H), 4.20 (4H, m, 2 × −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 3.75–3.81 (4H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub> and 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.723/3.721 (3H, s, −COOCH<sub>3</sub>), 3.69 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.57–3.69 (2H, m, −OC<i>H</i><sub>2</sub>(CH<sub>2</sub>)<sub>4</sub>CH<sub>3</sub>), 3.58 (3H, s, −COOCH<sub>3</sub>), 3.53 (3H, s, ring CH<sub>3</sub>), 3.453/3.445 (3H, s, ring CH<sub>3</sub>), 3.42 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.36 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.32 (3H, s, ring CH<sub>3</sub>), 2.52 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.21 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.13/2.12 (3H, d, <i>J</i> = 6.6 Hz, 3<sup>1</sup>-CH<sub>3</sub>), 2.11 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 1.82 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 1.75 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>(CH<sub>2</sub>)<sub>3</sub>CH<sub>3</sub>), 1.70 (3H, t, <i>J</i> = 7.7 Hz, 8-CH<sub>2</sub>C<i>H</i><sub>3</sub>), 1.694/1.687 (3H, d, <i>J</i> = 7.2 Hz, 18-CH<sub>3</sub>), 1.28–1.47 (2H, m, −O(CH<sub>2</sub>)<sub>2</sub>C<i>H</i><sub>2</sub>(CH<sub>2</sub>)<sub>2</sub>CH<sub>3</sub>), 1.23 (4H, m, −O(CH<sub>2</sub>)<sub>3</sub>(C<i>H</i><sub>2</sub>)<sub>2</sub>CH<sub>3</sub>), 0.79/0.78 (3H, distorted t, <i>J</i> ∼6.9 Hz, −O(CH<sub>2</sub>)<sub>5</sub>C<i>H</i><sub>3</sub>), −1.62 (1H, br s, core NH), −1.80 (1H, s, core NH); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>, δ ppm): 174.0, 173.6, 169.5, 168.9, 166.39/166.37, 156.2, 154.7, 154.3, 153.6, 149.03/149.02, 148.98, 147.5, 144.80/144.79, 138.93/138.88, 138.87, 138.3, 136.2, 134.83, 134.78/134.77, 134.4/134.3, 131.49/131.48, 131.0, 130.9/130.8, 129.6, 129.01, 128.98, 128.3, 127.56/127.55, 127.3, 124.4, 123.9, 123.8, 121.8, 109.2, 108.9, 102.6, 102.02/102.01, 101.5, 99.62/99.58, 93.2, 89.6, 89.3, 72.9/72.8, 70.9, 70.4, 69.69/69.67, 69.3, 68.3, 59.24, 59.23, 53.0, 52.2, 51.6, 49.31/49.30, 44.5, 38.0, 31.7, 31.13/31.11, 30.23/30.21, 29.7, 26.08/26.07, 25.0/24.9, 23.01/23.00, 22.57/22.56, 19.7, 17.7, 13.96/13.95, 12.0, 11.38/11.37, 11.12/11.09. Note: <sup>1</sup>H impurity peaks were observed at 1.27 (likely grease CH<sub>2</sub>), 0.89 (likely grease CH<sub>3</sub>), and 0.09 ppm (minor). One carbon peak is missing from this spectrum, presumably due to aggregation-induced line broadening. An additional <sup>13</sup>C peak, presumably due to grease impurity, was observed at 29.7 ppm.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Synthesis of Conjugate (<b>43</b>)</h3><div class="NLM_p">Compound <b>32</b> (50 mg, 0.071 mmol) was dissolved in 10 mL of dry THF and stirred under argon for 10 min. <b>39</b> (155.39 mg, 0.71 mmol) was added to the solution, and the reaction mixture was stirred for 12 h. The reaction was monitored by spectrophotometry. The reaction mixture was evaporated, and the residue was dissolved in 2.5% MeOH/CH<sub>2</sub>Cl<sub>2</sub> and then chromatographed on a short silica gel column using 20% MeOH/CDM to obtain pure product <b>40</b> with 76% yield (49.81 mg). MS (ESI) <i>m</i>/<i>z</i>: 929.58 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, 90:10 CDCl<sub>3</sub>/CD<sub>3</sub>OD, δ ppm): 9.94/9.93 (1H, s, meso 5-H), 9.72 (1H, s, meso 10-H), 8.803/8.801 (1H, s, meso 20-H), 5.95 (1H, q, <i>J</i> = 6.7 Hz, 3<sup>1</sup>-H), 5.52 (1H, d, <i>J</i> = 19.1 Hz, 15-C<i>H</i>H), 5.273/5.265 (1H, d, <i>J</i> = 19.1 Hz, 15-CH<i>H</i>), 4.48 (1H, q, <i>J</i> = 7.1 Hz, 18-H), 4.35 (1H, m, 17-H), 3.86 (1H, m, −NHC<i>H</i>HCH<sub>2</sub>CH<sub>2</sub>O−), 3.80 (2H, q, <i>J</i> = 7.6 Hz, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.75 (3H, s, −COOCH<sub>3</sub>), 3.74 (2H, t, <i>J</i> = 5.8 Hz, −NH(CH<sub>2</sub>)<sub>2</sub>C<i>H</i><sub>2</sub>O−), ∼3.69 (1H, m, −NHCH<i>H</i>CH<sub>2</sub>CH<sub>2</sub>O−), ∼3.56–3.71 (2H, m, −OC<i>H</i><sub>2</sub>(CH<sub>2</sub>)<sub>4</sub>CH<sub>3</sub>), 3.64 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>O−), 3.592/3.590 (3H, s, −COOCH<sub>3</sub>), ∼3.56 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>O−), 3.55 (3H, s, 12-CH<sub>3</sub>), 3.443/3.437 (3H, s, 2-CH<sub>3</sub>), 3.31 (3H, s, 7-CH<sub>3</sub>), ∼3.29 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>O−), 3.15/3.14 (2H, t, <i>J</i> = 5.8 Hz, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NH<sub>2</sub>), 3.09 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>O−), 2.78/2.77 (2H, t, <i>J</i> = 6.2 Hz, −OCH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>NH<sub>2</sub>), 2.56 (1H, m, 17-CH<sub>2</sub>C<i>H</i>H−), ∼2.20 (1H, m, 17-C<i>H</i>HCH<sub>2</sub>−), ∼2.16 (1H, m, 17-CH<sub>2</sub>CH<i>H</i>−), 2.116/2.105 (3H, d, <i>J</i> = 6.6 Hz, 3<sup>1</sup>-CH<sub>3</sub>), ∼2.114 (2H, m, −NHCH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>O−), 1.76 (1H, m, 17-CH<i>H</i>CH<sub>2</sub>−), 1.72 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>(CH<sub>2</sub>)<sub>3</sub>CH<sub>3</sub>), 1.71 (3H, t, <i>J</i> = 7.5 Hz, 8-CH<sub>2</sub>C<i>H</i><sub>3</sub>), 1.69/1.68 (3H, d, <i>J</i> = 7.1 Hz, 18-CH<sub>3</sub>), 1.54 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>NH<sub>2</sub>), 1.25–1.45 (2H, m, −O(CH<sub>2</sub>)<sub>2</sub>C<i>H</i><sub>2</sub>(CH<sub>2</sub>)<sub>2</sub>CH<sub>3</sub>), 1.18 (4H, m, −O(CH<sub>2</sub>)<sub>3</sub>(C<i>H</i><sub>2</sub>)<sub>2</sub>CH<sub>3</sub>), 0.74/0.72 (3H, t, <i>J</i> = 6.9 Hz, −O(CH<sub>2</sub>)<sub>5</sub>C<i>H</i><sub>3</sub>); <sup>13</sup>C NMR (100 MHz, 90:10 CDCl<sub>3</sub>/CD<sub>3</sub>OD, δ ppm): 174.6, 174.4, 170.7, 169.7, 167.09/167.07, 154.6, 149.4, 145.3, 139.23, 139.21/139.16, 136.8, 134.97/134.96, 134.8, 134.6/134.4, 131.6/131.5, 129.7, 128.21/128.20, 102.34/102.32, 101.7, 100.0/99.9, 93.8, 73.3/73.2, 70.7, 70.4, 70.07, 70.06/70.04, 69.82, 69.79/69.78, 69.68/69.67, 53.4, 52.5, 51.9, 49.60/49.58, 39.6, 38.8, 38.0, 32.01/32.00, 31.28/31.27, 30.43/30.41, 30.0, 29.6, 27.7, 26.34/26.32, 25.0/24.9, 23.2, 22.83/22.81, 19.9, 17.8, 14.05/14.03, 12.0, 11.50/11.48, 11.3/11.2. Note: Amide, amine, and core NH protons were not observed, likely due to chemical exchange. Minor <sup>1</sup>H impurity peaks were observed at various chemical shifts. The impurity at 1.23 ppm (likely grease CH<sub>2</sub>) is somewhat larger.</div><div class="NLM_p">To a solution of compound <b>40</b> (40 mg, 0.0431 mmol) and 3-aminobenzyl acetic acid <b>41</b> (16.92 mg, 0.0646 mmol) in 10 mL of dry DMF, (benzotriazol-1-yloxy)tris(dimethylamino) phosphonium hexafluorophosphate (BOP, 38.1 mg, 0.0861 mmol) and two drops of triethylamine were added. The reaction mixture was stirred at room temperature under an Ar atmosphere for overnight. It was then diluted with dichloromethane (20 mL), washed with water (3 × 20 mL), dried over anhydrous sodium sulfate, and concentrated down to yield the crude product, which was purified by a silica column by using 6% methanol in dichloromethane to obtain pure product <b>42</b> with 82% yield (41.42 mg). MS (ESI) <i>m</i>/<i>z</i>: 1173.54 (M + H<sup>+</sup>). For the characterization details, including the <sup>1</sup>H and <sup>13</sup>C-NMR spectra, please see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01735/suppl_file/jm0c01735_si_001.pdf" class="ext-link">Supporting Information</a>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ ppm): 9.95/9.93 (1H, s, meso 5-H), 9.72 (1H, s, meso 10-H), 8.78/8.77 (1H, s, meso 20-H), 7.33 (1H, dt, <i>J</i> = 7.8, ∼1.3 Hz, phenyl H), 7.27 (1H, m, phenyl H), 7.19 (1H, t, <i>J</i> ∼5 Hz, amide NH), 6.76 (1H, d, <i>J</i> = 7.6 Hz, phenyl H), 6.68 (1H, t, <i>J</i> = 7.7 Hz, phenyl H), 5.96/5.95 (1H, q, <i>J</i> = 6.6 Hz, 3<sup>1</sup>-H), 5.62/5.60 (1H, d, <i>J</i> = 19.0 Hz, 15-C<i>H</i>H), 5.20–5.33 (2H, m, 15-CH<i>H</i> and amide NH), 4.46 (1H, q, <i>J</i> = 7.2 Hz, 18-H), 4.37 (1H, m, 17-H), 4.02 (1H, m, −NHC<i>H</i>HCH<sub>2</sub>CH<sub>2</sub>O−), 3.82 (2H, q, <i>J</i> = 7.7 Hz, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.80/3.79 (3H, s, −COOCH<sub>3</sub>), ∼3.77 (1H, m, −NHCH<i>H</i>CH<sub>2</sub>CH<sub>2</sub>O−), 3.74 (2H, m, −NH(CH<sub>2</sub>)<sub>2</sub>C<i>H</i><sub>2</sub>O−), 3.57–3.70 (2H, m, −OC<i>H</i><sub>2</sub>(CH<sub>2</sub>)<sub>4</sub>CH<sub>3</sub>), 3.622/3.621 (3H, s, −COOCH<sub>3</sub>), 3.58 (3H, s, 12-CH<sub>3</sub>), 3.56 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>O−), 3.46/3.45 (3H, s, 2-CH<sub>3</sub>), ∼3.37 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>O−), 3.34 (3H, s, 7-CH<sub>3</sub>), 2.87/2.86 (1H, d, <i>J</i> = 15.1 Hz, −C<i>H</i>H–phenyl−), 2.82 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>O−), 2.81/2.80 (1H, d, <i>J</i> = 15.1 Hz, −CH<i>H</i>–phenyl−), 2.47–2.65 (3H, m, −NHC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>O– and17-CH<sub>2</sub>C<i>H</i>H−), 2.32–2.47 (4H, m, −NHCH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>O– and −OC<i>H</i><sub>2</sub>CH<sub>2</sub>O−), 2.05–2.27 (4H, m, 17-C<i>H</i>HCH<i>H–</i> and −NHCH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>O−), 2.13/2.11 (3H, d, <i>J</i> = 6.6 Hz, 3<sup>1</sup>-CH<sub>3</sub>), 1.67–1.83 (3H, m, 17-CH<i>H</i>CH<sub>2</sub>– and −OCH<sub>2</sub>C<i>H</i><sub>2</sub>(CH<sub>2</sub>)<sub>3</sub>CH<sub>3</sub>), 1.73 (3H, t, <i>J</i> = 7.6 Hz, 8-CH<sub>2</sub>C<i>H</i><sub>3</sub>), 1.70/1.69 (3H, d, <i>J</i> = 7.2 Hz, 18-CH<sub>3</sub>), 1.29–1.47 (2H, m, −O(CH<sub>2</sub>)<sub>2</sub>C<i>H</i><sub>2</sub>(CH<sub>2</sub>)<sub>2</sub>CH<sub>3</sub>), 1.23 (4H, m, −O(CH<sub>2</sub>)<sub>3</sub>(C<i>H</i><sub>2</sub>)<sub>2</sub>CH<sub>3</sub>), 0.86 (2H, m, −NHCH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>O−), 0.79/0.78 (3H, t, <i>J</i> = 6.9 Hz, −O(CH<sub>2</sub>)<sub>5</sub>C<i>H</i><sub>3</sub>), −1.67 (1H, br s, core NH), −1.88 (1H, s, core NH); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>, δ ppm): 173.9, 173.5, 169.5, 169.3, 168.8, 166.7, 154.0, 149.0, 144.7, 138.90/138.89, 138.8/138.7, 137.8, 137.4, 136.3, 135.8, 134.99/134.97, 134.7, 134.3/134.1, 130.8/130.7, 130.0, 129.7, 128.63/128.62, 128.2, 102.35/102.33, 101.3, 99.7/99.6, 94.3, 93.2, 73.0/72.9, 70.4, 70.35, 70.33, 70.0, 69.72/69.69, 69.13, 69.13/69.11, 53.1, 52.1, 51.6, 49.29/49.26, 42.52/42.51, 39.1, 37.7, 37.50/37.48, 31.78/31.77, 31.1, 30.3/30.2, 29.7, 29.2, 28.0, 26.11/26.09, 25.0/24.9, 23.0, 22.59/22.57, 19.7, 17.8, 13.99/13.97, 12.0, 11.4, 11.2/11.1. Note: <sup>1</sup>H impurity peaks were observed at 1.26 (likely grease CH<sub>2</sub>) and 0.87 ppm (likely grease CH<sub>3</sub>).</div><div class="NLM_p last">Triphenylarsine (6.27 mg, 0.0205 mmol) and Pd<sub>2</sub>dba<sub>3</sub> (9.37 mg, 0.0102 mmol) were added to a stirred solution of compound <b>42</b> (30 mg, 0.0256 mmol) and erlotinib <b>1</b> (15.09 mg, 0.0384 mmol) in dry THF (15 mL) and Et<sub>3</sub>N (2 mL). The reaction mixture was stirred at room temperature under an argon atmosphere overnight. The solvent evaporated and diluted with dichloromethane (20 mL), washed with water (3 × 20 mL), dried over anhydrous sodium sulfate, and concentrated to yield crude product <b>43</b>. It was purified by preparative TLC plates, and the pure compound was isolated in 65% yield (24 mg). MS (ESI) <i>m</i>/<i>z</i>: 1438.81 (M + H<sup>+</sup>). HRMS (ESI): calcd. for C<sub>82</sub>H<sub>104</sub>N<sub>9</sub>O<sub>14</sub> (M + H<sup>+</sup>) 1438.8131; found, 1438.8136. UV–vis (CH<sub>3</sub>OH, λ<sub>max</sub>, nm (abs)): 653 (5.3 × 10<sup>4</sup>), 497 (1.4 × 10<sup>4</sup>), 395 (1.6 × 10<sup>5</sup>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ ppm): 9.95/9.93 (1H, s, meso 5-H), 9.67 (1H, s, meso 10-H), 8.768/8.765 (1H, s, meso 20-H), 8.63 (1H, s, pyrimidine H), 8.01 (1H, br s, amine NH), 7.83 (1H, m, phenyl H), 7.65 (1H, m, phenyl H), 7.40 (1H, s, quinazoline 5-H), 7.25–7.31 (3H, m, amide NH and 2 × phenyl H), 7.15–7.19 (2H, m, 2 × phenyl H), 7.07 (1H, s, quinazoline 8-H), 7.06 (1H, t, <i>J</i> = 7.6 Hz, phenyl H), 6.91 (1H, m, phenyl H), 5.962/5.958 (1H, q, <i>J</i> = 6.7 Hz, 3<sup>1</sup>-H), 5.70/5.69 (1H, t, <i>J</i> ∼5.6 Hz, amide NH), 5.58/5.57 (1H, d, <i>J</i> = 18.9 Hz, 15-C<i>H</i>H), 5.28/5.27 (1H, d, <i>J</i> = 18.9 Hz, 15-CH<i>H</i>), 4.45 (1H, q, <i>J</i> = 7.2 Hz, 18-H), 4.35 (1H, d, <i>J</i> ∼10 Hz, 17-H), 4.05 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 4.02 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 3.94 (1H, m, −NHC<i>H</i>HCH<sub>2</sub>CH<sub>2</sub>O−), 3.80 (2H, q, <i>J</i> = 7.6 Hz, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.753/3.750 (3H, s, −COOCH<sub>3</sub>), ∼3.73 (1H, m, −NHCH<i>H</i>CH<sub>2</sub>CH<sub>2</sub>O−), ∼3.67 (2H, m, −NH(CH<sub>2</sub>)<sub>2</sub>C<i>H</i><sub>2</sub>O−), ∼3.65 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), ∼3.64 (2H, m, −OC<i>H</i><sub>2</sub>(CH<sub>2</sub>)<sub>4</sub>CH<sub>3</sub>), 3.606/3.603 (3H, s, −COOCH<sub>3</sub>), ∼3.53 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>O−), 3.525 (3H, s, ring CH<sub>3</sub>), 3.46/3.45 (3H, s, ring CH<sub>3</sub>), 3.36–3.43 (4H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub> and −OC<i>H</i><sub>2</sub>CH<sub>2</sub>O−), 3.347/3.345 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.33 (3H, s, ring CH<sub>3</sub>), 3.17/3.16 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.10 (2H, m, −C<i>H</i><sub>2</sub>–phenyl−), 2.89 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>O−), 2.67–2.85 (2H, m, −NHC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>O−), 2.42–2.61 (5H, m, 17-CH<sub>2</sub>C<i>H</i>H– and 2 × −OC<i>H</i><sub>2</sub>CH<sub>2</sub>O−), 2.08–2.24 (2H, m, 17-C<i>H</i>HCH<i>H</i>−), 2.13/2.12 (3H, d, <i>J</i> = 6.6 Hz, 3<sup>1</sup>-CH<sub>3</sub>), 2.07 (2H, m, −NHCH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>O−), ∼1.77 (1H, m, 17-CH<i>H</i>CH<sub>2</sub>−), ∼1.75 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>(CH<sub>2</sub>)<sub>3</sub>CH<sub>3</sub>), 1.73 (3H, t, <i>J</i> = 7.7 Hz, 8-CH<sub>2</sub>C<i>H</i><sub>3</sub>), 1.69/1.68 (3H, d, <i>J</i> = 7.2 Hz, 18-CH<sub>3</sub>), 1.29–1.47 (2H, m, −O(CH<sub>2</sub>)<sub>2</sub>C<i>H</i><sub>2</sub>(CH<sub>2</sub>)<sub>2</sub>CH<sub>3</sub>), 1.23 (4H, m, −O(CH<sub>2</sub>)<sub>3</sub>(C<i>H</i><sub>2</sub>)<sub>2</sub>CH<sub>3</sub>), 1.03 (2H, m, −NHCH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>O−), 0.79/0.78 (3H, distorted t, <i>J</i> ∼6.8 Hz, −O(CH<sub>2</sub>)<sub>5</sub>C<i>H</i><sub>3</sub>), −1.66 (1H, s, core NH), −1.89 (1H, s, core NH); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>, δ ppm): 173.9, 173.53/173.52, 170.1, 169.5, 168.91/168.90, 166.61/166.60, 156.4, 154.4, 154.1, 153.5, 149.0, 148.8, 147.5, 144.7, 139.1, 138.89/138.88, 138.8/138.7, 136.2, 135.4, 134.88/134.86, 134.6, 134.3/134.1, 132.2, 130.9/130.7, 130.1, 129.6, 129.1, 128.8, 128.6, 128.4/128.3, 126.9, 124.7, 123.6, 123.5, 122.1, 109.3, 108.6, 102.7, 102.23/102.21, 101.3, 99.63/99.57, 93.2, 89.6, 89.2, 72.9/72.8, 70.6, 70.35, 70.31, 70.29, 70.2, 70.0, 69.69/69.67, 69.31/69.29, 69.22/69.21, 69.0, 68.1, 59.1, 59.0, 53.0, 52.1, 51.6, 49.24/49.21, 43.1, 39.1, 37.74/37.73, 37.71, 31.75/31.74, 31.10/31.08, 30.23/30.21, 29.7, 29.2, 28.1, 26.09/26.07, 25.0/24.9, 23.0, 22.57/22.55, 19.7, 17.7, 13.97/13.95, 12.0, 11.39/11.38, 11.12/11.08. Note: <sup>1</sup>H impurity peaks were observed at 1.27 (likely grease CH<sub>2</sub>) and 0.89 ppm (likely grease CH<sub>3</sub>).</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Synthesis of Conjugate (<b>50</b>)</h3><div class="NLM_p">Methyl pheophorbide-a <b>44</b> (200 mg, 0.330 mmol) and amine <b>45</b> (95.8 mg, 0.66 mmol) were dissolved in 12 mL of dry THF. The reaction mixture was stirred at room temperature under an argon atmosphere overnight. The solvent was evaporated, and the crude product was dissolved in 15 mL of 70% TFA/DCM. The reaction mixture was stirred for 2 h, and the solvent was evaporated and diluted with dichloromethane (20 mL) and adjusted the pH to 6.6 by using saturated NaHCO<sub>3</sub> solution. The crude was purified by a silica column by using 5% methanol in dichloromethane to obtain pure product <b>46</b> with over 71% yield (156 mg). MS (ESI) <i>m</i>/<i>z</i>: 667.36 (M + H<sup>+</sup>).</div><div class="NLM_p">Compound <b>46</b> (120 mg, 0.18 mmol) was reacted with diglycolic anhydride (41.78 mg, 0.36 mmol) in 5 mL of DMF. The reaction mixture was stirred for 5 h yielding the intermediate carboxylic acid, which was activated twice with 0.5 M CDI (58. 36 mg, 0.36 mmol) for 1 h, followed by agitating with 0.5 M HOBt (48.64 mg, 0.36 mmol) and di-(3-aminopropyl) digol (396.47 mg, 1.8 mmol) for 5 h to afford PS-linker NH<sub>2</sub>. The crude product was purified by a silica column by using 20% methanol in dichloromethane to obtain pure product <b>47</b> with 59% yield (104.4 mg). MS (ESI) <i>m</i>/<i>z</i>: 983.56 (M + H<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, 80:20 CDCl<sub>3</sub>/CD<sub>3</sub>OD, δ ppm): 9.68 (1H, s, meso 10-H), 9.61 (1H, s, meso 5-H), 8.85 (1H, s, meso 20-H), 8.04 (1H, dd, <i>J</i> = 17.8, 11.5 Hz, 3-C<i>H</i>═CH<sub>2</sub>), 6.31 (1H, dd, <i>J</i> = 17.8, 1.3 Hz, 3-CH═C<i>H</i>H), 6.13 (1H, dd, <i>J</i> = 11.5, 1.3 Hz, 3-CH═CH<i>H</i>), 5.51 (1H, d, <i>J</i> = 19.0 Hz, 15-C<i>H</i>H), 5.28 (1H, d, <i>J</i> = 19.0 Hz, 15-CH<i>H</i>), 4.51 (1H, q, <i>J</i> = 7.2 Hz, 18-H), 4.36 (1H, m, 17-H), 4.14 (2H, s, −C(═O)C<i>H</i><sub>2</sub>OCH<sub>2</sub>C(═O)−), 4.03 (2H, s, −C(═O)CH<sub>2</sub>OC<i>H</i><sub>2</sub>C(═O)−), ∼3.95 (1H, m, −NHC<i>H</i>HCH<sub>2</sub>NH−), ∼3.87 (1H, m, −NHCH<i>H</i>CH<sub>2</sub>NH−), 3.78 (3H, s, −COOCH<sub>3</sub>), ∼3.76 (2H, q, <i>J</i> = 7.5 Hz, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), ∼3.73 (2H, m, −NHCH<sub>2</sub>C<i>H</i><sub>2</sub>NH−), 3.64 (3H, s, −COOCH<sub>3</sub>), 3.49 (3H, s, ring CH<sub>3</sub>), 3.46 (3H, s, ring CH<sub>3</sub>), 3.28 (3H, s, ring CH<sub>3</sub>), 2.92 (2H, m, −NHCH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>O−), 2.83 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>O−), 2.65 (1H, m, 17-CH<sub>2</sub>C<i>H</i>H−), 2.51 (2H, m, −NHC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>O−), 2.50 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>O−), 2.36 (2H, m, −NHC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>O−), ∼2.27 (1H, m, 17-CH<sub>2</sub>CH<i>H</i>−), ∼2.21 (1H, m, 17-C<i>H</i>HCH<sub>2</sub>−), ∼2.15 (1H, m, −OC<i>H</i>HCH<sub>2</sub>O−), ∼2.09 (1H, m, −OCH<i>H</i>CH<sub>2</sub>O−), ∼2.08 (1H, m, −OC<i>H</i>HCH<sub>2</sub>O−), ∼2.02 (1H, m, −NHCH<sub>2</sub>CH<sub>2</sub>C<i>H</i>HO−), ∼1.97 (1H, m, −OCH<i>H</i>CH<sub>2</sub>O−), ∼1.88 (1H, m, −NHCH<sub>2</sub>CH<sub>2</sub>CH<i>H</i>O−), ∼1.73 (1H, m, 17-CH<i>H</i>CH<sub>2</sub>−), 1.703 (3H, t, <i>J</i> = 7.5 Hz, 8-CH<sub>2</sub>C<i>H</i><sub>3</sub>), 1.695 (3H, d, <i>J</i> = 7.1 Hz, 18-CH<sub>3</sub>), ∼1.25 (2H, m, −NHCH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>O−), ∼0.80 (1H, m, −NHCH<sub>2</sub>C<i>H</i>HCH<sub>2</sub>O−), ∼0.68 (1H, m, −NHCH<sub>2</sub>CH<i>H</i>CH<sub>2</sub>O−); <sup>13</sup>C NMR (100 MHz, 80:20 CDCl<sub>3</sub>/CD<sub>3</sub>OD, δ ppm): 174.5, 174.4, 172.4, 170.4, 170.0, 169.8, 167.6, 154.9, 149.5, 145.5, 139.5, 136.9, 135.4, 135.3, 135.1, 134.8, 131.1, 129.8, 129.5, 128.0, 122.5, 102.6, 101.8, 99.1, 94.3, 70.63, 70.57, 69.7, 69.3, 69.1, 68.9, 68.7, 67.8, 53.5, 52.6, 52.0, 49.6, 41.3, 40.1, 39.6, 37.9, 36.2, 31.4, 30.1, 28.7, 26.5, 23.3, 19.9, 17.9, 12.3, 11.9, 11.4. Note: Amide, amine, and core NH protons were not observed, likely due to chemical exchange. <sup>1</sup>H impurity peaks were observed at 1.23 (likely grease CH<sub>2</sub>) and 0.85 ppm (likely grease CH<sub>3</sub>). The <sup>13</sup>C peak at 30.0 ppm is likely grease (CH<sub>2</sub>) impurity.</div><div class="NLM_p">To a solution of compound <b>47</b> (80 mg, 0.0814 mmol) and 3-idobenzyl acetic acid <b>48</b> (32 mg, 0.122 mmol) in 12 mL of dry DMF, (benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate (BOP, 72.1 mg, 0.163 mmol) and three drops of triethylamine were added. The reaction mixture was stirred at room temperature under an Ar atmosphere overnight. It was then diluted with dichloromethane (20 mL), washed with water (3 × 20 mL), dried over anhydrous sodium sulfate, and concentrated down to yield the crude product, which was purified by a silica column by using 6% methanol in dichloromethane to obtain pure product <b>49</b> with 79% yield (78.9 mg). MS (ESI) <i>m</i>/<i>z</i>: 1227.51 (M + H<sup>+</sup>). NMR (400 MHz, CDCl<sub>3</sub>, δ ppm): 9.57 (1H, s, meso 10-H), 9.46 (1H, s, meso 5-H), 8.79 (1H, s, meso 20-H), 8.21 (1H, t, <i>J</i> = 4.2 Hz, amide NH), 7.86 (1H, dd, <i>J</i> = 17.8, 11.5 Hz, 3-C<i>H</i>═CH<sub>2</sub>), 7.44 (1H, t, <i>J</i> = 5.7 Hz, amide NH), 7.373 (1H, m, phenyl H), 7.368 (1H, m, phenyl H), 7.00 (1H, bs, amide NH), 6.90 (1H, d, <i>J</i> = 7.8 Hz, phenyl H), 6.75 (1H, dd, <i>J</i> = 8.2, 7.7 Hz, phenyl H), 6.12 (1H, d, <i>J</i> = 18.0 Hz, 3-CH═C<i>H</i>H), 6.07 (1H, t, <i>J</i> ∼5.0 Hz, amide NH), 5.96 (1H, d, <i>J</i> = 11.5 Hz, 3-CH═CH<i>H</i>), 5.32 (1H, d, <i>J</i> = 18.8 Hz, 15-C<i>H</i>H), 5.17 (1H, d, <i>J</i> = 18.8 Hz, 15-CH<i>H</i>), 4.49 (1H, q, <i>J</i> = 7.2 Hz, 18-H), 4.35 (1H, m, 17-H), 4.06, 4.04 (2H, ABq, <i>J</i><sub>AB</sub> = 14.8 Hz, −C(═O)C<i>H</i><sub>2</sub>OCH<sub>2</sub>C(═O)−), 3.98 (2H, s, −C(═O)CH<sub>2</sub>OC<i>H</i><sub>2</sub>C(═O)−), 3.71 (2H, m, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.70 (3H, s, −COOCH<sub>3</sub>), 3.67 (3H, s, −COOCH<sub>3</sub>), 3.59 (1H, br s, −NHC<i>H</i>HCH<sub>2</sub>NH−), 3.49 (1H, br s, −NHCH<i>H</i>CH<sub>2</sub>NH−), 3.358 (1H, br s, −NHCH<sub>2</sub>C<i>H</i>HNH−), 3.356 (3H, s, 2-CH<sub>3</sub>), 3.29 (1H, br s, −NHCH<sub>2</sub>CH<i>H</i>NH−), 3.24 (3H, s, 12-CH<sub>3</sub>), 3.12 (3H, s, 7-CH<sub>3</sub>), 3.06, 3.03 (2H, ABq, <i>J</i><sub>AB</sub> = 15.1 Hz, −C(═O)C<i>H</i><sub>2</sub>–phenyl-I), 2.99 (2H, t, <i>J</i> = 5.8 Hz, −NHCH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>O−), 2.91 (2H, m, −NHC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>O−), 2.90 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>O−), 2.74 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>O−), ∼2.65 (1H, m, 17-CH<sub>2</sub>C<i>H</i>H−), 2.59 (2H, q, <i>J</i> = 6.5 Hz, −NHC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>O−), 2.41 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>O−), ∼2.30 (1H, m, 17-CH<sub>2</sub>CH<i>H</i>−), 2.25 (1H, m, 17-C<i>H</i>HCH<sub>2</sub>−), ∼2.22 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>O−), ∼2.23, ∼2.14 (2H, 2 × m, −NHCH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>O−), 1.81 (1H, m, 17-CH<i>H</i>CH<sub>2</sub>−), 1.70 (3H, d, <i>J</i> = 7.2 Hz, 18-CH<sub>3</sub>), 1.68 (3H, t, <i>J</i> = 7.6 Hz, 8-CH<sub>2</sub>C<i>H</i><sub>3</sub>), 1.30 (2H, m, −NHCH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>O−), 0.79 (2H, m, −NHCH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>O−), −1.66 (1H, s, core NH), −1.85 (1H, s, core NH); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>, δ ppm): 173.6, 173.5, 171.5, 170.1, 169.2, 169.1, 168.2, 166.8, 154.4, 149.0, 144.8, 139.0, 137.9, 137.5, 136.3, 135.8, 134.9, 134.6, 134.5, 134.3, 130.4, 130.1, 129.4, 129.0, 128.3, 127.2, 121.7, 102.1, 101.4, 98.7, 94.3, 93.8, 70.7, 70.6, 69.5, 69.4, 69.30, 69.27, 68.8, 68.1, 53.1, 52.2, 51.7, 49.2, 42.7, 41.0, 39.6, 37.8, 37.4, 36.3, 31.1, 29.7, 28.32, 28.30, 23.0, 19.6, 17.7, 12.0, 11.5, 11.2. Note: <sup>1</sup>H impurity peaks were observed at 1.27 ppm (likely grease CH<sub>2</sub>) and 0.86 ppm (likely grease CH<sub>3</sub>). The <sup>13</sup>C peak at 29.68 ppm is likely grease (CH<sub>2</sub>) impurity.</div><div class="NLM_p last">Triphenylarsine (9.97 mg, 0.0326 mmol) and Pd<sub>2</sub>dba<sub>3</sub> (14.9 mg, 0.017 mmol) were added to a stirred solution of compound <b>49</b> (50 mg, 0.0407 mmol) and erlotinib <b>1</b> (24 mg, 0.0611 mmol) in dry THF (15 mL) and Et<sub>3</sub>N (2 mL). The reaction mixture was stirred at room temperature under an argon atmosphere overnight. The solvent evaporated and diluted with dichloromethane (20 mL), washed with water (3 × 20 mL), dried over anhydrous sodium sulfate, and concentrated to yield crude product <b>50</b>. The crude <b>50</b> was purified by preparative TLC plates in 63% yield (38.32 mg). MS (ESI) <i>m</i>/<i>z</i>: 1492.7621 (M + H<sup>+</sup>). HRMS (ESI): calcd. for C<sub>83</sub>H<sub>102</sub>N<sub>11</sub>O<sub>5</sub> (M + H<sup>+</sup>) 1492.7621; found, 1492.7626. UV–vis (CH<sub>3</sub>OH, λ<sub>max</sub>, nm (abs)): 663 (5.25 × 10<sup>4</sup>), 610 (5.0 × 10<sup>3</sup>), 498 (1.4 × 10<sup>4</sup>), 400 (1.6 × 10<sup>5</sup>), 350 (5.4 × 10<sup>4</sup>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ ppm): 9.58 (1H, s, meso 10-H), 9.54 (1H, s, meso 5-H), 8.77 (1H, s, meso 20-H), 8.60 (1H, s, pyrimidine H), 8.31 (1H, br t, <i>J</i> = 4.6 Hz, −N<i>H</i>CH<sub>2</sub>CH<sub>2</sub>NH−), 8.17 (1H, s, amine NH), 7.98 (1H, dd, <i>J</i> = 17.8, 11.6 Hz, 3-C<i>H</i>═CH<sub>2</sub>), 7.88 (1H, m, phenyl H), 7.65 (1H, m, phenyl H), 7.50 (1H, br t, <i>J</i> = 5.7 Hz, −N<i>H</i>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>O−), 7.45 (1H, s, quinazoline 5-H), 7.40 (1H, br t, <i>J</i> ∼5.5 Hz, −NHCH<sub>2</sub>CH<sub>2</sub>N<i>H</i>−), 7.29 (1H, s, phenyl H), 7.22–7.28 (2H, m, 2 × phenyl H), 7.17 (1H, d, <i>J</i> = 7.7 Hz, phenyl H), 7.10 (1H, s, quinazoline 8-H), 7.06 (1H, t, <i>J</i> = 7.7 Hz, phenyl H), 6.97 (1H, d, <i>J</i> = 7.7 Hz, phenyl H), 6.33 (1H, t, <i>J</i> = 5.4 Hz, −N<i>H</i>CH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>O−), 6.26 (1H, d, <i>J</i> = 17.9 Hz, 3-CH═C<i>H</i>H), 6.07 (1H, dd, <i>J</i> = 11.6, 1.0 Hz, 3-CH═CH<i>H</i>), 5.42 (1H, d, <i>J</i> = 18.8 Hz, 15-C<i>H</i>H), 5.21 (1H, d, <i>J</i> = 18.8 Hz, 15-CH<i>H</i>), 4.44 (1H, q, <i>J</i> = 7.2 Hz, 18-H), 4.32 (1H, dd, <i>J</i> = 10.1, ∼1.4 Hz, 17-H), 4.11 (4H, m, 2 × −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 4.09, 4.08 (2H, ABq, <i>J</i><sub>AB</sub> = 15.1 Hz, −C(═O)C<i>H</i><sub>2</sub>OCH<sub>2</sub>C(═O)−), 3.98 (2H, s, −C(═O)CH<sub>2</sub>OC<i>H</i><sub>2</sub>C(═O)−), ∼3.7–3.8 (6H, m, −NHC<i>H</i><sub>2</sub>CH<sub>2</sub>NH– and 8-C<i>H</i><sub>2</sub>CH<sub>3</sub> and −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.70 (3H, s, −COOCH<sub>3</sub>), 3.622 (3H, s, −COOCH<sub>3</sub>), 3.621 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.57 (2H, m, −NHCH<sub>2</sub>C<i>H</i><sub>2</sub>NH−), 3.43 (3H, s, ring CH<sub>3</sub>), 3.39 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.36 (3H, s, ring CH<sub>3</sub>), 3.28 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.22 (3H, s, ring CH<sub>3</sub>), 3.20 (2H, s, −C<i>H</i><sub>2</sub>–phenyl-I), 2.95–3.03 (4H, m, −NHCH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>O– and −OC<i>H</i><sub>2</sub>CH<sub>2</sub>O−), 2.93 (2H, m, −NHC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>O−), 2.88 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>O−), 2.70 (2H, q, <i>J</i> ∼6.5 Hz, −NHC<i>H</i><sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>O−), 2.64 (2H, t, <i>J</i> ∼4.6 Hz, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>O−), ∼2.58 (1H, m, 17-CH<sub>2</sub>C<i>H</i>H−), 2.45 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>O−), ∼2.37 (2H, m, −NHCH<sub>2</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>O−), 2.13–2.27 (2H, m, 17-C<i>H</i>HCH<i>H</i>−), ∼1.74 (1H, m, 17-CH<i>H</i>CH<sub>2</sub>−), 1.69 (3H, t, <i>J</i> = 7.7 Hz, 8-CH<sub>2</sub>C<i>H</i><sub>3</sub>), 1.68 (3H, d, <i>J</i> = 7.1 Hz, 18-CH<sub>3</sub>), 1.29 (2H, m, −NHCH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>O−), 0.93 (2H, m, −NHCH<sub>2</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>O−), −1.63 (1H, s, core NH), −1.85 (1H, s, core NH); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>, δ ppm): 173.8, 173.5, 171.4, 170.6, 169.5, 169.1, 168.5, 166.8, 156.4, 154.5, 154.4, 153.6, 149.1, 148.7, 147.5, 144.9, 139.3, 139.1, 136.2, 135.6, 135.0, 134.7, 134.6, 134.4, 132.2, 130.4, 130.0, 129.5, 129.23, 129.18, 128.9, 128.6, 127.3, 126.7, 124.4, 123.4, 123.3, 122.0, 121.8, 109.4, 108.7, 103.3, 102.0, 101.4, 98.8, 93.8, 89.6, 89.2, 70.8, 70.75, 70.73, 70.4, 69.7, 69.50, 69.47, 69.4, 69.1, 69.0, 68.3, 68.2, 59.2, 59.1, 53.0, 52.2, 51.7, 49.2, 43.1, 40.8, 40.0, 37.8, 37.6, 36.5, 31.1, 29.7, 28.4, 28.3, 23.0, 19.6, 17.7, 12.1, 11.7, 11.3. Note: <sup>1</sup>H impurity peaks were observed at 1.26 (likely grease CH<sub>2</sub>) and 0.86 ppm (likely grease CH<sub>3</sub>).</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Synthesis of Conjugate (<b>53</b>)</h3><div class="NLM_p">Chlorin e<sub>6</sub><b>51</b> (100 mg, 0.168 mmol) was dissolved in dry CH<sub>2</sub>Cl<sub>2</sub>. Amounts of 35 mg DCC and 4.5 mg DMAP were added and allowed to stir until completely dissolved. After 3 h, 42 mg of 3-idobenzyl amine <b>6</b> and 15 uL of DIEA were mixed in CH<sub>2</sub>Cl<sub>2</sub> and added to the reaction mixture. The reaction was allowed to stir overnight, diluted with CH<sub>2</sub>Cl<sub>2</sub>, and then washed with 5% aqueous citric acid, followed by washing with brine and water. It was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and then evaporated. The residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> and treated with ethereal diazomethane. The residue was dissolved in 2% MeOH/CH<sub>2</sub>Cl<sub>2</sub> and purified via silica gel column chromatography using the same mobile phase to yield compound <b>52</b> with 51% yield (71.8 mg). MS (ESI) <i>m</i>/<i>z</i>: 840.28 (M + H<sup>+</sup>). For the characterization details, including the <sup>1</sup>H and <sup>13</sup>C-NMR spectra, please see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01735/suppl_file/jm0c01735_si_001.pdf" class="ext-link">Supporting Information</a>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ ppm): 9.73 (1H, s, meso 10-H), 9.57 (1H, s, meso 5-H), 8.76 (1H, s, meso 20-H), 8.04 (1H, dd, <i>J</i> = 17.9, 11.5 Hz, −C<i>H</i>═CH<sub>2</sub>), 7.42 (1H, br s, phenyl H), 7.38 (1H, dt, <i>J</i> = 7.8, ∼1.3 Hz, phenyl H), 6.98 (1H, d, <i>J</i> = 7.7 Hz, phenyl H), 6.77 (1H, t, <i>J</i> = 7.8 Hz, phenyl H), 6.35 (1H, dd, <i>J</i> = 17.9, 1.4 Hz, −CH═C<i>H</i>H), 6.15 (1H, dd, <i>J</i> = 11.6, 1.4 Hz, −CH═CH<i>H</i>), 5.92 (1H, br s, amide NH), 5.30 (1H, d, <i>J</i> = 18.6 Hz, 15-C<i>H</i>H−), 5.19 (1H, br d, <i>J</i> = 18.6 Hz, 15-CH<i>H</i>−), 4.38–4.49 (3H, m, 18-H and 17-H and −NHC<i>H</i>H–phenyl−), 4.26 (3H, s, −COOCH<sub>3</sub>), 4.18 (1H, dd, <i>J</i> = 15.0, 5.7 Hz, −NHCH<i>H</i>–phenyl−), 3.78 (2H, q, <i>J</i> = 7.6 Hz, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.62 (3H, s, ring CH<sub>3</sub>), 3.49 (3H, br s, −COOCH<sub>3</sub>), 3.47 (3H, s, ring CH<sub>3</sub>), 3.29 (3H, s, ring CH<sub>3</sub>), ∼2.57 (1H, m, 17-CH<sub>2</sub>C<i>H</i>H−), ∼2.26 (1H, m, 17-C<i>H</i>HCH<sub>2</sub>−), ∼2.22 (1H, m, 17-CH<sub>2</sub>CH<i>H</i>−), ∼1.80 (1H, m, 17-CH<i>H</i>CH<sub>2</sub>−), 1.73 (3H, t, <i>J</i> = 7.6 Hz, 8-CH<sub>2</sub>C<i>H</i><sub>3</sub>), 1.60 (3H, d, <i>J</i> = 7.2 Hz, 18-CH<sub>3</sub>), −1.36 (1H, br s, core NH), −1.50 (1H, s, core NH); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>, δ ppm): 173.2, 172.2, 169.8, 169.4, 166.9, 155.1, 149.2, 145.2, 140.6, 139.7, 136.5, 136.3, 136.20, 136.15, 135.5, 135.0, 134.7, 130.8, 129.9, 129.5, 129.2, 127.0, 124.0, 122.0, 102.4, 101.5, 99.0, 94.2, 93.7, 53.4, 52.9, 51.7, 49.1, 42.9, 41.0, 31.2, 29.8, 23.1, 19.6, 17.7, 12.4, 12.1, 11.3. Note: <sup>1</sup>H impurity peaks at 1.27 (likely grease CH<sub>2</sub>) 0.89 ppm (likely grease CH<sub>3</sub>) were observed.</div><div class="NLM_p last">Triphenylarsine (11.69 mg, 0.039 mmol) and Pd<sub>2</sub>dba<sub>3</sub> (17.48 mg, 0.0191 mmol) were added to a stirred solution of compound <b>52</b> (40 mg, 0.048 mmol) and erlotinib <b>1</b> (28.32 mg, 0.072 mmol) in dry THF (12 mL) and Et<sub>3</sub>N (2 mL). The reaction mixture was stirred at room temperature under an argon atmosphere overnight. The solvent evaporated and diluted with dichloromethane (20 mL), washed with water (3 × 20 mL), dried over anhydrous sodium sulfate, and concentrated to yield crude product <b>53</b>, which was purified by preparative TLC plates with 45% yield (23.7 mg). MS (ESI) <i>m</i>/<i>z</i>: 1105.52 (M + H<sup>+</sup>). HRMS (ESI): calcd. for C<sub>65</sub>H<sub>69</sub>N<sub>8</sub>O<sub>9</sub> (M + H<sup>+</sup>) 1105.5242; found, 1105.5249. UV–vis (CH<sub>3</sub>OH, λ<sub>max</sub>, nm (ε)): 663 (3.6 × 10<sup>4</sup>), 610 (4.3 × 10<sup>3</sup>), 500 (1.0 × 10<sup>4</sup>), 400 (1.2 × 10<sup>5</sup>), 349 (4.3 × 10<sup>4</sup>). For the characterization details, including the <sup>1</sup>H and <sup>13</sup>C-NMR spectra, please see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c01735/suppl_file/jm0c01735_si_001.pdf" class="ext-link">Supporting Information</a>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>, δ ppm): 9.69 (1H, s, meso 10-H), 9.54 (1H, s, meso 5-H), 8.71 (1H, s, meso 20-H), 8.63 (1H, s, pyrimidine H), 8.01 (1H, dd, <i>J</i> = 17.8, 11.6 Hz, 3-C<i>H</i>═CH<sub>2</sub>), 7.86 (1H, dd, <i>J</i> = 8.1, ∼1.3 Hz, phenyl H), 7.66 (1H, s, phenyl H), 7.43 (1H, br s, amine NH), 7.33 (1H, t, <i>J</i> ∼7.9 Hz, phenyl H), 7.32 (1H, s, phenyl H), 7.23 (1H, d, <i>J</i> = 7.6 Hz, phenyl H), 7.20 (2H, s, quinazoline 5-H and quinazoline 8-H), 7.17 (1H, d, <i>J</i> = 7.7 Hz, phenyl H), 7.03 (1H, t, <i>J</i> = 7.6 Hz, phenyl H), 6.96 (1H, d, <i>J</i> = 7.7 Hz, phenyl H), 6.32 (1H, dd, <i>J</i> = 17.9, 1.4 Hz, 3-CH═C<i>H</i>H), 6.12 (1H, dd, <i>J</i> = 11.6, 1.4 Hz, 3-CH═CH<i>H</i>), 6.05 (1H, br t, <i>J</i> ∼5.8 Hz, amide NH), 5.31 (1H, d, <i>J</i> = 18.6 Hz, 15-C<i>H</i>H), 5.17 (1H, br d, <i>J</i> = 18.6 Hz, 15-CH<i>H</i>), 4.59 (1H, dd, <i>J</i> = 14.7, 6.0 Hz, −C<i>H</i>H–phenyl−), 4.42 (1H, m, 17-H), 4.40 (1H, q, <i>J</i> = 7.3 Hz, 18-H), 4.26 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 4.24 (3H, s, −COOCH<sub>3</sub>), 4.18 (2H, m, −OC<i>H</i><sub>2</sub>CH<sub>2</sub>OCH<sub>3</sub>), 4.14 (1H, dd, <i>J</i> ∼15.1, 5.5 Hz, −CH<i>H</i>–phenyl−), 3.83 (2H, m, −OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.75 (2H, q, <i>J</i> = 7.6 Hz, 8-C<i>H</i><sub>2</sub>CH<sub>3</sub>), 3.74 (2H, m, OCH<sub>2</sub>C<i>H</i><sub>2</sub>OCH<sub>3</sub>), 3.57 (6H, br s, 12-CH<sub>3</sub> and −COOCH<sub>3</sub>), 3.46 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.42 (3H, s, 2-CH<sub>3</sub>), 3.40 (3H, s, −OCH<sub>2</sub>CH<sub>2</sub>OC<i>H</i><sub>3</sub>), 3.26 (3H, s, 7-CH<sub>3</sub>), 2.60 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.28 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 2.25 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 1.72 (1H, m, 1H of 17-CH<sub>2</sub>CH<sub>2</sub>−), 1.70 (3H, t, <i>J</i> = 7.6 Hz, 8-CH<sub>2</sub>C<i>H</i><sub>3</sub>), 1.56 (3H, d, <i>J</i> = 7.2 Hz, 18-CH<sub>3</sub>), −1.41 (1H, br s, core NH), −1.55 (1H, s, core NH); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>, δ ppm): 173.5, 172.2, 169.8, 169.4, 167.0, 156.1, 155.1, 154.6, 153.6, 149.1, 148.9, 147.6, 145.2, 139.7, 139.0, 138.6, 136.4, 136.2, 135.6, 135.0, 134.8, 131.0, 130.8, 130.3, 129.5, 129.2, 129.0, 128.3, 127.7, 126.9, 124.0, 123.9, 123.8, 123.2, 122.0, 121.5, 109.2, 108.9, 102.5, 102.3, 101.5, 99.0, 93.8, 89.3, 89.2, 70.9, 70.5, 69.3, 68.3, 59.28, 59.27, 53.4, 52.9, 51.8, 49.1, 43.3, 41.1, 31.5, 29.7, 23.0, 19.6, 17.7, 12.3, 12.1, 11.3. Note: <sup>1</sup>H impurity peaks were observed at 1.27 (likely grease CH<sub>2</sub>) and 0.89 ppm (likely grease CH<sub>3</sub>). Small <sup>13</sup>C impurity peaks were observed at 31.9, 29.3, 22.7, and 14.1 ppm.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Cell Biological Analysis of PS Uptake and Cell-Type Specificity</h3><div class="NLM_p last">Human head and neck tumor cells were isolated from surgical specimens of primary tumor tissues provided by RPCCC Tissue Procurement Services under the terms of an IRB-approved protocol. Each sample received was labeled with a laboratory code (HN-number). Tissues were minced and mildly digested with trypsin and plated unto a collagen-1 matrix in tissue culture dishes. Proliferating tumor epithelial (T-EC) and stromal cells (T-Fb) were obtained by proliferation under selective medium conditions as outlined previously for human lung tumor cells.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Similarly, long-term proliferating T-EC (HNT1) were isolated from a PDX tongue cancer tissue. The established FaDu hypopharyngeal cell line had been purchased from ATCCC and subjected to single-cell cloning (FaDu-49). To identify cell-type-specific PS binding, reconstituted co-cultures T-EC and T-Fb (ratio 1:200) were established on a collagen-1 matrix and grown to confluence in RPMI containing 10% FBS. In a few cases, the experiments included CFSE-stained T-Fb for visualization of the stromal cell population in co-cultures. Monotypic and co-cultures were incubated with RPMI containing PS in the range of 0–3000 M. After various time points, cultures ware washed with a PS-free medium containing 10% FBS and depending on the experimental setting and cultured for additional time periods (=chase). The cellular level of PS was recorded by imaging with an inverted fluorescence microscope (Zeiss or Nikon). The level of cell-associated fluorescent signal (pixel) was normalized to the recording time (s) and the cell number (1 × 10<sup>6</sup>) as described (Tracy et al.).<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Photoreaction involved exposure of the culture dish at 37 °C to 665 nm light of a diode laser at a 6 mW/cm<sup>2</sup> fluence rate to a total of 3 J/cm<sup>2</sup> fluence. Cells were either immediately extracted by lysis in RIPA buffer or cultured for additional 24 h in a growth medium. Surviving cells were determined after tryspin release from culture support based on trypan blue exclusion. Proteins (STAT3, EGFR) in the cell lysates separated on SDS polyacrylamide gels and analyzed by immunoblotting as described previously.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> The immune signals for STAT3 were quantified by scanning of the blots and expressed as a percentage of conversion from monomeric to homodimeric forms.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> <i>In Vitro</i> Photosensitizing Efficacy of PS by the MTT Assay</h3><div class="NLM_p last">UMUC3 or FaDu cells were grown in T75 flasks in media supplemented with 10% FBS and 1% penicillin streptomycin. To begin the cytotoxicity assay, cells were harvested from the T75 flasks, counted, and plated in 96-well plates between 0.01 × 10<sup>6</sup> to 0.05 × 10<sup>6</sup> cells/ml and 100 μL per well. A photosensitizer was added after the cells have adhered to the plate (24 h after plating). The top photosensitizer dose on each plate was 1600 nM, with a 2-fold dilution for each subsequent dose. Plates were exposed to either no light (0 J/cm<sup>2</sup>) or 1 J/cm<sup>2</sup> at 565 mW and a spot size of 15 cm. After 48 h, 20 μL of MTT was added to each well, and 3 h later MTT was added to the cells. The metabolized MTT was solubilized in DMSO and read using a plate reader at 570 nm. Plates were analyzed using Graphpad Prism 8 to determine the IC<sub>50</sub>.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> <i>In Vivo</i> Tumor Uptake and PDT Efficacy</h3><div class="NLM_p">SCID mice bearing either UMUC3 or FaDu tumors at the flank/shoulder were subjected for whole body fluorescence imaging at various timepoints after PS injection intravenously. The tumor, liver, and skin uptakes were measured by an IVIS (Perkin Elmer) <i>in vivo</i> imaging system, and pharmacokinetic profiles of the PSs were evaluated. Images were collected at various time points, and average radiant efficiency of PS in tumors was determined.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><div class="NLM_p last">For evaluating <i>in vivo</i> PDT efficacy, the tumored mice restrained in acrylic holders after injecting the PS. The tumors were exposed to laser light at the longest wavelength absorption and maximal uptake time of the PS. The total light dose was 135 J/cm<sup>2</sup> for a period of 30 min, with a fluence rate of 75 mW/cm<sup>2</sup>. The tumor regrowth was measured daily, and as per approved protocol, the mice with tumor regrowth >400 mm<sup>3</sup> were euthanized.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i56"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01735" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63751" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63751" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01735?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01735</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">(i) NMR (<sup>1</sup>H and <sup>13</sup>C) details and spectra of new compounds, (ii) (Table S1) a summary of NMR analysis (chemical shifts) of compounds, (iii) magnification (100×) of <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> of the main manuscript, (iv) (Table S2) molecular formula strings, and (v) (Table S3) analysis (including HPLC) of PS-Erlotinib conjugates (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01735/suppl_file/jm0c01735_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Erlotinib spreadsheet new (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01735/suppl_file/jm0c01735_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01735/suppl_file/jm0c01735_si_001.pdf">jm0c01735_si_001.pdf (5.39 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01735/suppl_file/jm0c01735_si_002.csv">jm0c01735_si_002.csv (8.72 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01735" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73364" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73364" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Heinz Baumann</span> - <span class="hlFld-Affiliation affiliation">Molecular
and Cellular Biology, Roswell Park Comprehensive
Cancer Center Buffalo, Buffalo, New York 14263, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#9dd5f8f4f3e7b3fffce8f0fcf3f3ddeff2eeeaf8f1f1edfceff6b3f2effa"><span class="__cf_email__" data-cfemail="82cae7ebecf8ace0e3f7efe3ececc2f0edf1f5e7eeeef2e3f0e9acedf0e5">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ravindra K. Pandey</span> - <span class="hlFld-Affiliation affiliation">PDT Center, Cell Stress Biology, Roswell Park Comprehensive Cancer Center Buffalo, Buffalo, New York 14223, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9889-4860" title="Orcid link">http://orcid.org/0000-0002-9889-4860</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#deacbfa8b7b0baacbff0aebfb0babba79eacb1ada9bbb2b2aebfacb5f0b1acb9"><span class="__cf_email__" data-cfemail="562437203f383224377826373832332f1624392521333a3a2637243d78392431">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ravindra R. Cheruku</span> - <span class="hlFld-Affiliation affiliation">PDT Center, Cell Stress Biology, Roswell Park Comprehensive Cancer Center Buffalo, Buffalo, New York 14223, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph Cacaccio</span> - <span class="hlFld-Affiliation affiliation">PDT Center, Cell Stress Biology, Roswell Park Comprehensive Cancer Center Buffalo, Buffalo, New York 14223, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Farukh A. Durrani</span> - <span class="hlFld-Affiliation affiliation">PDT Center, Cell Stress Biology, Roswell Park Comprehensive Cancer Center Buffalo, Buffalo, New York 14223, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Walter A. Tabaczynski</span> - <span class="hlFld-Affiliation affiliation">PDT Center, Cell Stress Biology, Roswell Park Comprehensive Cancer Center Buffalo, Buffalo, New York 14223, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ramona Watson</span> - <span class="hlFld-Affiliation affiliation">PDT Center, Cell Stress Biology, Roswell Park Comprehensive Cancer Center Buffalo, Buffalo, New York 14223, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin Siters</span> - <span class="hlFld-Affiliation affiliation">Photolitec,
LLC, 73 High Street, Buffalo, New York 14223, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph R. Missert</span> - <span class="hlFld-Affiliation affiliation">PDT Center, Cell Stress Biology, Roswell Park Comprehensive Cancer Center Buffalo, Buffalo, New York 14223, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Erin C. Tracy</span> - <span class="hlFld-Affiliation affiliation">Molecular
and Cellular Biology, Roswell Park Comprehensive
Cancer Center Buffalo, Buffalo, New York 14263, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mykhaylo Dukh</span> - <span class="hlFld-Affiliation affiliation">PDT Center, Cell Stress Biology, Roswell Park Comprehensive Cancer Center Buffalo, Buffalo, New York 14223, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Khurshid Guru</span> - <span class="hlFld-Affiliation affiliation">Department
of Urology, Roswell Park Comprehensive Cancer
Center Buffalo, Buffalo, New York 14263, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4551-4676" title="Orcid link">http://orcid.org/0000-0002-4551-4676</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard C. Koya</span> - <span class="hlFld-Affiliation affiliation">Department
of Immunology, Roswell Park Comprehensive
Cancer Center Buffalo, Buffalo, New York 14263, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pawel Kalinski</span> - <span class="hlFld-Affiliation affiliation">Department
of Immunology, Roswell Park Comprehensive
Cancer Center Buffalo, Buffalo, New York 14263, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): RRC, JC, FAD, KS, JRM, ECT, KG, HB and RKP are a part of patent application related to this project, submitted to the United States Patent Office.<br /></br><p class="inlineNote">Dr. Cheruku, Mr. Cacaccio, Dr. Durrani, Dr. Siters, Mr. Missert, Dr. Guru, Dr. Baumann, and Dr. Pandey listed as authors in this manuscript are also the inventors of a patent application submitted to the United States Patent Office.</p></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i58">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01157" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01157" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors are highly thankful to Photolitec LLC, Buffalo, NY (R.K.P.), Roswell Park Alliance Foundation (R.K.P., K.G., P.K., and R.C.K.), and NIH (PO1, CA055791, H.B. and R.K.P.) for the financial support. A partial support from the shared resources of the RPCI support grant (P30CA16056) is also appreciated.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">PS</td><td class="NLM_def"><p class="first last">photosensitizers</p></td></tr><tr><td class="NLM_term">PDT</td><td class="NLM_def"><p class="first last">photodynamic therapy</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">NIR</td><td class="NLM_def"><p class="first last">near-infrared</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i60">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44674" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44674" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 48 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Juarranz, Á.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaén, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz-Rodríguez, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuevas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González, S.</span></span> <span> </span><span class="NLM_article-title">Photodynamic therapy of cancer: Basic principles and applications</span>. <i>Clin. Transl. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.1007/s12094-008-0172-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1007%2Fs12094-008-0172-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=18321817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BD1cXls1Cisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=148-154&author=%C3%81.+Juarranzauthor=P.+Ja%C3%A9nauthor=F.+Sanz-Rodr%C3%ADguezauthor=J.+Cuevasauthor=S.+Gonz%C3%A1lez&title=Photodynamic+therapy+of+cancer%3A+Basic+principles+and+applications&doi=10.1007%2Fs12094-008-0172-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Photodynamic therapy of cancer. Basic principles and applications</span></div><div class="casAuthors">Juarranz, Angeles; Jaen, Pedro; Sanz-Rodriguez, Francisco; Cuevas, Jesus; Gonzalez, Salvador</div><div class="citationInfo"><span class="NLM_cas:title">Clinical & Translational Oncology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">148-154</span>CODEN:
                <span class="NLM_cas:coden">CTOLAM</span>;
        ISSN:<span class="NLM_cas:issn">1699-048X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Photodynamic therapy (PDT) is a minimally invasive therapeutic modality approved for clin. treatment of several types of cancer and non-oncol. disorders.  In PDT, a compd. with photosensitizing properties (photosensitizer, PS) is selectively accumulated in malignant tissues.  The subsequent activation of the PS by visible light, preferentially in the red region of the visible spectrum (λ≥600 nm), where tissues are more permeable to light, generates reactive oxygen species, mainly singlet oxygen (1O2), responsible for cytotoxicity of neoplastic cells and tumor regression.  There are three main mechanisms described by which 1O2 contributes to the destruction of tumors by PDT: direct cellular damage, vascular shutdown and activation of immune response against tumor cells.  The advantages of PDT over other conventional cancer treatments are its low systemic toxicity and its ability to selectively destroy tumors accessible to light.  Therefore, PDT is being used for the treatment of endoscopically accessible tumors such as lung, bladder, gastrointestinal and gynaecol. neoplasms, and also in dermatol. for the treatment of non-melanoma skin cancers (basal cell carcinoma) and precancerous diseases (actinic keratosis).  Photofrin, ALA and its ester derivs. are the main compds. used in clin. trials, though newer and more efficient PSs are being evaluated nowadays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWlkUgRA99HbVg90H21EOLACvtfcHk0lgBDAO0vgCezA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXls1Cisbk%253D&md5=def01f96d817e695b02b79f0f2f4b2a8</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs12094-008-0172-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12094-008-0172-2%26sid%3Dliteratum%253Aachs%26aulast%3DJuarranz%26aufirst%3D%25C3%2581.%26aulast%3DJa%25C3%25A9n%26aufirst%3DP.%26aulast%3DSanz-Rodr%25C3%25ADguez%26aufirst%3DF.%26aulast%3DCuevas%26aufirst%3DJ.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DS.%26atitle%3DPhotodynamic%2520therapy%2520of%2520cancer%253A%2520Basic%2520principles%2520and%2520applications%26jtitle%3DClin.%2520Transl.%2520Oncol.%26date%3D2008%26volume%3D10%26spage%3D148%26epage%3D154%26doi%3D10.1007%2Fs12094-008-0172-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kessel, D.</span></span> <span> </span><span class="NLM_article-title">Photodynamic therapy: A brief history</span>. <i>J. Clin. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1581</span>, <span class="refDoi"> DOI: 10.3390/jcm8101581</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.3390%2Fjcm8101581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmsFaqur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=1581&author=D.+Kessel&title=Photodynamic+therapy%3A+A+brief+history&doi=10.3390%2Fjcm8101581"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Photodynamic therapy: a brief history</span></div><div class="casAuthors">Kessel, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1581</span>CODEN:
                <span class="NLM_cas:coden">JCMOHK</span>;
        ISSN:<span class="NLM_cas:issn">2077-0383</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) involves the selective sensitization of tissues to light.  A major advance in the field occurred when Thomas Dougherty at the Roswell Park Cancer Institute initiated a series of clin. studies that eventually led to FDA approval of the procedure.  This report contains a summary of Dougherty's contributions and an assessment of where this has led, along with a summary of implications for future drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_MOHilslPhbVg90H21EOLACvtfcHk0lgBDAO0vgCezA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmsFaqur0%253D&md5=df0723c38b940fd6a5a1174e171e2763</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3390%2Fjcm8101581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fjcm8101581%26sid%3Dliteratum%253Aachs%26aulast%3DKessel%26aufirst%3DD.%26atitle%3DPhotodynamic%2520therapy%253A%2520A%2520brief%2520history%26jtitle%3DJ.%2520Clin.%2520Med.%26date%3D2019%26volume%3D8%26spage%3D1581%26doi%3D10.3390%2Fjcm8101581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">and references therein.</p></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hiramatsu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawabata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ono, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyatake, S.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroiwa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicente, M. G. H.</span></span> <span> </span><span class="NLM_article-title">Tetrakis(p-carboranylthio-tetrafluorophenyl) chlorin (TPFC): Application for photodynamic therapy and boron neutron capture therapy</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">962</span>– <span class="NLM_lpage">970</span>, <span class="refDoi"> DOI: 10.1002/jps.24317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1002%2Fjps.24317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFKlu7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2015&pages=962-970&author=R.+Hiramatsuauthor=S.+Kawabataauthor=H.+Tanakaauthor=Y.+Sakuraiauthor=M.+Suzukiauthor=K.+Onoauthor=S.-I.+Miyatakeauthor=T.+Kuroiwaauthor=E.+Haoauthor=M.+G.+H.+Vicente&title=Tetrakis%28p-carboranylthio-tetrafluorophenyl%29+chlorin+%28TPFC%29%3A+Application+for+photodynamic+therapy+and+boron+neutron+capture+therapy&doi=10.1002%2Fjps.24317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Tetrakis(p-Carboranylthio-Tetrafluorophenyl)Chlorin (TPFC): Application for Photodynamic Therapy and Boron Neutron Capture Therapy</span></div><div class="casAuthors">Hiramatsu, Ryo; Kawabata, Shinji; Tanaka, Hiroki; Sakurai, Yoshinori; Suzuki, Minoru; Ono, Koji; Miyatake, Shin-ichi; Kuroiwa, Toshihiko; Hao, Erhong; Vicente, M. Graca H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">962-970</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Carboranyl-contg. chlorins have emerged as promising dual sensitizers for use in both photodynamic therapy (PDT) and boron neutron capture therapy (BNCT), by virtue of their known tumor affinity, low cytotoxicity in dark conditions, and their strong absorptions in the red region of the optical spectrum.  Tetrakis(p-carboranylthio-tetrafluorophenyl)chlorin (TPFC) is a new synthetic carboranyl-contg. chlorin of high boron content (24% by wt.).  To evaluate TPFC's applicability as sensitizer for both PDT and BNCT, we performed an in vitro and in vivo study using F98 rat glioma cells and F98 rat glioma-bearing brain tumor models.  For the in vivo BNCT study, we used boronophenylalanine (BPA), which is currently used in clin. BNCT studies, via i.v. administration (i.v.) and/or used TPFC via convection-enhanced delivery (CED), a method for local drug infusion directly into the brain.  In the in vitro PDT study, the cell surviving fraction following laser irradn. (9 J/cm2) was 0.035 whereas in the in vitro BNCT study, the cell surviving fraction following neutron irradn. (thermal neutron = 1.73 × 1012 n/cm2) was 0.04.  In the in vivo BNCT study, the median survival time following concomitant administration of BPA (i.v.) and TPFC (CED) was 42 days (95% confidence interval; 37-43 days). © 2014 Wiley Periodicals, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1WsvcveA8i7Vg90H21EOLACvtfcHk0liGYISnEIMdeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFKlu7nN&md5=08f970b1804b11f92e31e2af468936b0</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fjps.24317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.24317%26sid%3Dliteratum%253Aachs%26aulast%3DHiramatsu%26aufirst%3DR.%26aulast%3DKawabata%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DSakurai%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DOno%26aufirst%3DK.%26aulast%3DMiyatake%26aufirst%3DS.-I.%26aulast%3DKuroiwa%26aufirst%3DT.%26aulast%3DHao%26aufirst%3DE.%26aulast%3DVicente%26aufirst%3DM.%2BG.%2BH.%26atitle%3DTetrakis%2528p-carboranylthio-tetrafluorophenyl%2529%2520chlorin%2520%2528TPFC%2529%253A%2520Application%2520for%2520photodynamic%2520therapy%2520and%2520boron%2520neutron%2520capture%2520therapy%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2015%26volume%3D104%26spage%3D962%26epage%3D970%26doi%3D10.1002%2Fjps.24317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lo, P.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Morgade, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, D. K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumoulin, F.</span></span> <span> </span><span class="NLM_article-title">The unique features and promises of phthalocyanines as advanced photosensitisers for photodynamic therapy of cancer</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1041</span>– <span class="NLM_lpage">1056</span>, <span class="refDoi"> DOI: 10.1039/C9CS00129H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1039%2FC9CS00129H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=31845688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVSnu77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2020&pages=1041-1056&author=P.-C.+Loauthor=M.+S.+Rodr%C3%ADguez-Morgadeauthor=R.+K.+Pandeyauthor=D.+K.+P.+Ngauthor=T.+Torresauthor=F.+Dumoulin&title=The+unique+features+and+promises+of+phthalocyanines+as+advanced+photosensitisers+for+photodynamic+therapy+of+cancer&doi=10.1039%2FC9CS00129H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The unique features and promises of phthalocyanines as advanced photosensitisers for photodynamic therapy of cancer</span></div><div class="casAuthors">Lo, Pui-Chi; Rodriguez-Morgade, M. Salome; Pandey, Ravindra K.; Ng, Dennis K. P.; Torres, Tomas; Dumoulin, Fabienne</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1041-1056</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Phthalocyanines exhibit superior photoproperties that make them a surely attractive class of photosensitizers for photodynamic therapy of cancer.  Several derivs. are at various phases of clin. trials, and efforts have been put continuously to improve their photodynamic efficacy.  To this end, various strategies have been applied to develop advanced phthalocyanines with optimized photoproperties, dual therapeutic actions, tumor-targeting properties and/or specific activation at tumor sites.  The advantageous properties and potential of phthalocyanines as advanced photosensitizers for photodynamic therapy of cancer are highlighted in this tutorial review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyq_GPDCHKSLVg90H21EOLACvtfcHk0liGYISnEIMdeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVSnu77I&md5=f600e873a969140fd13ef35efafbca81</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1039%2FC9CS00129H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9CS00129H%26sid%3Dliteratum%253Aachs%26aulast%3DLo%26aufirst%3DP.-C.%26aulast%3DRodr%25C3%25ADguez-Morgade%26aufirst%3DM.%2BS.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26aulast%3DNg%26aufirst%3DD.%2BK.%2BP.%26aulast%3DTorres%26aufirst%3DT.%26aulast%3DDumoulin%26aufirst%3DF.%26atitle%3DThe%2520unique%2520features%2520and%2520promises%2520of%2520phthalocyanines%2520as%2520advanced%2520photosensitisers%2520for%2520photodynamic%2520therapy%2520of%2520cancer%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2020%26volume%3D49%26spage%3D1041%26epage%3D1056%26doi%3D10.1039%2FC9CS00129H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shaker, Y. M.</span>; <span class="NLM_string-name">Sweed, A. M. K.</span>; <span class="NLM_string-name">Moylan, C.</span>; <span class="NLM_string-name">Rogers, L.</span>; <span class="NLM_string-name">Ryan, A. A.</span>; <span class="NLM_string-name">Pettidemange, R.</span>; <span class="NLM_string-name">Senge, M. O.</span></span> <span> </span><span class="NLM_article-title">Current developments in UsingMESO-(TETRA) substituted porphyrins for PDT</span> In  <i>HANDBOOK OF PHOTODYNAMIC THERAPY</i>; Updates on Recent Applications of Porphyrin-Based Compound (Eds: <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span>; <span class="NLM_string-name">Kessel, D.</span>; <span class="NLM_string-name">Dougherty, T. J.</span></span>), <span class="NLM_publisher-name">World Scientific</span><i>:</i> <span class="NLM_publisher-loc">New Jersey</span>, <span class="NLM_year">2016</span>, pp.  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">149</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1142%2F9789814719650_0003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=95-149&author=Y.+M.+Shaker&author=A.+M.+K.+Sweed&author=C.+Moylan&author=L.+Rogers&author=A.+A.+Ryan&author=R.+Pettidemange&author=M.+O.+Sengeauthor=R.+K.+Pandey&author=D.+Kessel&author=T.+J.+Dougherty&title=HANDBOOK+OF+PHOTODYNAMIC+THERAPY"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1142%2F9789814719650_0003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1142%252F9789814719650_0003%26sid%3Dliteratum%253Aachs%26aulast%3DShaker%26aufirst%3DY.%2BM.%26atitle%3DCurrent%2520developments%2520in%2520UsingMESO-%2528TETRA%2529%2520substituted%2520porphyrins%2520for%2520PDT%26btitle%3DHANDBOOK%2520OF%2520PHOTODYNAMIC%2520THERAPY%26aulast%3DPandey%26aufirst%3DR.%2BK.%26pub%3DWorld%2520Scientific%26date%3D2016%26spage%3D95%26epage%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ethirajan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">The role of porphyrin chemistry in tumor imaging and photodynamic therapy</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">340</span>– <span class="NLM_lpage">362</span>, <span class="refDoi"> DOI: 10.1039/B915149B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1039%2FB915149B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=20694259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFKju7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2011&pages=340-362&author=M.+Ethirajanauthor=Y.+Chenauthor=P.+Joshiauthor=R.+K.+Pandey&title=The+role+of+porphyrin+chemistry+in+tumor+imaging+and+photodynamic+therapy&doi=10.1039%2FB915149B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The role of porphyrin chemistry in tumor imaging and photodynamic therapy</span></div><div class="casAuthors">Ethirajan, Manivannan; Chen, Yihui; Joshi, Penny; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">340-362</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  In recent years several review articles and books have been published on the use of porphyrin-based compds. in photodynamic therapy (PDT).  This crit. review is focused on (i) the basic concept of PDT, (ii) advantages of long-wavelength absorbing photosensitizers (PS), (iii) a brief discussion on recent advances in developing PDT agents, and (iv) the various synthetic strategies designed at the Roswell Park Cancer Institute, Buffalo, for developing highly effective long-wavelength PDT agents and their utility in constructing the conjugates with tumor-imaging and therapeutic potential (Theranostics).  The clin. status of certain selected PDT agents is also summarized (205 refs.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwaO6TvgtDibVg90H21EOLACvtfcHk0lh55bmZjFQ4YQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFKju7bF&md5=b462478255e32db5d073a892c64e2d52</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1039%2FB915149B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB915149B%26sid%3Dliteratum%253Aachs%26aulast%3DEthirajan%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DJoshi%26aufirst%3DP.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DThe%2520role%2520of%2520porphyrin%2520chemistry%2520in%2520tumor%2520imaging%2520and%2520photodynamic%2520therapy%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2011%26volume%3D40%26spage%3D340%26epage%3D362%26doi%3D10.1039%2FB915149B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abrahamse, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamblin, M. R.</span></span> <span> </span><span class="NLM_article-title">New photosensitizers for photodynamic therapy</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>473</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">364</span>, <span class="refDoi"> DOI: 10.1042/BJ20150942</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1042%2FBJ20150942" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=26862179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC28Xitleqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=473&publication_year=2016&pages=347-364&author=H.+Abrahamseauthor=M.+R.+Hamblin&title=New+photosensitizers+for+photodynamic+therapy&doi=10.1042%2FBJ20150942"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">New photosensitizers for photodynamic therapy</span></div><div class="casAuthors">Abrahamse, Heidi; Hamblin, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">473</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">347-364</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) was discovered more than 100 years ago, and has since become a well-studied therapy for cancer and various non-malignant diseases including infections.  PDT uses photosensitizers (PSs, non-toxic dyes) that are activated by absorption of visible light to initially form the excited singlet state, followed by transition to the long-lived excited triplet state.  This triplet state can undergo photochem. reactions in the presence of oxygen to form reactive oxygen species (including singlet oxygen) that can destroy cancer cells, pathogenic microbes and unwanted tissue.  The dual-specificity of PDT relies on accumulation of the PS in diseased tissue and also on localized light delivery.  Tetrapyrrole structures such as porphyrins, chlorins, bacteriochlorins and phthalocyanines with appropriate functionalization have been widely investigated in PDT, and several compds. have received clin. approval.  Other mol. structures including the synthetic dyes classes as phenothiazinium, squaraine and BODIPY (boron-dipyrromethene), transition metal complexes, and natural products such as hypericin, riboflavin and curcumin have been investigated.  Targeted PDT uses PSs conjugated to antibodies, peptides, proteins and other ligands with specific cellular receptors.  Nanotechnol. has made a significant contribution to PDT, giving rise to approaches such as nanoparticle delivery, fullerene-based PSs, titania photocatalysis, and the use of upconverting nanoparticles to increase light penetration into tissue.  Future directions include photochem. internalization, genetically encoded protein PSs, theranostics, two-photon absorption PDT, and sonodynamic therapy using ultrasound.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFTuFcH5GS87Vg90H21EOLACvtfcHk0ljZ0QqmS6tKwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xitleqsrc%253D&md5=9ad9b594476ad2c3452189212f0827b7</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1042%2FBJ20150942&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20150942%26sid%3Dliteratum%253Aachs%26aulast%3DAbrahamse%26aufirst%3DH.%26aulast%3DHamblin%26aufirst%3DM.%2BR.%26atitle%3DNew%2520photosensitizers%2520for%2520photodynamic%2520therapy%26jtitle%3DBiochem.%2520J.%26date%3D2016%26volume%3D473%26spage%3D347%26epage%3D364%26doi%3D10.1042%2FBJ20150942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olivo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhuvaneshwari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucky, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dendukuri, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thong, P. S.-P.</span></span> <span> </span><span class="NLM_article-title">Targeted therapy of cancer using photodynamic therapy in combination with multi-faceted anti-tumor modalities</span>. <i>Pharmaceuticals</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1507</span>– <span class="NLM_lpage">1529</span>, <span class="refDoi"> DOI: 10.3390/ph3051507</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.3390%2Fph3051507" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=27713315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A280%3ADC%252BC2svnvFehsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=1507-1529&author=M.+Olivoauthor=R.+Bhuvaneshwariauthor=S.+S.+Luckyauthor=N.+Dendukuriauthor=P.+S.-P.+Thong&title=Targeted+therapy+of+cancer+using+photodynamic+therapy+in+combination+with+multi-faceted+anti-tumor+modalities&doi=10.3390%2Fph3051507"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted Therapy of Cancer Using Photodynamic Therapy in Combination with Multi-faceted Anti-Tumor Modalities</span></div><div class="casAuthors">Olivo Malini; Bhuvaneswari Ramaswamy; Lucky Sasidharan Swarnalatha; Dendukuri Nagamani; Soo-Ping Thong Patricia; Olivo Malini; Olivo Malini; Olivo Malini</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceuticals (Basel, Switzerland)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1507-1529</span>
        ISSN:<span class="NLM_cas:issn">1424-8247</span>.
    </div><div class="casAbstract">Photodynamic therapy (PDT) has emerged as one of the important therapeutic options in the management of cancer and other diseases.  PDT involves a tumor-localized photosensitizer (PS), which when appropriately illuminated by visible light converts oxygen into cytotoxic reactive oxygen species (ROS), that attack key structural entities within the targeted cells, ultimately resulting in necrosis or apoptosis.  Though PDT is a selective modality, it can be further enhanced by combining other targeted therapeutic strategies that include the use of synthetic peptides and nanoparticles for selective delivery of photosensitizers.  Another potentially promising strategy is the application of targeted therapeutics that exploit a myriad of critical pathways involved in tumorigenesis and metastasis.  Vascular disrupting agents that eradicate tumor vasculature during PDT and anti-angiogenic agents that targets specific molecular pathways and prevent the formation of new blood vessels are novel therapeutic approaches that have been shown to improve treatment outcome.  In addition to the well-documented mechanisms of direct cell killing and damage to the tumor vasculature, PDT can also activate the body's immune response against tumors.  Numerous pre-clinical studies and clinical observations have demonstrated the immuno-stimulatory capability of PDT.  Herein, we aim to integrate the most important findings with regard to the combination of PDT and other novel targeted therapy approaches, detailing its potential in cancer photomedicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTcX-JV3ebU8lVwdslNBF-tfW6udTcc2eal28hXsA3PQrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2svnvFehsA%253D%253D&md5=733f9165055d9446747852dad44e5d9c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3390%2Fph3051507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph3051507%26sid%3Dliteratum%253Aachs%26aulast%3DOlivo%26aufirst%3DM.%26aulast%3DBhuvaneshwari%26aufirst%3DR.%26aulast%3DLucky%26aufirst%3DS.%2BS.%26aulast%3DDendukuri%26aufirst%3DN.%26aulast%3DThong%26aufirst%3DP.%2BS.-P.%26atitle%3DTargeted%2520therapy%2520of%2520cancer%2520using%2520photodynamic%2520therapy%2520in%2520combination%2520with%2520multi-faceted%2520anti-tumor%2520modalities%26jtitle%3DPharmaceuticals%26date%3D2010%26volume%3D3%26spage%3D1507%26epage%3D1529%26doi%3D10.3390%2Fph3051507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.</span></span> <span> </span><span class="NLM_article-title">Photosensitizer-conjugated human serum albumin nanoparticles for effective photodynamic therapy</span>. <i>Theranostics</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">230</span>– <span class="NLM_lpage">239</span>, <span class="refDoi"> DOI: 10.7150/thno/v01p0230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.7150%2Fthno%2Fv01p0230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=21562630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC38Xislalt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=230-239&author=H.+Jeongauthor=M.+Huhauthor=S.+J.+Leeauthor=H.+Kooauthor=I.+C.+Kwonauthor=S.+Y.+Jeongauthor=K.+Kim&title=Photosensitizer-conjugated+human+serum+albumin+nanoparticles+for+effective+photodynamic+therapy&doi=10.7150%2Fthno%2Fv01p0230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Photosensitizer-conjugated human serum albumin nanoparticles for effective photodynamic therapy</span></div><div class="casAuthors">Jeong, Hayoung; Huh, Myung Sook; Lee, So Jin; Koo, Heebeom; Kwon, Ick Chan; Jeong, Seo Young; Kim, Kwangmeyung</div><div class="citationInfo"><span class="NLM_cas:title">Theranostics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">230-239</span>CODEN:
                <span class="NLM_cas:coden">THERDS</span>;
        ISSN:<span class="NLM_cas:issn">1838-7640</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) is an emerging theranostic modality for various cancers and diseases.  The focus of this study was the development of tumor-targeting albumin nanoparticles contg. photosensitizers for efficient PDT.  To produce tumor-targeting albumin nanoparticles, the hydrophobic photosensitizer, chlorin e6 (Ce6), was chem. conjugated to human serum albumin (HSA).  The conjugates formed self-assembled nanoparticle structures with an av. diam. of 88 nm under aq. conditions.  As expected, the Ce6-conjugated HSA nanoparticles (Ce6-HSA-NPs) were nontoxic in their native state, but upon illumination with the appropriate wavelength of light, they produced singlet oxygen and damaged target tumor cells in a cell culture system.  Importantly, when the nanoparticles were injected through the tail vein into tumor-bearing HT-29 mice, Ce6-HSA-NPs compared with free Ce6 revealed enhanced tumor-specific biodistribution and successful therapeutic results following laser irradn.  These results suggest that highly tumor-specific albumin nanoparticles have the potential to serve not only as efficient therapeutic agents, but also as photo-dynamic imaging (PDI) reagents in cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxENd6gh5SCLVg90H21EOLACvtfcHk0lgyJvkHbN505g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xislalt7g%253D&md5=ce84235141759d3743bcd180825a4fe9</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.7150%2Fthno%2Fv01p0230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno%252Fv01p0230%26sid%3Dliteratum%253Aachs%26aulast%3DJeong%26aufirst%3DH.%26aulast%3DHuh%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DKoo%26aufirst%3DH.%26aulast%3DKwon%26aufirst%3DI.%2BC.%26aulast%3DJeong%26aufirst%3DS.%2BY.%26aulast%3DKim%26aufirst%3DK.%26atitle%3DPhotosensitizer-conjugated%2520human%2520serum%2520albumin%2520nanoparticles%2520for%2520effective%2520photodynamic%2520therapy%26jtitle%3DTheranostics%26date%3D2011%26volume%3D1%26spage%3D230%26epage%3D239%26doi%3D10.7150%2Fthno%2Fv01p0230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Z.</span></span> <span> </span><span class="NLM_article-title">Mitochondria-targeting organic nanoparticles for enhanced photodynamic/photothermal therapy</span>. <i>ACS Appl. Mater. Interfaces</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">30077</span>– <span class="NLM_lpage">30084</span>, <span class="refDoi"> DOI: 10.1021/acsami.0c06144</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsami.0c06144" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtF2hsrvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2020&pages=30077-30084&author=C.+Liauthor=W.+Zhangauthor=S.+Liuauthor=X.+Huauthor=Z.+Xie&title=Mitochondria-targeting+organic+nanoparticles+for+enhanced+photodynamic%2Fphotothermal+therapy&doi=10.1021%2Facsami.0c06144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria-Targeting Organic Nanoparticles for Enhanced Photodynamic/Photothermal Therapy</span></div><div class="casAuthors">Li, Chaonan; Zhang, Wei; Liu, Shi; Hu, Xiuli; Xie, Zhigang</div><div class="citationInfo"><span class="NLM_cas:title">ACS Applied Materials & Interfaces</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">30077-30084</span>CODEN:
                <span class="NLM_cas:coden">AAMICK</span>;
        ISSN:<span class="NLM_cas:issn">1944-8244</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Organelle-targeting techniques have been proved to be promising approaches for enhanced cancer treatment, esp. phototherapy, because it can greatly improve the efficiency of photosensitizers.  In this work, we designed and synthesized a mitochondria-targeting diketopyrrolopyrrole-based photosensitizer (DPP2+) for synergistic photodynamic/photothermal therapy upon irradn.  The obtained mitochondria-targeting nanoparticles (DPP2+ NPs) could produce thermal energy and singlet oxygen under 635 nm laser irradn. with ideal cytocompatibility.  Importantly, DPP2+ NPs are more likely to enter the cells and target mitochondria.  In in vitro and in vivo antitumor expts., DPP2+ NPs showed highly effective antitumor effects, suggesting that mitochondria-targeting photosensitizers have potential for cancer treatment.  The present work provides an alternative strategy to mitochondria-targeting mol. engineering and highlights the potential of org. nanomaterials in biomedical fields and cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpjq0mGliRebVg90H21EOLACvtfcHk0lhjYOFjYi-mFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtF2hsrvI&md5=b1718e86bebcb80d0b5ffce63f82cb8f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facsami.0c06144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsami.0c06144%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DXie%26aufirst%3DZ.%26atitle%3DMitochondria-targeting%2520organic%2520nanoparticles%2520for%2520enhanced%2520photodynamic%252Fphotothermal%2520therapy%26jtitle%3DACS%2520Appl.%2520Mater.%2520Interfaces%26date%3D2020%26volume%3D12%26spage%3D30077%26epage%3D30084%26doi%3D10.1021%2Facsami.0c06144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span> <span> </span><span class="NLM_article-title">A single molecule drug targeting photosensitizer for enhanced breast cancer photothermal therapy</span>. <i>Small</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1907677</span>, <span class="refDoi"> DOI: 10.1002/smll.201907677</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1002%2Fsmll.201907677" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnsV2gu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2020&pages=1907677&author=Y.+Zouauthor=M.+Liauthor=T.+Xiongauthor=X.+Zhaoauthor=J.+Duauthor=J.+Fanauthor=X.+Peng&title=A+single+molecule+drug+targeting+photosensitizer+for+enhanced+breast+cancer+photothermal+therapy&doi=10.1002%2Fsmll.201907677"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A Single Molecule Drug Targeting Photosensitizer for Enhanced Breast Cancer Photothermal Therapy</span></div><div class="casAuthors">Zou, Yang; Li, Mingle; Xiong, Tao; Zhao, Xueze; Du, Jianjun; Fan, Jiangli; Peng, Xiaojun</div><div class="citationInfo"><span class="NLM_cas:title">Small</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1907677</span>CODEN:
                <span class="NLM_cas:coden">SMALBC</span>;
        ISSN:<span class="NLM_cas:issn">1613-6810</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Targeting is one of the most important strategies for enhancing the efficacy of cancer photothermal therapy (PTT) and reducing damage to surrounding normal tissues.  Compared with the traditional targeting approaches, the active targeting of breast cancer cells in PTT using chemotherapeutic drugs, such as tamoxifen (TAM), in combination with single-mol. photothermal photosensitizers has superior selectivity and therapeutic effects.  However, single-mol. drug-targeting photosensitizers for improved PTT efficacy are not widely reported.  Accordingly, herein, a near-IR induced small-mol. photothermal photosensitizer (CyT) is developed that actively targets the estrogen receptors (ERs) of breast cancer cells as well as targets mitochondria by structure-inherent targeting.  Cell uptake and cytotoxicity studies using different types of cells show that CyT enhances the efficiency of TAM-based PTT by targeting ER-overexpressing breast cancer cells and selectively killing them.  In vivo expts. demonstrate that CyT can be used as a photothermal agent for fluorescence imaging-guided PTT.  More importantly, the i.v. injection of CyT results in better targeting and efficiency of tumor inhibition compared with that achieved with the TAM-free control mol. Cy.  Thus, the study presents an excellent small-mol. photothermal agent for breast cancer therapy with potential clin. application prospects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb_lXa8yub0LVg90H21EOLACvtfcHk0lhjYOFjYi-mFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnsV2gu7Y%253D&md5=dc099a317f9ea1301a4d3e228908b37d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fsmll.201907677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsmll.201907677%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DXiong%26aufirst%3DT.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DPeng%26aufirst%3DX.%26atitle%3DA%2520single%2520molecule%2520drug%2520targeting%2520photosensitizer%2520for%2520enhanced%2520breast%2520cancer%2520photothermal%2520therapy%26jtitle%3DSmall%26date%3D2020%26volume%3D16%26spage%3D1907677%26doi%3D10.1002%2Fsmll.201907677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mamblin, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizvi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maytin, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasan, T.</span></span> <span> </span><span class="NLM_article-title">Pegylation of a chlorin(e6) polymer conjugate increases tumor targeting of photosensitizer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">7155</span>– <span class="NLM_lpage">7162</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=11585749" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=7155-7162&author=M.+R.+Mamblinauthor=J.+L.+Millerauthor=I.+Rizviauthor=B.+Ortelauthor=E.+V.+Maytinauthor=T.+Hasan&title=Pegylation+of+a+chlorin%28e6%29+polymer+conjugate+increases+tumor+targeting+of+photosensitizer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMamblin%26aufirst%3DM.%2BR.%26aulast%3DMiller%26aufirst%3DJ.%2BL.%26aulast%3DRizvi%26aufirst%3DI.%26aulast%3DOrtel%26aufirst%3DB.%26aulast%3DMaytin%26aufirst%3DE.%2BV.%26aulast%3DHasan%26aufirst%3DT.%26atitle%3DPegylation%2520of%2520a%2520chlorin%2528e6%2529%2520polymer%2520conjugate%2520increases%2520tumor%2520targeting%2520of%2520photosensitizer%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D7155%26epage%3D7162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shim, Y. K.</span></span> <span> </span><span class="NLM_article-title">Advance in photosensitizers and light delivery for photodynamic therapy</span>. <i>Clin. Endosc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.5946/ce.2013.46.1.7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.5946%2Fce.2013.46.1.7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=23423543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A280%3ADC%252BC3szpsValsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2013&pages=7-23&author=I.+Yoonauthor=J.+Z.+Liauthor=Y.+K.+Shim&title=Advance+in+photosensitizers+and+light+delivery+for+photodynamic+therapy&doi=10.5946%2Fce.2013.46.1.7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Advance in photosensitizers and light delivery for photodynamic therapy</span></div><div class="casAuthors">Yoon Il; Li Jia Zhu; Shim Young Key</div><div class="citationInfo"><span class="NLM_cas:title">Clinical endoscopy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-23</span>
        ISSN:<span class="NLM_cas:issn">2234-2400</span>.
    </div><div class="casAbstract">The brief history of photodynamic therapy (PDT) research has been focused on photosensitizers (PSs) and light delivery was introduced recently.  The appropriate PSs were developed from the first generation PS Photofrin (QLT) to the second (chlorins or bacteriochlorins derivatives) and third (conjugated PSs on carrier) generations PSs to overcome undesired disadvantages, and to increase selective tumor accumulation and excellent targeting.  For the synthesis of new chlorin PSs chlorophyll a is isolated from natural plants or algae, and converted to methyl pheophorbide a (MPa) as an important starting material for further synthesis.  MPa has various active functional groups easily modified for the preparation of different kinds of PSs, such as methyl pyropheophorbide a, purpurin-18, purpurinimide, and chlorin e6 derivatives.  Combination therapy, such as chemotherapy and photothermal therapy with PDT, is shortly described here.  Advanced light delivery system is shown to establish successful clinical applications of PDT.  Phtodynamic efficiency of the PSs with light delivery was investigated in vitro and/or in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRH_YB4UKV2tDQLBVDQn4bCfW6udTcc2eYcGnhCC_A3Abntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szpsValsg%253D%253D&md5=d0f57b767d464bc0ad916a0e86a7fe95</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.5946%2Fce.2013.46.1.7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5946%252Fce.2013.46.1.7%26sid%3Dliteratum%253Aachs%26aulast%3DYoon%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DJ.%2BZ.%26aulast%3DShim%26aufirst%3DY.%2BK.%26atitle%3DAdvance%2520in%2520photosensitizers%2520and%2520light%2520delivery%2520for%2520photodynamic%2520therapy%26jtitle%3DClin.%2520Endosc.%26date%3D2013%26volume%3D46%26spage%3D7%26epage%3D23%26doi%3D10.5946%2Fce.2013.46.1.7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Si, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span> <span> </span><span class="NLM_article-title">Diketopyrrolopyrrole-based photosensitizers conjugated with chemotherapeutic agents for multimodal tumor therapy</span>. <i>ACS Appl. Mater. Interfaces</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">30398</span>– <span class="NLM_lpage">30405</span>, <span class="refDoi"> DOI: 10.1021/acsami.7b09025</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsami.7b09025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlyhsL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=30398-30405&author=Y.+Caiauthor=P.+Liangauthor=Q.+Tangauthor=W.+Siauthor=P.+Chenauthor=Q.+Zhangauthor=X.+Dong&title=Diketopyrrolopyrrole-based+photosensitizers+conjugated+with+chemotherapeutic+agents+for+multimodal+tumor+therapy&doi=10.1021%2Facsami.7b09025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Diketopyrrolopyrrole-Based Photosensitizers Conjugated with Chemotherapeutic Agents for Multimodal Tumor Therapy</span></div><div class="casAuthors">Cai, Yu; Liang, Pingping; Tang, Qianyun; Si, Weili; Chen, Peng; Zhang, Qi; Dong, Xiaochen</div><div class="citationInfo"><span class="NLM_cas:title">ACS Applied Materials & Interfaces</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">30398-30405</span>CODEN:
                <span class="NLM_cas:coden">AAMICK</span>;
        ISSN:<span class="NLM_cas:issn">1944-8244</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">For synergistic cancer therapy, it is highly desirable to devise a single multifunctional agent to combine photodynamic therapy (PDT), photothermal therapy (PTT), and chemotherapy, which is sol. and excitable at low irradn., as well as able to selectively target tumors and achieve high efficacy.  Toward this ambition, here the chemotherapy drugs chlorambucil (Cb), and all trans retinoic acid (ATRA) are covalently conjugated onto a small dye mol. diketopyrrolopyrrole (DPP-Cb and DPP-ATRA).  The sol. nanoparticles (NPs) of DPP-Cb and DPP-ATRA formed by repptn. can selectively accumulate in tumors, release chemotherapy drugs under acidic conditions, and exhibit efficient reactive oxygen species (ROS) generation and photothermal conversion under the irradn. of a low power xenon lamp (40 mW/cm2).  We show in vitro and in vivo that both NPs can effectively kill cancer cells and suppress cancer growth at a low dose (0.4 mg/kg).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRZVi8uDtTOrVg90H21EOLACvtfcHk0lg41T6mYVDUTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlyhsL3F&md5=1850ed022fbbf4bc184f771bbd401670</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facsami.7b09025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsami.7b09025%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DY.%26aulast%3DLiang%26aufirst%3DP.%26aulast%3DTang%26aufirst%3DQ.%26aulast%3DSi%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DDong%26aufirst%3DX.%26atitle%3DDiketopyrrolopyrrole-based%2520photosensitizers%2520conjugated%2520with%2520chemotherapeutic%2520agents%2520for%2520multimodal%2520tumor%2520therapy%26jtitle%3DACS%2520Appl.%2520Mater.%2520Interfaces%26date%3D2017%26volume%3D9%26spage%3D30398%26epage%3D30405%26doi%3D10.1021%2Facsami.7b09025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sandland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, R. W.</span></span> <span> </span><span class="NLM_article-title">Photosensitizer antibody-drug conjugates: Past, present and future</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">975</span>– <span class="NLM_lpage">993</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.9b00055</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.9b00055" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtFCqur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2019&pages=975-993&author=J.+Sandlandauthor=R.+W.+Boyle&title=Photosensitizer+antibody-drug+conjugates%3A+Past%2C+present+and+future&doi=10.1021%2Facs.bioconjchem.9b00055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Photosensitizer Antibody-Drug Conjugates: Past, Present, and Future</span></div><div class="casAuthors">Sandland, Jordon; Boyle, Ross W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">975-993</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This Review aims to highlight key aspects of tetrapyrrole-based antibody-drug conjugates (ADCs) and significant developments in the field since 2010.  Many new conjugation methods have been developed and employed in the past decade, and assocd. with this, there has been a rising interest in theranostic conjugates.  We have investigated the physicochem. properties that tetrapyrroles need to possess in order to be viable photosensitizers for conjugation to antibodies.  Differences in conjugation strategies are discussed, and structure-activity relationships of tetrapyrrole-antibody conjugates are reported, where available.  As the elegance of bioconjugation techniques has increased, it has paved the way for exceptionally phototoxic, yet highly selective, tetrapyrrole-antibody conjugates, with photocytotoxicities in the nanomolar range, to be synthesized and biol. evaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRa8MnnISHn7Vg90H21EOLACvtfcHk0lg41T6mYVDUTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtFCqur0%253D&md5=09989d6e2a37e2b715c399035b03a160</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.9b00055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.9b00055%26sid%3Dliteratum%253Aachs%26aulast%3DSandland%26aufirst%3DJ.%26aulast%3DBoyle%26aufirst%3DR.%2BW.%26atitle%3DPhotosensitizer%2520antibody-drug%2520conjugates%253A%2520Past%252C%2520present%2520and%2520future%26jtitle%3DBioconjugate%2520Chem.%26date%3D2019%26volume%3D30%26spage%3D975%26epage%3D993%26doi%3D10.1021%2Facs.bioconjchem.9b00055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">and references therein.</p></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drain, C. M.</span></span> <span> </span><span class="NLM_article-title">Efficient synthesis and photodynamic activity of porphyrin saccharide conjugates: Targeting and incapacitating cancer cells</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">10918</span>– <span class="NLM_lpage">10929</span>, <span class="refDoi"> DOI: 10.1021/bi049272v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi049272v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVSntLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=10918-10929&author=X.+Chenauthor=L.+Huiauthor=D.+A.+Fosterauthor=C.+M.+Drain&title=Efficient+synthesis+and+photodynamic+activity+of+porphyrin+saccharide+conjugates%3A+Targeting+and+incapacitating+cancer+cells&doi=10.1021%2Fbi049272v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient Synthesis and Photodynamic Activity of Porphyrin-Saccharide Conjugates: Targeting and Incapacitating Cancer Cells</span></div><div class="casAuthors">Chen, Xin; Hui, Li; Foster, David A.; Drain, Charles Michael</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">10918-10929</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Since the role of saccharides in cell recognition, metab., and cell labeling is well-established, the conjugation of saccharides to drugs is an active area of research.  Thus, one goal in the use of saccharide-drug conjugates is to impart a greater specificity toward a given cell type or other targets.  Although widely used to treat some cancers and age related macular degeneration, the drugs used in photodynamic therapy (PDT) display poor chem. selectivity toward the intended targets, and uptake by cells most likely arises from passive, diffusional processes.  Instead, the specific irradn. of the target tissues, and the formation of the toxic species in situ, are the primary factors that modulate the selectivity in the present mode of PDT.  We report herein a two-step method to make nonhydrolyzable saccharide-porphyrin conjugates in high yields using a tetra(pentafluorophenyl)porphyrin and the thio deriv. of the sugar.  As a demonstration of their properties, the selective uptake (and/or binding) of these compds. to several cancer cell types was examd., followed by an investigation of their photodynamic properties.  As expected, different malignant cell types take up one type of saccharide-porphyrin conjugate preferentially over others; for example, human breast cancer cells (MDA-MB-231) absorb a tetraglucose-porphyrin conjugate over the corresponding galactose deriv.  Doseametric studies reveal that these saccharide-porphyrin conjugates exhibit varying PDT responses depending on drug concn. and irradn. energy.  Using 20 μM conjugate and greater irradn. energy induces cell death by necrosis.  When 10-20 μM conjugate and less irradn. energy are used, both necrosis and apoptosis are obsd.  Using 10 μM and the least irradn. energy, a significant redn. in cell migration is obsd., which indicates a redn. in aggressiveness of the cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE6qduaudJLrVg90H21EOLACvtfcHk0lhhMPVfKk_F8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVSntLc%253D&md5=92ddb299a014ca6975853a80ce8b5028</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fbi049272v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi049272v%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DHui%26aufirst%3DL.%26aulast%3DFoster%26aufirst%3DD.%2BA.%26aulast%3DDrain%26aufirst%3DC.%2BM.%26atitle%3DEfficient%2520synthesis%2520and%2520photodynamic%2520activity%2520of%2520porphyrin%2520saccharide%2520conjugates%253A%2520Targeting%2520and%2520incapacitating%2520cancer%2520cells%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D10918%26epage%3D10929%26doi%3D10.1021%2Fbi049272v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Missert, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oseroff, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Synthesis of β-galactose conjugated chlorins derived by enyne metathesis as galectin-specific photosensitizers for photodynamic therapy</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">8709</span>– <span class="NLM_lpage">8716</span>, <span class="refDoi"> DOI: 10.1021/jo0105080</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0105080" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosVOiu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=8709-8716&author=G.+Zhengauthor=A.+Grahamauthor=M.+Shibataauthor=J.+R.+Missertauthor=A.+R.+Oseroffauthor=T.+J.+Doughertyauthor=R.+K.+Pandey&title=Synthesis+of+%CE%B2-galactose+conjugated+chlorins+derived+by+enyne+metathesis+as+galectin-specific+photosensitizers+for+photodynamic+therapy&doi=10.1021%2Fjo0105080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of β-Galactose-Conjugated Chlorins Derived by Enyne Metathesis as Galectin-Specific Photosensitizers for Photodynamic Therapy</span></div><div class="casAuthors">Zheng, Gang; Graham, Andrew; Shibata, Masayuki; Missert, Joseph R.; Oseroff, Allan R.; Dougherty, Thomas J.; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">8709-8716</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A first report on the synthesis and biol. evaluation of the β-galactose-conjugated purpurinimides (a class of chlorins contg. a six-membered fused imide ring system) as Gal-1 (galectin-1) recognized photosensitizers, prepd. from purpurin-N-propargylimide via enyne metathesis, is discussed.  On the basis of examn. of the available crystal structure of the galectin-1 N-acetyllactose amine complex, it was considered that the chlorin-based photosensitizers could be introduced into a carbohydrate skeleton to expand the repertoire of the galectin-1-specific ligands.  Preliminary mol. modeling anal. utilizing the modeled photosensitizers and the available crystal structures of galectin-carbohydrate complexes indicated that addn. of the photosensitizer to the carbohydrate moiety at an appropriate position does not interfere with the galectin-carbohydrate recognition.  Under similar drug and light doses, compared to the free purpurinimide analog, the purpurinimides conjugated either with galactose or with lactose (Gal(β1-4)-Glc) produced a considerable increase in photosensitizing efficacy in vitro.  This indicates the possibility for development of a new class of specific photosensitizers for photodynamic therapy (PDT) based on recognition of a cellular receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo33EhZ-smElLVg90H21EOLACvtfcHk0lhmIwWZ6CsGHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosVOiu7w%253D&md5=bf9a8503b3c40ba6a6471d4f59403b9e</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjo0105080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0105080%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DG.%26aulast%3DGraham%26aufirst%3DA.%26aulast%3DShibata%26aufirst%3DM.%26aulast%3DMissert%26aufirst%3DJ.%2BR.%26aulast%3DOseroff%26aufirst%3DA.%2BR.%26aulast%3DDougherty%26aufirst%3DT.%2BJ.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DSynthesis%2520of%2520%25CE%25B2-galactose%2520conjugated%2520chlorins%2520derived%2520by%2520enyne%2520metathesis%2520as%2520galectin-specific%2520photosensitizers%2520for%2520photodynamic%2520therapy%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26spage%3D8709%26epage%3D8716%26doi%3D10.1021%2Fjo0105080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Missert, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellnier, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Conjugation of 2-(1′-hexyloxyethyl)-2-devinylpyropheophorbide-a (HPPH) to carbohydrates changes its subcellular distribution and enhances photodynamic activity in vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">4306</span>– <span class="NLM_lpage">4318</span>, <span class="refDoi"> DOI: 10.1021/jm9001617</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9001617" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntVSrsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4306-4318&author=X.+Zhengauthor=J.+Morganauthor=S.+K.+Pandeyauthor=Y.+Chenauthor=E.+Tracyauthor=H.+Baumannauthor=J.+R.+Missertauthor=C.+Battauthor=J.+Jacksonauthor=D.+A.+Bellnierauthor=B.+W.+Hendersonauthor=R.+K.+Pandey&title=Conjugation+of+2-%281%E2%80%B2-hexyloxyethyl%29-2-devinylpyropheophorbide-a+%28HPPH%29+to+carbohydrates+changes+its+subcellular+distribution+and+enhances+photodynamic+activity+in+vivo&doi=10.1021%2Fjm9001617"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Conjugation of 2-(1'-Hexyloxyethyl)-2-devinylpyropheophorbide-a (HPPH) to Carbohydrates Changes its Subcellular Distribution and Enhances Photodynamic Activity in Vivo</span></div><div class="casAuthors">Zheng, Xiang; Morgan, Janet; Pandey, Suresh K.; Chen, Yihui; Tracy, Erin; Baumann, Heinz; Missert, Joseph R.; Batt, Carrie; Jackson, Jennifer; Bellnier, David A.; Henderson, Barbara W.; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4306-4318</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The carbohydrate moieties on conjugating with 3-(1'-hexyloxyethyl)-3-devinyl pyropeophorbide-a (HPPH) altered the uptake and intracellular localization from mitochondria to lysosomes.  In vitro, HPPH-Gal (I) PDT showed increased PDT efficacy over HPPH-PDT as detectable by the oxidative crosslinking of nonphosphorylated STAT3 and cell killing in ABCG2-expressing RIF cells but not in ABCG2-neg. Colon26 cells.  This increased efficacy in RIF cells could at least partially be attributed to increased cellular accumulation of I, suggesting a role of the ABCG2 transporter for which HPPH is a substrate.  While such differences in the accumulation in HPPH derivs. by tumor tissue in vivo were not detectable, I still showed an elevated light dose-dependent activity compared to HPPH in mice bearing RIF as well as Colon26 tumors.  Further optimization of the carbohydrate conjugates at variable treatment parameters in vivo is currently underway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkzKd5zZ2b0rVg90H21EOLACvtfcHk0lhmIwWZ6CsGHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntVSrsr0%253D&md5=355371956077ac7a6ecc89833664aad5</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm9001617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9001617%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DMorgan%26aufirst%3DJ.%26aulast%3DPandey%26aufirst%3DS.%2BK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DTracy%26aufirst%3DE.%26aulast%3DBaumann%26aufirst%3DH.%26aulast%3DMissert%26aufirst%3DJ.%2BR.%26aulast%3DBatt%26aufirst%3DC.%26aulast%3DJackson%26aufirst%3DJ.%26aulast%3DBellnier%26aufirst%3DD.%2BA.%26aulast%3DHenderson%26aufirst%3DB.%2BW.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DConjugation%2520of%25202-%25281%25E2%2580%25B2-hexyloxyethyl%2529-2-devinylpyropheophorbide-a%2520%2528HPPH%2529%2520to%2520carbohydrates%2520changes%2520its%2520subcellular%2520distribution%2520and%2520enhances%2520photodynamic%2520activity%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4306%26epage%3D4318%26doi%3D10.1021%2Fjm9001617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Substrate affinity of photosensitizers derived from chlorophyll-a: The ABCG2 transporter affects the phototoxic response of side population stem cell-like cancer cells to photodynamic therapy</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1789</span>– <span class="NLM_lpage">1804</span>, <span class="refDoi"> DOI: 10.1021/mp100154j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp100154j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFSjurrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=1789-1804&author=J.+Morganauthor=J.+D.+Jacksonauthor=X.+Zhengauthor=S.+K.+Pandeyauthor=R.+K.+Pandey&title=Substrate+affinity+of+photosensitizers+derived+from+chlorophyll-a%3A+The+ABCG2+transporter+affects+the+phototoxic+response+of+side+population+stem+cell-like+cancer+cells+to+photodynamic+therapy&doi=10.1021%2Fmp100154j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate Affinity of Photosensitizers Derived from Chlorophyll-a: The ABCG2 Transporter Affects the Phototoxic Response of Side Population Stem Cell-like Cancer Cells to Photodynamic Therapy</span></div><div class="casAuthors">Morgan, Janet; Jackson, Jennifer D.; Zheng, Xiang; Pandey, Suresh K.; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1789-1804</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Photosensitizers (PS) synthesized with the aim of optimizing photodynamic therapy (PDT) of tumors do not always fulfill their potential when tested in vitro and in vivo in different tumor models.  The ATP-dependent transporter ABCG2, a multidrug resistant pump expressed at variable levels in cancerous cells, can bind and efflux a wide range of structurally different classes of compds. including several PS used preclinically and clin. such as porphyrins and chlorins.  ABCG2 may lower intracellular levels of substrate PS below the threshold for cell death in tumors treated by PDT, leaving resistant cells to repopulate the tumor.  To det. some of the structural factors that affect substrate affinity of PS for ABCG2, we used an ABCG2-expressing cell line (HEK 293 482R) and its nonexpressing counterpart, and tyrosine kinase ABCG2 inhibitors in a simple flow cytometric assay to identify PS effluxed by the ABCG2 pump.  We tested a series of conjugates of substrate PS with different groups attached at different positions on the tetrapyrrole macrocycle to examine whether a change in affinity for the pump occurred and whether such changes depended on the position or the structure/type of the attached group.  PS without substitutions including pyropheophorbides and purpurinimides were generally substrates for ABCG2, but carbohydrate groups conjugated at positions 8, 12, 13, and 17 but not at position 3 abrogated ABCG2 affinity regardless of structure or linking moiety.  At position 3, affinity was retained with the addn. of iodobenzene, alkyl chains and monosaccharides, but not with disaccharides.  This suggests that structural characteristics at position 3 may offer important contributions to requirements for binding to ABCG2.  We examd. several tumor cell lines for ABCG2 activity, and found that although some cell lines had negligible ABCG2 activity in bulk, they contained a small ABCG2-expressing side population (SP) thought to contain cells which are responsible for initiating tumor regrowth.  We examd. the relevance of the SP to PDT resistance with ABCG2 substrates in vitro and in vivo in the murine mammary tumor 4T1.  We show for the first time in vivo that the substrate PS HPPH (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a) but not the nonsubstrate PS HPPH-Gal (a galactose conjugate of HPPH) selectively preserved the SP which was primarily responsible for regrowth in vitro.  The SP could be targeted by addn. of imatinib mesylate, a tyrosine kinase inhibitor which inhibits the ATPase activity of ABCG2, and prevents efflux of substrates.  A PDT resistant SP may be responsible for recurrences obsd. both preclinically and clin.  To prevent ABCG2 mediated resistance, choosing nonsubstrate PS or administering an ABCG2 inhibitor alongside a substrate PS might be advantageous when treating ABCG2-expressing tumors with PDT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSSGTD8kwyhrVg90H21EOLACvtfcHk0liSokMbsduZvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFSjurrM&md5=668a1009391c86ad4b55abd75c67e7ff</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fmp100154j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp100154j%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DJ.%26aulast%3DJackson%26aufirst%3DJ.%2BD.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DPandey%26aufirst%3DS.%2BK.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DSubstrate%2520affinity%2520of%2520photosensitizers%2520derived%2520from%2520chlorophyll-a%253A%2520The%2520ABCG2%2520transporter%2520affects%2520the%2520phototoxic%2520response%2520of%2520side%2520population%2520stem%2520cell-like%2520cancer%2520cells%2520to%2520photodynamic%2520therapy%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2010%26volume%3D7%26spage%3D1789%26epage%3D1804%26doi%3D10.1021%2Fmp100154j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, P. M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavaleiro, J. A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro, C. A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomé, J. P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, R.</span></span> <span> </span><span class="NLM_article-title">Galactodendritic phthalocyanine targets carbohydrate-binding proteins enhancing photodynamic therapy</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e95529</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0095529</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1371%2Fjournal.pone.0095529" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=24763311" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=P.+M.+R.+Pereiraauthor=S.+Silvaauthor=J.+A.+S.+Cavaleiroauthor=C.+A.+F.+Ribeiroauthor=J.+P.+C.+Tom%C3%A9author=R.+Fernandes&title=Galactodendritic+phthalocyanine+targets+carbohydrate-binding+proteins+enhancing+photodynamic+therapy&doi=10.1371%2Fjournal.pone.0095529"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0095529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0095529%26sid%3Dliteratum%253Aachs%26aulast%3DPereira%26aufirst%3DP.%2BM.%2BR.%26aulast%3DSilva%26aufirst%3DS.%26aulast%3DCavaleiro%26aufirst%3DJ.%2BA.%2BS.%26aulast%3DRibeiro%26aufirst%3DC.%2BA.%2BF.%26aulast%3DTom%25C3%25A9%26aufirst%3DJ.%2BP.%2BC.%26aulast%3DFernandes%26aufirst%3DR.%26atitle%3DGalactodendritic%2520phthalocyanine%2520targets%2520carbohydrate-binding%2520proteins%2520enhancing%2520photodynamic%2520therapy%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0095529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Z.</span></span> <span> </span><span class="NLM_article-title">Potent peptide-conjugated silicon phthalocyanines for tumor photodynamic therapy</span>. <i>J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">310</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.7150/jca.22362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.7150%2Fjca.22362" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=29344278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A280%3ADC%252BC1MvhslGgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=310-320&author=Q.+Liuauthor=M.+Pangauthor=S.+Tanauthor=J.+Wangauthor=Q.+Chenauthor=K.+Wangauthor=W.+Wuauthor=Z.+Hong&title=Potent+peptide-conjugated+silicon+phthalocyanines+for+tumor+photodynamic+therapy&doi=10.7150%2Fjca.22362"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Potent peptide-conjugated silicon phthalocyanines for tumor photodynamic therapy</span></div><div class="casAuthors">Liu Qian; Wang Jin; Hong Zhangyong; Pang Mingpei; Chen Qingle; Wu Wenjie; Tan Sihai; Wang Kai</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cancer</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">310-320</span>
        ISSN:<span class="NLM_cas:issn">1837-9664</span>.
    </div><div class="casAbstract">Phthalocyanines (Pcs) are a group of promising photosensitizers for use in photodynamic therapy (PDT).  However, their extremely low solubility and their strong tendency to aggregate in aqueous solution greatly restrict their application.  Conjugation of Pc macrocycles with peptide ligands could be a very useful strategy to optimize the physical properties of Pcs not only by increasing their water solubility and reducing their aggregation but also by endowing the conjugates with a tumor-targeting capability.  To develop highly potent photosensitizers for tumor PDT, we prepared new peptide-conjugated photosensitizers using silicon Pc (SiPc), which has much higher photodynamic activity than zinc Pcs, as the light activation moiety and the cRGDfK peptide (or simply cRGD) as the peptide moiety.  A polyethylene glycol linker and an extra carboxylic acid group were also tested for introduction into the conjugates to optimize the conjugate structure.  The conjugates' photophysical and photodynamic behaviors were then carefully evaluated and compared using in vitro and in vivo experiments.  One of the prepared conjugates, RGD-(Linker)2-Glu-SiPc, showed excellent physical properties and photodynamic activity, with an EC50 (half maximal effective concentration) of 10-20 nM toward various cancer cells.  This conjugate eradicated human glioblastoma U87-MG tumors in a xenograft murine tumor model after only one dose of photodynamic treatment, with no tumor regrowth during observation for up to 35 days.  The conjugate RGD-(Linker)2-Glu-SiPc thus showed highly promising potential for use in tumor treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSy1-fUapkcWcScOqQTSkOffW6udTcc2eYil_fh0VHpPrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvhslGgsQ%253D%253D&md5=20fb1222078e472522cec9eb2cb374f8</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.7150%2Fjca.22362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fjca.22362%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DPang%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DHong%26aufirst%3DZ.%26atitle%3DPotent%2520peptide-conjugated%2520silicon%2520phthalocyanines%2520for%2520tumor%2520photodynamic%2520therapy%26jtitle%3DJ.%2520Cancer%26date%3D2018%26volume%3D9%26spage%3D310%26epage%3D320%26doi%3D10.7150%2Fjca.22362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Srivatsan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ethirajan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Missert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Conjugation of cRGD peptide to chlorophyll-a based photosensitizer (HPPH) alters its pharmacokinetics with enhanced tumor-imaging and photosensitizing (PDT) efficacy</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1186</span>– <span class="NLM_lpage">1197</span>, <span class="refDoi"> DOI: 10.1021/mp200018y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp200018y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC3MXot1Cltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=1186-1197&author=A.+Srivatsanauthor=M.+Ethirajanauthor=S.+K.+Pandeyauthor=S.+Dubeyauthor=X.+Zhengauthor=T.-H.+Liuauthor=M.+Shibataauthor=J.+Missertauthor=J.+Morganauthor=R.+K.+Pandey&title=Conjugation+of+cRGD+peptide+to+chlorophyll-a+based+photosensitizer+%28HPPH%29+alters+its+pharmacokinetics+with+enhanced+tumor-imaging+and+photosensitizing+%28PDT%29+efficacy&doi=10.1021%2Fmp200018y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Conjugation of cRGD Peptide to Chlorophyll a Based Photosensitizer (HPPH) Alters Its Pharmacokinetics with Enhanced Tumor-Imaging and Photosensitizing (PDT) Efficacy</span></div><div class="casAuthors">Srivatsan, Avinash; Ethirajan, Manivannan; Pandey, Suresh K.; Dubey, Shipra; Zheng, Xiang; Liu, Ting-Hsiu; Shibata, Masayuki; Missert, Joseph; Morgan, Janet; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1186-1197</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The αvβ3 integrin receptor plays an important role in human metastasis and tumor-induced angiogenesis.  Cyclic Arg-Gly-Asp (cRGD) peptide represents a selective αvβ3 integrin ligand that has been extensively used for research, therapy, and diagnosis of neoangiogenesis.  For developing photosensitizers with enhanced PDT efficacy, we here report the synthesis of a series of bifunctional agents in which the 3-(1'-hexyloxyethyl)-3-devinylpyropheophorbide a (HPPH), a chlorophyll-based photosensitizer, was conjugated to cRGD and the related analogs.  The cell uptake and in vitro PDT efficacy of the conjugates were studied in αvβ3 integrin overexpressing U87 and 4T1 cell lines whereas the in vivo PDT efficacy and fluorescence-imaging potential of the conjugates were compared with the corresponding nonconjugated photosensitizer HPPH in 4T1 tumors.  Compared to HPPH, the HPPH-cRGD conjugate in which the arginine and aspartic acid moieties were available for binding to two subunits of αvβ3 integrin showed faster clearance, enhanced tumor imaging and enhanced PDT efficacy at 2-4 h postinjection.  Mol. modeling studies also confirmed that the presence of the HPPH moiety in HPPH-cRGD conjugate does not interfere with specific recognition of cRGD by αvβ3 integrin.  Compared to U87 and 4T1 cells the HPPH-cRGD showed significantly low photosensitizing efficacy in A431 (αvβ3 neg.) tumor cells, suggesting possible target specificity of the conjugate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEnvNJrWfkErVg90H21EOLACvtfcHk0ljR3spvap7a6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXot1Cltr0%253D&md5=19b20682aed1fe3f7acef8a4b7348f11</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fmp200018y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp200018y%26sid%3Dliteratum%253Aachs%26aulast%3DSrivatsan%26aufirst%3DA.%26aulast%3DEthirajan%26aufirst%3DM.%26aulast%3DPandey%26aufirst%3DS.%2BK.%26aulast%3DDubey%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DT.-H.%26aulast%3DShibata%26aufirst%3DM.%26aulast%3DMissert%26aufirst%3DJ.%26aulast%3DMorgan%26aufirst%3DJ.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DConjugation%2520of%2520cRGD%2520peptide%2520to%2520chlorophyll-a%2520based%2520photosensitizer%2520%2528HPPH%2529%2520alters%2520its%2520pharmacokinetics%2520with%2520enhanced%2520tumor-imaging%2520and%2520photosensitizing%2520%2528PDT%2529%2520efficacy%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2011%26volume%3D8%26spage%3D1186%26epage%3D1197%26doi%3D10.1021%2Fmp200018y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyoshi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okazaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohtsuki, T.</span></span> <span> </span><span class="NLM_article-title">Endosomal escape of peptide-photosensitizer conjugates is affected by amino acid sequences near the photosensitizer</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">916</span>– <span class="NLM_lpage">922</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.0c00046</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.0c00046" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisVSitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2020&pages=916-922&author=Y.+Miyoshiauthor=M.+Kadonoauthor=S.+Okazakiauthor=A.+Nishimuraauthor=M.+Kitamatsuauthor=K.+Watanabeauthor=T.+Ohtsuki&title=Endosomal+escape+of+peptide-photosensitizer+conjugates+is+affected+by+amino+acid+sequences+near+the+photosensitizer&doi=10.1021%2Facs.bioconjchem.0c00046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Endosomal Escape of Peptide-Photosensitizer Conjugates Is Affected by Amino Acid Sequences near the Photosensitizer</span></div><div class="casAuthors">Miyoshi, Yuichi; Kadono, Maho; Okazaki, Shigetoshi; Nishimura, Ayano; Kitamatsu, Mizuki; Watanabe, Kazunori; Ohtsuki, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">916-922</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cell-penetrating peptides (CPPs) are widely used for the intracellular delivery of peptides and proteins, but CPP fusion peptides and proteins are often transported by endocytosis and trapped in endosomes.  Photochem. internalization (PCI) is a method for the endosomal escape of the trapped peptide or protein and release into the cytosol using light and photosensitizers.  In PCI, endosomal membranes are thought to be destabilized by singlet oxygen (1O2) photogenerated from photosensitizers localized in endosomes.  We previously developed CPP-cargo-photosensitizer (PS) conjugates able to photodependently enter the cytosol via the PCI mechanism.  For example, TatU1A-PS (a covalent complex of Tat [CPP], U1A RNA-binding protein [cargo], and PS) can photodependently deliver RNAs into the cytosol, and TatBim-PS (a covalent complex of Tat, Bim [cargo], and PS) can photoinduce apoptosis in mammalian cells.  However, for many newly created conjugates, the induction of PCI has been insufficient.  We hypothesized that the amino acid linker sequence (XX) adjacent to the photosensitizer is an important determinant of PCI efficiency.  In this study, using CPP-cargo-XX-PS platforms, we examd. the relationship between PCI efficiency and the linker amino acid sequence near the photosensitizer.  We found that hydrophobic FF and LL linkers enhanced the PCI efficiencies of both TatBim-XX-PS and TatU1A-XX-PS.  The effectiveness of the linker depended, in part, on both the cargo moiety and the photosensitizer.  These results may guide the design of CPP-cargo-PS conjugates conferring broad target functions for PCI and photodynamic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBwsHjYWws9rVg90H21EOLACvtfcHk0liyqfAMNIUk5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisVSitrg%253D&md5=b70a0b24a88664150c3e17dbfa7788c7</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.0c00046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.0c00046%26sid%3Dliteratum%253Aachs%26aulast%3DMiyoshi%26aufirst%3DY.%26aulast%3DKadono%26aufirst%3DM.%26aulast%3DOkazaki%26aufirst%3DS.%26aulast%3DNishimura%26aufirst%3DA.%26aulast%3DKitamatsu%26aufirst%3DM.%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DOhtsuki%26aufirst%3DT.%26atitle%3DEndosomal%2520escape%2520of%2520peptide-photosensitizer%2520conjugates%2520is%2520affected%2520by%2520amino%2520acid%2520sequences%2520near%2520the%2520photosensitizer%26jtitle%3DBioconjugate%2520Chem.%26date%3D2020%26volume%3D31%26spage%3D916%26epage%3D922%26doi%3D10.1021%2Facs.bioconjchem.0c00046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fronczek, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibrian-Vazquez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jois, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicente, M. G. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis of BODIPY-peptide conjugates for fluorescence labeling of EGFR over-expressing cells</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1566</span>– <span class="NLM_lpage">1579</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.7b00211</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.7b00211" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtFCgt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2017&pages=1566-1579&author=N.+Zhaoauthor=T.+M.+Williamsauthor=Z.+Zhouauthor=F.+R.+Fronczekauthor=M.+Sibrian-Vazquezauthor=S.+D.+Joisauthor=M.+G.+H.+Vicente&title=Synthesis+of+BODIPY-peptide+conjugates+for+fluorescence+labeling+of+EGFR+over-expressing+cells&doi=10.1021%2Facs.bioconjchem.7b00211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of BODIPY-Peptide Conjugates for Fluorescence Labeling of EGFR Overexpressing Cells</span></div><div class="casAuthors">Zhao, Ning; Williams, Tyrslai M.; Zhou, Zehua; Fronczek, Frank R.; Sibrian-Vazquez, Martha; Jois, Seetharama D.; Vicente, M. Graca H.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1566-1579</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Regioselective functionalization of 2,3,5,6,8-pentachloro-BODIPY 1 produced unsym. BODIPY 5, bearing an isothiocyanate group suitable for conjugation, in only four steps.  The x-ray structure of 5 reveals a nearly planar BODIPY core with aryl dihedral angles in the range 47.4° - 62.9°.  Conjugation of 5 to two EGFR-targeting pegylated peptides, 3PEG-LARLLT (6) and 3PEG-GYHWYGYTPQNVI (7), under mild conditions (30 min at room temp.), afforded BODIPY conjugates 8 and 9 in 50-80% isolated yields.  These conjugates show red shifted absorption and emission spectra compared with 5, in the near-IR region, and were evaluated as potential fluorescence imaging agents for EGRF over-expressing cells.  SPR and docking studies suggested that conjugate 8 bearing the LARLLT sequence binds to EGFR more effectively than 9 bearing the GYHWYGYTPQNVI peptide, in part due to the lower soly. of 9, and its tendency for aggregation at concns. >10 μM.  Studies in human carcinoma HEp2 cells over-expressing EGFR demonstrated low dark and photo-cytotoxicities for BODIPY 5 and the two peptide conjugates and remarkably high cellular uptake for both conjugates 8 and 9, up to 90-fold compared with BODIPY 5 after 1 h.  Fluorescence imaging studies in HEp2 cells revealed subcellular localization of the BODIPY-peptide conjugates mainly in the Golgi app. and the cell lysosomes.  The low cytotoxicity of the new conjugates and their remarkably high uptake into EGFR over-expressing cells renders them promising imaging agents for cancers over-expressing EGFR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq4NQ6i-3q97Vg90H21EOLACvtfcHk0lhvS1TtfY95pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtFCgt70%253D&md5=eecb517375968874f20434e9d1dd8942</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.7b00211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.7b00211%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DN.%26aulast%3DWilliams%26aufirst%3DT.%2BM.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DFronczek%26aufirst%3DF.%2BR.%26aulast%3DSibrian-Vazquez%26aufirst%3DM.%26aulast%3DJois%26aufirst%3DS.%2BD.%26aulast%3DVicente%26aufirst%3DM.%2BG.%2BH.%26atitle%3DSynthesis%2520of%2520BODIPY-peptide%2520conjugates%2520for%2520fluorescence%2520labeling%2520of%2520EGFR%2520over-expressing%2520cells%26jtitle%3DBioconjugate%2520Chem.%26date%3D2017%26volume%3D28%26spage%3D1566%26epage%3D1579%26doi%3D10.1021%2Facs.bioconjchem.7b00211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Railkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanford, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crooks, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckhaus, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haines, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choyke, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, P. K.</span></span> <span> </span><span class="NLM_article-title">Targeting epidermal Growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) expressing bladder cancer using combination photoimmunotherapy (PIT)</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2084</span>, <span class="refDoi"> DOI: 10.1038/s41598-019-38575-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1038%2Fs41598-019-38575-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=30765854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A280%3ADC%252BB3cfjs1ertg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=2084&author=M.+R.+Siddiquiauthor=R.+Railkarauthor=T.+Sanfordauthor=D.+R.+Crooksauthor=M.+A.+Eckhausauthor=D.+Hainesauthor=P.+L.+Choykeauthor=H.+Kobayashiauthor=P.+K.+Agarwal&title=Targeting+epidermal+Growth+factor+receptor+%28EGFR%29+and+human+epidermal+growth+factor+receptor+2+%28HER2%29+expressing+bladder+cancer+using+combination+photoimmunotherapy+%28PIT%29&doi=10.1038%2Fs41598-019-38575-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT)</span></div><div class="casAuthors">Siddiqui Mohammad R; Railkar Reema; Sanford Thomas; Crooks Daniel R; Agarwal Piyush K; Siddiqui Mohammad R; Eckhaus Michael A; Haines Diana; Choyke Peter L; Kobayashi Hisataka</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2084</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Bladder cancer (BC) is heterogeneous and expresses various cell surface targets.  Photoimmunotherapy (PIT) involves monoclonal antibodies (MAbs) conjugated to a photoabsorber (PA), IR Dye 700Dx, and then activated by near infra-red light (NIR) to specifically target tumors.  We have demonstrated that tumors expressing EGFR can be targeted with PIT.  However, PIT may be less effective when a tumor lacks "overwhelming" expression of a single target such as EGFR.  We present a combinatorial PIT approach for targeting BC expressing EGFR and HER2, using PA- labeled panitumumab (pan) and trastuzumab (tra), respectively.  Human BC tissues and cell lines were analyzed for EGFR and HER2 expression.  Efficacy of PA-labeled MAbs singly and in combination was analyzed.  About 45% of BC tissues stain for both EGFR and HER2.  In vitro, the combination of pan IR700 and tra IR700 with NIR was more efficacious than either agent alone.  Tumor xenografts treated with combination PIT showed significant tumor growth retardation.  Combination PIT is a promising approach for treating BC with low/moderate expression of surface receptors.  In addition, given the molecular heterogeneity of bladder cancer, targeting more than one surface receptor may allow for more effective cell death across different bladder tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQFkXAZSfXPu1m8bhe6roZYfW6udTcc2eYRQxlUpFC1xbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cfjs1ertg%253D%253D&md5=b122f0ff033918997853f55d72b9b2d0</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fs41598-019-38575-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-019-38575-x%26sid%3Dliteratum%253Aachs%26aulast%3DSiddiqui%26aufirst%3DM.%2BR.%26aulast%3DRailkar%26aufirst%3DR.%26aulast%3DSanford%26aufirst%3DT.%26aulast%3DCrooks%26aufirst%3DD.%2BR.%26aulast%3DEckhaus%26aufirst%3DM.%2BA.%26aulast%3DHaines%26aufirst%3DD.%26aulast%3DChoyke%26aufirst%3DP.%2BL.%26aulast%3DKobayashi%26aufirst%3DH.%26aulast%3DAgarwal%26aufirst%3DP.%2BK.%26atitle%3DTargeting%2520epidermal%2520Growth%2520factor%2520receptor%2520%2528EGFR%2529%2520and%2520human%2520epidermal%2520growth%2520factor%2520receptor%25202%2520%2528HER2%2529%2520expressing%2520bladder%2520cancer%2520using%2520combination%2520photoimmunotherapy%2520%2528PIT%2529%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26spage%3D2084%26doi%3D10.1038%2Fs41598-019-38575-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carlsson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wester, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De La Torre, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malmström, P.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gådmark, T.</span></span> <span> </span><span class="NLM_article-title">EGFR-expression in primary urinary bladder cancer and corresponding metastases and the relation to HER2-expression. On the possibility to target these receptors with radionuclides</span>. <i>Radiol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.2478/raon-2014-0015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.2478%2Fraon-2014-0015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=25810701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlvV2qtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2015&pages=50-58&author=J.+Carlssonauthor=K.+Westerauthor=M.+De+La+Torreauthor=P.-U.+Malmstr%C3%B6mauthor=T.+G%C3%A5dmark&title=EGFR-expression+in+primary+urinary+bladder+cancer+and+corresponding+metastases+and+the+relation+to+HER2-expression.+On+the+possibility+to+target+these+receptors+with+radionuclides&doi=10.2478%2Fraon-2014-0015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">EGFR-expression in primary urinary bladder cancer and corresponding metastases and the relation to HER2-expression. On the possibility to target these receptors with radionuclides</span></div><div class="casAuthors">Carlsson, Joergen; Wester, Kenneth; De La Torre, Manuel; Malmstroem, Per-Uno; Gardmark, Truls</div><div class="citationInfo"><span class="NLM_cas:title">Radiology and Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-58</span>CODEN:
                <span class="NLM_cas:coden">RONCEM</span>;
        ISSN:<span class="NLM_cas:issn">1318-2099</span>.
    
            (<span class="NLM_cas:orgname">Association of Radiology and Oncology</span>)
        </div><div class="casAbstract">Background. There is limited effect of tyrosine kinase inhibitors or "naked" antibodies binding EGFR or HER2 for therapy of metastasized urinary bladder cancer and these methods are therefore not routinely used.  Targeting radionuclides to the extracellular domain of the receptors is potentially a better possibility.  Methods. EGFR- and HER2-expression was analyzed for primary tumors and corresponding metastases from 72 patients using immunohistochem. and the internationally recommended HercepTest.  Intracellular mutations were not analyzed since only the receptors were considered as targets and intracellular abnormalities should have minor effect on radiation dose.  Results. EGFR was pos. in 71% of the primary tumors and 69% of corresponding metastases.  Local and distant metastases were EGFR-pos. in 75% and 66% of the cases, resp.  The expression frequency of HER2 in related lesions was slightly higher (data from previous study).  The EGFR-pos. tumors expressed EGFR in metastases in 86% of the cases.  The co-expression of EGFR and HER2 was 57% for tumors and 53% for metastases.  Only 3% and 10% of the lesions were neg. for both receptors in tumors and metastases, resp.  Thus, targeting these receptors with radionuclides might be applied for most patients.  Conclusions. At least one of the EGFR- or HER2-receptors was present in most cases and co-expressed in more than half the cases.  It is therefore interesting to deliver radionuclides for whole-body receptor-anal., dosimetry and therapy.  This can hopefully compensate for resistance to other therapies and more patients can hopefully be treated with curative instead of palliative intention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1jaAIjco_JrVg90H21EOLACvtfcHk0lhFDCZU1I70WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlvV2qtbw%253D&md5=ac2ca5c4af2f86183a771a4f21d4ad77</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2478%2Fraon-2014-0015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2478%252Fraon-2014-0015%26sid%3Dliteratum%253Aachs%26aulast%3DCarlsson%26aufirst%3DJ.%26aulast%3DWester%26aufirst%3DK.%26aulast%3DDe%2BLa%2BTorre%26aufirst%3DM.%26aulast%3DMalmstr%25C3%25B6m%26aufirst%3DP.-U.%26aulast%3DG%25C3%25A5dmark%26aufirst%3DT.%26atitle%3DEGFR-expression%2520in%2520primary%2520urinary%2520bladder%2520cancer%2520and%2520corresponding%2520metastases%2520and%2520the%2520relation%2520to%2520HER2-expression.%2520On%2520the%2520possibility%2520to%2520target%2520these%2520receptors%2520with%2520radionuclides%26jtitle%3DRadiol.%2520Oncol.%26date%3D2015%26volume%3D49%26spage%3D50%26epage%3D58%26doi%3D10.2478%2Fraon-2014-0015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zouhair, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azria, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozsahin, M.</span></span> <span> </span><span class="NLM_article-title">The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications</span>. <i>Radiat. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">11</span>, <span class="refDoi"> DOI: 10.1186/1748-717X-1-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1186%2F1748-717X-1-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=16722544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A280%3ADC%252BD28vlslKisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=11&author=M.+Zimmermannauthor=A.+Zouhairauthor=D.+Azriaauthor=M.+Ozsahin&title=The+epidermal+growth+factor+receptor+%28EGFR%29+in+head+and+neck+cancer%3A+its+role+and+treatment+implications&doi=10.1186%2F1748-717X-1-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications</span></div><div class="casAuthors">Zimmermann Michel; Zouhair Abderrahim; Azria David; Ozsahin Mahmut</div><div class="citationInfo"><span class="NLM_cas:title">Radiation oncology (London, England)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11</span>
        ISSN:<span class="NLM_cas:issn">1748-717X</span>.
    </div><div class="casAbstract">Epidermal growth factor receptor (EGFR) is a member of the ErbB family of receptors.  Its stimulation by endogenous ligands, EGF or transforming growth factor-alpha (TGF-alpha) results in activation of intracellular tyrosine kinase, therefore, cell cycle progression.  High levels of EGFR expression are correlated with poor prognosis and resistance to radiation therapy in a variety of cancers, mostly in squamous-cell carcinoma of the head and neck (SCCHN).  Blocking the EGFR by a monoclonal antibody results in inhibition of the stimulation of the receptor, therefore, in inhibition of cell proliferation, enhanced apoptosis, and reduced angiogenesis, invasiveness and metastases.  The EGFR is a prime target for new anticancer therapy in SCCHN, and other agents in development include small molecular tyrosine kinase inhibitors and antisense therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR6W6i8OdWq-ENoizSOkG_FfW6udTcc2eYIRG2exT_LR7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28vlslKisA%253D%253D&md5=41e635e6bd014f04738d5db82e6027c1</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1186%2F1748-717X-1-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1748-717X-1-11%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DM.%26aulast%3DZouhair%26aufirst%3DA.%26aulast%3DAzria%26aufirst%3DD.%26aulast%3DOzsahin%26aufirst%3DM.%26atitle%3DThe%2520epidermal%2520growth%2520factor%2520receptor%2520%2528EGFR%2529%2520in%2520head%2520and%2520neck%2520cancer%253A%2520its%2520role%2520and%2520treatment%2520implications%26jtitle%3DRadiat.%2520Oncol.%26date%3D2006%26volume%3D1%26spage%3D11%26doi%3D10.1186%2F1748-717X-1-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shigematsu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estess, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegelman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shay, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spitz, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wistuba, I. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minna, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gazdar, A. F.</span></span> <span> </span><span class="NLM_article-title">polymorphisms, mutations, and amplification of the EGFR Gene in non-small cell lung cancers</span>. <i>PLoS Med.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e125</span> <span class="refDoi"> DOI: 10.1371/journal.pmed.0040125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1371%2Fjournal.pmed.0040125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=17455987" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&author=M.+Nomuraauthor=H.+Shigematsuauthor=L.+Liauthor=M.+Suzukiauthor=T.+Takahashiauthor=P.+Estessauthor=M.+Siegelmanauthor=Z.+Fengauthor=H.+Katoauthor=A.+Marchettiauthor=J.+W.+Shayauthor=M.+R.+Spitzauthor=I.+I.+Wistubaauthor=J.+D.+Minnaauthor=A.+F.+Gazdar&title=polymorphisms%2C+mutations%2C+and+amplification+of+the+EGFR+Gene+in+non-small+cell+lung+cancers&doi=10.1371%2Fjournal.pmed.0040125"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pmed.0040125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pmed.0040125%26sid%3Dliteratum%253Aachs%26aulast%3DNomura%26aufirst%3DM.%26aulast%3DShigematsu%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DEstess%26aufirst%3DP.%26aulast%3DSiegelman%26aufirst%3DM.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DKato%26aufirst%3DH.%26aulast%3DMarchetti%26aufirst%3DA.%26aulast%3DShay%26aufirst%3DJ.%2BW.%26aulast%3DSpitz%26aufirst%3DM.%2BR.%26aulast%3DWistuba%26aufirst%3DI.%2BI.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DGazdar%26aufirst%3DA.%2BF.%26atitle%3Dpolymorphisms%252C%2520mutations%252C%2520and%2520amplification%2520of%2520the%2520EGFR%2520Gene%2520in%2520non-small%2520cell%2520lung%2520cancers%26jtitle%3DPLoS%2520Med.%26date%3D2007%26volume%3D4%26doi%3D10.1371%2Fjournal.pmed.0040125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mark, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motoi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerald, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travis, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornmann, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veach, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarkson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bromberg, J. F.</span></span> <span> </span><span class="NLM_article-title">Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas</span>. <i>J. Clin. Invest</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">3846</span>– <span class="NLM_lpage">3856</span>, <span class="refDoi"> DOI: 10.1172/JCI31871</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1172%2FJCI31871" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=18060032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsValsL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2007&pages=3846-3856&author=S.+P.+Gaoauthor=K.+G.+Markauthor=K.+Leslieauthor=W.+Paoauthor=N.+Motoiauthor=W.+L.+Geraldauthor=W.+D.+Travisauthor=W.+Bornmannauthor=D.+Veachauthor=B.+Clarksonauthor=J.+F.+Bromberg&title=Mutations+in+the+EGFR+kinase+domain+mediate+STAT3+activation+via+IL-6+production+in+human+lung+adenocarcinomas&doi=10.1172%2FJCI31871"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas</span></div><div class="casAuthors">Gao, Sizhi Paul; Mark, Kavin G.; Leslie, Kenneth; Pao, William; Motoi, Noriko; Gerald, William L.; Travis, William D.; Bornmann, William; Veach, Darren; Clarkson, Bayard; Bromberg, Jacqueline F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3846-3856</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Persistently activated or tyrosine-phosphorylated STAT3 (pSTAT3) is found in 50% of lung adenocarcinomas.  PSTAT3 is found in primary adenocarcinomas and cell lines harboring somatic-activating mutations in the tyrosine kinase domain of EGFR.  Treatment of cell lines with either an EGFR inhibitor or an src kinase inhibitor had no effect on pSTAT3 levels, whereas a pan-JAK inhibitor (P6) blocked activation of STAT3 and inhibited tumorigenesis.  Cell lines expressing these persistently activated mutant EGFRs also produced high IL-6 levels, and blockade of the IL-6/gp130/JAK pathway led to a decrease in pSTAT3 levels.  In addn., redn. of IL-6 levels by RNA interference led to a decrease in tumorigenesis.  Introduction of persistently activated EGFR into immortalized breast epithelial cells led to tumorigenesis, IL-6 expression, and STAT3 activation, all of which could be inhibited with P6 or gp130 blockade.  Furthermore, inhibition of EGFR activity in multiple cell lines partially blocked transcription of IL-6 and concurrently decreased prodn. and release of IL-6.  Finally, immunohistochem. anal. revealed a pos. correlation between pSTAT3 and IL-6 positivity in primary lung adenocarcinomas.  Therefore, mutant EGFR could activate the gp130/JAK/STAT3 pathway by IL-6 upregulation in primary human lung adenocarcinomas, making this pathway a potential target for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-fCYAz8G9S7Vg90H21EOLACvtfcHk0liJj3AChkgaEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsValsL%252FO&md5=4043bc2cf3aecbfbfb3fbd8bf99d6aef</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1172%2FJCI31871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI31871%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DS.%2BP.%26aulast%3DMark%26aufirst%3DK.%2BG.%26aulast%3DLeslie%26aufirst%3DK.%26aulast%3DPao%26aufirst%3DW.%26aulast%3DMotoi%26aufirst%3DN.%26aulast%3DGerald%26aufirst%3DW.%2BL.%26aulast%3DTravis%26aufirst%3DW.%2BD.%26aulast%3DBornmann%26aufirst%3DW.%26aulast%3DVeach%26aufirst%3DD.%26aulast%3DClarkson%26aufirst%3DB.%26aulast%3DBromberg%26aufirst%3DJ.%2BF.%26atitle%3DMutations%2520in%2520the%2520EGFR%2520kinase%2520domain%2520mediate%2520STAT3%2520activation%2520via%2520IL-6%2520production%2520in%2520human%2520lung%2520adenocarcinomas%26jtitle%3DJ.%2520Clin.%2520Invest%26date%3D2007%26volume%3D117%26spage%3D3846%26epage%3D3856%26doi%3D10.1172%2FJCI31871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellnier, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greco, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaughan, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weishaupt, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, T. J.</span></span> <span> </span><span class="NLM_article-title">An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4000</span>– <span class="NLM_lpage">4007</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=9307285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADyaK2sXmtFehsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=4000-4007&author=B.+W.+Hendersonauthor=D.+A.+Bellnierauthor=W.+R.+Grecoauthor=A.+Sharmaauthor=R.+K.+Pandeyauthor=L.+A.+Vaughanauthor=K.+R.+Weishauptauthor=T.+J.+Dougherty&title=An+in+vivo+quantitative+structure-activity+relationship+for+a+congeneric+series+of+pyropheophorbide+derivatives+as+photosensitizers+for+photodynamic+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy</span></div><div class="casAuthors">Henderson, Barbara W.; Bellnier, David A.; Greco, William R.; Sharma, Amarnath; Pandey, Ravindra K.; Vaughan, Lurine A.; Weishaupt, Kenneth R.; Dougherty, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4000-4007</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">An in vivo quant. structure-activity relationship (QSAR) study was carried out on a congeneric series of pyropheophorbide photosensitizers to identify structural features crit. for their antitumor activity in photodynamic therapy (PDT).  The structural elements evaluated in this study include the length and shape (alkyl, alkenyl, cyclic, and secondary analogs) of the ether side chain.  C3H mice, harboring the radiation-induced fibrosarcoma tumor model, were used to study three biol. response endpoints: tumor growth delay, tumor cell lethality, and vascular perfusion.  All three endpoints revealed highly similar QSAR patterns that constituted a function of the alkyl ether chain length and drug lipophilicity, which is defined as the log of the octanol:water partition coeff. (log P).  When the illumination of tumor, tumor cells, or cutaneous vasculature occurred 24 h after sensitizer administration, activities were minimal with analogs of log P ≤ 5, increased dramatically between log P of 5-6, and peaked between log P of 5.6-6.6.  Activities declined gradually with higher log P.  The lack of activity of the least-lipophilic analogs was explained in large part by their poor biodistribution characteristics, which yielded negligible tumor and plasma drug levels at the time of treatment with light.  The progressively lower potencies of the most lipophilic analogs cannot be explained through the overall tumor and plasma pharmacokinetics of photosensitizer because tumor and plasma concns. progressively increased with lipophilicity.  When compensated for differences in tumor photosensitizer concn., the 1-hexyl deriv. (optimal lipophilicity) was 5-fold more potent than the 1-dodecyl deriv. (more lipophilic) and 3-fold more potent than the 1-pentyl analog (less lipophilic), indicating that, in addn. to the overall tumor pharmacokinetics, pharmacodynamic factors may influence PDT activity.  Drug lipophilicity was highly predictive for photodynamic activity.  QSAR modeling revealed that direct antitumor effects and vascular PDT effects may be governed by common mechanisms, and that the mere assocn. of high levels of photosensitizer in the tumor tissue is not sufficient for optimal PDT efficiency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8jr9wz9QNVbVg90H21EOLACvtfcHk0liJj3AChkgaEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmtFehsLg%253D&md5=a1b891da5bee6c012242bc129ea28636</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHenderson%26aufirst%3DB.%2BW.%26aulast%3DBellnier%26aufirst%3DD.%2BA.%26aulast%3DGreco%26aufirst%3DW.%2BR.%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26aulast%3DVaughan%26aufirst%3DL.%2BA.%26aulast%3DWeishaupt%26aufirst%3DK.%2BR.%26aulast%3DDougherty%26aufirst%3DT.%2BJ.%26atitle%3DAn%2520in%2520vivo%2520quantitative%2520structure-activity%2520relationship%2520for%2520a%2520congeneric%2520series%2520of%2520pyropheophorbide%2520derivatives%2520as%2520photosensitizers%2520for%2520photodynamic%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26spage%3D4000%26epage%3D4007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goswami, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gryshuk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Missert, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oseroff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, T. J.</span></span> <span> </span><span class="NLM_article-title">Nature: A rich source for developing multifunctional agents. Tumor-imaging and photodynamic therapy</span>. <i>Lasers Surg. Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">445</span>– <span class="NLM_lpage">467</span>, <span class="refDoi"> DOI: 10.1002/lsm.20352</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1002%2Flsm.20352" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=16788930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A280%3ADC%252BD28zosFCnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2006&pages=445-467&author=R.+K.+Pandeyauthor=L.+N.+Goswamiauthor=Y.+Chenauthor=A.+Gryshukauthor=J.+R.+Missertauthor=A.+Oseroffauthor=T.+J.+Dougherty&title=Nature%3A+A+rich+source+for+developing+multifunctional+agents.+Tumor-imaging+and+photodynamic+therapy&doi=10.1002%2Flsm.20352"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Nature: a rich source for developing multifunctional agents. Tumor-imaging and photodynamic therapy</span></div><div class="casAuthors">Pandey Ravindra K; Goswami Lalit N; Chen Yihui; Gryshuk Amy; Missert Joseph R; Oseroff Allan; Dougherty Thomas J</div><div class="citationInfo"><span class="NLM_cas:title">Lasers in surgery and medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">445-67</span>
        ISSN:<span class="NLM_cas:issn">0196-8092</span>.
    </div><div class="casAbstract">The purpose of this review is to call attention in the use of chlorophyll-a and bacteriochlorophyll-a to develop more than 600 photosensitizers (lambda (max) 660 nm-800 nm) during the last 15 years (1990-2005) at the Photodynamic Therapy Center, Roswell Park Cancer Institute, Buffalo.  This article mainly includes the chemistry, preclinical results, and brief clinical data of some of the most effective photosensitizers.  The utility of the tumor-avid photosensitizers in developing multimodality agents (imaging and therapy) is also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQZrU4dU_XG5DdblLE_E9PWfW6udTcc2eYSM6Z3XJrgM7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28zosFCnuw%253D%253D&md5=4d6da90479d36b451478771987e0ab09</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Flsm.20352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Flsm.20352%26sid%3Dliteratum%253Aachs%26aulast%3DPandey%26aufirst%3DR.%2BK.%26aulast%3DGoswami%26aufirst%3DL.%2BN.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DGryshuk%26aufirst%3DA.%26aulast%3DMissert%26aufirst%3DJ.%2BR.%26aulast%3DOseroff%26aufirst%3DA.%26aulast%3DDougherty%26aufirst%3DT.%2BJ.%26atitle%3DNature%253A%2520A%2520rich%2520source%2520for%2520developing%2520multifunctional%2520agents.%2520Tumor-imaging%2520and%2520photodynamic%2520therapy%26jtitle%3DLasers%2520Surg.%2520Med.%26date%3D2006%26volume%3D38%26spage%3D445%26epage%3D467%26doi%3D10.1002%2Flsm.20352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baron, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scull, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berlin, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormick, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colussi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenney, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olenick, N. L.</span></span> <span> </span><span class="NLM_article-title">Photodynamic therapy with the phthalocyanine photosensitizer PC-4: The case experience with preclinical mechanistic and early clinical-translational studies</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>224</i></span>,  <span class="NLM_fpage">290</span>– <span class="NLM_lpage">299</span>, <span class="refDoi"> DOI: 10.1016/j.taap.2007.01.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1016%2Fj.taap.2007.01.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=17397888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtF2mtL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=224&publication_year=2007&pages=290-299&author=J.+D.+Millerauthor=E.+D.+Baronauthor=H.+Scullauthor=A.+Hsiaauthor=J.+C.+Berlinauthor=T.+McCormickauthor=V.+Colussiauthor=M.+F.+Kenneyauthor=K.+D.+Cooperauthor=N.+L.+Olenick&title=Photodynamic+therapy+with+the+phthalocyanine+photosensitizer+PC-4%3A+The+case+experience+with+preclinical+mechanistic+and+early+clinical-translational+studies&doi=10.1016%2Fj.taap.2007.01.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: The case experience with preclinical mechanistic and early clinical-translational studies</span></div><div class="casAuthors">Miller, Janine D.; Baron, Elma D.; Scull, Heather; Hsia, Andrew; Berlin, Jeffrey C.; McCormick, Thomas; Colussi, Valdir; Kenney, Malcolm E.; Cooper, Kevin D.; Oleinick, Nancy L.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">224</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">290-299</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Photodynamic therapy (PDT) is emerging as a promising non-invasive treatment for cancers.  PDT involves either local or systemic administration of a photosensitizing drug, which preferentially localizes within the tumor, followed by illumination of the involved organ with light, usually from a laser source.  Here, we provide a selective overview of our experience with PDT at Case Western Reserve University, specifically with the silicon phthalocyanine photosensitizer Pc 4.  We first review our in vitro studies evaluating the mechanism of cell killing by Pc 4-PDT.  Then we briefly describe our clin. experience in a Phase I trial of Pc 4-PDT and our preliminary translational studies evaluating the mechanisms behind tumor responses.  Preclin. work identified (a) cardiolipin and the anti-apoptotic proteins Bcl-2 and Bcl-xL as targets of Pc 4-PDT, (b) the intrinsic pathway of apoptosis, with the key participation of caspase-3, as a central response of many human cancer cells to Pc 4-PDT, (c) signaling pathways that could modify apoptosis, and (d) a formulation by which Pc 4 could be applied topically to human skin and penetrate at least through the basal layer of the epidermis.  Clin.-translational studies enabled us to develop an immunohistochem. assay for caspase-3 activation, using biopsies from patients treated with topical Pc 4 in a Phase I PDT trial for cutaneous T-cell lymphoma.  Results suggest that this assay may be used as an early biomarker of clin. response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppT2jU6mhi77Vg90H21EOLACvtfcHk0lgHa7iaz-QoAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtF2mtL7E&md5=3a2583b4343e01948f940ce5d3bc8c05</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2007.01.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2007.01.025%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DJ.%2BD.%26aulast%3DBaron%26aufirst%3DE.%2BD.%26aulast%3DScull%26aufirst%3DH.%26aulast%3DHsia%26aufirst%3DA.%26aulast%3DBerlin%26aufirst%3DJ.%2BC.%26aulast%3DMcCormick%26aufirst%3DT.%26aulast%3DColussi%26aufirst%3DV.%26aulast%3DKenney%26aufirst%3DM.%2BF.%26aulast%3DCooper%26aufirst%3DK.%2BD.%26aulast%3DOlenick%26aufirst%3DN.%2BL.%26atitle%3DPhotodynamic%2520therapy%2520with%2520the%2520phthalocyanine%2520photosensitizer%2520PC-4%253A%2520The%2520case%2520experience%2520with%2520preclinical%2520mechanistic%2520and%2520early%2520clinical-translational%2520studies%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2007%26volume%3D224%26spage%3D290%26epage%3D299%26doi%3D10.1016%2Fj.taap.2007.01.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rigual, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shafirstein, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellnier, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunar, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracy, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohrbach, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilding, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merzianu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, B. W.</span></span> <span> </span><span class="NLM_article-title">Photodynamic therapy with 3-(1′-hexyloxyethyl) pyropheophorbide-a for cancer of the oral cavity</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">6605</span>– <span class="NLM_lpage">6613</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-13-1735</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1158%2F1078-0432.CCR-13-1735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=24088736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVOitbzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=6605-6613&author=N.+Rigualauthor=G.+Shafirsteinauthor=M.+T.+Cooperauthor=H.+Baumannauthor=D.+A.+Bellnierauthor=U.+Sunarauthor=E.+C.+Tracyauthor=D.+J.+Rohrbachauthor=G.+Wildingauthor=W.+Tanauthor=M.+Sullivanauthor=M.+Merzianuauthor=B.+W.+Henderson&title=Photodynamic+therapy+with+3-%281%E2%80%B2-hexyloxyethyl%29+pyropheophorbide-a+for+cancer+of+the+oral+cavity&doi=10.1158%2F1078-0432.CCR-13-1735"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Photodynamic Therapy with 3-(1'-Hexyloxyethyl) Pyropheophorbide a for Cancer of the Oral Cavity</span></div><div class="casAuthors">Rigual, Nestor; Shafirstein, Gal; Cooper, Michele T.; Baumann, Heinz; Bellnier, David A.; Sunar, Ulas; Tracy, Erin C.; Rohrbach, Daniel J.; Wilding, Gregory; Tan, Wei; Sullivan, Maureen; Merzianu, Mihai; Henderson, Barbara W.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6605-6613</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: The primary objective was to evaluate safety of 3-(1'-hexyloxyethyl)pyropheophorbide-a (HPPH) photodynamic therapy (HPPH-PDT) for dysplasia and early squamous cell carcinoma of the head and neck (HNSCC).  Secondary objectives were the assessment of treatment response and reporters for an effective PDT reaction.  Exptl. Design: Patients with histol. proven oral dysplasia, carcinoma in situ, or early-stage HNSCC were enrolled in two sequentially conducted dose escalation studies with an expanded cohort at the highest dose level.  These studies used an HPPH dose of 4 mg/m2 and light doses from 50 to 140 J/cm2.  Pathol. tumor responses were assessed at 3 mo.  Clin. follow up range was 5 to 40 mo.  PDT induced crosslinking of STAT3 were assessed as potential indicators of PDT effective reaction.  Results: Forty patients received HPPH-PDT.  Common adverse events were pain and treatment site edema.  Biopsy proven complete response rates were 46% for dysplasia and carcinoma in situ and 82% for squamous cell carcinomas (SCC) lesions at 140 J/cm2.  The responses in the carcinoma in situ/dysplasia cohort are not durable.  The PDT-induced STAT3 cross-links is significantly higher (P = 0.0033) in SCC than in carcinoma in situ/dysplasia for all light doses.  Conclusion: HPPH-PDT is safe for the treatment of carcinoma in situ/dysplasia and early-stage cancer of the oral cavity.  Early-stage oral HNSCC seems to respond better to HPPH-PDT in comparison with premalignant lesions.  The degree of STAT3 crosslinking is a significant reporter to evaluate HPPH-PDT-mediated photoreaction.  Clin Cancer Res; 19(23); 6605-13. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIQWpi_NIP-LVg90H21EOLACvtfcHk0liuhgCoYD_YqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVOitbzL&md5=964872d2b2a2b4c8c86e6496d1aafc3a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-1735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-1735%26sid%3Dliteratum%253Aachs%26aulast%3DRigual%26aufirst%3DN.%26aulast%3DShafirstein%26aufirst%3DG.%26aulast%3DCooper%26aufirst%3DM.%2BT.%26aulast%3DBaumann%26aufirst%3DH.%26aulast%3DBellnier%26aufirst%3DD.%2BA.%26aulast%3DSunar%26aufirst%3DU.%26aulast%3DTracy%26aufirst%3DE.%2BC.%26aulast%3DRohrbach%26aufirst%3DD.%2BJ.%26aulast%3DWilding%26aufirst%3DG.%26aulast%3DTan%26aufirst%3DW.%26aulast%3DSullivan%26aufirst%3DM.%26aulast%3DMerzianu%26aufirst%3DM.%26aulast%3DHenderson%26aufirst%3DB.%2BW.%26atitle%3DPhotodynamic%2520therapy%2520with%25203-%25281%25E2%2580%25B2-hexyloxyethyl%2529%2520pyropheophorbide-a%2520for%2520cancer%2520of%2520the%2520oral%2520cavity%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D6605%26epage%3D6613%26doi%3D10.1158%2F1078-0432.CCR-13-1735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nava, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allamaneni, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilding, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, B. W.</span></span> <span> </span><span class="NLM_article-title">Photodynamic therapy (PDT) using HPPH for the treatment of precancerous lesions associated with Barrett’s esophagus</span>. <i>Lasers Surg. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">705</span>– <span class="NLM_lpage">712</span>, <span class="refDoi"> DOI: 10.1002/lsm.21112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1002%2Flsm.21112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=22057498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A280%3ADC%252BC3MbmvFOitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2011&pages=705-712&author=H.+R.+Navaauthor=S.+S.+Allamaneniauthor=T.+J.+Doughertyauthor=M.+T.+Cooperauthor=W.+Tanauthor=G.+Wildingauthor=B.+W.+Henderson&title=Photodynamic+therapy+%28PDT%29+using+HPPH+for+the+treatment+of+precancerous+lesions+associated+with+Barrett%E2%80%99s+esophagus&doi=10.1002%2Flsm.21112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Photodynamic therapy (PDT) using HPPH for the treatment of precancerous lesions associated with Barrett's esophagus</span></div><div class="casAuthors">Nava Hector R; Allamaneni Shyam S; Dougherty Thomas J; Cooper Michele T; Tan Wei; Wilding Gregory; Henderson Barbara W</div><div class="citationInfo"><span class="NLM_cas:title">Lasers in surgery and medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">705-12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND OBJECTIVES:  Photodynamic therapy (PDT) with porfimer sodium, FDA approved to treat premalignant lesions in Barrett's esophagus, causes photosensitivity for 6-8 weeks.  HPPH (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a) shows minimal photosensitization of short duration and promising efficacy in preclinical studies.  Here we explore toxicity and optimal drug and light dose with endoscopic HPPH-PDT.  We also want to know the efficacy of one time treatment with HPPH-PDT.  STUDY DESIGN/MATERIALS AND METHODS:  Two nonrandomized dose escalation studies were performed (18 patients each) with biopsy-proven high grade dysplasia or early intramucosal adenocarcinoma of esophagus.  HPPH doses ranged from 3 to 6 mg/m2 .  At 24 or 48 hours after HPPH administration the lesions received one endoscopic exposure to 150, 175, or 200 J/cm of 665 nm light.  RESULTS:  Most patients experienced mild to moderate chest pain requiring symptomatic treatment only.  Six patients experienced grade 3 and 4 adverse events (16.6%).  Three esophageal strictures were treated with dilatation.  No clear pattern of dose dependence of toxicities emerged.  In the drug dose ranging study (light dose of 150 J/cm at 48 hours), 3 and 4 mg/m2 of HPPH emerged as most effective.  In the light dose ranging study (3 or 4 mg/m2 HPPH, light at 24 hours), complete response rates (disappearance of high grade dysplasia and early carcinoma) of 72% were achieved at 1 year, with all patients treated with 3 mg/m2 HPPH plus 175 J/cm and 4 mg/m2 HPPH plus 150 J/cm showing complete responses at 1 year.  CONCLUSIONS:  HPPH-PDT for precancerous lesions in Barrett's esophagus appears to be safe and showing promising efficacy.  Further clinical studies are required to establish the use of HPPH-PDT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQPQNcby4MGQcKL0FlyGHDofW6udTcc2ebEAPAoCqijM7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MbmvFOitQ%253D%253D&md5=e8bf682c3ae45fb06b83c83e18ee3811</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Flsm.21112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Flsm.21112%26sid%3Dliteratum%253Aachs%26aulast%3DNava%26aufirst%3DH.%2BR.%26aulast%3DAllamaneni%26aufirst%3DS.%2BS.%26aulast%3DDougherty%26aufirst%3DT.%2BJ.%26aulast%3DCooper%26aufirst%3DM.%2BT.%26aulast%3DTan%26aufirst%3DW.%26aulast%3DWilding%26aufirst%3DG.%26aulast%3DHenderson%26aufirst%3DB.%2BW.%26atitle%3DPhotodynamic%2520therapy%2520%2528PDT%2529%2520using%2520HPPH%2520for%2520the%2520treatment%2520of%2520precancerous%2520lesions%2520associated%2520with%2520Barrett%25E2%2580%2599s%2520esophagus%26jtitle%3DLasers%2520Surg.%2520Med.%26date%3D2011%26volume%3D43%26spage%3D705%26epage%3D712%26doi%3D10.1002%2Flsm.21112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Loewen, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellnier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, T.</span></span> <span> </span><span class="NLM_article-title">Endobronchial photodynamic therapy for lung cancer</span>. <i>Lasers Surg. Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">364</span>– <span class="NLM_lpage">370</span>, <span class="refDoi"> DOI: 10.1002/lsm.20354</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1002%2Flsm.20354" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=16788932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A280%3ADC%252BD28zosFCmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2006&pages=364-370&author=G.+M.+Loewenauthor=R.+Pandeyauthor=D.+Bellnierauthor=B.+Hendersonauthor=T.+Dougherty&title=Endobronchial+photodynamic+therapy+for+lung+cancer&doi=10.1002%2Flsm.20354"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Endobronchial photodynamic therapy for lung cancer</span></div><div class="casAuthors">Loewen Gregory M; Pandey Ravindra; Bellnier David; Henderson Barbara; Dougherty Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Lasers in surgery and medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">364-70</span>
        ISSN:<span class="NLM_cas:issn">0196-8092</span>.
    </div><div class="casAbstract">BACKGROUND AND OBJECTIVE:  Endobronchial photodynamic therapy (PDT) is a minimally invasive technique for the palliation of major airway obstruction from lung cancer, and for the treatment of endobronchial microinvasive lung cancer.  STUDY DESIGN:  Results of reported clinical trials were compared, and the author's preliminary results with second generation photosensitizers were also reviewed.  RESULTS:  A review of the clinical experience with endobronchial PDT is provided.  Potential advantages of PDT include the duration of palliation achieved through the delayed cellular effects of PDT within tumor.  Side-effects from FDA-approved photosensitizer (Photofrin, Porfimer sodium, Axcan Scandipharm, Montreal, Quebec) include skin photosensitivity.  HPPH (2-[1-hexyloxyethyl]-2 devinyl pyropheophorbide) is an example of a second-generation photosensitize that shows promise in the treatment of lung cancer, and appears to be free from significant skin photosensitivity.  CONCLUSION:  PDT is an effective tool for the palliation of endobronchial lung cancers which obstruct the central airways and is also effective for the treatment of central microinvasive carcinoma and carcinoma in situ of the central airways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQZrU4dU_XG5EEgZCMqtRBifW6udTcc2ebEAPAoCqijM7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28zosFCmsw%253D%253D&md5=7bce2750bef84c5f894f15de97950edd</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Flsm.20354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Flsm.20354%26sid%3Dliteratum%253Aachs%26aulast%3DLoewen%26aufirst%3DG.%2BM.%26aulast%3DPandey%26aufirst%3DR.%26aulast%3DBellnier%26aufirst%3DD.%26aulast%3DHenderson%26aufirst%3DB.%26aulast%3DDougherty%26aufirst%3DT.%26atitle%3DEndobronchial%2520photodynamic%2520therapy%2520for%2520lung%2520cancer%26jtitle%3DLasers%2520Surg.%2520Med.%26date%3D2006%26volume%3D38%26spage%3D364%26epage%3D370%26doi%3D10.1002%2Flsm.20354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gryshuk, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajjad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abouzeid, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charamisinau, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabi, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oseroff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Multimodality agents for tumor imaging (PET,Fluorescence) and photodynamic therapy. A possible “See and Treat” approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">6286</span>– <span class="NLM_lpage">6295</span>, <span class="refDoi"> DOI: 10.1021/jm050427m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050427m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpslWrsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6286-6295&author=S.+K.+Pandeyauthor=A.+L.+Gryshukauthor=M.+Sajjadauthor=X.+Zhengauthor=Y.+Chenauthor=M.+M.+Abouzeidauthor=J.+Morganauthor=I.+Charamisinauauthor=H.+A.+Nabiauthor=A.+Oseroffauthor=R.+K.+Pandey&title=Multimodality+agents+for+tumor+imaging+%28PET%2CFluorescence%29+and+photodynamic+therapy.+A+possible+%E2%80%9CSee+and+Treat%E2%80%9D+approach&doi=10.1021%2Fjm050427m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Multimodality Agents for Tumor Imaging (PET, Fluorescence) and Photodynamic Therapy. A Possible "See and Treat" Approach</span></div><div class="casAuthors">Pandey, Suresh K.; Gryshuk, Amy L.; Sajjad, Munawwar; Zheng, Xiang; Chen, Yihui; Abouzeid, Mohei M.; Morgan, Janet; Charamisinau, Ivan; Nabi, Hani A.; Oseroff, Allan; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6286-6295</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Me 3-(1'-m-iodobenzyloxyethyl)-3-devinylpyropheophorbide-a (2), obtained in a sequence of reactions from pyropheophorbide-a (a chlorophyll-a deriv.), was found to be a promising imaging agent and a photosensitizer for photodynamic therapy (PDT).  The electrophillic arom. iodination of the corresponding trimethylstannyl intermediate with Na124I in the presence of an Iodogen bead afforded 124I-labeled photosensitizer 4 with >95% radioactive specificity.  In addn. to drug-uptake, the light fluence and fluence rate that were used for the light treatment had a significant impact in long-term tumor cure.  The iodo photosensitizer 2 (nonlabeled analog of 4) produced 100% tumor cure (5/5 mice were tumor free on day 60) at a dose of 1.5 μmol/kg and a light dose of 128 J/cm2, 14 mW/cm2 for 2.5 h (λmax 665 nm) at 24 h postinjection.  The photosensitizer also showed promising tumor fluorescence and PET imaging ability.  Our present work demonstrates the utility of the first 124I-labeled photosensitizer as a "multimodality agent", which could further be improved by using more tumor-avid and/or target-specific photosensitizers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_kQddhnZ04LVg90H21EOLACvtfcHk0lir5kS32BLeUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpslWrsb0%253D&md5=65ad82b5d6a51f28ac4d0bf998f90e2e</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm050427m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050427m%26sid%3Dliteratum%253Aachs%26aulast%3DPandey%26aufirst%3DS.%2BK.%26aulast%3DGryshuk%26aufirst%3DA.%2BL.%26aulast%3DSajjad%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DAbouzeid%26aufirst%3DM.%2BM.%26aulast%3DMorgan%26aufirst%3DJ.%26aulast%3DCharamisinau%26aufirst%3DI.%26aulast%3DNabi%26aufirst%3DH.%2BA.%26aulast%3DOseroff%26aufirst%3DA.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DMultimodality%2520agents%2520for%2520tumor%2520imaging%2520%2528PET%252CFluorescence%2529%2520and%2520photodynamic%2520therapy.%2520A%2520possible%2520%25E2%2580%259CSee%2520and%2520Treat%25E2%2580%259D%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6286%26epage%3D6295%26doi%3D10.1021%2Fjm050427m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Srivatsan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pera, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marko, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durrani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Missert, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajjad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Highlights on the imaging (nuclear/fluorescence) and phototherapeutic potential of a tri-functional chlorophyll-a analog with no significant toxicity in mice and rats</span>. <i>J. Photochem. Photobiol., B</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_fpage">111998</span>, <span class="refDoi"> DOI: 10.1016/j.jphotobiol.2020.111998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1016%2Fj.jphotobiol.2020.111998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=32862090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhslWqtL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&pages=111998&author=A.+Srivatsanauthor=P.+Peraauthor=P.+Joshiauthor=A.+J.+Markoauthor=F.+Durraniauthor=J.+R.+Missertauthor=L.+Curtinauthor=S.+Sextonauthor=R.+Yaoauthor=M.+Sajjadauthor=R.+K.+Pandey&title=Highlights+on+the+imaging+%28nuclear%2Ffluorescence%29+and+phototherapeutic+potential+of+a+tri-functional+chlorophyll-a+analog+with+no+significant+toxicity+in+mice+and+rats&doi=10.1016%2Fj.jphotobiol.2020.111998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Highlights on the imaging (nuclear/fluorescence) and phototherapeutic potential of a tri-functional chlorophyll-a analog with no significant toxicity in mice and rats</span></div><div class="casAuthors">Srivatsan, Avinash; Pera, Paula; Joshi, Penny; Marko, Aimee J.; Durrani, Farukh; Missert, Joseph R.; Curtin, Leslie; Sexton, Sandra; Yao, Rutao; Sajjad, Munawwar; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Photochemistry and Photobiology, B: Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">211</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111998</span>CODEN:
                <span class="NLM_cas:coden">JPPBEG</span>;
        ISSN:<span class="NLM_cas:issn">1011-1344</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Herein we report the positron emission tomog. (PET) imaging potential of a 124I-labeled radiopharmaceutical (PET-ONCO).  In tumored mice, it shows high uptake in a variety of tumors: brain (GL261, U87), Colon (Colon26), lung (Lewis lung), breast (4 T1), bladder (UMUC3), pancreas (PANC-1) implanted in mice.  This agent also shows promise for imaging assocd. metastatic disease (breast to lung, to bone).  Interestingly, the iodinated compd. derived from chlorophyll-a, in combination with the corresponding 124I-analog, can serve as a dual imaging agent (PET/fluorescence, complimentary to each other), with an option of photodynamic therapy (PDT).  In contrast to Fluorine-18 (half-life 110 min), the Iodine-124 radionuclide has a phys. half-life of roughly 4 days.  Thus, unlike 18F-FDG, PET-ONCO can be transported longer distances.  While the time for optimal tumor-uptake was obsd. at 24 h, improved tumor contrasts of both primary and metastasis were obtained at 48 and 72 h post- injection (i. v.) of PET-ONCO.  In both mice and rats at a single dose study, PET-ONCO did not show any organ toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJYeUadessMLVg90H21EOLACvtfcHk0lh4sUwSLrV1TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhslWqtL7L&md5=32fe3770b0151a63801d91bd9ba1b102</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.jphotobiol.2020.111998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jphotobiol.2020.111998%26sid%3Dliteratum%253Aachs%26aulast%3DSrivatsan%26aufirst%3DA.%26aulast%3DPera%26aufirst%3DP.%26aulast%3DJoshi%26aufirst%3DP.%26aulast%3DMarko%26aufirst%3DA.%2BJ.%26aulast%3DDurrani%26aufirst%3DF.%26aulast%3DMissert%26aufirst%3DJ.%2BR.%26aulast%3DCurtin%26aufirst%3DL.%26aulast%3DSexton%26aufirst%3DS.%26aulast%3DYao%26aufirst%3DR.%26aulast%3DSajjad%26aufirst%3DM.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DHighlights%2520on%2520the%2520imaging%2520%2528nuclear%252Ffluorescence%2529%2520and%2520phototherapeutic%2520potential%2520of%2520a%2520tri-functional%2520chlorophyll-a%2520analog%2520with%2520no%2520significant%2520toxicity%2520in%2520mice%2520and%2520rats%26jtitle%3DJ.%2520Photochem.%2520Photobiol.%252C%2520B%26date%3D2020%26spage%3D111998%26doi%3D10.1016%2Fj.jphotobiol.2020.111998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheruku, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cacaccio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durrani, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabaczynski, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Khouly, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuzumi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Missert, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajjad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandra, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guru, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Epidermal growth factor receptor-targeted multifunctional photosensitizers for bladder cancer imaging and photodynamic therapy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">2598</span>– <span class="NLM_lpage">2617</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01927</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01927" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtFGjsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=2598-2617&author=R.+R.+Cherukuauthor=J.+Cacaccioauthor=F.+A.+Durraniauthor=W.+A.+Tabaczynskiauthor=R.+Watsonauthor=A.+Markoauthor=R.+Kumarauthor=M.+E.+El-Khoulyauthor=S.+Fukuzumiauthor=J.+R.+Missertauthor=R.+Yaoauthor=M.+Sajjadauthor=D.+Chandraauthor=K.+Guruauthor=R.+K.+Pandey&title=Epidermal+growth+factor+receptor-targeted+multifunctional+photosensitizers+for+bladder+cancer+imaging+and+photodynamic+therapy&doi=10.1021%2Facs.jmedchem.8b01927"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Epidermal Growth Factor Receptor-Targeted Multifunctional Photosensitizers for Bladder Cancer Imaging and Photodynamic Therapy</span></div><div class="casAuthors">Cheruku, Ravindra R.; Cacaccio, Joseph; Durrani, Farukh A.; Tabaczynski, Walter A.; Watson, Ramona; Marko, Aimee; Kumar, Rahul; El-Khouly, Mohamed E.; Fukuzumi, Shunichi; Missert, Joseph R.; Yao, Rutao; Sajjad, Munawwar; Chandra, Dhyan; Guru, Khurshid; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2598-2617</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The in vitro and in vivo anticancer activity of iodinated photosensitizers (PSs) with and without an erlotinib moiety was investigated in UMUC3 [epidermal growth factor (EGFR)-pos.] and T24 (EGFR-low) cell lines and tumored mice.  Both the erlotinib-conjugated PSs 3 and 5 showed EGFR target specificity, but the position-3 erlotinib-PS conjugate 3 demonstrated lower photodynamic therapy efficacy than the corresponding non-erlotinib analog 1, whereas the conjugate 5 contg. an erlotinib moiety at position-17 of the PS showed higher tumor uptake and long-term tumor cure (severe combined immunodeficient mice bearing UMUC3 tumors).  PS-erlotinib conjugates in the absence of light were ineffective in vitro and in vivo, but robust apoptotic and necrotic cell death was obsd. in bladder cancer cells after exposing them to a laser light at 665 nm.  In contrast to 18F-fluorodeoxyglucose, a positron emission tomog. agent, the position-17 erlotinib conjugate (124I-analog 6) showed enhanced UMUC3 tumor contrast even at a low imaging dose of 15 μCi/mouse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOrPTZ88ZGOrVg90H21EOLACvtfcHk0lh4sUwSLrV1TA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtFGjsrg%253D&md5=2b6d6c1387d3d847f9a0be8b3f8ee1b1</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01927%26sid%3Dliteratum%253Aachs%26aulast%3DCheruku%26aufirst%3DR.%2BR.%26aulast%3DCacaccio%26aufirst%3DJ.%26aulast%3DDurrani%26aufirst%3DF.%2BA.%26aulast%3DTabaczynski%26aufirst%3DW.%2BA.%26aulast%3DWatson%26aufirst%3DR.%26aulast%3DMarko%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DEl-Khouly%26aufirst%3DM.%2BE.%26aulast%3DFukuzumi%26aufirst%3DS.%26aulast%3DMissert%26aufirst%3DJ.%2BR.%26aulast%3DYao%26aufirst%3DR.%26aulast%3DSajjad%26aufirst%3DM.%26aulast%3DChandra%26aufirst%3DD.%26aulast%3DGuru%26aufirst%3DK.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DEpidermal%2520growth%2520factor%2520receptor-targeted%2520multifunctional%2520photosensitizers%2520for%2520bladder%2520cancer%2520imaging%2520and%2520photodynamic%2520therapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D2598%26epage%3D2617%26doi%3D10.1021%2Facs.jmedchem.8b01927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pera, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabaczynski, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siters, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kryman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheruku, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durrani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Missert, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohulchanskyy, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracy, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Highly effective dual-function near-infrared (NIR) photosensitizer for fluorescence imaging and photodynamic therapy (PDT) of cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">9774</span>– <span class="NLM_lpage">9787</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00890</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00890" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1ylu7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9774-9787&author=N.+Patelauthor=P.+Peraauthor=P.+Joshiauthor=M.+Dukhauthor=W.+A.+Tabaczynskiauthor=K.+E.+Sitersauthor=M.+Krymanauthor=R.+R.+Cherukuauthor=F.+Durraniauthor=J.+R.+Missertauthor=R.+Watsonauthor=T.+Y.+Ohulchanskyyauthor=E.+C.+Tracyauthor=H.+Baumannauthor=R.+K.+Pandey&title=Highly+effective+dual-function+near-infrared+%28NIR%29+photosensitizer+for+fluorescence+imaging+and+photodynamic+therapy+%28PDT%29+of+cancer&doi=10.1021%2Facs.jmedchem.6b00890"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Effective Dual-Function Near-Infrared (NIR) Photosensitizer for Fluorescence Imaging and Photodynamic Therapy (PDT) of Cancer</span></div><div class="casAuthors">Patel, Nayan; Pera, Paula; Joshi, Penny; Dukh, Mykhaylo; Tabaczynski, Walter A.; Siters, Kevin E.; Kryman, Mark; Cheruku, Ravindra R.; Durrani, Farukh; Missert, Joseph R.; Watson, Ramona; Ohulchanskyy, Tymish Y.; Tracy, Erin C.; Baumann, Heinz; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9774-9787</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report herein the synthesis and biol. efficacy of near-IR (NIR), bacteriochlorin analogs: 3-(1'-butyloxy)ethyl-3-deacetyl-bacteriopurpurin-18-N-butylimide Me ester (3) and the corresponding carboxylic acid 10.  In in vitro assays, compared to its Me ester analog 3, the corresponding carboxylic acid deriv. 10 showed higher photosensitizing efficacy.  However, due to drastically different pharmacokinetics in vivo, the PS 3 (HPLC purity >99%) showed higher tumor uptake and long-term tumor cure than 10 (HPLC purity >96.5%) in BALB/c mice bearing Colon 26 tumors.  Isomerically pure R- and S- isomers of 3 (3a and 3b, purity by HPLC > 99%) under similar treatment parameters showed identical efficacy in vitro and in vivo.  In addn., photosensitizer (PS) 3 showed limited skin phototoxicity and provides an addnl. advantage over the clin. approved chem. complex hematoporphyrin deriv. as well as other porphyrin-based PDT agents, which makes 3 a promising dual-function agent for fluorescence-guided surgery with an option of phototherapy of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCI6Ows2GCs7Vg90H21EOLACvtfcHk0li5m4TAXOnDpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1ylu7nF&md5=8bf2b0ce63bffd5f2ecb1e2032bea519</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00890%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DPera%26aufirst%3DP.%26aulast%3DJoshi%26aufirst%3DP.%26aulast%3DDukh%26aufirst%3DM.%26aulast%3DTabaczynski%26aufirst%3DW.%2BA.%26aulast%3DSiters%26aufirst%3DK.%2BE.%26aulast%3DKryman%26aufirst%3DM.%26aulast%3DCheruku%26aufirst%3DR.%2BR.%26aulast%3DDurrani%26aufirst%3DF.%26aulast%3DMissert%26aufirst%3DJ.%2BR.%26aulast%3DWatson%26aufirst%3DR.%26aulast%3DOhulchanskyy%26aufirst%3DT.%2BY.%26aulast%3DTracy%26aufirst%3DE.%2BC.%26aulast%3DBaumann%26aufirst%3DH.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DHighly%2520effective%2520dual-function%2520near-infrared%2520%2528NIR%2529%2520photosensitizer%2520for%2520fluorescence%2520imaging%2520and%2520photodynamic%2520therapy%2520%2528PDT%2529%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D9774%26epage%3D9787%26doi%3D10.1021%2Facs.jmedchem.6b00890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ethirajan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">William, W. H.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohkubo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuzumi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Remarkable Regioselective Position-10 Bromination of Bacteriopyropheophorbide-a and Ring-B Reduced Pyropheophorbide-a</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1956</span>– <span class="NLM_lpage">1959</span>, <span class="refDoi"> DOI: 10.1021/ol200314v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol200314v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFKnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=1956-1959&author=M.+Ethirajanauthor=P.+Joshiauthor=W.+H.+Williamauthor=K.+Ohkuboauthor=S.+Fukuzumiauthor=R.+K.+Pandey&title=Remarkable+Regioselective+Position-10+Bromination+of+Bacteriopyropheophorbide-a+and+Ring-B+Reduced+Pyropheophorbide-a&doi=10.1021%2Fol200314v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Remarkable Regioselective Position-10 Bromination of Bacteriopyropheophorbide-a and Ring-B Reduced Pyropheophorbide-a</span></div><div class="casAuthors">Ethirajan, Manivannan; Joshi, Penny; William, White H.; Ohkubo, Kei; Fukuzumi, Shunichi; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1956-1959</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Both bacteriopyropheophorbide-a and ring-B reduced pyropheophorbide-a on reacting with NBS (N-bromosuccinimide) undergo electrophilic bromination to provide 10-bromo analogs, e.g., I.  The electronic nature of the substituents present at position-3 did not make any difference in the regioselective outcome of the brominated products.  These relatively stable brominated chlorins and bacteriochlorins provide an easy way of introducing a wide variety of functionalities, which could be extremely useful in developing improved agents for biomedical applications and supramol. chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyGVJ4wzHIUbVg90H21EOLACvtfcHk0liD-ZgeCtA8mA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFKnsbg%253D&md5=920d9a2332653d5891b12a1d745dc340</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fol200314v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol200314v%26sid%3Dliteratum%253Aachs%26aulast%3DEthirajan%26aufirst%3DM.%26aulast%3DJoshi%26aufirst%3DP.%26aulast%3DWilliam%26aufirst%3DW.%2BH.%26aulast%3DOhkubo%26aufirst%3DK.%26aulast%3DFukuzumi%26aufirst%3DS.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DRemarkable%2520Regioselective%2520Position-10%2520Bromination%2520of%2520Bacteriopyropheophorbide-a%2520and%2520Ring-B%2520Reduced%2520Pyropheophorbide-a%26jtitle%3DOrg.%2520Lett.%26date%3D2011%26volume%3D13%26spage%3D1956%26epage%3D1959%26doi%3D10.1021%2Fol200314v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jinadasa, R. G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicente, M. G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, K. M.</span></span> <span> </span><span class="NLM_article-title">Syntheses and cellular investigations of 17<sup>3</sup>–, 15<sup>2</sup>–, and 13<sup>1</sup>–amino acid derivatives of chlorin e<sub>6</sub></span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">7464</span>– <span class="NLM_lpage">7476</span>, <span class="refDoi"> DOI: 10.1021/jm2005139</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2005139" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1OrsbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7464-7476&author=R.+G.+W.+Jinadasaauthor=X.+Huauthor=M.+G.+H.+Vicenteauthor=K.+M.+Smith&title=Syntheses+and+cellular+investigations+of+173%E2%80%93%2C+152%E2%80%93%2C+and+131%E2%80%93amino+acid+derivatives+of+chlorin+e6&doi=10.1021%2Fjm2005139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Syntheses and Cellular Investigations of 173-, 152-, and 131-Amino Acid Derivatives of Chlorin e6</span></div><div class="casAuthors">Jinadasa, R. G. Waruna; Hu, Xiaoke; Vicente, M. Graca H.; Smith, Kevin M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7464-7476</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of amino acid conjugates of chlorin e6, contg. lysine or aspartic acid residues in positions 173, 152, or 131 of the macrocycle were synthesized and investigated as photosensitizers for photodynamic therapy of tumors.  All three regioisomers were synthesized in good yields and in five steps or less from pheophytin a.  In vitro investigations using human carcinoma HEp2 cells show that the 152-lysyl regioisomers accumulate the most within cells, and the most phototoxic are the 131 regioisomers.  The main determinant of biol. efficacy appears to be the conjugation site, probably because of mol. conformation.  Mol. modeling investigations reveal that the 173-substituted chlorin e6 conjugates are L-shaped, the 152 and 131 regioisomers assume extended conformations, and the 131 derivs. are nearly linear.  It is hypothesized that the 131-aspartylchlorin e6 conjugate may be a more efficient photosensitizer for PDT than the com. currently used 152 deriv.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqno9Qefi9hr7Vg90H21EOLACvtfcHk0liD-ZgeCtA8mA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1OrsbnF&md5=7e41a50d85c88fafbd6936c21ca23a5f</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm2005139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2005139%26sid%3Dliteratum%253Aachs%26aulast%3DJinadasa%26aufirst%3DR.%2BG.%2BW.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DVicente%26aufirst%3DM.%2BG.%2BH.%26aulast%3DSmith%26aufirst%3DK.%2BM.%26atitle%3DSyntheses%2520and%2520cellular%2520investigations%2520of%2520173%25E2%2580%2593%252C%2520152%25E2%2580%2593%252C%2520and%2520131%25E2%2580%2593amino%2520acid%2520derivatives%2520of%2520chlorin%2520e6%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7464%26epage%3D7476%26doi%3D10.1021%2Fjm2005139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumlin, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Constantine, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoudia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellnier, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodgers, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, T. J.</span></span> <span> </span><span class="NLM_article-title">Alkyl ether analogs of chlorophyll-α derivatives: Part 1. Synthesis, photophysical properties, and photodynamic efficacy</span>. <i>Photochem. Photobiol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">194</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.1111/j.1751-1097.1996.tb02442.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1111%2Fj.1751-1097.1996.tb02442.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=8787014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADyaK28XjvF2js74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1996&pages=194-204&author=R.+K.+Pandeyauthor=A.+B.+Sumlinauthor=S.+Constantineauthor=M.+Aoudiaauthor=W.+R.+Potterauthor=D.+A.+Bellnierauthor=B.+W.+Hendersonauthor=M.+A.+Rodgersauthor=K.+M.+Smithauthor=T.+J.+Dougherty&title=Alkyl+ether+analogs+of+chlorophyll-%CE%B1+derivatives%3A+Part+1.+Synthesis%2C+photophysical+properties%2C+and+photodynamic+efficacy&doi=10.1111%2Fj.1751-1097.1996.tb02442.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Alkyl ether analogs of chlorophyll-a derivatives: part 1. synthesis, photophysical properties and photodynamic efficacy</span></div><div class="casAuthors">Pandey, Ravindra K.; Sumlin, Adam B.; Constantine, Scott; Aoudia, Mohamed; Potter, William R.; Bellnier, David A.; Henderson, Barbara W.; Rodgers, Michael A.; Smith, Kevin M.; Dougherty, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Photochemistry and Photobiology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">194-204</span>CODEN:
                <span class="NLM_cas:coden">PHCBAP</span>;
        ISSN:<span class="NLM_cas:issn">0031-8655</span>.
    
            (<span class="NLM_cas:orgname">American Society for Photobiology</span>)
        </div><div class="casAbstract">The synthesis, preliminary in vivo biol. activity, singlet oxygen and fluorescence yields of a series of alkyl ether derivs. of chlorophyll-a analogs are described.  For short-chain carbon ethers (1-7 carbon units), it was obsd. that the biol. activity increased by increasing the length of the carbon chain, being max. in compds. with n-hexyl and n-heptyl chains.  Related sensitizers prepd. by reacting 2-(1-bromoethyl)-2-devinylpyropheophorbide-a with (sec)alcs. were found to be less effective.  Under similar treatment conditions, photosensitizers contg. cis- and trans- 3-hexenyl side chains were ineffective.  Thus, both stereochem. and steric factors caused differences in sensitizing activity.  In general, pyropheophorbide-a analogs were found to be more active than related chlorin e6 derivs., in which the isocyclic ring (ring "E") was cleaved.  Related photosensitizers in the 9-deoxy- series were found to be as effective as the corresponding pyropheophorbide-a analogs.  The photosensitizers prepd. from pyropheophorbide-a Me ester and chlorin e6 tri-Me ester have long wavelength absorption at 660 nm (ε 45 000 to 50 000).  Redn. of the carbonyl group in the pyropheophorbide-a to methylene (ring E) resulted in a blue shift to 648 nm (ε 38 000).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDDQ0hvF51IbVg90H21EOLACvtfcHk0lggGtljXK5pFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjvF2js74%253D&md5=04400c1a6d5e6bde846e9a0dcb4c33b9</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1111%2Fj.1751-1097.1996.tb02442.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1751-1097.1996.tb02442.x%26sid%3Dliteratum%253Aachs%26aulast%3DPandey%26aufirst%3DR.%2BK.%26aulast%3DSumlin%26aufirst%3DA.%2BB.%26aulast%3DConstantine%26aufirst%3DS.%26aulast%3DAoudia%26aufirst%3DM.%26aulast%3DPotter%26aufirst%3DW.%2BR.%26aulast%3DBellnier%26aufirst%3DD.%2BA.%26aulast%3DHenderson%26aufirst%3DB.%2BW.%26aulast%3DRodgers%26aufirst%3DM.%2BA.%26aulast%3DSmith%26aufirst%3DK.%2BM.%26aulast%3DDougherty%26aufirst%3DT.%2BJ.%26atitle%3DAlkyl%2520ether%2520analogs%2520of%2520chlorophyll-%25CE%25B1%2520derivatives%253A%2520Part%25201.%2520Synthesis%252C%2520photophysical%2520properties%252C%2520and%2520photodynamic%2520efficacy%26jtitle%3DPhotochem.%2520Photobiol.%26date%3D1996%26volume%3D64%26spage%3D194%26epage%3D204%26doi%3D10.1111%2Fj.1751-1097.1996.tb02442.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tracy, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, H.</span></span> <span> </span><span class="NLM_article-title">Cell-type selective phototoxicity achieved with chlorophyll-a derived photosensitizers in a co-culture system of primary human tumor and normal lung cells</span>. <i>Photochem. Photobiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">1405</span>– <span class="NLM_lpage">1418</span>, <span class="refDoi"> DOI: 10.1111/j.1751-1097.2011.00992.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1111%2Fj.1751-1097.2011.00992.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=21883244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFehs7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2011&pages=1405-1418&author=E.+C.+Tracyauthor=M.+J.+Bowmanauthor=R.+K.+Pandeyauthor=B.+W.+Hendersonauthor=H.+Baumann&title=Cell-type+selective+phototoxicity+achieved+with+chlorophyll-a+derived+photosensitizers+in+a+co-culture+system+of+primary+human+tumor+and+normal+lung+cells&doi=10.1111%2Fj.1751-1097.2011.00992.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-type selective phototoxicity achieved with chlorophyll-a derived photosensitizers in a co-culture system of primary human tumor and normal lung cells</span></div><div class="casAuthors">Tracy, Erin C.; Bowman, Mary J.; Pandey, Ravindra K.; Henderson, Barbara W.; Baumann, Heinz</div><div class="citationInfo"><span class="NLM_cas:title">Photochemistry and Photobiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1405-1418</span>CODEN:
                <span class="NLM_cas:coden">PHCBAP</span>;
        ISSN:<span class="NLM_cas:issn">0031-8655</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The ATP-dependent transporter ABCG2 exports certain photosensitizers (PS) from cells, implying that the enhanced expression of ABCG2 by cancer cells may confer resistance to photodynamic therapy (PDT) mediated by those PS.  In 35 patient-derived primary cultures of lung epithelial and stromal cells, PS with different subcellular localization and affinity for ABCG2 displayed cell-type specific retention both independent and dependent on ABCG2.  In the majority of cases, the ABCG2 substrate 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) was lost from fibroblastic cells more rapidly than from their epithelial counterparts, even in the absence of detectable ABCG2 expression, facilitating selective eradication by PDT of epithelial over fibroblastic cells in tumor/stroma co-cultures.  Pairwise comparison of normal and transformed epithelial cells also identified tumor cells with elevated or reduced retention of HPPH, depending on ABCG2.  Enhanced ABCG2 expression led to the selective PDT survival of tumor cells in tumor/stroma co-cultures.  This survival pattern was reversible through HPPH derivs. that are not ABCG2 substrates or the ABCG2 inhibitor imatinib mesylate.  PS retention, not differences in subcellular distribution or cell signaling responses, was detg. cell type selective death by PDT.  These data suggest that up-front knowledge of tumor characteristics, specifically ABCG2 status, could be helpful in individualized PDT treatment design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuy85WXtaX0LVg90H21EOLACvtfcHk0lhwkT6G6DeTfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFehs7nJ&md5=b53520002604260ce9204fe31d83a67c</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1111%2Fj.1751-1097.2011.00992.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1751-1097.2011.00992.x%26sid%3Dliteratum%253Aachs%26aulast%3DTracy%26aufirst%3DE.%2BC.%26aulast%3DBowman%26aufirst%3DM.%2BJ.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26aulast%3DHenderson%26aufirst%3DB.%2BW.%26aulast%3DBaumann%26aufirst%3DH.%26atitle%3DCell-type%2520selective%2520phototoxicity%2520achieved%2520with%2520chlorophyll-a%2520derived%2520photosensitizers%2520in%2520a%2520co-culture%2520system%2520of%2520primary%2520human%2520tumor%2520and%2520normal%2520lung%2520cells%26jtitle%3DPhotochem.%2520Photobiol.%26date%3D2011%26volume%3D87%26spage%3D1405%26epage%3D1418%26doi%3D10.1111%2Fj.1751-1097.2011.00992.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tracy, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, H.</span></span> <span> </span><span class="NLM_article-title">Interleukin-1α is the major alarmin of lung epithelial cells released during photodynamic therapy to induce inflammatory mediators in fibroblasts</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">1534</span>– <span class="NLM_lpage">1546</span>, <span class="refDoi"> DOI: 10.1038/bjc.2012.429</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1038%2Fbjc.2012.429" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=22996613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFOntLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2012&pages=1534-1546&author=E.+C.+Tracyauthor=M.+J.+Bowmanauthor=B.+W.+Hendersonauthor=H.+Baumann&title=Interleukin-1%CE%B1+is+the+major+alarmin+of+lung+epithelial+cells+released+during+photodynamic+therapy+to+induce+inflammatory+mediators+in+fibroblasts&doi=10.1038%2Fbjc.2012.429"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Interleukin-1α is the major alarmin of lung epithelial cells released during photodynamic therapy to induce inflammatory mediators in fibroblasts</span></div><div class="casAuthors">Tracy, E. C.; Bowman, M. J.; Henderson, B. W.; Baumann, H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1534-1546</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: Photodynamic therapy (PDT) causes tissue damage that initiates a local inflammatory response.  Post-PDT reactions are considered to assist in mobilising the immune system thereby affecting tumor recurrence.  The initiating process of the PDT-dependent tissue reaction remains to be detd.  Methods: Primary cultures of human lung cells were established.  The photoreaction mediated by pyropheophorbide-a, at specific subcellular sites and levels resulting in the release of alarmins by epithelial cells (Eps), was defined by immunoblot analyses and expression profiling.  The activity of Ep-derived factors to stimulate expression of proinflammatory mediators, including IL-6, and to enhance neutrophil binding by fibroblasts (Fbs) was detd. by functional bioassays.  Results: Epithelial cells release IL-1β as the primary Fb-stimulatory activity under basal conditions.  Intracellular IL-1α, externalized following photoreaction, accounts for most of the PDT-mediated Fb activation.  Expression of IL-1 is subject to increase or loss during oncogenic transformation resulting in altered alarmin functions mobilisable by PDT.  Photoreaction by a cell surface-bound photosensitizer (PS) is 10-fold more effective than PSs localized to mitochondria or lysosomes.  High-dose intracellular, but not cell surface, photoreaction inactivates IL-1 and reduces Fb stimulation.  Conclusion: These in vitro data suggest that the subcellular site and intensity of photoreaction influence the magnitude of the stromal cell response to the local damage and, in part, support the relationship of PDT dose and level of post-PDT inflammatory response obsd. in vivo.  British Journal of Cancer (2012) 107, 1534-1546; doi:10.1038/bjc.2012.429 www.bjcancer.com Published online 20 Sept. 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZlyBtcytZrLVg90H21EOLACvtfcHk0lhwkT6G6DeTfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFOntLnN&md5=a7b145009c8e52455b46d5709e955ce3</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2012.429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2012.429%26sid%3Dliteratum%253Aachs%26aulast%3DTracy%26aufirst%3DE.%2BC.%26aulast%3DBowman%26aufirst%3DM.%2BJ.%26aulast%3DHenderson%26aufirst%3DB.%2BW.%26aulast%3DBaumann%26aufirst%3DH.%26atitle%3DInterleukin-1%25CE%25B1%2520is%2520the%2520major%2520alarmin%2520of%2520lung%2520epithelial%2520cells%2520released%2520during%2520photodynamic%2520therapy%2520to%2520induce%2520inflammatory%2520mediators%2520in%2520fibroblasts%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2012%26volume%3D107%26spage%3D1534%26epage%3D1546%26doi%3D10.1038%2Fbjc.2012.429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tracy, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, H.</span></span> <span> </span><span class="NLM_article-title">Cell-specific retention and action of pheophorbide-based photosensitizers in human lung cancer cells</span>. <i>Photochem. Photobiol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">846</span>– <span class="NLM_lpage">859</span>, <span class="refDoi"> DOI: 10.1111/php.13043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1111%2Fphp.13043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=30378688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlalu7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2019&pages=846-859&author=E.+C.+Tracyauthor=M.-J.+Bowmanauthor=R.+K.+Pandeyauthor=H.+Baumann&title=Cell-specific+retention+and+action+of+pheophorbide-based+photosensitizers+in+human+lung+cancer+cells&doi=10.1111%2Fphp.13043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-specific Retention and Action of Pheophorbide-based Photosensitizers in Human Lung Cancer Cells</span></div><div class="casAuthors">Tracy, Erin C.; Bowman, Mary-Jo; Pandey, Ravendra K.; Baumann, Heinz</div><div class="citationInfo"><span class="NLM_cas:title">Photochemistry and Photobiology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">846-859</span>CODEN:
                <span class="NLM_cas:coden">PHCBAP</span>;
        ISSN:<span class="NLM_cas:issn">0031-8655</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">This study detd. in primary cultures of human lung cancer cells the cell specificity of chlorin-based photosensitizers.  Epithelial cells (ECs) preferentially retained 3-[1-hexyloxyethyl]-2-devinylpyropheophorbide-a (HPPH) and related structural variants.  Tumor-assocd. fibroblasts (Fb) differ from EC by a higher efflux rate of HPPH.  Immunoblot analyses indicated dimerization of STAT3 as a reliable biomarker of the photoreaction.  Compared to mitochondria/ER-localized photoreaction by HPPH, the photoreaction by lysosomally targeted HPPH-lactose showed a trend toward lower STAT3 crosslinking.  Lethal consequence of the photoreaction differed between EC and Fb with the latter cells being more resistant.  A survey of lung tumor cases indicated a large quant. range by which EC retains HPPH.  The specificity of HPPH retention defined in vitro could be confirmed in vivo in selected cases grown as xenografts.  HPPH retention as a function of the tetrapyrrole structure was evaluated by altering side groups on the porphyrin macrocycle.  The presence or absence of a carboxylic acid at position 172 proved to be crit.  A benzyl group at position 20 enhanced retention in a subset of cancer cells with low HPPH binding.  This study indicated exptl. tools that are potentially effective in defining the photosensitizer preference and application for individual patient's cancer lesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZZPJcoCyWl7Vg90H21EOLACvtfcHk0lgYjk7L_LnedQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlalu7bM&md5=86fd09f02fc57101933e5c994680aa75</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1111%2Fphp.13043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fphp.13043%26sid%3Dliteratum%253Aachs%26aulast%3DTracy%26aufirst%3DE.%2BC.%26aulast%3DBowman%26aufirst%3DM.-J.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26aulast%3DBaumann%26aufirst%3DH.%26atitle%3DCell-specific%2520retention%2520and%2520action%2520of%2520pheophorbide-based%2520photosensitizers%2520in%2520human%2520lung%2520cancer%2520cells%26jtitle%3DPhotochem.%2520Photobiol.%26date%3D2019%26volume%3D95%26spage%3D846%26epage%3D859%26doi%3D10.1111%2Fphp.13043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oseroff, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, H.</span></span> <span> </span><span class="NLM_article-title">Photodynamic therapy causes cross-linking of signal transducer and activator of transcription proteins and attenuation of interleukin-6 cytokine responsiveness in epithelial cells</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">6579</span>– <span class="NLM_lpage">6587</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-04-1580</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1158%2F0008-5472.CAN-04-1580" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=15374971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsFOlurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=6579-6587&author=W.+Liuauthor=A.+R.+Oseroffauthor=H.+Baumann&title=Photodynamic+therapy+causes+cross-linking+of+signal+transducer+and+activator+of+transcription+proteins+and+attenuation+of+interleukin-6+cytokine+responsiveness+in+epithelial+cells&doi=10.1158%2F0008-5472.CAN-04-1580"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Photodynamic Therapy Causes Cross-linking of Signal Transducer and Activator of Transcription Proteins and Attenuation of Interleukin-6 Cytokine Responsiveness in Epithelial Cells</span></div><div class="casAuthors">Liu, Weiguo; Oseroff, Allan R.; Baumann, Heinz</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6579-6587</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) is a local treatment of cancers.  The principle of PDT is the prodn. of reactive oxygen species, in particular singlet oxygen, by light activation of a photosensitizer introduced into the target cells.  The direct photochem. and subsequent redox reactions can lead to cell death.  This study sought to identify effects occurring during PDT and some of their consequences in surviving cells.  Using epithelial cells in tissue culture and in tumors, several distinct PDT-mediated reactions were found, including global dephosphorylation of proteins, induced phosphorylation of a 71-kDa protein, initiation of cellular stress responses, structural modification and loss of epidermal growth factor receptor, and crosslinking of proteins.  Specific covalent crosslinking of nonactivated signal transducer and activator of transcription (STAT)-3, and to a lesser extent of STAT1 and STAT4, correlated with PDT dose.  Cross-linked STAT3 was primarily localized to the cytoplasm and failed to bind to DNA.  The combination of STAT crosslinking and inactivation of receptor functions rendered PDT-treated cells refractory for at least 24 h to interleukin-6 and oncostatin M, cytokines known to be elevated at site of tissue damage and inflammation.  It is suggested that the loss of responsiveness to these inflammatory cytokines in the PDT-treated field assists tumor cells in evading the growth-suppressive activity of these mediators expected to be present at tissue sites after PDT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJmC1378qh6bVg90H21EOLACvtfcHk0lgYjk7L_LnedQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsFOlurg%253D&md5=6376c4186014f50bb462abaeda094cf4</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-1580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-1580%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DOseroff%26aufirst%3DA.%2BR.%26aulast%3DBaumann%26aufirst%3DH.%26atitle%3DPhotodynamic%2520therapy%2520causes%2520cross-linking%2520of%2520signal%2520transducer%2520and%2520activator%2520of%2520transcription%2520proteins%2520and%2520attenuation%2520of%2520interleukin-6%2520cytokine%2520responsiveness%2520in%2520epithelial%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D6579%26epage%3D6587%26doi%3D10.1158%2F0008-5472.CAN-04-1580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Srivatsan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pera, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Missert, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracy, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabaczynski, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajjad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Effect of chirality on cellular uptake, imaging and photodynamic therapy of photosensitizers derived from chlorophyll-a</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3603</span>– <span class="NLM_lpage">3617</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1016%2Fj.bmc.2015.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=25936263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsVeqtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=3603-3617&author=A.+Srivatsanauthor=P.+Peraauthor=P.+Joshiauthor=Y.+Wangauthor=J.+R.+Missertauthor=E.+C.+Tracyauthor=W.+A.+Tabaczynskiauthor=R.+Yaoauthor=M.+Sajjadauthor=H.+Baumannauthor=R.+K.+Pandey&title=Effect+of+chirality+on+cellular+uptake%2C+imaging+and+photodynamic+therapy+of+photosensitizers+derived+from+chlorophyll-a&doi=10.1016%2Fj.bmc.2015.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of chirality on cellular uptake, imaging and photodynamic therapy of photosensitizers derived from chlorophyll-a</span></div><div class="casAuthors">Srivatsan, Avinash; Pera, Paula; Joshi, Penny; Wang, Yanfang; Missert, Joseph R.; Tracy, Erin C.; Tabaczynski, Walter A.; Yao, Rutao; Sajjad, Munawwar; Baumann, Heinz; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3603-3617</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We have previously shown that the 124I-analog of Me 3-(1'-m-iodobenzyloxy) ethyl-3-devinyl-pyropheophorbide-a derived as racemic mixt. from chlorophyll-a can be used for PET (positron emission tomog.)-imaging in animal tumor models.  On the other hand, as a non-radioactive analog, it showed excellent fluorescence and photodynamic therapy (PDT) efficacy.  Thus, a single agent in a mixt. of radioactive (124I-) and non-radioactive (127I) material can be used for both dual-imaging and PDT of cancer.  Before advancing to Phase I human clin. trials, we evaluated the activity of the individual isomers as well as the impact of a chiral center at position-31 in directing in vitro/in vivo cellular uptake, intracellular localization, epithelial tumor cell-specific retention, fluorescence/PET imaging, and photosensitizing ability.  The results indicate that both isomers (racemates), either as Me ester or carboxylic acid, were equally effective.  However, the Me ester analogs, due to subcellular deposition into vesicular structures, were preferentially retained.  All derivs. contg. carboxylic acid at the position-172 were noted to be substrate for the ABCG2 (a member of the ATP binding cassette transporters) protein explaining their low retention in lung tumor cells expressing this transporter.  The compds. in which the chirality at position-3 has been substituted by a non-chiral functionality showed reduced cellular uptake, retention and lower PDT efficacy in mice bearing murine Colon26 tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc4VikWQsT3LVg90H21EOLACvtfcHk0lhFIctUhki0xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsVeqtr8%253D&md5=ce58e5a8ae06afe14296a0de6b87d24f</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DSrivatsan%26aufirst%3DA.%26aulast%3DPera%26aufirst%3DP.%26aulast%3DJoshi%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMissert%26aufirst%3DJ.%2BR.%26aulast%3DTracy%26aufirst%3DE.%2BC.%26aulast%3DTabaczynski%26aufirst%3DW.%2BA.%26aulast%3DYao%26aufirst%3DR.%26aulast%3DSajjad%26aufirst%3DM.%26aulast%3DBaumann%26aufirst%3DH.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DEffect%2520of%2520chirality%2520on%2520cellular%2520uptake%252C%2520imaging%2520and%2520photodynamic%2520therapy%2520of%2520photosensitizers%2520derived%2520from%2520chlorophyll-a%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D3603%26epage%3D3617%26doi%3D10.1016%2Fj.bmc.2015.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spernyak, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, W. H.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ethirajan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goswami, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turowski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Missert, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazurchuk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Hexylether derivative of pyropheophorbide-a (HPPH) on conjugating with 3gadolinium(III) aminobenzyldiethylenetriaminepentaacetic acid shows potential for in vivo tumor imaging (MR, fluorescence) and photodynamic therapy</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">828</span>– <span class="NLM_lpage">835</span>, <span class="refDoi"> DOI: 10.1021/bc9005317</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc9005317" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksF2lsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=828-835&author=J.+A.+Spernyakauthor=W.+H.+Whiteauthor=M.+Ethirajanauthor=N.+J.+Patelauthor=L.+Goswamiauthor=Y.+Chenauthor=S.+Turowskiauthor=J.+R.+Missertauthor=C.+Battauthor=R.+Mazurchukauthor=R.+K.+Pandey&title=Hexylether+derivative+of+pyropheophorbide-a+%28HPPH%29+on+conjugating+with+3gadolinium%28III%29+aminobenzyldiethylenetriaminepentaacetic+acid+shows+potential+for+in+vivo+tumor+imaging+%28MR%2C+fluorescence%29+and+photodynamic+therapy&doi=10.1021%2Fbc9005317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Hexylether Derivative of Pyropheophorbide-a (HPPH) on Conjugating with 3Gadolinium(III) Aminobenzyldiethylenetriaminepentaacetic Acid Shows Potential for in Vivo Tumor Imaging (MR, Fluorescence) and Photodynamic Therapy</span></div><div class="casAuthors">Spernyak, Joseph A.; White, William H., III; Ethirajan, Manivannan; Patel, Nayan J.; Goswami, Lalit; Chen, Yihui; Turowski, Steven; Missert, Joseph R.; Batt, Carrie; Mazurchuk, Richard; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">828-835</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Conjugates of 3-(1'-hexyloxyethyl)-3-devinyl pyropheophorbide-a (HPPH) with multiple Gd(III)aminobenzyl diethylenetriamine pentacetic acid (ADTPA) moieties were evaluated for tumor imaging and photodynamic therapy (PDT).  In vivo studies performed in both mice and rat tumor models resulted in a significant MR signal enhancement of tumors relative to surrounding tissues at 24 h postinjection.  The water-sol. (pH: 7.4) HPPH-3Gd(III) ADTPA conjugate demonstrated high potential for tumor imaging by MR and fluorescence.  This agent also produced long-term tumor cures via PDT.  An in vivo biodistribution study with the corresponding 14C-analog also showed significant tumor uptake 24 h postinjection.  Toxicol. evaluations of HPHH-3Gd(III)ADTPA administered at and above imaging/therapeutic doses did not show any evidence of organ toxicity.  Our present study illustrates a novel approach for the development of water-sol. "multifunctional agents", demonstrating efficacy for tumor imaging (MR and fluorescence) and phototherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBKHMDEWcLLbVg90H21EOLACvtfcHk0lh6VGrnJpLmxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksF2lsL0%253D&md5=8a8ac3bdad4a8fccb17ee993184d3e2a</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fbc9005317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc9005317%26sid%3Dliteratum%253Aachs%26aulast%3DSpernyak%26aufirst%3DJ.%2BA.%26aulast%3DWhite%26aufirst%3DW.%2BH.%26aulast%3DEthirajan%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DN.%2BJ.%26aulast%3DGoswami%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DTurowski%26aufirst%3DS.%26aulast%3DMissert%26aufirst%3DJ.%2BR.%26aulast%3DBatt%26aufirst%3DC.%26aulast%3DMazurchuk%26aufirst%3DR.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DHexylether%2520derivative%2520of%2520pyropheophorbide-a%2520%2528HPPH%2529%2520on%2520conjugating%2520with%25203gadolinium%2528III%2529%2520aminobenzyldiethylenetriaminepentaacetic%2520acid%2520shows%2520potential%2520for%2520in%2520vivo%2520tumor%2520imaging%2520%2528MR%252C%2520fluorescence%2529%2520and%2520photodynamic%2520therapy%26jtitle%3DBioconjugate%2520Chem.%26date%3D2010%26volume%3D21%26spage%3D828%26epage%3D835%26doi%3D10.1021%2Fbc9005317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 2 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shimin  Gao</span>, <span class="hlFld-ContribAuthor ">Chengjie  Li</span>, <span class="hlFld-ContribAuthor ">Glib  Baryshnikov</span>, <span class="hlFld-ContribAuthor ">Hans  Ågren</span>, <span class="hlFld-ContribAuthor ">Qizhao  Li</span>, <span class="hlFld-ContribAuthor ">Yongshu  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">Stable thiophene-embedded N-confused homoporphyrins: Partial conjugation, fusion and fluoride binding. </span><span class="cited-content_cbyCitation_journal-name">Dyes and Pigments</span><span> <strong>2021,</strong> <em>194 </em>, 109612. <a href="https://doi.org/10.1016/j.dyepig.2021.109612" title="DOI URL">https://doi.org/10.1016/j.dyepig.2021.109612</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.dyepig.2021.109612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.dyepig.2021.109612%26sid%3Dliteratum%253Aachs%26jtitle%3DDyes%2520and%2520Pigments%26atitle%3DStable%252Bthiophene-embedded%252BN-confused%252Bhomoporphyrins%25253A%252BPartial%252Bconjugation%25252C%252Bfusion%252Band%252Bfluoride%252Bbinding%26aulast%3DGao%26aufirst%3DShimin%26date%3D2021%26volume%3D194%26spage%3D109612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nichole E. M.  Kaufman</span>, <span class="hlFld-ContribAuthor ">Simran  Dhingra</span>, <span class="hlFld-ContribAuthor ">Seetharama D.  Jois</span>, <span class="hlFld-ContribAuthor ">Maria da Graça H.  Vicente</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Targeting of Epidermal Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor Receptor (VEGFR). </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (4)
                                     , 1076. <a href="https://doi.org/10.3390/molecules26041076" title="DOI URL">https://doi.org/10.3390/molecules26041076</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26041076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26041076%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DMolecular%252BTargeting%252Bof%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252B%252528EGFR%252529%252Band%252BVascular%252BEndothelial%252BGrowth%252BFactor%252BReceptor%252B%252528VEGFR%252529%26aulast%3DKaufman%26aufirst%3DNichole%2BE.%2BM.%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D4%26spage%3D1076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0023.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of the starting chlorins and bacteriochlorin used in present study retention.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0013.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Erlotinib Moiety Conjugated at Position 17 of the Hexyl Ether Analogue of Pyropheophorbide-a</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0014.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Erlotinib Moiety Conjugated at Position 3 of Pyropheophorbide-a and Bacteriopyropheophorbide-a</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0015.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Erlotinib Moiety Conjugated either at the <i>p-</i>Position of the Benzyloxy Group Having a Chiral Center at Position 3(1′) or at the <i>m-</i>Position without a Chiral Center at Position 3(1′) of the Conjugate</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0016.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Erlotinib Moiety Conjugated at Position 20 of Methyl Meso-pyropheophorbide-a</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0017.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Hexyl Ether Analogue of Pyropheophorbide-a (HPPH) Conjugated with Three Erlotinib Moieties</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0018.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Erlotinib Moiety Conjugated to the Fused Imide Ring Systems of Purpurinimide and</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0019.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Erlotinib Moiety Conjugated at Position 13 of Chlorin e<sub>6</sub> with an Amide Linker</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0020.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Erlotinib Moiety Conjugated at Position 13 of Chlorin e<sub>6</sub> with an Ethylene Glycol Linker</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0021.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Erlotinib Moiety Conjugated at Position 13 of Chlorin by a Longer Ethylene Glycol Linker</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0022.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Erlotinib Moiety Conjugated at Position 15 of Chlorin e<sub>6</sub></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Uptake and retention by HNT1 cells (passage 116). Confluent cell cultures were incubated for 30 min in the serum-free medium containing 3.2 μM of the indicated PS. The cellular level and subcellular distribution of PS fluorescence indicates the binding to and mode of uptake by the cells. Subsequent treatment of the cells for 5 h with serum and the PS-containing medium determines the competing effect of serum proteins on uptake and steady-state accumulation of the PSs. Follow-up incubation for 15 h in the serum-containing medium but without PS provided an estimate for the rate of egress of PS from cells. PS fluorescence is recorded at 100× magnification by different-length exposure of the camera. Images allow digital quantification of the PS fluorescence level.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Cell-type specific retention of erlotinib conjugates. Five-day-old co-cultures of FaDu-49 and CFSE-stained HN-121 T-Fb were incubated with the medium containing 10% FBS and 1.6 μM PS followed by a 48-h chase in medium without PS. Cell-associated fluorescence signals were recorded.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Five-day-old co-cultures of HN-143T-EC with HN-166T-Fb were incubated with the medium containing 10% FBS and 3 μM indicated PS for 5 h and then chased for 40 h with the medium without PS. Phase contrast images at 100× magnification (upper panel in each section) and corresponding fluorescent images of all cultures (500 ms exposure time) were taken at the indicated time points (lower panel in each section). Fluorescent pictures are shown in the monochrome format as photographed for optimal presentation of the fluorescent signals.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. PS-dose dependent photoreaction in HN-85-1-3 T-EC. Level of PS taken up was quantified by fluorescence prior to 665 nm light treatment (3 J/cm<sup>2</sup>). (A) Immunoblot analysis of STAT3 and EGFR immediately after light treatment. (B) Duplicate cultures were incubated for 24 h after PDT, and then the percentage of surviving cells determined.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compounds selected to determine the impact of structural requirements for tumor uptake and <i>in vivo</i> PDT efficacy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. <i>In vivo</i> uptake of PS <b>10</b> in tumor, liver, and skin of female SCID mice bearing UMUC3 tumor, at the doses of 0.47, 0.25, and 0.125 μmole/kg (A)–(C); <b>PS 11</b> at a dose of 0. 47 μmole/kg (D); and <b>PS 19</b> and <b>HPPH</b> at a dose of 0.47 μmol/kg (E, F). The comparative <i>in vivo</i> efficacies of <b>PS 10</b> at variable drug doses (0.47, 0.25, and 0.125 μmol/kg) and <b>PS 19</b> and <b>HPPH</b> at a dose of 0.47 μmole/kg are shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>G. All tumors were exposed with the same light dose (665 nm, 135 J/cm<sup>2</sup>, 75 mW/cm<sup>2</sup>), at the time of maximal tumor uptake of the PS. For PS-uptake study (tumor, liver, and skin), three female SCID mice bearing UMUC3 tumors were used (A)–(<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). For determining <i>in vivo</i> efficacy, the number of female SCID mice used in each study is indicated in (G). Statistical analysis; log rank (Mantel–Cox test), <i>p</i>-value:<0.0001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. <i>In vivo</i> uptake of PS <b>10</b> at the dose of 0.47, 0.25, and 0.125 μmole/kg and <b>HPPH</b> in tumor, liver, and skin of female SCID mice bearing FaDu tumors (three mice/group), is shown in (A)–(D), respectively. The <i>in vivo</i> PDT efficacy (long-term tumor response) of PS <b>10</b> at variable doses: 0.47, 0.25, and 0.125 μmole/kg and <b>HPPH</b> at a dose of 0.47 μmole/kg, is shown in (E). Tumors were exposed to light (665 nm, 135 J/cm<sup>2</sup>, 75 mW/cm<sup>2</sup>) at 24 h post injection, and tumor growth was measured daily for 60 days. For the PS-uptake study (tumor, liver, and skin), three female SCID mice bearing FaDu tumors were used (A)–(D). For determining <i>in vivo</i> efficacy, the number of female SCID mice used in each study is indicated in (E). Statistical analysis; log rank (Mantel–Cox test), <i>p</i>-value:<0.0001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Structure of the PS–Erlotinib conjugates in which the erlotinib moiety is attached either at <i>meta-</i> (PS <b>10</b>) or <i>para</i>-position (PS <b>16</b>) of the pyropheophorbide-a.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. <i>In vivo</i> uptake of PS <b>16</b> at a dose of 0.47μmole/kg in tumor, liver, and skin of female SCID mice bearing (A) UMUC3 and (B) FaDu tumors. The <i>in vivo</i> PDT efficacy (long-term tumor response) of PS <b>16</b> at a dose of 0.47 μmole/kg and PS <b>16</b> for UMUC 3 and FaDu tumors are shown (C) and (D), respectively. The tumors were exposed to light (665 nm, 135 J/cm<sup>2</sup>, 75 mW/cm<sup>2</sup>) at 24 h post injection of the PS. A direct correlation between the PS uptake and tumor response (cure) was observed (kg). Statistical analysis log rank (Mantel–Cox test), (C) UMUC3, <i>p</i>-value: <0.0001, and (D) FaDu tumors, <i>p</i>-value: 0.0019. For PS-uptake study (tumor, liver, and skin), three female SCID mice bearing either UMUC3 or FaDu tumors were used (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>A,B). For determining <i>in vivo</i> efficacy, the number of female SCID mice used in each study is indicated in <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>C,D.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/medium/jm0c01735_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0012.jpeg" id="rightTab-GRAPHIC-d7e2132-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. <i>In vivo</i> uptake of PS <b>5</b> at the dose of 0.47 mmol/kg in tumor, liver and skin of female SCID mice bearing (A) UMUC3 tumors and  (B) FaDu tumors. The in vivo PDT efficacy (long-term tumor response) of PS <b>5</b> at a dose of 0.47 μmole/kg for UMUC3 and FADU tumors is shown in  (C) and (D) respectively. The tumors were exposed to light (665 nm, 135 J/cm<sup>2</sup>, 75 mW/cm<sup>2</sup>) at 24 h post-injection of the PS. A direct correlation between the PS uptake and  tumor response (cure) was observed. For PS-uptake study (tumor, liver and skin), 3 female SCID mice bearing either UMUC3 or FaDu tumors were used (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>A,B). For determining <i>in vivo</i> efficacy, the number of female SCID mice used in each study are indicated in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>C,D. Statistical analysis log rank (Mantel−Cox test), (C): <i>p</i>-value: <0.0046 and (D): <i>p</i>-value: 0.0153.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-1/acs.jmedchem.0c01735/20210107/images/large/jm0c01735_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01735&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i60">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80725" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80725" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 48 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Juarranz, Á.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaén, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz-Rodríguez, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuevas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González, S.</span></span> <span> </span><span class="NLM_article-title">Photodynamic therapy of cancer: Basic principles and applications</span>. <i>Clin. Transl. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.1007/s12094-008-0172-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1007%2Fs12094-008-0172-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=18321817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BD1cXls1Cisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=148-154&author=%C3%81.+Juarranzauthor=P.+Ja%C3%A9nauthor=F.+Sanz-Rodr%C3%ADguezauthor=J.+Cuevasauthor=S.+Gonz%C3%A1lez&title=Photodynamic+therapy+of+cancer%3A+Basic+principles+and+applications&doi=10.1007%2Fs12094-008-0172-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Photodynamic therapy of cancer. Basic principles and applications</span></div><div class="casAuthors">Juarranz, Angeles; Jaen, Pedro; Sanz-Rodriguez, Francisco; Cuevas, Jesus; Gonzalez, Salvador</div><div class="citationInfo"><span class="NLM_cas:title">Clinical & Translational Oncology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">148-154</span>CODEN:
                <span class="NLM_cas:coden">CTOLAM</span>;
        ISSN:<span class="NLM_cas:issn">1699-048X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Photodynamic therapy (PDT) is a minimally invasive therapeutic modality approved for clin. treatment of several types of cancer and non-oncol. disorders.  In PDT, a compd. with photosensitizing properties (photosensitizer, PS) is selectively accumulated in malignant tissues.  The subsequent activation of the PS by visible light, preferentially in the red region of the visible spectrum (λ≥600 nm), where tissues are more permeable to light, generates reactive oxygen species, mainly singlet oxygen (1O2), responsible for cytotoxicity of neoplastic cells and tumor regression.  There are three main mechanisms described by which 1O2 contributes to the destruction of tumors by PDT: direct cellular damage, vascular shutdown and activation of immune response against tumor cells.  The advantages of PDT over other conventional cancer treatments are its low systemic toxicity and its ability to selectively destroy tumors accessible to light.  Therefore, PDT is being used for the treatment of endoscopically accessible tumors such as lung, bladder, gastrointestinal and gynaecol. neoplasms, and also in dermatol. for the treatment of non-melanoma skin cancers (basal cell carcinoma) and precancerous diseases (actinic keratosis).  Photofrin, ALA and its ester derivs. are the main compds. used in clin. trials, though newer and more efficient PSs are being evaluated nowadays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWlkUgRA99HbVg90H21EOLACvtfcHk0lgUTWEahyu6CQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXls1Cisbk%253D&md5=def01f96d817e695b02b79f0f2f4b2a8</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs12094-008-0172-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12094-008-0172-2%26sid%3Dliteratum%253Aachs%26aulast%3DJuarranz%26aufirst%3D%25C3%2581.%26aulast%3DJa%25C3%25A9n%26aufirst%3DP.%26aulast%3DSanz-Rodr%25C3%25ADguez%26aufirst%3DF.%26aulast%3DCuevas%26aufirst%3DJ.%26aulast%3DGonz%25C3%25A1lez%26aufirst%3DS.%26atitle%3DPhotodynamic%2520therapy%2520of%2520cancer%253A%2520Basic%2520principles%2520and%2520applications%26jtitle%3DClin.%2520Transl.%2520Oncol.%26date%3D2008%26volume%3D10%26spage%3D148%26epage%3D154%26doi%3D10.1007%2Fs12094-008-0172-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kessel, D.</span></span> <span> </span><span class="NLM_article-title">Photodynamic therapy: A brief history</span>. <i>J. Clin. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1581</span>, <span class="refDoi"> DOI: 10.3390/jcm8101581</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.3390%2Fjcm8101581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmsFaqur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2019&pages=1581&author=D.+Kessel&title=Photodynamic+therapy%3A+A+brief+history&doi=10.3390%2Fjcm8101581"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Photodynamic therapy: a brief history</span></div><div class="casAuthors">Kessel, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1581</span>CODEN:
                <span class="NLM_cas:coden">JCMOHK</span>;
        ISSN:<span class="NLM_cas:issn">2077-0383</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) involves the selective sensitization of tissues to light.  A major advance in the field occurred when Thomas Dougherty at the Roswell Park Cancer Institute initiated a series of clin. studies that eventually led to FDA approval of the procedure.  This report contains a summary of Dougherty's contributions and an assessment of where this has led, along with a summary of implications for future drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_MOHilslPhbVg90H21EOLACvtfcHk0liLb6rZ_Humcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmsFaqur0%253D&md5=df0723c38b940fd6a5a1174e171e2763</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3390%2Fjcm8101581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fjcm8101581%26sid%3Dliteratum%253Aachs%26aulast%3DKessel%26aufirst%3DD.%26atitle%3DPhotodynamic%2520therapy%253A%2520A%2520brief%2520history%26jtitle%3DJ.%2520Clin.%2520Med.%26date%3D2019%26volume%3D8%26spage%3D1581%26doi%3D10.3390%2Fjcm8101581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">and references therein.</p></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hiramatsu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawabata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakurai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ono, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyatake, S.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroiwa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicente, M. G. H.</span></span> <span> </span><span class="NLM_article-title">Tetrakis(p-carboranylthio-tetrafluorophenyl) chlorin (TPFC): Application for photodynamic therapy and boron neutron capture therapy</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">962</span>– <span class="NLM_lpage">970</span>, <span class="refDoi"> DOI: 10.1002/jps.24317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1002%2Fjps.24317" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFKlu7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2015&pages=962-970&author=R.+Hiramatsuauthor=S.+Kawabataauthor=H.+Tanakaauthor=Y.+Sakuraiauthor=M.+Suzukiauthor=K.+Onoauthor=S.-I.+Miyatakeauthor=T.+Kuroiwaauthor=E.+Haoauthor=M.+G.+H.+Vicente&title=Tetrakis%28p-carboranylthio-tetrafluorophenyl%29+chlorin+%28TPFC%29%3A+Application+for+photodynamic+therapy+and+boron+neutron+capture+therapy&doi=10.1002%2Fjps.24317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Tetrakis(p-Carboranylthio-Tetrafluorophenyl)Chlorin (TPFC): Application for Photodynamic Therapy and Boron Neutron Capture Therapy</span></div><div class="casAuthors">Hiramatsu, Ryo; Kawabata, Shinji; Tanaka, Hiroki; Sakurai, Yoshinori; Suzuki, Minoru; Ono, Koji; Miyatake, Shin-ichi; Kuroiwa, Toshihiko; Hao, Erhong; Vicente, M. Graca H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">962-970</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Carboranyl-contg. chlorins have emerged as promising dual sensitizers for use in both photodynamic therapy (PDT) and boron neutron capture therapy (BNCT), by virtue of their known tumor affinity, low cytotoxicity in dark conditions, and their strong absorptions in the red region of the optical spectrum.  Tetrakis(p-carboranylthio-tetrafluorophenyl)chlorin (TPFC) is a new synthetic carboranyl-contg. chlorin of high boron content (24% by wt.).  To evaluate TPFC's applicability as sensitizer for both PDT and BNCT, we performed an in vitro and in vivo study using F98 rat glioma cells and F98 rat glioma-bearing brain tumor models.  For the in vivo BNCT study, we used boronophenylalanine (BPA), which is currently used in clin. BNCT studies, via i.v. administration (i.v.) and/or used TPFC via convection-enhanced delivery (CED), a method for local drug infusion directly into the brain.  In the in vitro PDT study, the cell surviving fraction following laser irradn. (9 J/cm2) was 0.035 whereas in the in vitro BNCT study, the cell surviving fraction following neutron irradn. (thermal neutron = 1.73 × 1012 n/cm2) was 0.04.  In the in vivo BNCT study, the median survival time following concomitant administration of BPA (i.v.) and TPFC (CED) was 42 days (95% confidence interval; 37-43 days). © 2014 Wiley Periodicals, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1WsvcveA8i7Vg90H21EOLACvtfcHk0lgcAeuLlj_TMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFKlu7nN&md5=08f970b1804b11f92e31e2af468936b0</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1002%2Fjps.24317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.24317%26sid%3Dliteratum%253Aachs%26aulast%3DHiramatsu%26aufirst%3DR.%26aulast%3DKawabata%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DSakurai%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DOno%26aufirst%3DK.%26aulast%3DMiyatake%26aufirst%3DS.-I.%26aulast%3DKuroiwa%26aufirst%3DT.%26aulast%3DHao%26aufirst%3DE.%26aulast%3DVicente%26aufirst%3DM.%2BG.%2BH.%26atitle%3DTetrakis%2528p-carboranylthio-tetrafluorophenyl%2529%2520chlorin%2520%2528TPFC%2529%253A%2520Application%2520for%2520photodynamic%2520therapy%2520and%2520boron%2520neutron%2520capture%2520therapy%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2015%26volume%3D104%26spage%3D962%26epage%3D970%26doi%3D10.1002%2Fjps.24317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lo, P.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Morgade, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, D. K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumoulin, F.</span></span> <span> </span><span class="NLM_article-title">The unique features and promises of phthalocyanines as advanced photosensitisers for photodynamic therapy of cancer</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1041</span>– <span class="NLM_lpage">1056</span>, <span class="refDoi"> DOI: 10.1039/C9CS00129H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1039%2FC9CS00129H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=31845688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVSnu77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2020&pages=1041-1056&author=P.-C.+Loauthor=M.+S.+Rodr%C3%ADguez-Morgadeauthor=R.+K.+Pandeyauthor=D.+K.+P.+Ngauthor=T.+Torresauthor=F.+Dumoulin&title=The+unique+features+and+promises+of+phthalocyanines+as+advanced+photosensitisers+for+photodynamic+therapy+of+cancer&doi=10.1039%2FC9CS00129H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The unique features and promises of phthalocyanines as advanced photosensitisers for photodynamic therapy of cancer</span></div><div class="casAuthors">Lo, Pui-Chi; Rodriguez-Morgade, M. Salome; Pandey, Ravindra K.; Ng, Dennis K. P.; Torres, Tomas; Dumoulin, Fabienne</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1041-1056</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Phthalocyanines exhibit superior photoproperties that make them a surely attractive class of photosensitizers for photodynamic therapy of cancer.  Several derivs. are at various phases of clin. trials, and efforts have been put continuously to improve their photodynamic efficacy.  To this end, various strategies have been applied to develop advanced phthalocyanines with optimized photoproperties, dual therapeutic actions, tumor-targeting properties and/or specific activation at tumor sites.  The advantageous properties and potential of phthalocyanines as advanced photosensitizers for photodynamic therapy of cancer are highlighted in this tutorial review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyq_GPDCHKSLVg90H21EOLACvtfcHk0ljhh_BBgmCUaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVSnu77I&md5=f600e873a969140fd13ef35efafbca81</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1039%2FC9CS00129H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC9CS00129H%26sid%3Dliteratum%253Aachs%26aulast%3DLo%26aufirst%3DP.-C.%26aulast%3DRodr%25C3%25ADguez-Morgade%26aufirst%3DM.%2BS.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26aulast%3DNg%26aufirst%3DD.%2BK.%2BP.%26aulast%3DTorres%26aufirst%3DT.%26aulast%3DDumoulin%26aufirst%3DF.%26atitle%3DThe%2520unique%2520features%2520and%2520promises%2520of%2520phthalocyanines%2520as%2520advanced%2520photosensitisers%2520for%2520photodynamic%2520therapy%2520of%2520cancer%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2020%26volume%3D49%26spage%3D1041%26epage%3D1056%26doi%3D10.1039%2FC9CS00129H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shaker, Y. M.</span>; <span class="NLM_string-name">Sweed, A. M. K.</span>; <span class="NLM_string-name">Moylan, C.</span>; <span class="NLM_string-name">Rogers, L.</span>; <span class="NLM_string-name">Ryan, A. A.</span>; <span class="NLM_string-name">Pettidemange, R.</span>; <span class="NLM_string-name">Senge, M. O.</span></span> <span> </span><span class="NLM_article-title">Current developments in UsingMESO-(TETRA) substituted porphyrins for PDT</span> In  <i>HANDBOOK OF PHOTODYNAMIC THERAPY</i>; Updates on Recent Applications of Porphyrin-Based Compound (Eds: <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span>; <span class="NLM_string-name">Kessel, D.</span>; <span class="NLM_string-name">Dougherty, T. J.</span></span>), <span class="NLM_publisher-name">World Scientific</span><i>:</i> <span class="NLM_publisher-loc">New Jersey</span>, <span class="NLM_year">2016</span>, pp.  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">149</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1142%2F9789814719650_0003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=95-149&author=Y.+M.+Shaker&author=A.+M.+K.+Sweed&author=C.+Moylan&author=L.+Rogers&author=A.+A.+Ryan&author=R.+Pettidemange&author=M.+O.+Sengeauthor=R.+K.+Pandey&author=D.+Kessel&author=T.+J.+Dougherty&title=HANDBOOK+OF+PHOTODYNAMIC+THERAPY"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1142%2F9789814719650_0003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1142%252F9789814719650_0003%26sid%3Dliteratum%253Aachs%26aulast%3DShaker%26aufirst%3DY.%2BM.%26atitle%3DCurrent%2520developments%2520in%2520UsingMESO-%2528TETRA%2529%2520substituted%2520porphyrins%2520for%2520PDT%26btitle%3DHANDBOOK%2520OF%2520PHOTODYNAMIC%2520THERAPY%26aulast%3DPandey%26aufirst%3DR.%2BK.%26pub%3DWorld%2520Scientific%26date%3D2016%26spage%3D95%26epage%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ethirajan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">The role of porphyrin chemistry in tumor imaging and photodynamic therapy</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">340</span>– <span class="NLM_lpage">362</span>, <span class="refDoi"> DOI: 10.1039/B915149B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1039%2FB915149B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=20694259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFKju7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2011&pages=340-362&author=M.+Ethirajanauthor=Y.+Chenauthor=P.+Joshiauthor=R.+K.+Pandey&title=The+role+of+porphyrin+chemistry+in+tumor+imaging+and+photodynamic+therapy&doi=10.1039%2FB915149B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The role of porphyrin chemistry in tumor imaging and photodynamic therapy</span></div><div class="casAuthors">Ethirajan, Manivannan; Chen, Yihui; Joshi, Penny; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">340-362</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  In recent years several review articles and books have been published on the use of porphyrin-based compds. in photodynamic therapy (PDT).  This crit. review is focused on (i) the basic concept of PDT, (ii) advantages of long-wavelength absorbing photosensitizers (PS), (iii) a brief discussion on recent advances in developing PDT agents, and (iv) the various synthetic strategies designed at the Roswell Park Cancer Institute, Buffalo, for developing highly effective long-wavelength PDT agents and their utility in constructing the conjugates with tumor-imaging and therapeutic potential (Theranostics).  The clin. status of certain selected PDT agents is also summarized (205 refs.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwaO6TvgtDibVg90H21EOLACvtfcHk0ljhh_BBgmCUaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFKju7bF&md5=b462478255e32db5d073a892c64e2d52</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1039%2FB915149B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB915149B%26sid%3Dliteratum%253Aachs%26aulast%3DEthirajan%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DJoshi%26aufirst%3DP.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DThe%2520role%2520of%2520porphyrin%2520chemistry%2520in%2520tumor%2520imaging%2520and%2520photodynamic%2520therapy%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2011%26volume%3D40%26spage%3D340%26epage%3D362%26doi%3D10.1039%2FB915149B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abrahamse, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamblin, M. R.</span></span> <span> </span><span class="NLM_article-title">New photosensitizers for photodynamic therapy</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>473</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">364</span>, <span class="refDoi"> DOI: 10.1042/BJ20150942</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1042%2FBJ20150942" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=26862179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC28Xitleqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=473&publication_year=2016&pages=347-364&author=H.+Abrahamseauthor=M.+R.+Hamblin&title=New+photosensitizers+for+photodynamic+therapy&doi=10.1042%2FBJ20150942"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">New photosensitizers for photodynamic therapy</span></div><div class="casAuthors">Abrahamse, Heidi; Hamblin, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">473</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">347-364</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) was discovered more than 100 years ago, and has since become a well-studied therapy for cancer and various non-malignant diseases including infections.  PDT uses photosensitizers (PSs, non-toxic dyes) that are activated by absorption of visible light to initially form the excited singlet state, followed by transition to the long-lived excited triplet state.  This triplet state can undergo photochem. reactions in the presence of oxygen to form reactive oxygen species (including singlet oxygen) that can destroy cancer cells, pathogenic microbes and unwanted tissue.  The dual-specificity of PDT relies on accumulation of the PS in diseased tissue and also on localized light delivery.  Tetrapyrrole structures such as porphyrins, chlorins, bacteriochlorins and phthalocyanines with appropriate functionalization have been widely investigated in PDT, and several compds. have received clin. approval.  Other mol. structures including the synthetic dyes classes as phenothiazinium, squaraine and BODIPY (boron-dipyrromethene), transition metal complexes, and natural products such as hypericin, riboflavin and curcumin have been investigated.  Targeted PDT uses PSs conjugated to antibodies, peptides, proteins and other ligands with specific cellular receptors.  Nanotechnol. has made a significant contribution to PDT, giving rise to approaches such as nanoparticle delivery, fullerene-based PSs, titania photocatalysis, and the use of upconverting nanoparticles to increase light penetration into tissue.  Future directions include photochem. internalization, genetically encoded protein PSs, theranostics, two-photon absorption PDT, and sonodynamic therapy using ultrasound.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFTuFcH5GS87Vg90H21EOLACvtfcHk0lgFkTtlk73-bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xitleqsrc%253D&md5=9ad9b594476ad2c3452189212f0827b7</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1042%2FBJ20150942&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20150942%26sid%3Dliteratum%253Aachs%26aulast%3DAbrahamse%26aufirst%3DH.%26aulast%3DHamblin%26aufirst%3DM.%2BR.%26atitle%3DNew%2520photosensitizers%2520for%2520photodynamic%2520therapy%26jtitle%3DBiochem.%2520J.%26date%3D2016%26volume%3D473%26spage%3D347%26epage%3D364%26doi%3D10.1042%2FBJ20150942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olivo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhuvaneshwari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucky, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dendukuri, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thong, P. S.-P.</span></span> <span> </span><span class="NLM_article-title">Targeted therapy of cancer using photodynamic therapy in combination with multi-faceted anti-tumor modalities</span>. <i>Pharmaceuticals</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1507</span>– <span class="NLM_lpage">1529</span>, <span class="refDoi"> DOI: 10.3390/ph3051507</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.3390%2Fph3051507" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=27713315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A280%3ADC%252BC2svnvFehsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=1507-1529&author=M.+Olivoauthor=R.+Bhuvaneshwariauthor=S.+S.+Luckyauthor=N.+Dendukuriauthor=P.+S.-P.+Thong&title=Targeted+therapy+of+cancer+using+photodynamic+therapy+in+combination+with+multi-faceted+anti-tumor+modalities&doi=10.3390%2Fph3051507"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted Therapy of Cancer Using Photodynamic Therapy in Combination with Multi-faceted Anti-Tumor Modalities</span></div><div class="casAuthors">Olivo Malini; Bhuvaneswari Ramaswamy; Lucky Sasidharan Swarnalatha; Dendukuri Nagamani; Soo-Ping Thong Patricia; Olivo Malini; Olivo Malini; Olivo Malini</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceuticals (Basel, Switzerland)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1507-1529</span>
        ISSN:<span class="NLM_cas:issn">1424-8247</span>.
    </div><div class="casAbstract">Photodynamic therapy (PDT) has emerged as one of the important therapeutic options in the management of cancer and other diseases.  PDT involves a tumor-localized photosensitizer (PS), which when appropriately illuminated by visible light converts oxygen into cytotoxic reactive oxygen species (ROS), that attack key structural entities within the targeted cells, ultimately resulting in necrosis or apoptosis.  Though PDT is a selective modality, it can be further enhanced by combining other targeted therapeutic strategies that include the use of synthetic peptides and nanoparticles for selective delivery of photosensitizers.  Another potentially promising strategy is the application of targeted therapeutics that exploit a myriad of critical pathways involved in tumorigenesis and metastasis.  Vascular disrupting agents that eradicate tumor vasculature during PDT and anti-angiogenic agents that targets specific molecular pathways and prevent the formation of new blood vessels are novel therapeutic approaches that have been shown to improve treatment outcome.  In addition to the well-documented mechanisms of direct cell killing and damage to the tumor vasculature, PDT can also activate the body's immune response against tumors.  Numerous pre-clinical studies and clinical observations have demonstrated the immuno-stimulatory capability of PDT.  Herein, we aim to integrate the most important findings with regard to the combination of PDT and other novel targeted therapy approaches, detailing its potential in cancer photomedicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTcX-JV3ebU8lVwdslNBF-tfW6udTcc2eZNksu3iBo6Yrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2svnvFehsA%253D%253D&md5=733f9165055d9446747852dad44e5d9c</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3390%2Fph3051507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph3051507%26sid%3Dliteratum%253Aachs%26aulast%3DOlivo%26aufirst%3DM.%26aulast%3DBhuvaneshwari%26aufirst%3DR.%26aulast%3DLucky%26aufirst%3DS.%2BS.%26aulast%3DDendukuri%26aufirst%3DN.%26aulast%3DThong%26aufirst%3DP.%2BS.-P.%26atitle%3DTargeted%2520therapy%2520of%2520cancer%2520using%2520photodynamic%2520therapy%2520in%2520combination%2520with%2520multi-faceted%2520anti-tumor%2520modalities%26jtitle%3DPharmaceuticals%26date%3D2010%26volume%3D3%26spage%3D1507%26epage%3D1529%26doi%3D10.3390%2Fph3051507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.</span></span> <span> </span><span class="NLM_article-title">Photosensitizer-conjugated human serum albumin nanoparticles for effective photodynamic therapy</span>. <i>Theranostics</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">230</span>– <span class="NLM_lpage">239</span>, <span class="refDoi"> DOI: 10.7150/thno/v01p0230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.7150%2Fthno%2Fv01p0230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=21562630" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC38Xislalt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=230-239&author=H.+Jeongauthor=M.+Huhauthor=S.+J.+Leeauthor=H.+Kooauthor=I.+C.+Kwonauthor=S.+Y.+Jeongauthor=K.+Kim&title=Photosensitizer-conjugated+human+serum+albumin+nanoparticles+for+effective+photodynamic+therapy&doi=10.7150%2Fthno%2Fv01p0230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Photosensitizer-conjugated human serum albumin nanoparticles for effective photodynamic therapy</span></div><div class="casAuthors">Jeong, Hayoung; Huh, Myung Sook; Lee, So Jin; Koo, Heebeom; Kwon, Ick Chan; Jeong, Seo Young; Kim, Kwangmeyung</div><div class="citationInfo"><span class="NLM_cas:title">Theranostics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">230-239</span>CODEN:
                <span class="NLM_cas:coden">THERDS</span>;
        ISSN:<span class="NLM_cas:issn">1838-7640</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) is an emerging theranostic modality for various cancers and diseases.  The focus of this study was the development of tumor-targeting albumin nanoparticles contg. photosensitizers for efficient PDT.  To produce tumor-targeting albumin nanoparticles, the hydrophobic photosensitizer, chlorin e6 (Ce6), was chem. conjugated to human serum albumin (HSA).  The conjugates formed self-assembled nanoparticle structures with an av. diam. of 88 nm under aq. conditions.  As expected, the Ce6-conjugated HSA nanoparticles (Ce6-HSA-NPs) were nontoxic in their native state, but upon illumination with the appropriate wavelength of light, they produced singlet oxygen and damaged target tumor cells in a cell culture system.  Importantly, when the nanoparticles were injected through the tail vein into tumor-bearing HT-29 mice, Ce6-HSA-NPs compared with free Ce6 revealed enhanced tumor-specific biodistribution and successful therapeutic results following laser irradn.  These results suggest that highly tumor-specific albumin nanoparticles have the potential to serve not only as efficient therapeutic agents, but also as photo-dynamic imaging (PDI) reagents in cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxENd6gh5SCLVg90H21EOLACvtfcHk0lhZ0c9v2G-msQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xislalt7g%253D&md5=ce84235141759d3743bcd180825a4fe9</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.7150%2Fthno%2Fv01p0230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno%252Fv01p0230%26sid%3Dliteratum%253Aachs%26aulast%3DJeong%26aufirst%3DH.%26aulast%3DHuh%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DS.%2BJ.%26aulast%3DKoo%26aufirst%3DH.%26aulast%3DKwon%26aufirst%3DI.%2BC.%26aulast%3DJeong%26aufirst%3DS.%2BY.%26aulast%3DKim%26aufirst%3DK.%26atitle%3DPhotosensitizer-conjugated%2520human%2520serum%2520albumin%2520nanoparticles%2520for%2520effective%2520photodynamic%2520therapy%26jtitle%3DTheranostics%26date%3D2011%26volume%3D1%26spage%3D230%26epage%3D239%26doi%3D10.7150%2Fthno%2Fv01p0230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Z.</span></span> <span> </span><span class="NLM_article-title">Mitochondria-targeting organic nanoparticles for enhanced photodynamic/photothermal therapy</span>. <i>ACS Appl. Mater. Interfaces</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">30077</span>– <span class="NLM_lpage">30084</span>, <span class="refDoi"> DOI: 10.1021/acsami.0c06144</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsami.0c06144" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtF2hsrvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2020&pages=30077-30084&author=C.+Liauthor=W.+Zhangauthor=S.+Liuauthor=X.+Huauthor=Z.+Xie&title=Mitochondria-targeting+organic+nanoparticles+for+enhanced+photodynamic%2Fphotothermal+therapy&doi=10.1021%2Facsami.0c06144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Mitochondria-Targeting Organic Nanoparticles for Enhanced Photodynamic/Photothermal Therapy</span></div><div class="casAuthors">Li, Chaonan; Zhang, Wei; Liu, Shi; Hu, Xiuli; Xie, Zhigang</div><div class="citationInfo"><span class="NLM_cas:title">ACS Applied Materials & Interfaces</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">30077-30084</span>CODEN:
                <span class="NLM_cas:coden">AAMICK</span>;
        ISSN:<span class="NLM_cas:issn">1944-8244</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Organelle-targeting techniques have been proved to be promising approaches for enhanced cancer treatment, esp. phototherapy, because it can greatly improve the efficiency of photosensitizers.  In this work, we designed and synthesized a mitochondria-targeting diketopyrrolopyrrole-based photosensitizer (DPP2+) for synergistic photodynamic/photothermal therapy upon irradn.  The obtained mitochondria-targeting nanoparticles (DPP2+ NPs) could produce thermal energy and singlet oxygen under 635 nm laser irradn. with ideal cytocompatibility.  Importantly, DPP2+ NPs are more likely to enter the cells and target mitochondria.  In in vitro and in vivo antitumor expts., DPP2+ NPs showed highly effective antitumor effects, suggesting that mitochondria-targeting photosensitizers have potential for cancer treatment.  The present work provides an alternative strategy to mitochondria-targeting mol. engineering and highlights the potential of org. nanomaterials in biomedical fields and cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpjq0mGliRebVg90H21EOLACvtfcHk0lhZ0c9v2G-msQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtF2hsrvI&md5=b1718e86bebcb80d0b5ffce63f82cb8f</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facsami.0c06144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsami.0c06144%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DXie%26aufirst%3DZ.%26atitle%3DMitochondria-targeting%2520organic%2520nanoparticles%2520for%2520enhanced%2520photodynamic%252Fphotothermal%2520therapy%26jtitle%3DACS%2520Appl.%2520Mater.%2520Interfaces%26date%3D2020%26volume%3D12%26spage%3D30077%26epage%3D30084%26doi%3D10.1021%2Facsami.0c06144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, X.</span></span> <span> </span><span class="NLM_article-title">A single molecule drug targeting photosensitizer for enhanced breast cancer photothermal therapy</span>. <i>Small</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1907677</span>, <span class="refDoi"> DOI: 10.1002/smll.201907677</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1002%2Fsmll.201907677" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnsV2gu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2020&pages=1907677&author=Y.+Zouauthor=M.+Liauthor=T.+Xiongauthor=X.+Zhaoauthor=J.+Duauthor=J.+Fanauthor=X.+Peng&title=A+single+molecule+drug+targeting+photosensitizer+for+enhanced+breast+cancer+photothermal+therapy&doi=10.1002%2Fsmll.201907677"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A Single Molecule Drug Targeting Photosensitizer for Enhanced Breast Cancer Photothermal Therapy</span></div><div class="casAuthors">Zou, Yang; Li, Mingle; Xiong, Tao; Zhao, Xueze; Du, Jianjun; Fan, Jiangli; Peng, Xiaojun</div><div class="citationInfo"><span class="NLM_cas:title">Small</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">1907677</span>CODEN:
                <span class="NLM_cas:coden">SMALBC</span>;
        ISSN:<span class="NLM_cas:issn">1613-6810</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Targeting is one of the most important strategies for enhancing the efficacy of cancer photothermal therapy (PTT) and reducing damage to surrounding normal tissues.  Compared with the traditional targeting approaches, the active targeting of breast cancer cells in PTT using chemotherapeutic drugs, such as tamoxifen (TAM), in combination with single-mol. photothermal photosensitizers has superior selectivity and therapeutic effects.  However, single-mol. drug-targeting photosensitizers for improved PTT efficacy are not widely reported.  Accordingly, herein, a near-IR induced small-mol. photothermal photosensitizer (CyT) is developed that actively targets the estrogen receptors (ERs) of breast cancer cells as well as targets mitochondria by structure-inherent targeting.  Cell uptake and cytotoxicity studies using different types of cells show that CyT enhances the efficiency of TAM-based PTT by targeting ER-overexpressing breast cancer cells and selectively killing them.  In vivo expts. demonstrate that CyT can be used as a photothermal agent for fluorescence imaging-guided PTT.  More importantly, the i.v. injection of CyT results in better targeting and efficiency of tumor inhibition compared with that achieved with the TAM-free control mol. Cy.  Thus, the study presents an excellent small-mol. photothermal agent for breast cancer therapy with potential clin. application prospects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpb_lXa8yub0LVg90H21EOLACvtfcHk0lgHazTCh3zcrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnsV2gu7Y%253D&md5=dc099a317f9ea1301a4d3e228908b37d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fsmll.201907677&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsmll.201907677%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DXiong%26aufirst%3DT.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DPeng%26aufirst%3DX.%26atitle%3DA%2520single%2520molecule%2520drug%2520targeting%2520photosensitizer%2520for%2520enhanced%2520breast%2520cancer%2520photothermal%2520therapy%26jtitle%3DSmall%26date%3D2020%26volume%3D16%26spage%3D1907677%26doi%3D10.1002%2Fsmll.201907677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mamblin, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizvi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maytin, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasan, T.</span></span> <span> </span><span class="NLM_article-title">Pegylation of a chlorin(e6) polymer conjugate increases tumor targeting of photosensitizer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">7155</span>– <span class="NLM_lpage">7162</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=11585749" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2001&pages=7155-7162&author=M.+R.+Mamblinauthor=J.+L.+Millerauthor=I.+Rizviauthor=B.+Ortelauthor=E.+V.+Maytinauthor=T.+Hasan&title=Pegylation+of+a+chlorin%28e6%29+polymer+conjugate+increases+tumor+targeting+of+photosensitizer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMamblin%26aufirst%3DM.%2BR.%26aulast%3DMiller%26aufirst%3DJ.%2BL.%26aulast%3DRizvi%26aufirst%3DI.%26aulast%3DOrtel%26aufirst%3DB.%26aulast%3DMaytin%26aufirst%3DE.%2BV.%26aulast%3DHasan%26aufirst%3DT.%26atitle%3DPegylation%2520of%2520a%2520chlorin%2528e6%2529%2520polymer%2520conjugate%2520increases%2520tumor%2520targeting%2520of%2520photosensitizer%26jtitle%3DCancer%2520Res.%26date%3D2001%26volume%3D61%26spage%3D7155%26epage%3D7162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shim, Y. K.</span></span> <span> </span><span class="NLM_article-title">Advance in photosensitizers and light delivery for photodynamic therapy</span>. <i>Clin. Endosc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.5946/ce.2013.46.1.7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.5946%2Fce.2013.46.1.7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=23423543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A280%3ADC%252BC3szpsValsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2013&pages=7-23&author=I.+Yoonauthor=J.+Z.+Liauthor=Y.+K.+Shim&title=Advance+in+photosensitizers+and+light+delivery+for+photodynamic+therapy&doi=10.5946%2Fce.2013.46.1.7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Advance in photosensitizers and light delivery for photodynamic therapy</span></div><div class="casAuthors">Yoon Il; Li Jia Zhu; Shim Young Key</div><div class="citationInfo"><span class="NLM_cas:title">Clinical endoscopy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-23</span>
        ISSN:<span class="NLM_cas:issn">2234-2400</span>.
    </div><div class="casAbstract">The brief history of photodynamic therapy (PDT) research has been focused on photosensitizers (PSs) and light delivery was introduced recently.  The appropriate PSs were developed from the first generation PS Photofrin (QLT) to the second (chlorins or bacteriochlorins derivatives) and third (conjugated PSs on carrier) generations PSs to overcome undesired disadvantages, and to increase selective tumor accumulation and excellent targeting.  For the synthesis of new chlorin PSs chlorophyll a is isolated from natural plants or algae, and converted to methyl pheophorbide a (MPa) as an important starting material for further synthesis.  MPa has various active functional groups easily modified for the preparation of different kinds of PSs, such as methyl pyropheophorbide a, purpurin-18, purpurinimide, and chlorin e6 derivatives.  Combination therapy, such as chemotherapy and photothermal therapy with PDT, is shortly described here.  Advanced light delivery system is shown to establish successful clinical applications of PDT.  Phtodynamic efficiency of the PSs with light delivery was investigated in vitro and/or in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRH_YB4UKV2tDQLBVDQn4bCfW6udTcc2ebxE7QamwkMs7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szpsValsg%253D%253D&md5=d0f57b767d464bc0ad916a0e86a7fe95</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.5946%2Fce.2013.46.1.7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5946%252Fce.2013.46.1.7%26sid%3Dliteratum%253Aachs%26aulast%3DYoon%26aufirst%3DI.%26aulast%3DLi%26aufirst%3DJ.%2BZ.%26aulast%3DShim%26aufirst%3DY.%2BK.%26atitle%3DAdvance%2520in%2520photosensitizers%2520and%2520light%2520delivery%2520for%2520photodynamic%2520therapy%26jtitle%3DClin.%2520Endosc.%26date%3D2013%26volume%3D46%26spage%3D7%26epage%3D23%26doi%3D10.5946%2Fce.2013.46.1.7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Si, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span> <span> </span><span class="NLM_article-title">Diketopyrrolopyrrole-based photosensitizers conjugated with chemotherapeutic agents for multimodal tumor therapy</span>. <i>ACS Appl. Mater. Interfaces</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">30398</span>– <span class="NLM_lpage">30405</span>, <span class="refDoi"> DOI: 10.1021/acsami.7b09025</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsami.7b09025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlyhsL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=30398-30405&author=Y.+Caiauthor=P.+Liangauthor=Q.+Tangauthor=W.+Siauthor=P.+Chenauthor=Q.+Zhangauthor=X.+Dong&title=Diketopyrrolopyrrole-based+photosensitizers+conjugated+with+chemotherapeutic+agents+for+multimodal+tumor+therapy&doi=10.1021%2Facsami.7b09025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Diketopyrrolopyrrole-Based Photosensitizers Conjugated with Chemotherapeutic Agents for Multimodal Tumor Therapy</span></div><div class="casAuthors">Cai, Yu; Liang, Pingping; Tang, Qianyun; Si, Weili; Chen, Peng; Zhang, Qi; Dong, Xiaochen</div><div class="citationInfo"><span class="NLM_cas:title">ACS Applied Materials & Interfaces</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">30398-30405</span>CODEN:
                <span class="NLM_cas:coden">AAMICK</span>;
        ISSN:<span class="NLM_cas:issn">1944-8244</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">For synergistic cancer therapy, it is highly desirable to devise a single multifunctional agent to combine photodynamic therapy (PDT), photothermal therapy (PTT), and chemotherapy, which is sol. and excitable at low irradn., as well as able to selectively target tumors and achieve high efficacy.  Toward this ambition, here the chemotherapy drugs chlorambucil (Cb), and all trans retinoic acid (ATRA) are covalently conjugated onto a small dye mol. diketopyrrolopyrrole (DPP-Cb and DPP-ATRA).  The sol. nanoparticles (NPs) of DPP-Cb and DPP-ATRA formed by repptn. can selectively accumulate in tumors, release chemotherapy drugs under acidic conditions, and exhibit efficient reactive oxygen species (ROS) generation and photothermal conversion under the irradn. of a low power xenon lamp (40 mW/cm2).  We show in vitro and in vivo that both NPs can effectively kill cancer cells and suppress cancer growth at a low dose (0.4 mg/kg).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRZVi8uDtTOrVg90H21EOLACvtfcHk0lgHazTCh3zcrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlyhsL3F&md5=1850ed022fbbf4bc184f771bbd401670</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facsami.7b09025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsami.7b09025%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DY.%26aulast%3DLiang%26aufirst%3DP.%26aulast%3DTang%26aufirst%3DQ.%26aulast%3DSi%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DDong%26aufirst%3DX.%26atitle%3DDiketopyrrolopyrrole-based%2520photosensitizers%2520conjugated%2520with%2520chemotherapeutic%2520agents%2520for%2520multimodal%2520tumor%2520therapy%26jtitle%3DACS%2520Appl.%2520Mater.%2520Interfaces%26date%3D2017%26volume%3D9%26spage%3D30398%26epage%3D30405%26doi%3D10.1021%2Facsami.7b09025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sandland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, R. W.</span></span> <span> </span><span class="NLM_article-title">Photosensitizer antibody-drug conjugates: Past, present and future</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">975</span>– <span class="NLM_lpage">993</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.9b00055</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.9b00055" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtFCqur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2019&pages=975-993&author=J.+Sandlandauthor=R.+W.+Boyle&title=Photosensitizer+antibody-drug+conjugates%3A+Past%2C+present+and+future&doi=10.1021%2Facs.bioconjchem.9b00055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Photosensitizer Antibody-Drug Conjugates: Past, Present, and Future</span></div><div class="casAuthors">Sandland, Jordon; Boyle, Ross W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">975-993</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This Review aims to highlight key aspects of tetrapyrrole-based antibody-drug conjugates (ADCs) and significant developments in the field since 2010.  Many new conjugation methods have been developed and employed in the past decade, and assocd. with this, there has been a rising interest in theranostic conjugates.  We have investigated the physicochem. properties that tetrapyrroles need to possess in order to be viable photosensitizers for conjugation to antibodies.  Differences in conjugation strategies are discussed, and structure-activity relationships of tetrapyrrole-antibody conjugates are reported, where available.  As the elegance of bioconjugation techniques has increased, it has paved the way for exceptionally phototoxic, yet highly selective, tetrapyrrole-antibody conjugates, with photocytotoxicities in the nanomolar range, to be synthesized and biol. evaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRa8MnnISHn7Vg90H21EOLACvtfcHk0ljREAQEmj_pOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtFCqur0%253D&md5=09989d6e2a37e2b715c399035b03a160</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.9b00055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.9b00055%26sid%3Dliteratum%253Aachs%26aulast%3DSandland%26aufirst%3DJ.%26aulast%3DBoyle%26aufirst%3DR.%2BW.%26atitle%3DPhotosensitizer%2520antibody-drug%2520conjugates%253A%2520Past%252C%2520present%2520and%2520future%26jtitle%3DBioconjugate%2520Chem.%26date%3D2019%26volume%3D30%26spage%3D975%26epage%3D993%26doi%3D10.1021%2Facs.bioconjchem.9b00055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">and references therein.</p></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drain, C. M.</span></span> <span> </span><span class="NLM_article-title">Efficient synthesis and photodynamic activity of porphyrin saccharide conjugates: Targeting and incapacitating cancer cells</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">10918</span>– <span class="NLM_lpage">10929</span>, <span class="refDoi"> DOI: 10.1021/bi049272v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi049272v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVSntLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2004&pages=10918-10929&author=X.+Chenauthor=L.+Huiauthor=D.+A.+Fosterauthor=C.+M.+Drain&title=Efficient+synthesis+and+photodynamic+activity+of+porphyrin+saccharide+conjugates%3A+Targeting+and+incapacitating+cancer+cells&doi=10.1021%2Fbi049272v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient Synthesis and Photodynamic Activity of Porphyrin-Saccharide Conjugates: Targeting and Incapacitating Cancer Cells</span></div><div class="casAuthors">Chen, Xin; Hui, Li; Foster, David A.; Drain, Charles Michael</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">10918-10929</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Since the role of saccharides in cell recognition, metab., and cell labeling is well-established, the conjugation of saccharides to drugs is an active area of research.  Thus, one goal in the use of saccharide-drug conjugates is to impart a greater specificity toward a given cell type or other targets.  Although widely used to treat some cancers and age related macular degeneration, the drugs used in photodynamic therapy (PDT) display poor chem. selectivity toward the intended targets, and uptake by cells most likely arises from passive, diffusional processes.  Instead, the specific irradn. of the target tissues, and the formation of the toxic species in situ, are the primary factors that modulate the selectivity in the present mode of PDT.  We report herein a two-step method to make nonhydrolyzable saccharide-porphyrin conjugates in high yields using a tetra(pentafluorophenyl)porphyrin and the thio deriv. of the sugar.  As a demonstration of their properties, the selective uptake (and/or binding) of these compds. to several cancer cell types was examd., followed by an investigation of their photodynamic properties.  As expected, different malignant cell types take up one type of saccharide-porphyrin conjugate preferentially over others; for example, human breast cancer cells (MDA-MB-231) absorb a tetraglucose-porphyrin conjugate over the corresponding galactose deriv.  Doseametric studies reveal that these saccharide-porphyrin conjugates exhibit varying PDT responses depending on drug concn. and irradn. energy.  Using 20 μM conjugate and greater irradn. energy induces cell death by necrosis.  When 10-20 μM conjugate and less irradn. energy are used, both necrosis and apoptosis are obsd.  Using 10 μM and the least irradn. energy, a significant redn. in cell migration is obsd., which indicates a redn. in aggressiveness of the cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE6qduaudJLrVg90H21EOLACvtfcHk0ljREAQEmj_pOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVSntLc%253D&md5=92ddb299a014ca6975853a80ce8b5028</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fbi049272v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi049272v%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DX.%26aulast%3DHui%26aufirst%3DL.%26aulast%3DFoster%26aufirst%3DD.%2BA.%26aulast%3DDrain%26aufirst%3DC.%2BM.%26atitle%3DEfficient%2520synthesis%2520and%2520photodynamic%2520activity%2520of%2520porphyrin%2520saccharide%2520conjugates%253A%2520Targeting%2520and%2520incapacitating%2520cancer%2520cells%26jtitle%3DBiochemistry%26date%3D2004%26volume%3D43%26spage%3D10918%26epage%3D10929%26doi%3D10.1021%2Fbi049272v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Missert, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oseroff, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Synthesis of β-galactose conjugated chlorins derived by enyne metathesis as galectin-specific photosensitizers for photodynamic therapy</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">8709</span>– <span class="NLM_lpage">8716</span>, <span class="refDoi"> DOI: 10.1021/jo0105080</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo0105080" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosVOiu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2001&pages=8709-8716&author=G.+Zhengauthor=A.+Grahamauthor=M.+Shibataauthor=J.+R.+Missertauthor=A.+R.+Oseroffauthor=T.+J.+Doughertyauthor=R.+K.+Pandey&title=Synthesis+of+%CE%B2-galactose+conjugated+chlorins+derived+by+enyne+metathesis+as+galectin-specific+photosensitizers+for+photodynamic+therapy&doi=10.1021%2Fjo0105080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of β-Galactose-Conjugated Chlorins Derived by Enyne Metathesis as Galectin-Specific Photosensitizers for Photodynamic Therapy</span></div><div class="casAuthors">Zheng, Gang; Graham, Andrew; Shibata, Masayuki; Missert, Joseph R.; Oseroff, Allan R.; Dougherty, Thomas J.; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">8709-8716</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A first report on the synthesis and biol. evaluation of the β-galactose-conjugated purpurinimides (a class of chlorins contg. a six-membered fused imide ring system) as Gal-1 (galectin-1) recognized photosensitizers, prepd. from purpurin-N-propargylimide via enyne metathesis, is discussed.  On the basis of examn. of the available crystal structure of the galectin-1 N-acetyllactose amine complex, it was considered that the chlorin-based photosensitizers could be introduced into a carbohydrate skeleton to expand the repertoire of the galectin-1-specific ligands.  Preliminary mol. modeling anal. utilizing the modeled photosensitizers and the available crystal structures of galectin-carbohydrate complexes indicated that addn. of the photosensitizer to the carbohydrate moiety at an appropriate position does not interfere with the galectin-carbohydrate recognition.  Under similar drug and light doses, compared to the free purpurinimide analog, the purpurinimides conjugated either with galactose or with lactose (Gal(β1-4)-Glc) produced a considerable increase in photosensitizing efficacy in vitro.  This indicates the possibility for development of a new class of specific photosensitizers for photodynamic therapy (PDT) based on recognition of a cellular receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo33EhZ-smElLVg90H21EOLACvtfcHk0ljREAQEmj_pOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosVOiu7w%253D&md5=bf9a8503b3c40ba6a6471d4f59403b9e</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjo0105080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0105080%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DG.%26aulast%3DGraham%26aufirst%3DA.%26aulast%3DShibata%26aufirst%3DM.%26aulast%3DMissert%26aufirst%3DJ.%2BR.%26aulast%3DOseroff%26aufirst%3DA.%2BR.%26aulast%3DDougherty%26aufirst%3DT.%2BJ.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DSynthesis%2520of%2520%25CE%25B2-galactose%2520conjugated%2520chlorins%2520derived%2520by%2520enyne%2520metathesis%2520as%2520galectin-specific%2520photosensitizers%2520for%2520photodynamic%2520therapy%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2001%26volume%3D66%26spage%3D8709%26epage%3D8716%26doi%3D10.1021%2Fjo0105080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Missert, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellnier, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Conjugation of 2-(1′-hexyloxyethyl)-2-devinylpyropheophorbide-a (HPPH) to carbohydrates changes its subcellular distribution and enhances photodynamic activity in vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">4306</span>– <span class="NLM_lpage">4318</span>, <span class="refDoi"> DOI: 10.1021/jm9001617</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9001617" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntVSrsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4306-4318&author=X.+Zhengauthor=J.+Morganauthor=S.+K.+Pandeyauthor=Y.+Chenauthor=E.+Tracyauthor=H.+Baumannauthor=J.+R.+Missertauthor=C.+Battauthor=J.+Jacksonauthor=D.+A.+Bellnierauthor=B.+W.+Hendersonauthor=R.+K.+Pandey&title=Conjugation+of+2-%281%E2%80%B2-hexyloxyethyl%29-2-devinylpyropheophorbide-a+%28HPPH%29+to+carbohydrates+changes+its+subcellular+distribution+and+enhances+photodynamic+activity+in+vivo&doi=10.1021%2Fjm9001617"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Conjugation of 2-(1'-Hexyloxyethyl)-2-devinylpyropheophorbide-a (HPPH) to Carbohydrates Changes its Subcellular Distribution and Enhances Photodynamic Activity in Vivo</span></div><div class="casAuthors">Zheng, Xiang; Morgan, Janet; Pandey, Suresh K.; Chen, Yihui; Tracy, Erin; Baumann, Heinz; Missert, Joseph R.; Batt, Carrie; Jackson, Jennifer; Bellnier, David A.; Henderson, Barbara W.; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4306-4318</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The carbohydrate moieties on conjugating with 3-(1'-hexyloxyethyl)-3-devinyl pyropeophorbide-a (HPPH) altered the uptake and intracellular localization from mitochondria to lysosomes.  In vitro, HPPH-Gal (I) PDT showed increased PDT efficacy over HPPH-PDT as detectable by the oxidative crosslinking of nonphosphorylated STAT3 and cell killing in ABCG2-expressing RIF cells but not in ABCG2-neg. Colon26 cells.  This increased efficacy in RIF cells could at least partially be attributed to increased cellular accumulation of I, suggesting a role of the ABCG2 transporter for which HPPH is a substrate.  While such differences in the accumulation in HPPH derivs. by tumor tissue in vivo were not detectable, I still showed an elevated light dose-dependent activity compared to HPPH in mice bearing RIF as well as Colon26 tumors.  Further optimization of the carbohydrate conjugates at variable treatment parameters in vivo is currently underway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkzKd5zZ2b0rVg90H21EOLACvtfcHk0ljif25q3Wl0Mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntVSrsr0%253D&md5=355371956077ac7a6ecc89833664aad5</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm9001617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9001617%26sid%3Dliteratum%253Aachs%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DMorgan%26aufirst%3DJ.%26aulast%3DPandey%26aufirst%3DS.%2BK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DTracy%26aufirst%3DE.%26aulast%3DBaumann%26aufirst%3DH.%26aulast%3DMissert%26aufirst%3DJ.%2BR.%26aulast%3DBatt%26aufirst%3DC.%26aulast%3DJackson%26aufirst%3DJ.%26aulast%3DBellnier%26aufirst%3DD.%2BA.%26aulast%3DHenderson%26aufirst%3DB.%2BW.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DConjugation%2520of%25202-%25281%25E2%2580%25B2-hexyloxyethyl%2529-2-devinylpyropheophorbide-a%2520%2528HPPH%2529%2520to%2520carbohydrates%2520changes%2520its%2520subcellular%2520distribution%2520and%2520enhances%2520photodynamic%2520activity%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4306%26epage%3D4318%26doi%3D10.1021%2Fjm9001617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Substrate affinity of photosensitizers derived from chlorophyll-a: The ABCG2 transporter affects the phototoxic response of side population stem cell-like cancer cells to photodynamic therapy</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1789</span>– <span class="NLM_lpage">1804</span>, <span class="refDoi"> DOI: 10.1021/mp100154j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp100154j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFSjurrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2010&pages=1789-1804&author=J.+Morganauthor=J.+D.+Jacksonauthor=X.+Zhengauthor=S.+K.+Pandeyauthor=R.+K.+Pandey&title=Substrate+affinity+of+photosensitizers+derived+from+chlorophyll-a%3A+The+ABCG2+transporter+affects+the+phototoxic+response+of+side+population+stem+cell-like+cancer+cells+to+photodynamic+therapy&doi=10.1021%2Fmp100154j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate Affinity of Photosensitizers Derived from Chlorophyll-a: The ABCG2 Transporter Affects the Phototoxic Response of Side Population Stem Cell-like Cancer Cells to Photodynamic Therapy</span></div><div class="casAuthors">Morgan, Janet; Jackson, Jennifer D.; Zheng, Xiang; Pandey, Suresh K.; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1789-1804</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Photosensitizers (PS) synthesized with the aim of optimizing photodynamic therapy (PDT) of tumors do not always fulfill their potential when tested in vitro and in vivo in different tumor models.  The ATP-dependent transporter ABCG2, a multidrug resistant pump expressed at variable levels in cancerous cells, can bind and efflux a wide range of structurally different classes of compds. including several PS used preclinically and clin. such as porphyrins and chlorins.  ABCG2 may lower intracellular levels of substrate PS below the threshold for cell death in tumors treated by PDT, leaving resistant cells to repopulate the tumor.  To det. some of the structural factors that affect substrate affinity of PS for ABCG2, we used an ABCG2-expressing cell line (HEK 293 482R) and its nonexpressing counterpart, and tyrosine kinase ABCG2 inhibitors in a simple flow cytometric assay to identify PS effluxed by the ABCG2 pump.  We tested a series of conjugates of substrate PS with different groups attached at different positions on the tetrapyrrole macrocycle to examine whether a change in affinity for the pump occurred and whether such changes depended on the position or the structure/type of the attached group.  PS without substitutions including pyropheophorbides and purpurinimides were generally substrates for ABCG2, but carbohydrate groups conjugated at positions 8, 12, 13, and 17 but not at position 3 abrogated ABCG2 affinity regardless of structure or linking moiety.  At position 3, affinity was retained with the addn. of iodobenzene, alkyl chains and monosaccharides, but not with disaccharides.  This suggests that structural characteristics at position 3 may offer important contributions to requirements for binding to ABCG2.  We examd. several tumor cell lines for ABCG2 activity, and found that although some cell lines had negligible ABCG2 activity in bulk, they contained a small ABCG2-expressing side population (SP) thought to contain cells which are responsible for initiating tumor regrowth.  We examd. the relevance of the SP to PDT resistance with ABCG2 substrates in vitro and in vivo in the murine mammary tumor 4T1.  We show for the first time in vivo that the substrate PS HPPH (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a) but not the nonsubstrate PS HPPH-Gal (a galactose conjugate of HPPH) selectively preserved the SP which was primarily responsible for regrowth in vitro.  The SP could be targeted by addn. of imatinib mesylate, a tyrosine kinase inhibitor which inhibits the ATPase activity of ABCG2, and prevents efflux of substrates.  A PDT resistant SP may be responsible for recurrences obsd. both preclinically and clin.  To prevent ABCG2 mediated resistance, choosing nonsubstrate PS or administering an ABCG2 inhibitor alongside a substrate PS might be advantageous when treating ABCG2-expressing tumors with PDT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSSGTD8kwyhrVg90H21EOLACvtfcHk0ljif25q3Wl0Mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFSjurrM&md5=668a1009391c86ad4b55abd75c67e7ff</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fmp100154j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp100154j%26sid%3Dliteratum%253Aachs%26aulast%3DMorgan%26aufirst%3DJ.%26aulast%3DJackson%26aufirst%3DJ.%2BD.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DPandey%26aufirst%3DS.%2BK.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DSubstrate%2520affinity%2520of%2520photosensitizers%2520derived%2520from%2520chlorophyll-a%253A%2520The%2520ABCG2%2520transporter%2520affects%2520the%2520phototoxic%2520response%2520of%2520side%2520population%2520stem%2520cell-like%2520cancer%2520cells%2520to%2520photodynamic%2520therapy%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2010%26volume%3D7%26spage%3D1789%26epage%3D1804%26doi%3D10.1021%2Fmp100154j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, P. M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavaleiro, J. A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ribeiro, C. A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomé, J. P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, R.</span></span> <span> </span><span class="NLM_article-title">Galactodendritic phthalocyanine targets carbohydrate-binding proteins enhancing photodynamic therapy</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e95529</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0095529</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1371%2Fjournal.pone.0095529" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=24763311" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=P.+M.+R.+Pereiraauthor=S.+Silvaauthor=J.+A.+S.+Cavaleiroauthor=C.+A.+F.+Ribeiroauthor=J.+P.+C.+Tom%C3%A9author=R.+Fernandes&title=Galactodendritic+phthalocyanine+targets+carbohydrate-binding+proteins+enhancing+photodynamic+therapy&doi=10.1371%2Fjournal.pone.0095529"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0095529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0095529%26sid%3Dliteratum%253Aachs%26aulast%3DPereira%26aufirst%3DP.%2BM.%2BR.%26aulast%3DSilva%26aufirst%3DS.%26aulast%3DCavaleiro%26aufirst%3DJ.%2BA.%2BS.%26aulast%3DRibeiro%26aufirst%3DC.%2BA.%2BF.%26aulast%3DTom%25C3%25A9%26aufirst%3DJ.%2BP.%2BC.%26aulast%3DFernandes%26aufirst%3DR.%26atitle%3DGalactodendritic%2520phthalocyanine%2520targets%2520carbohydrate-binding%2520proteins%2520enhancing%2520photodynamic%2520therapy%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0095529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Z.</span></span> <span> </span><span class="NLM_article-title">Potent peptide-conjugated silicon phthalocyanines for tumor photodynamic therapy</span>. <i>J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">310</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.7150/jca.22362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.7150%2Fjca.22362" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=29344278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A280%3ADC%252BC1MvhslGgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=310-320&author=Q.+Liuauthor=M.+Pangauthor=S.+Tanauthor=J.+Wangauthor=Q.+Chenauthor=K.+Wangauthor=W.+Wuauthor=Z.+Hong&title=Potent+peptide-conjugated+silicon+phthalocyanines+for+tumor+photodynamic+therapy&doi=10.7150%2Fjca.22362"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Potent peptide-conjugated silicon phthalocyanines for tumor photodynamic therapy</span></div><div class="casAuthors">Liu Qian; Wang Jin; Hong Zhangyong; Pang Mingpei; Chen Qingle; Wu Wenjie; Tan Sihai; Wang Kai</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cancer</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">310-320</span>
        ISSN:<span class="NLM_cas:issn">1837-9664</span>.
    </div><div class="casAbstract">Phthalocyanines (Pcs) are a group of promising photosensitizers for use in photodynamic therapy (PDT).  However, their extremely low solubility and their strong tendency to aggregate in aqueous solution greatly restrict their application.  Conjugation of Pc macrocycles with peptide ligands could be a very useful strategy to optimize the physical properties of Pcs not only by increasing their water solubility and reducing their aggregation but also by endowing the conjugates with a tumor-targeting capability.  To develop highly potent photosensitizers for tumor PDT, we prepared new peptide-conjugated photosensitizers using silicon Pc (SiPc), which has much higher photodynamic activity than zinc Pcs, as the light activation moiety and the cRGDfK peptide (or simply cRGD) as the peptide moiety.  A polyethylene glycol linker and an extra carboxylic acid group were also tested for introduction into the conjugates to optimize the conjugate structure.  The conjugates' photophysical and photodynamic behaviors were then carefully evaluated and compared using in vitro and in vivo experiments.  One of the prepared conjugates, RGD-(Linker)2-Glu-SiPc, showed excellent physical properties and photodynamic activity, with an EC50 (half maximal effective concentration) of 10-20 nM toward various cancer cells.  This conjugate eradicated human glioblastoma U87-MG tumors in a xenograft murine tumor model after only one dose of photodynamic treatment, with no tumor regrowth during observation for up to 35 days.  The conjugate RGD-(Linker)2-Glu-SiPc thus showed highly promising potential for use in tumor treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSy1-fUapkcWcScOqQTSkOffW6udTcc2ebSP-01qU0Wybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvhslGgsQ%253D%253D&md5=20fb1222078e472522cec9eb2cb374f8</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.7150%2Fjca.22362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fjca.22362%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DPang%26aufirst%3DM.%26aulast%3DTan%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DHong%26aufirst%3DZ.%26atitle%3DPotent%2520peptide-conjugated%2520silicon%2520phthalocyanines%2520for%2520tumor%2520photodynamic%2520therapy%26jtitle%3DJ.%2520Cancer%26date%3D2018%26volume%3D9%26spage%3D310%26epage%3D320%26doi%3D10.7150%2Fjca.22362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Srivatsan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ethirajan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, T.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Missert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Conjugation of cRGD peptide to chlorophyll-a based photosensitizer (HPPH) alters its pharmacokinetics with enhanced tumor-imaging and photosensitizing (PDT) efficacy</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1186</span>– <span class="NLM_lpage">1197</span>, <span class="refDoi"> DOI: 10.1021/mp200018y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp200018y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC3MXot1Cltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=1186-1197&author=A.+Srivatsanauthor=M.+Ethirajanauthor=S.+K.+Pandeyauthor=S.+Dubeyauthor=X.+Zhengauthor=T.-H.+Liuauthor=M.+Shibataauthor=J.+Missertauthor=J.+Morganauthor=R.+K.+Pandey&title=Conjugation+of+cRGD+peptide+to+chlorophyll-a+based+photosensitizer+%28HPPH%29+alters+its+pharmacokinetics+with+enhanced+tumor-imaging+and+photosensitizing+%28PDT%29+efficacy&doi=10.1021%2Fmp200018y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Conjugation of cRGD Peptide to Chlorophyll a Based Photosensitizer (HPPH) Alters Its Pharmacokinetics with Enhanced Tumor-Imaging and Photosensitizing (PDT) Efficacy</span></div><div class="casAuthors">Srivatsan, Avinash; Ethirajan, Manivannan; Pandey, Suresh K.; Dubey, Shipra; Zheng, Xiang; Liu, Ting-Hsiu; Shibata, Masayuki; Missert, Joseph; Morgan, Janet; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1186-1197</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The αvβ3 integrin receptor plays an important role in human metastasis and tumor-induced angiogenesis.  Cyclic Arg-Gly-Asp (cRGD) peptide represents a selective αvβ3 integrin ligand that has been extensively used for research, therapy, and diagnosis of neoangiogenesis.  For developing photosensitizers with enhanced PDT efficacy, we here report the synthesis of a series of bifunctional agents in which the 3-(1'-hexyloxyethyl)-3-devinylpyropheophorbide a (HPPH), a chlorophyll-based photosensitizer, was conjugated to cRGD and the related analogs.  The cell uptake and in vitro PDT efficacy of the conjugates were studied in αvβ3 integrin overexpressing U87 and 4T1 cell lines whereas the in vivo PDT efficacy and fluorescence-imaging potential of the conjugates were compared with the corresponding nonconjugated photosensitizer HPPH in 4T1 tumors.  Compared to HPPH, the HPPH-cRGD conjugate in which the arginine and aspartic acid moieties were available for binding to two subunits of αvβ3 integrin showed faster clearance, enhanced tumor imaging and enhanced PDT efficacy at 2-4 h postinjection.  Mol. modeling studies also confirmed that the presence of the HPPH moiety in HPPH-cRGD conjugate does not interfere with specific recognition of cRGD by αvβ3 integrin.  Compared to U87 and 4T1 cells the HPPH-cRGD showed significantly low photosensitizing efficacy in A431 (αvβ3 neg.) tumor cells, suggesting possible target specificity of the conjugate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEnvNJrWfkErVg90H21EOLACvtfcHk0liry04WaMiJYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXot1Cltr0%253D&md5=19b20682aed1fe3f7acef8a4b7348f11</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fmp200018y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp200018y%26sid%3Dliteratum%253Aachs%26aulast%3DSrivatsan%26aufirst%3DA.%26aulast%3DEthirajan%26aufirst%3DM.%26aulast%3DPandey%26aufirst%3DS.%2BK.%26aulast%3DDubey%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DT.-H.%26aulast%3DShibata%26aufirst%3DM.%26aulast%3DMissert%26aufirst%3DJ.%26aulast%3DMorgan%26aufirst%3DJ.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DConjugation%2520of%2520cRGD%2520peptide%2520to%2520chlorophyll-a%2520based%2520photosensitizer%2520%2528HPPH%2529%2520alters%2520its%2520pharmacokinetics%2520with%2520enhanced%2520tumor-imaging%2520and%2520photosensitizing%2520%2528PDT%2529%2520efficacy%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2011%26volume%3D8%26spage%3D1186%26epage%3D1197%26doi%3D10.1021%2Fmp200018y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyoshi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okazaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohtsuki, T.</span></span> <span> </span><span class="NLM_article-title">Endosomal escape of peptide-photosensitizer conjugates is affected by amino acid sequences near the photosensitizer</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">916</span>– <span class="NLM_lpage">922</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.0c00046</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.0c00046" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisVSitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2020&pages=916-922&author=Y.+Miyoshiauthor=M.+Kadonoauthor=S.+Okazakiauthor=A.+Nishimuraauthor=M.+Kitamatsuauthor=K.+Watanabeauthor=T.+Ohtsuki&title=Endosomal+escape+of+peptide-photosensitizer+conjugates+is+affected+by+amino+acid+sequences+near+the+photosensitizer&doi=10.1021%2Facs.bioconjchem.0c00046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Endosomal Escape of Peptide-Photosensitizer Conjugates Is Affected by Amino Acid Sequences near the Photosensitizer</span></div><div class="casAuthors">Miyoshi, Yuichi; Kadono, Maho; Okazaki, Shigetoshi; Nishimura, Ayano; Kitamatsu, Mizuki; Watanabe, Kazunori; Ohtsuki, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">916-922</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cell-penetrating peptides (CPPs) are widely used for the intracellular delivery of peptides and proteins, but CPP fusion peptides and proteins are often transported by endocytosis and trapped in endosomes.  Photochem. internalization (PCI) is a method for the endosomal escape of the trapped peptide or protein and release into the cytosol using light and photosensitizers.  In PCI, endosomal membranes are thought to be destabilized by singlet oxygen (1O2) photogenerated from photosensitizers localized in endosomes.  We previously developed CPP-cargo-photosensitizer (PS) conjugates able to photodependently enter the cytosol via the PCI mechanism.  For example, TatU1A-PS (a covalent complex of Tat [CPP], U1A RNA-binding protein [cargo], and PS) can photodependently deliver RNAs into the cytosol, and TatBim-PS (a covalent complex of Tat, Bim [cargo], and PS) can photoinduce apoptosis in mammalian cells.  However, for many newly created conjugates, the induction of PCI has been insufficient.  We hypothesized that the amino acid linker sequence (XX) adjacent to the photosensitizer is an important determinant of PCI efficiency.  In this study, using CPP-cargo-XX-PS platforms, we examd. the relationship between PCI efficiency and the linker amino acid sequence near the photosensitizer.  We found that hydrophobic FF and LL linkers enhanced the PCI efficiencies of both TatBim-XX-PS and TatU1A-XX-PS.  The effectiveness of the linker depended, in part, on both the cargo moiety and the photosensitizer.  These results may guide the design of CPP-cargo-PS conjugates conferring broad target functions for PCI and photodynamic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBwsHjYWws9rVg90H21EOLACvtfcHk0liry04WaMiJYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisVSitrg%253D&md5=b70a0b24a88664150c3e17dbfa7788c7</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.0c00046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.0c00046%26sid%3Dliteratum%253Aachs%26aulast%3DMiyoshi%26aufirst%3DY.%26aulast%3DKadono%26aufirst%3DM.%26aulast%3DOkazaki%26aufirst%3DS.%26aulast%3DNishimura%26aufirst%3DA.%26aulast%3DKitamatsu%26aufirst%3DM.%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DOhtsuki%26aufirst%3DT.%26atitle%3DEndosomal%2520escape%2520of%2520peptide-photosensitizer%2520conjugates%2520is%2520affected%2520by%2520amino%2520acid%2520sequences%2520near%2520the%2520photosensitizer%26jtitle%3DBioconjugate%2520Chem.%26date%3D2020%26volume%3D31%26spage%3D916%26epage%3D922%26doi%3D10.1021%2Facs.bioconjchem.0c00046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fronczek, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibrian-Vazquez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jois, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicente, M. G. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis of BODIPY-peptide conjugates for fluorescence labeling of EGFR over-expressing cells</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1566</span>– <span class="NLM_lpage">1579</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.7b00211</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.7b00211" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtFCgt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2017&pages=1566-1579&author=N.+Zhaoauthor=T.+M.+Williamsauthor=Z.+Zhouauthor=F.+R.+Fronczekauthor=M.+Sibrian-Vazquezauthor=S.+D.+Joisauthor=M.+G.+H.+Vicente&title=Synthesis+of+BODIPY-peptide+conjugates+for+fluorescence+labeling+of+EGFR+over-expressing+cells&doi=10.1021%2Facs.bioconjchem.7b00211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of BODIPY-Peptide Conjugates for Fluorescence Labeling of EGFR Overexpressing Cells</span></div><div class="casAuthors">Zhao, Ning; Williams, Tyrslai M.; Zhou, Zehua; Fronczek, Frank R.; Sibrian-Vazquez, Martha; Jois, Seetharama D.; Vicente, M. Graca H.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1566-1579</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Regioselective functionalization of 2,3,5,6,8-pentachloro-BODIPY 1 produced unsym. BODIPY 5, bearing an isothiocyanate group suitable for conjugation, in only four steps.  The x-ray structure of 5 reveals a nearly planar BODIPY core with aryl dihedral angles in the range 47.4° - 62.9°.  Conjugation of 5 to two EGFR-targeting pegylated peptides, 3PEG-LARLLT (6) and 3PEG-GYHWYGYTPQNVI (7), under mild conditions (30 min at room temp.), afforded BODIPY conjugates 8 and 9 in 50-80% isolated yields.  These conjugates show red shifted absorption and emission spectra compared with 5, in the near-IR region, and were evaluated as potential fluorescence imaging agents for EGRF over-expressing cells.  SPR and docking studies suggested that conjugate 8 bearing the LARLLT sequence binds to EGFR more effectively than 9 bearing the GYHWYGYTPQNVI peptide, in part due to the lower soly. of 9, and its tendency for aggregation at concns. >10 μM.  Studies in human carcinoma HEp2 cells over-expressing EGFR demonstrated low dark and photo-cytotoxicities for BODIPY 5 and the two peptide conjugates and remarkably high cellular uptake for both conjugates 8 and 9, up to 90-fold compared with BODIPY 5 after 1 h.  Fluorescence imaging studies in HEp2 cells revealed subcellular localization of the BODIPY-peptide conjugates mainly in the Golgi app. and the cell lysosomes.  The low cytotoxicity of the new conjugates and their remarkably high uptake into EGFR over-expressing cells renders them promising imaging agents for cancers over-expressing EGFR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq4NQ6i-3q97Vg90H21EOLACvtfcHk0ljG179Rgxl91A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtFCgt70%253D&md5=eecb517375968874f20434e9d1dd8942</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.7b00211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.7b00211%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DN.%26aulast%3DWilliams%26aufirst%3DT.%2BM.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DFronczek%26aufirst%3DF.%2BR.%26aulast%3DSibrian-Vazquez%26aufirst%3DM.%26aulast%3DJois%26aufirst%3DS.%2BD.%26aulast%3DVicente%26aufirst%3DM.%2BG.%2BH.%26atitle%3DSynthesis%2520of%2520BODIPY-peptide%2520conjugates%2520for%2520fluorescence%2520labeling%2520of%2520EGFR%2520over-expressing%2520cells%26jtitle%3DBioconjugate%2520Chem.%26date%3D2017%26volume%3D28%26spage%3D1566%26epage%3D1579%26doi%3D10.1021%2Facs.bioconjchem.7b00211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siddiqui, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Railkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanford, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crooks, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckhaus, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haines, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choyke, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agarwal, P. K.</span></span> <span> </span><span class="NLM_article-title">Targeting epidermal Growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) expressing bladder cancer using combination photoimmunotherapy (PIT)</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">2084</span>, <span class="refDoi"> DOI: 10.1038/s41598-019-38575-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1038%2Fs41598-019-38575-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=30765854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A280%3ADC%252BB3cfjs1ertg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=2084&author=M.+R.+Siddiquiauthor=R.+Railkarauthor=T.+Sanfordauthor=D.+R.+Crooksauthor=M.+A.+Eckhausauthor=D.+Hainesauthor=P.+L.+Choykeauthor=H.+Kobayashiauthor=P.+K.+Agarwal&title=Targeting+epidermal+Growth+factor+receptor+%28EGFR%29+and+human+epidermal+growth+factor+receptor+2+%28HER2%29+expressing+bladder+cancer+using+combination+photoimmunotherapy+%28PIT%29&doi=10.1038%2Fs41598-019-38575-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT)</span></div><div class="casAuthors">Siddiqui Mohammad R; Railkar Reema; Sanford Thomas; Crooks Daniel R; Agarwal Piyush K; Siddiqui Mohammad R; Eckhaus Michael A; Haines Diana; Choyke Peter L; Kobayashi Hisataka</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2084</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Bladder cancer (BC) is heterogeneous and expresses various cell surface targets.  Photoimmunotherapy (PIT) involves monoclonal antibodies (MAbs) conjugated to a photoabsorber (PA), IR Dye 700Dx, and then activated by near infra-red light (NIR) to specifically target tumors.  We have demonstrated that tumors expressing EGFR can be targeted with PIT.  However, PIT may be less effective when a tumor lacks "overwhelming" expression of a single target such as EGFR.  We present a combinatorial PIT approach for targeting BC expressing EGFR and HER2, using PA- labeled panitumumab (pan) and trastuzumab (tra), respectively.  Human BC tissues and cell lines were analyzed for EGFR and HER2 expression.  Efficacy of PA-labeled MAbs singly and in combination was analyzed.  About 45% of BC tissues stain for both EGFR and HER2.  In vitro, the combination of pan IR700 and tra IR700 with NIR was more efficacious than either agent alone.  Tumor xenografts treated with combination PIT showed significant tumor growth retardation.  Combination PIT is a promising approach for treating BC with low/moderate expression of surface receptors.  In addition, given the molecular heterogeneity of bladder cancer, targeting more than one surface receptor may allow for more effective cell death across different bladder tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQFkXAZSfXPu1m8bhe6roZYfW6udTcc2eZunKlIHjTgO7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cfjs1ertg%253D%253D&md5=b122f0ff033918997853f55d72b9b2d0</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fs41598-019-38575-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-019-38575-x%26sid%3Dliteratum%253Aachs%26aulast%3DSiddiqui%26aufirst%3DM.%2BR.%26aulast%3DRailkar%26aufirst%3DR.%26aulast%3DSanford%26aufirst%3DT.%26aulast%3DCrooks%26aufirst%3DD.%2BR.%26aulast%3DEckhaus%26aufirst%3DM.%2BA.%26aulast%3DHaines%26aufirst%3DD.%26aulast%3DChoyke%26aufirst%3DP.%2BL.%26aulast%3DKobayashi%26aufirst%3DH.%26aulast%3DAgarwal%26aufirst%3DP.%2BK.%26atitle%3DTargeting%2520epidermal%2520Growth%2520factor%2520receptor%2520%2528EGFR%2529%2520and%2520human%2520epidermal%2520growth%2520factor%2520receptor%25202%2520%2528HER2%2529%2520expressing%2520bladder%2520cancer%2520using%2520combination%2520photoimmunotherapy%2520%2528PIT%2529%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26spage%3D2084%26doi%3D10.1038%2Fs41598-019-38575-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carlsson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wester, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De La Torre, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malmström, P.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gådmark, T.</span></span> <span> </span><span class="NLM_article-title">EGFR-expression in primary urinary bladder cancer and corresponding metastases and the relation to HER2-expression. On the possibility to target these receptors with radionuclides</span>. <i>Radiol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">58</span>, <span class="refDoi"> DOI: 10.2478/raon-2014-0015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.2478%2Fraon-2014-0015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=25810701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlvV2qtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2015&pages=50-58&author=J.+Carlssonauthor=K.+Westerauthor=M.+De+La+Torreauthor=P.-U.+Malmstr%C3%B6mauthor=T.+G%C3%A5dmark&title=EGFR-expression+in+primary+urinary+bladder+cancer+and+corresponding+metastases+and+the+relation+to+HER2-expression.+On+the+possibility+to+target+these+receptors+with+radionuclides&doi=10.2478%2Fraon-2014-0015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">EGFR-expression in primary urinary bladder cancer and corresponding metastases and the relation to HER2-expression. On the possibility to target these receptors with radionuclides</span></div><div class="casAuthors">Carlsson, Joergen; Wester, Kenneth; De La Torre, Manuel; Malmstroem, Per-Uno; Gardmark, Truls</div><div class="citationInfo"><span class="NLM_cas:title">Radiology and Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">50-58</span>CODEN:
                <span class="NLM_cas:coden">RONCEM</span>;
        ISSN:<span class="NLM_cas:issn">1318-2099</span>.
    
            (<span class="NLM_cas:orgname">Association of Radiology and Oncology</span>)
        </div><div class="casAbstract">Background. There is limited effect of tyrosine kinase inhibitors or "naked" antibodies binding EGFR or HER2 for therapy of metastasized urinary bladder cancer and these methods are therefore not routinely used.  Targeting radionuclides to the extracellular domain of the receptors is potentially a better possibility.  Methods. EGFR- and HER2-expression was analyzed for primary tumors and corresponding metastases from 72 patients using immunohistochem. and the internationally recommended HercepTest.  Intracellular mutations were not analyzed since only the receptors were considered as targets and intracellular abnormalities should have minor effect on radiation dose.  Results. EGFR was pos. in 71% of the primary tumors and 69% of corresponding metastases.  Local and distant metastases were EGFR-pos. in 75% and 66% of the cases, resp.  The expression frequency of HER2 in related lesions was slightly higher (data from previous study).  The EGFR-pos. tumors expressed EGFR in metastases in 86% of the cases.  The co-expression of EGFR and HER2 was 57% for tumors and 53% for metastases.  Only 3% and 10% of the lesions were neg. for both receptors in tumors and metastases, resp.  Thus, targeting these receptors with radionuclides might be applied for most patients.  Conclusions. At least one of the EGFR- or HER2-receptors was present in most cases and co-expressed in more than half the cases.  It is therefore interesting to deliver radionuclides for whole-body receptor-anal., dosimetry and therapy.  This can hopefully compensate for resistance to other therapies and more patients can hopefully be treated with curative instead of palliative intention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1jaAIjco_JrVg90H21EOLACvtfcHk0ljG179Rgxl91A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlvV2qtbw%253D&md5=ac2ca5c4af2f86183a771a4f21d4ad77</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2478%2Fraon-2014-0015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2478%252Fraon-2014-0015%26sid%3Dliteratum%253Aachs%26aulast%3DCarlsson%26aufirst%3DJ.%26aulast%3DWester%26aufirst%3DK.%26aulast%3DDe%2BLa%2BTorre%26aufirst%3DM.%26aulast%3DMalmstr%25C3%25B6m%26aufirst%3DP.-U.%26aulast%3DG%25C3%25A5dmark%26aufirst%3DT.%26atitle%3DEGFR-expression%2520in%2520primary%2520urinary%2520bladder%2520cancer%2520and%2520corresponding%2520metastases%2520and%2520the%2520relation%2520to%2520HER2-expression.%2520On%2520the%2520possibility%2520to%2520target%2520these%2520receptors%2520with%2520radionuclides%26jtitle%3DRadiol.%2520Oncol.%26date%3D2015%26volume%3D49%26spage%3D50%26epage%3D58%26doi%3D10.2478%2Fraon-2014-0015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zimmermann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zouhair, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azria, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozsahin, M.</span></span> <span> </span><span class="NLM_article-title">The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications</span>. <i>Radiat. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">11</span>, <span class="refDoi"> DOI: 10.1186/1748-717X-1-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1186%2F1748-717X-1-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=16722544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A280%3ADC%252BD28vlslKisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=11&author=M.+Zimmermannauthor=A.+Zouhairauthor=D.+Azriaauthor=M.+Ozsahin&title=The+epidermal+growth+factor+receptor+%28EGFR%29+in+head+and+neck+cancer%3A+its+role+and+treatment+implications&doi=10.1186%2F1748-717X-1-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications</span></div><div class="casAuthors">Zimmermann Michel; Zouhair Abderrahim; Azria David; Ozsahin Mahmut</div><div class="citationInfo"><span class="NLM_cas:title">Radiation oncology (London, England)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11</span>
        ISSN:<span class="NLM_cas:issn">1748-717X</span>.
    </div><div class="casAbstract">Epidermal growth factor receptor (EGFR) is a member of the ErbB family of receptors.  Its stimulation by endogenous ligands, EGF or transforming growth factor-alpha (TGF-alpha) results in activation of intracellular tyrosine kinase, therefore, cell cycle progression.  High levels of EGFR expression are correlated with poor prognosis and resistance to radiation therapy in a variety of cancers, mostly in squamous-cell carcinoma of the head and neck (SCCHN).  Blocking the EGFR by a monoclonal antibody results in inhibition of the stimulation of the receptor, therefore, in inhibition of cell proliferation, enhanced apoptosis, and reduced angiogenesis, invasiveness and metastases.  The EGFR is a prime target for new anticancer therapy in SCCHN, and other agents in development include small molecular tyrosine kinase inhibitors and antisense therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR6W6i8OdWq-ENoizSOkG_FfW6udTcc2eYWgha3WQmmWLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28vlslKisA%253D%253D&md5=41e635e6bd014f04738d5db82e6027c1</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1186%2F1748-717X-1-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1748-717X-1-11%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DM.%26aulast%3DZouhair%26aufirst%3DA.%26aulast%3DAzria%26aufirst%3DD.%26aulast%3DOzsahin%26aufirst%3DM.%26atitle%3DThe%2520epidermal%2520growth%2520factor%2520receptor%2520%2528EGFR%2529%2520in%2520head%2520and%2520neck%2520cancer%253A%2520its%2520role%2520and%2520treatment%2520implications%26jtitle%3DRadiat.%2520Oncol.%26date%3D2006%26volume%3D1%26spage%3D11%26doi%3D10.1186%2F1748-717X-1-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shigematsu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estess, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegelman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchetti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shay, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spitz, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wistuba, I. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minna, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gazdar, A. F.</span></span> <span> </span><span class="NLM_article-title">polymorphisms, mutations, and amplification of the EGFR Gene in non-small cell lung cancers</span>. <i>PLoS Med.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e125</span> <span class="refDoi"> DOI: 10.1371/journal.pmed.0040125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1371%2Fjournal.pmed.0040125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=17455987" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&author=M.+Nomuraauthor=H.+Shigematsuauthor=L.+Liauthor=M.+Suzukiauthor=T.+Takahashiauthor=P.+Estessauthor=M.+Siegelmanauthor=Z.+Fengauthor=H.+Katoauthor=A.+Marchettiauthor=J.+W.+Shayauthor=M.+R.+Spitzauthor=I.+I.+Wistubaauthor=J.+D.+Minnaauthor=A.+F.+Gazdar&title=polymorphisms%2C+mutations%2C+and+amplification+of+the+EGFR+Gene+in+non-small+cell+lung+cancers&doi=10.1371%2Fjournal.pmed.0040125"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pmed.0040125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pmed.0040125%26sid%3Dliteratum%253Aachs%26aulast%3DNomura%26aufirst%3DM.%26aulast%3DShigematsu%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DT.%26aulast%3DEstess%26aufirst%3DP.%26aulast%3DSiegelman%26aufirst%3DM.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DKato%26aufirst%3DH.%26aulast%3DMarchetti%26aufirst%3DA.%26aulast%3DShay%26aufirst%3DJ.%2BW.%26aulast%3DSpitz%26aufirst%3DM.%2BR.%26aulast%3DWistuba%26aufirst%3DI.%2BI.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DGazdar%26aufirst%3DA.%2BF.%26atitle%3Dpolymorphisms%252C%2520mutations%252C%2520and%2520amplification%2520of%2520the%2520EGFR%2520Gene%2520in%2520non-small%2520cell%2520lung%2520cancers%26jtitle%3DPLoS%2520Med.%26date%3D2007%26volume%3D4%26doi%3D10.1371%2Fjournal.pmed.0040125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mark, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motoi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerald, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Travis, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornmann, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veach, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarkson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bromberg, J. F.</span></span> <span> </span><span class="NLM_article-title">Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas</span>. <i>J. Clin. Invest</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">3846</span>– <span class="NLM_lpage">3856</span>, <span class="refDoi"> DOI: 10.1172/JCI31871</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1172%2FJCI31871" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=18060032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsValsL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2007&pages=3846-3856&author=S.+P.+Gaoauthor=K.+G.+Markauthor=K.+Leslieauthor=W.+Paoauthor=N.+Motoiauthor=W.+L.+Geraldauthor=W.+D.+Travisauthor=W.+Bornmannauthor=D.+Veachauthor=B.+Clarksonauthor=J.+F.+Bromberg&title=Mutations+in+the+EGFR+kinase+domain+mediate+STAT3+activation+via+IL-6+production+in+human+lung+adenocarcinomas&doi=10.1172%2FJCI31871"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas</span></div><div class="casAuthors">Gao, Sizhi Paul; Mark, Kavin G.; Leslie, Kenneth; Pao, William; Motoi, Noriko; Gerald, William L.; Travis, William D.; Bornmann, William; Veach, Darren; Clarkson, Bayard; Bromberg, Jacqueline F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3846-3856</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Persistently activated or tyrosine-phosphorylated STAT3 (pSTAT3) is found in 50% of lung adenocarcinomas.  PSTAT3 is found in primary adenocarcinomas and cell lines harboring somatic-activating mutations in the tyrosine kinase domain of EGFR.  Treatment of cell lines with either an EGFR inhibitor or an src kinase inhibitor had no effect on pSTAT3 levels, whereas a pan-JAK inhibitor (P6) blocked activation of STAT3 and inhibited tumorigenesis.  Cell lines expressing these persistently activated mutant EGFRs also produced high IL-6 levels, and blockade of the IL-6/gp130/JAK pathway led to a decrease in pSTAT3 levels.  In addn., redn. of IL-6 levels by RNA interference led to a decrease in tumorigenesis.  Introduction of persistently activated EGFR into immortalized breast epithelial cells led to tumorigenesis, IL-6 expression, and STAT3 activation, all of which could be inhibited with P6 or gp130 blockade.  Furthermore, inhibition of EGFR activity in multiple cell lines partially blocked transcription of IL-6 and concurrently decreased prodn. and release of IL-6.  Finally, immunohistochem. anal. revealed a pos. correlation between pSTAT3 and IL-6 positivity in primary lung adenocarcinomas.  Therefore, mutant EGFR could activate the gp130/JAK/STAT3 pathway by IL-6 upregulation in primary human lung adenocarcinomas, making this pathway a potential target for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-fCYAz8G9S7Vg90H21EOLACvtfcHk0ljBNnCe1_f-Qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsValsL%252FO&md5=4043bc2cf3aecbfbfb3fbd8bf99d6aef</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1172%2FJCI31871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI31871%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DS.%2BP.%26aulast%3DMark%26aufirst%3DK.%2BG.%26aulast%3DLeslie%26aufirst%3DK.%26aulast%3DPao%26aufirst%3DW.%26aulast%3DMotoi%26aufirst%3DN.%26aulast%3DGerald%26aufirst%3DW.%2BL.%26aulast%3DTravis%26aufirst%3DW.%2BD.%26aulast%3DBornmann%26aufirst%3DW.%26aulast%3DVeach%26aufirst%3DD.%26aulast%3DClarkson%26aufirst%3DB.%26aulast%3DBromberg%26aufirst%3DJ.%2BF.%26atitle%3DMutations%2520in%2520the%2520EGFR%2520kinase%2520domain%2520mediate%2520STAT3%2520activation%2520via%2520IL-6%2520production%2520in%2520human%2520lung%2520adenocarcinomas%26jtitle%3DJ.%2520Clin.%2520Invest%26date%3D2007%26volume%3D117%26spage%3D3846%26epage%3D3856%26doi%3D10.1172%2FJCI31871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellnier, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greco, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaughan, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weishaupt, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, T. J.</span></span> <span> </span><span class="NLM_article-title">An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">4000</span>– <span class="NLM_lpage">4007</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=9307285" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADyaK2sXmtFehsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=4000-4007&author=B.+W.+Hendersonauthor=D.+A.+Bellnierauthor=W.+R.+Grecoauthor=A.+Sharmaauthor=R.+K.+Pandeyauthor=L.+A.+Vaughanauthor=K.+R.+Weishauptauthor=T.+J.+Dougherty&title=An+in+vivo+quantitative+structure-activity+relationship+for+a+congeneric+series+of+pyropheophorbide+derivatives+as+photosensitizers+for+photodynamic+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy</span></div><div class="casAuthors">Henderson, Barbara W.; Bellnier, David A.; Greco, William R.; Sharma, Amarnath; Pandey, Ravindra K.; Vaughan, Lurine A.; Weishaupt, Kenneth R.; Dougherty, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4000-4007</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">An in vivo quant. structure-activity relationship (QSAR) study was carried out on a congeneric series of pyropheophorbide photosensitizers to identify structural features crit. for their antitumor activity in photodynamic therapy (PDT).  The structural elements evaluated in this study include the length and shape (alkyl, alkenyl, cyclic, and secondary analogs) of the ether side chain.  C3H mice, harboring the radiation-induced fibrosarcoma tumor model, were used to study three biol. response endpoints: tumor growth delay, tumor cell lethality, and vascular perfusion.  All three endpoints revealed highly similar QSAR patterns that constituted a function of the alkyl ether chain length and drug lipophilicity, which is defined as the log of the octanol:water partition coeff. (log P).  When the illumination of tumor, tumor cells, or cutaneous vasculature occurred 24 h after sensitizer administration, activities were minimal with analogs of log P ≤ 5, increased dramatically between log P of 5-6, and peaked between log P of 5.6-6.6.  Activities declined gradually with higher log P.  The lack of activity of the least-lipophilic analogs was explained in large part by their poor biodistribution characteristics, which yielded negligible tumor and plasma drug levels at the time of treatment with light.  The progressively lower potencies of the most lipophilic analogs cannot be explained through the overall tumor and plasma pharmacokinetics of photosensitizer because tumor and plasma concns. progressively increased with lipophilicity.  When compensated for differences in tumor photosensitizer concn., the 1-hexyl deriv. (optimal lipophilicity) was 5-fold more potent than the 1-dodecyl deriv. (more lipophilic) and 3-fold more potent than the 1-pentyl analog (less lipophilic), indicating that, in addn. to the overall tumor pharmacokinetics, pharmacodynamic factors may influence PDT activity.  Drug lipophilicity was highly predictive for photodynamic activity.  QSAR modeling revealed that direct antitumor effects and vascular PDT effects may be governed by common mechanisms, and that the mere assocn. of high levels of photosensitizer in the tumor tissue is not sufficient for optimal PDT efficiency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8jr9wz9QNVbVg90H21EOLACvtfcHk0ljBNnCe1_f-Qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmtFehsLg%253D&md5=a1b891da5bee6c012242bc129ea28636</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHenderson%26aufirst%3DB.%2BW.%26aulast%3DBellnier%26aufirst%3DD.%2BA.%26aulast%3DGreco%26aufirst%3DW.%2BR.%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26aulast%3DVaughan%26aufirst%3DL.%2BA.%26aulast%3DWeishaupt%26aufirst%3DK.%2BR.%26aulast%3DDougherty%26aufirst%3DT.%2BJ.%26atitle%3DAn%2520in%2520vivo%2520quantitative%2520structure-activity%2520relationship%2520for%2520a%2520congeneric%2520series%2520of%2520pyropheophorbide%2520derivatives%2520as%2520photosensitizers%2520for%2520photodynamic%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26spage%3D4000%26epage%3D4007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goswami, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gryshuk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Missert, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oseroff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, T. J.</span></span> <span> </span><span class="NLM_article-title">Nature: A rich source for developing multifunctional agents. Tumor-imaging and photodynamic therapy</span>. <i>Lasers Surg. Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">445</span>– <span class="NLM_lpage">467</span>, <span class="refDoi"> DOI: 10.1002/lsm.20352</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1002%2Flsm.20352" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=16788930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A280%3ADC%252BD28zosFCnuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2006&pages=445-467&author=R.+K.+Pandeyauthor=L.+N.+Goswamiauthor=Y.+Chenauthor=A.+Gryshukauthor=J.+R.+Missertauthor=A.+Oseroffauthor=T.+J.+Dougherty&title=Nature%3A+A+rich+source+for+developing+multifunctional+agents.+Tumor-imaging+and+photodynamic+therapy&doi=10.1002%2Flsm.20352"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Nature: a rich source for developing multifunctional agents. Tumor-imaging and photodynamic therapy</span></div><div class="casAuthors">Pandey Ravindra K; Goswami Lalit N; Chen Yihui; Gryshuk Amy; Missert Joseph R; Oseroff Allan; Dougherty Thomas J</div><div class="citationInfo"><span class="NLM_cas:title">Lasers in surgery and medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">445-67</span>
        ISSN:<span class="NLM_cas:issn">0196-8092</span>.
    </div><div class="casAbstract">The purpose of this review is to call attention in the use of chlorophyll-a and bacteriochlorophyll-a to develop more than 600 photosensitizers (lambda (max) 660 nm-800 nm) during the last 15 years (1990-2005) at the Photodynamic Therapy Center, Roswell Park Cancer Institute, Buffalo.  This article mainly includes the chemistry, preclinical results, and brief clinical data of some of the most effective photosensitizers.  The utility of the tumor-avid photosensitizers in developing multimodality agents (imaging and therapy) is also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQZrU4dU_XG5DdblLE_E9PWfW6udTcc2ebWusAlFptIILntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28zosFCnuw%253D%253D&md5=4d6da90479d36b451478771987e0ab09</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1002%2Flsm.20352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Flsm.20352%26sid%3Dliteratum%253Aachs%26aulast%3DPandey%26aufirst%3DR.%2BK.%26aulast%3DGoswami%26aufirst%3DL.%2BN.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DGryshuk%26aufirst%3DA.%26aulast%3DMissert%26aufirst%3DJ.%2BR.%26aulast%3DOseroff%26aufirst%3DA.%26aulast%3DDougherty%26aufirst%3DT.%2BJ.%26atitle%3DNature%253A%2520A%2520rich%2520source%2520for%2520developing%2520multifunctional%2520agents.%2520Tumor-imaging%2520and%2520photodynamic%2520therapy%26jtitle%3DLasers%2520Surg.%2520Med.%26date%3D2006%26volume%3D38%26spage%3D445%26epage%3D467%26doi%3D10.1002%2Flsm.20352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baron, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scull, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berlin, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormick, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colussi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenney, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olenick, N. L.</span></span> <span> </span><span class="NLM_article-title">Photodynamic therapy with the phthalocyanine photosensitizer PC-4: The case experience with preclinical mechanistic and early clinical-translational studies</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>224</i></span>,  <span class="NLM_fpage">290</span>– <span class="NLM_lpage">299</span>, <span class="refDoi"> DOI: 10.1016/j.taap.2007.01.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1016%2Fj.taap.2007.01.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=17397888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtF2mtL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=224&publication_year=2007&pages=290-299&author=J.+D.+Millerauthor=E.+D.+Baronauthor=H.+Scullauthor=A.+Hsiaauthor=J.+C.+Berlinauthor=T.+McCormickauthor=V.+Colussiauthor=M.+F.+Kenneyauthor=K.+D.+Cooperauthor=N.+L.+Olenick&title=Photodynamic+therapy+with+the+phthalocyanine+photosensitizer+PC-4%3A+The+case+experience+with+preclinical+mechanistic+and+early+clinical-translational+studies&doi=10.1016%2Fj.taap.2007.01.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: The case experience with preclinical mechanistic and early clinical-translational studies</span></div><div class="casAuthors">Miller, Janine D.; Baron, Elma D.; Scull, Heather; Hsia, Andrew; Berlin, Jeffrey C.; McCormick, Thomas; Colussi, Valdir; Kenney, Malcolm E.; Cooper, Kevin D.; Oleinick, Nancy L.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">224</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">290-299</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Photodynamic therapy (PDT) is emerging as a promising non-invasive treatment for cancers.  PDT involves either local or systemic administration of a photosensitizing drug, which preferentially localizes within the tumor, followed by illumination of the involved organ with light, usually from a laser source.  Here, we provide a selective overview of our experience with PDT at Case Western Reserve University, specifically with the silicon phthalocyanine photosensitizer Pc 4.  We first review our in vitro studies evaluating the mechanism of cell killing by Pc 4-PDT.  Then we briefly describe our clin. experience in a Phase I trial of Pc 4-PDT and our preliminary translational studies evaluating the mechanisms behind tumor responses.  Preclin. work identified (a) cardiolipin and the anti-apoptotic proteins Bcl-2 and Bcl-xL as targets of Pc 4-PDT, (b) the intrinsic pathway of apoptosis, with the key participation of caspase-3, as a central response of many human cancer cells to Pc 4-PDT, (c) signaling pathways that could modify apoptosis, and (d) a formulation by which Pc 4 could be applied topically to human skin and penetrate at least through the basal layer of the epidermis.  Clin.-translational studies enabled us to develop an immunohistochem. assay for caspase-3 activation, using biopsies from patients treated with topical Pc 4 in a Phase I PDT trial for cutaneous T-cell lymphoma.  Results suggest that this assay may be used as an early biomarker of clin. response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppT2jU6mhi77Vg90H21EOLACvtfcHk0ljZdHYtFY1kjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtF2mtL7E&md5=3a2583b4343e01948f940ce5d3bc8c05</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2007.01.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2007.01.025%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DJ.%2BD.%26aulast%3DBaron%26aufirst%3DE.%2BD.%26aulast%3DScull%26aufirst%3DH.%26aulast%3DHsia%26aufirst%3DA.%26aulast%3DBerlin%26aufirst%3DJ.%2BC.%26aulast%3DMcCormick%26aufirst%3DT.%26aulast%3DColussi%26aufirst%3DV.%26aulast%3DKenney%26aufirst%3DM.%2BF.%26aulast%3DCooper%26aufirst%3DK.%2BD.%26aulast%3DOlenick%26aufirst%3DN.%2BL.%26atitle%3DPhotodynamic%2520therapy%2520with%2520the%2520phthalocyanine%2520photosensitizer%2520PC-4%253A%2520The%2520case%2520experience%2520with%2520preclinical%2520mechanistic%2520and%2520early%2520clinical-translational%2520studies%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2007%26volume%3D224%26spage%3D290%26epage%3D299%26doi%3D10.1016%2Fj.taap.2007.01.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rigual, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shafirstein, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellnier, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sunar, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracy, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohrbach, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilding, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merzianu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, B. W.</span></span> <span> </span><span class="NLM_article-title">Photodynamic therapy with 3-(1′-hexyloxyethyl) pyropheophorbide-a for cancer of the oral cavity</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">6605</span>– <span class="NLM_lpage">6613</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-13-1735</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1158%2F1078-0432.CCR-13-1735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=24088736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVOitbzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=6605-6613&author=N.+Rigualauthor=G.+Shafirsteinauthor=M.+T.+Cooperauthor=H.+Baumannauthor=D.+A.+Bellnierauthor=U.+Sunarauthor=E.+C.+Tracyauthor=D.+J.+Rohrbachauthor=G.+Wildingauthor=W.+Tanauthor=M.+Sullivanauthor=M.+Merzianuauthor=B.+W.+Henderson&title=Photodynamic+therapy+with+3-%281%E2%80%B2-hexyloxyethyl%29+pyropheophorbide-a+for+cancer+of+the+oral+cavity&doi=10.1158%2F1078-0432.CCR-13-1735"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Photodynamic Therapy with 3-(1'-Hexyloxyethyl) Pyropheophorbide a for Cancer of the Oral Cavity</span></div><div class="casAuthors">Rigual, Nestor; Shafirstein, Gal; Cooper, Michele T.; Baumann, Heinz; Bellnier, David A.; Sunar, Ulas; Tracy, Erin C.; Rohrbach, Daniel J.; Wilding, Gregory; Tan, Wei; Sullivan, Maureen; Merzianu, Mihai; Henderson, Barbara W.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6605-6613</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: The primary objective was to evaluate safety of 3-(1'-hexyloxyethyl)pyropheophorbide-a (HPPH) photodynamic therapy (HPPH-PDT) for dysplasia and early squamous cell carcinoma of the head and neck (HNSCC).  Secondary objectives were the assessment of treatment response and reporters for an effective PDT reaction.  Exptl. Design: Patients with histol. proven oral dysplasia, carcinoma in situ, or early-stage HNSCC were enrolled in two sequentially conducted dose escalation studies with an expanded cohort at the highest dose level.  These studies used an HPPH dose of 4 mg/m2 and light doses from 50 to 140 J/cm2.  Pathol. tumor responses were assessed at 3 mo.  Clin. follow up range was 5 to 40 mo.  PDT induced crosslinking of STAT3 were assessed as potential indicators of PDT effective reaction.  Results: Forty patients received HPPH-PDT.  Common adverse events were pain and treatment site edema.  Biopsy proven complete response rates were 46% for dysplasia and carcinoma in situ and 82% for squamous cell carcinomas (SCC) lesions at 140 J/cm2.  The responses in the carcinoma in situ/dysplasia cohort are not durable.  The PDT-induced STAT3 cross-links is significantly higher (P = 0.0033) in SCC than in carcinoma in situ/dysplasia for all light doses.  Conclusion: HPPH-PDT is safe for the treatment of carcinoma in situ/dysplasia and early-stage cancer of the oral cavity.  Early-stage oral HNSCC seems to respond better to HPPH-PDT in comparison with premalignant lesions.  The degree of STAT3 crosslinking is a significant reporter to evaluate HPPH-PDT-mediated photoreaction.  Clin Cancer Res; 19(23); 6605-13. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIQWpi_NIP-LVg90H21EOLACvtfcHk0ljZdHYtFY1kjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVOitbzL&md5=964872d2b2a2b4c8c86e6496d1aafc3a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-13-1735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-13-1735%26sid%3Dliteratum%253Aachs%26aulast%3DRigual%26aufirst%3DN.%26aulast%3DShafirstein%26aufirst%3DG.%26aulast%3DCooper%26aufirst%3DM.%2BT.%26aulast%3DBaumann%26aufirst%3DH.%26aulast%3DBellnier%26aufirst%3DD.%2BA.%26aulast%3DSunar%26aufirst%3DU.%26aulast%3DTracy%26aufirst%3DE.%2BC.%26aulast%3DRohrbach%26aufirst%3DD.%2BJ.%26aulast%3DWilding%26aufirst%3DG.%26aulast%3DTan%26aufirst%3DW.%26aulast%3DSullivan%26aufirst%3DM.%26aulast%3DMerzianu%26aufirst%3DM.%26aulast%3DHenderson%26aufirst%3DB.%2BW.%26atitle%3DPhotodynamic%2520therapy%2520with%25203-%25281%25E2%2580%25B2-hexyloxyethyl%2529%2520pyropheophorbide-a%2520for%2520cancer%2520of%2520the%2520oral%2520cavity%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2013%26volume%3D19%26spage%3D6605%26epage%3D6613%26doi%3D10.1158%2F1078-0432.CCR-13-1735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nava, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allamaneni, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilding, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, B. W.</span></span> <span> </span><span class="NLM_article-title">Photodynamic therapy (PDT) using HPPH for the treatment of precancerous lesions associated with Barrett’s esophagus</span>. <i>Lasers Surg. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">705</span>– <span class="NLM_lpage">712</span>, <span class="refDoi"> DOI: 10.1002/lsm.21112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1002%2Flsm.21112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=22057498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A280%3ADC%252BC3MbmvFOitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2011&pages=705-712&author=H.+R.+Navaauthor=S.+S.+Allamaneniauthor=T.+J.+Doughertyauthor=M.+T.+Cooperauthor=W.+Tanauthor=G.+Wildingauthor=B.+W.+Henderson&title=Photodynamic+therapy+%28PDT%29+using+HPPH+for+the+treatment+of+precancerous+lesions+associated+with+Barrett%E2%80%99s+esophagus&doi=10.1002%2Flsm.21112"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Photodynamic therapy (PDT) using HPPH for the treatment of precancerous lesions associated with Barrett's esophagus</span></div><div class="casAuthors">Nava Hector R; Allamaneni Shyam S; Dougherty Thomas J; Cooper Michele T; Tan Wei; Wilding Gregory; Henderson Barbara W</div><div class="citationInfo"><span class="NLM_cas:title">Lasers in surgery and medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">705-12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND OBJECTIVES:  Photodynamic therapy (PDT) with porfimer sodium, FDA approved to treat premalignant lesions in Barrett's esophagus, causes photosensitivity for 6-8 weeks.  HPPH (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a) shows minimal photosensitization of short duration and promising efficacy in preclinical studies.  Here we explore toxicity and optimal drug and light dose with endoscopic HPPH-PDT.  We also want to know the efficacy of one time treatment with HPPH-PDT.  STUDY DESIGN/MATERIALS AND METHODS:  Two nonrandomized dose escalation studies were performed (18 patients each) with biopsy-proven high grade dysplasia or early intramucosal adenocarcinoma of esophagus.  HPPH doses ranged from 3 to 6 mg/m2 .  At 24 or 48 hours after HPPH administration the lesions received one endoscopic exposure to 150, 175, or 200 J/cm of 665 nm light.  RESULTS:  Most patients experienced mild to moderate chest pain requiring symptomatic treatment only.  Six patients experienced grade 3 and 4 adverse events (16.6%).  Three esophageal strictures were treated with dilatation.  No clear pattern of dose dependence of toxicities emerged.  In the drug dose ranging study (light dose of 150 J/cm at 48 hours), 3 and 4 mg/m2 of HPPH emerged as most effective.  In the light dose ranging study (3 or 4 mg/m2 HPPH, light at 24 hours), complete response rates (disappearance of high grade dysplasia and early carcinoma) of 72% were achieved at 1 year, with all patients treated with 3 mg/m2 HPPH plus 175 J/cm and 4 mg/m2 HPPH plus 150 J/cm showing complete responses at 1 year.  CONCLUSIONS:  HPPH-PDT for precancerous lesions in Barrett's esophagus appears to be safe and showing promising efficacy.  Further clinical studies are required to establish the use of HPPH-PDT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQPQNcby4MGQcKL0FlyGHDofW6udTcc2eYrMwsXQFbG1bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MbmvFOitQ%253D%253D&md5=e8bf682c3ae45fb06b83c83e18ee3811</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Flsm.21112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Flsm.21112%26sid%3Dliteratum%253Aachs%26aulast%3DNava%26aufirst%3DH.%2BR.%26aulast%3DAllamaneni%26aufirst%3DS.%2BS.%26aulast%3DDougherty%26aufirst%3DT.%2BJ.%26aulast%3DCooper%26aufirst%3DM.%2BT.%26aulast%3DTan%26aufirst%3DW.%26aulast%3DWilding%26aufirst%3DG.%26aulast%3DHenderson%26aufirst%3DB.%2BW.%26atitle%3DPhotodynamic%2520therapy%2520%2528PDT%2529%2520using%2520HPPH%2520for%2520the%2520treatment%2520of%2520precancerous%2520lesions%2520associated%2520with%2520Barrett%25E2%2580%2599s%2520esophagus%26jtitle%3DLasers%2520Surg.%2520Med.%26date%3D2011%26volume%3D43%26spage%3D705%26epage%3D712%26doi%3D10.1002%2Flsm.21112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Loewen, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellnier, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, T.</span></span> <span> </span><span class="NLM_article-title">Endobronchial photodynamic therapy for lung cancer</span>. <i>Lasers Surg. Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">364</span>– <span class="NLM_lpage">370</span>, <span class="refDoi"> DOI: 10.1002/lsm.20354</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1002%2Flsm.20354" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=16788932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A280%3ADC%252BD28zosFCmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2006&pages=364-370&author=G.+M.+Loewenauthor=R.+Pandeyauthor=D.+Bellnierauthor=B.+Hendersonauthor=T.+Dougherty&title=Endobronchial+photodynamic+therapy+for+lung+cancer&doi=10.1002%2Flsm.20354"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Endobronchial photodynamic therapy for lung cancer</span></div><div class="casAuthors">Loewen Gregory M; Pandey Ravindra; Bellnier David; Henderson Barbara; Dougherty Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Lasers in surgery and medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">364-70</span>
        ISSN:<span class="NLM_cas:issn">0196-8092</span>.
    </div><div class="casAbstract">BACKGROUND AND OBJECTIVE:  Endobronchial photodynamic therapy (PDT) is a minimally invasive technique for the palliation of major airway obstruction from lung cancer, and for the treatment of endobronchial microinvasive lung cancer.  STUDY DESIGN:  Results of reported clinical trials were compared, and the author's preliminary results with second generation photosensitizers were also reviewed.  RESULTS:  A review of the clinical experience with endobronchial PDT is provided.  Potential advantages of PDT include the duration of palliation achieved through the delayed cellular effects of PDT within tumor.  Side-effects from FDA-approved photosensitizer (Photofrin, Porfimer sodium, Axcan Scandipharm, Montreal, Quebec) include skin photosensitivity.  HPPH (2-[1-hexyloxyethyl]-2 devinyl pyropheophorbide) is an example of a second-generation photosensitize that shows promise in the treatment of lung cancer, and appears to be free from significant skin photosensitivity.  CONCLUSION:  PDT is an effective tool for the palliation of endobronchial lung cancers which obstruct the central airways and is also effective for the treatment of central microinvasive carcinoma and carcinoma in situ of the central airways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQZrU4dU_XG5EEgZCMqtRBifW6udTcc2eYrMwsXQFbG1bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28zosFCmsw%253D%253D&md5=7bce2750bef84c5f894f15de97950edd</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Flsm.20354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Flsm.20354%26sid%3Dliteratum%253Aachs%26aulast%3DLoewen%26aufirst%3DG.%2BM.%26aulast%3DPandey%26aufirst%3DR.%26aulast%3DBellnier%26aufirst%3DD.%26aulast%3DHenderson%26aufirst%3DB.%26aulast%3DDougherty%26aufirst%3DT.%26atitle%3DEndobronchial%2520photodynamic%2520therapy%2520for%2520lung%2520cancer%26jtitle%3DLasers%2520Surg.%2520Med.%26date%3D2006%26volume%3D38%26spage%3D364%26epage%3D370%26doi%3D10.1002%2Flsm.20354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gryshuk, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajjad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abouzeid, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charamisinau, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabi, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oseroff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Multimodality agents for tumor imaging (PET,Fluorescence) and photodynamic therapy. A possible “See and Treat” approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">6286</span>– <span class="NLM_lpage">6295</span>, <span class="refDoi"> DOI: 10.1021/jm050427m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050427m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpslWrsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6286-6295&author=S.+K.+Pandeyauthor=A.+L.+Gryshukauthor=M.+Sajjadauthor=X.+Zhengauthor=Y.+Chenauthor=M.+M.+Abouzeidauthor=J.+Morganauthor=I.+Charamisinauauthor=H.+A.+Nabiauthor=A.+Oseroffauthor=R.+K.+Pandey&title=Multimodality+agents+for+tumor+imaging+%28PET%2CFluorescence%29+and+photodynamic+therapy.+A+possible+%E2%80%9CSee+and+Treat%E2%80%9D+approach&doi=10.1021%2Fjm050427m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Multimodality Agents for Tumor Imaging (PET, Fluorescence) and Photodynamic Therapy. A Possible "See and Treat" Approach</span></div><div class="casAuthors">Pandey, Suresh K.; Gryshuk, Amy L.; Sajjad, Munawwar; Zheng, Xiang; Chen, Yihui; Abouzeid, Mohei M.; Morgan, Janet; Charamisinau, Ivan; Nabi, Hani A.; Oseroff, Allan; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6286-6295</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Me 3-(1'-m-iodobenzyloxyethyl)-3-devinylpyropheophorbide-a (2), obtained in a sequence of reactions from pyropheophorbide-a (a chlorophyll-a deriv.), was found to be a promising imaging agent and a photosensitizer for photodynamic therapy (PDT).  The electrophillic arom. iodination of the corresponding trimethylstannyl intermediate with Na124I in the presence of an Iodogen bead afforded 124I-labeled photosensitizer 4 with >95% radioactive specificity.  In addn. to drug-uptake, the light fluence and fluence rate that were used for the light treatment had a significant impact in long-term tumor cure.  The iodo photosensitizer 2 (nonlabeled analog of 4) produced 100% tumor cure (5/5 mice were tumor free on day 60) at a dose of 1.5 μmol/kg and a light dose of 128 J/cm2, 14 mW/cm2 for 2.5 h (λmax 665 nm) at 24 h postinjection.  The photosensitizer also showed promising tumor fluorescence and PET imaging ability.  Our present work demonstrates the utility of the first 124I-labeled photosensitizer as a "multimodality agent", which could further be improved by using more tumor-avid and/or target-specific photosensitizers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_kQddhnZ04LVg90H21EOLACvtfcHk0ljewNNU4faCSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpslWrsb0%253D&md5=65ad82b5d6a51f28ac4d0bf998f90e2e</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm050427m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050427m%26sid%3Dliteratum%253Aachs%26aulast%3DPandey%26aufirst%3DS.%2BK.%26aulast%3DGryshuk%26aufirst%3DA.%2BL.%26aulast%3DSajjad%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DAbouzeid%26aufirst%3DM.%2BM.%26aulast%3DMorgan%26aufirst%3DJ.%26aulast%3DCharamisinau%26aufirst%3DI.%26aulast%3DNabi%26aufirst%3DH.%2BA.%26aulast%3DOseroff%26aufirst%3DA.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DMultimodality%2520agents%2520for%2520tumor%2520imaging%2520%2528PET%252CFluorescence%2529%2520and%2520photodynamic%2520therapy.%2520A%2520possible%2520%25E2%2580%259CSee%2520and%2520Treat%25E2%2580%259D%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6286%26epage%3D6295%26doi%3D10.1021%2Fjm050427m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Srivatsan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pera, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marko, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durrani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Missert, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajjad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Highlights on the imaging (nuclear/fluorescence) and phototherapeutic potential of a tri-functional chlorophyll-a analog with no significant toxicity in mice and rats</span>. <i>J. Photochem. Photobiol., B</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_fpage">111998</span>, <span class="refDoi"> DOI: 10.1016/j.jphotobiol.2020.111998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1016%2Fj.jphotobiol.2020.111998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=32862090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhslWqtL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&pages=111998&author=A.+Srivatsanauthor=P.+Peraauthor=P.+Joshiauthor=A.+J.+Markoauthor=F.+Durraniauthor=J.+R.+Missertauthor=L.+Curtinauthor=S.+Sextonauthor=R.+Yaoauthor=M.+Sajjadauthor=R.+K.+Pandey&title=Highlights+on+the+imaging+%28nuclear%2Ffluorescence%29+and+phototherapeutic+potential+of+a+tri-functional+chlorophyll-a+analog+with+no+significant+toxicity+in+mice+and+rats&doi=10.1016%2Fj.jphotobiol.2020.111998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Highlights on the imaging (nuclear/fluorescence) and phototherapeutic potential of a tri-functional chlorophyll-a analog with no significant toxicity in mice and rats</span></div><div class="casAuthors">Srivatsan, Avinash; Pera, Paula; Joshi, Penny; Marko, Aimee J.; Durrani, Farukh; Missert, Joseph R.; Curtin, Leslie; Sexton, Sandra; Yao, Rutao; Sajjad, Munawwar; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Photochemistry and Photobiology, B: Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">211</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111998</span>CODEN:
                <span class="NLM_cas:coden">JPPBEG</span>;
        ISSN:<span class="NLM_cas:issn">1011-1344</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Herein we report the positron emission tomog. (PET) imaging potential of a 124I-labeled radiopharmaceutical (PET-ONCO).  In tumored mice, it shows high uptake in a variety of tumors: brain (GL261, U87), Colon (Colon26), lung (Lewis lung), breast (4 T1), bladder (UMUC3), pancreas (PANC-1) implanted in mice.  This agent also shows promise for imaging assocd. metastatic disease (breast to lung, to bone).  Interestingly, the iodinated compd. derived from chlorophyll-a, in combination with the corresponding 124I-analog, can serve as a dual imaging agent (PET/fluorescence, complimentary to each other), with an option of photodynamic therapy (PDT).  In contrast to Fluorine-18 (half-life 110 min), the Iodine-124 radionuclide has a phys. half-life of roughly 4 days.  Thus, unlike 18F-FDG, PET-ONCO can be transported longer distances.  While the time for optimal tumor-uptake was obsd. at 24 h, improved tumor contrasts of both primary and metastasis were obtained at 48 and 72 h post- injection (i. v.) of PET-ONCO.  In both mice and rats at a single dose study, PET-ONCO did not show any organ toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJYeUadessMLVg90H21EOLACvtfcHk0lhVXU6QByDKJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhslWqtL7L&md5=32fe3770b0151a63801d91bd9ba1b102</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.jphotobiol.2020.111998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jphotobiol.2020.111998%26sid%3Dliteratum%253Aachs%26aulast%3DSrivatsan%26aufirst%3DA.%26aulast%3DPera%26aufirst%3DP.%26aulast%3DJoshi%26aufirst%3DP.%26aulast%3DMarko%26aufirst%3DA.%2BJ.%26aulast%3DDurrani%26aufirst%3DF.%26aulast%3DMissert%26aufirst%3DJ.%2BR.%26aulast%3DCurtin%26aufirst%3DL.%26aulast%3DSexton%26aufirst%3DS.%26aulast%3DYao%26aufirst%3DR.%26aulast%3DSajjad%26aufirst%3DM.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DHighlights%2520on%2520the%2520imaging%2520%2528nuclear%252Ffluorescence%2529%2520and%2520phototherapeutic%2520potential%2520of%2520a%2520tri-functional%2520chlorophyll-a%2520analog%2520with%2520no%2520significant%2520toxicity%2520in%2520mice%2520and%2520rats%26jtitle%3DJ.%2520Photochem.%2520Photobiol.%252C%2520B%26date%3D2020%26spage%3D111998%26doi%3D10.1016%2Fj.jphotobiol.2020.111998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheruku, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cacaccio, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durrani, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabaczynski, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Khouly, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuzumi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Missert, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajjad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandra, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guru, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Epidermal growth factor receptor-targeted multifunctional photosensitizers for bladder cancer imaging and photodynamic therapy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">2598</span>– <span class="NLM_lpage">2617</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01927</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01927" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtFGjsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=2598-2617&author=R.+R.+Cherukuauthor=J.+Cacaccioauthor=F.+A.+Durraniauthor=W.+A.+Tabaczynskiauthor=R.+Watsonauthor=A.+Markoauthor=R.+Kumarauthor=M.+E.+El-Khoulyauthor=S.+Fukuzumiauthor=J.+R.+Missertauthor=R.+Yaoauthor=M.+Sajjadauthor=D.+Chandraauthor=K.+Guruauthor=R.+K.+Pandey&title=Epidermal+growth+factor+receptor-targeted+multifunctional+photosensitizers+for+bladder+cancer+imaging+and+photodynamic+therapy&doi=10.1021%2Facs.jmedchem.8b01927"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Epidermal Growth Factor Receptor-Targeted Multifunctional Photosensitizers for Bladder Cancer Imaging and Photodynamic Therapy</span></div><div class="casAuthors">Cheruku, Ravindra R.; Cacaccio, Joseph; Durrani, Farukh A.; Tabaczynski, Walter A.; Watson, Ramona; Marko, Aimee; Kumar, Rahul; El-Khouly, Mohamed E.; Fukuzumi, Shunichi; Missert, Joseph R.; Yao, Rutao; Sajjad, Munawwar; Chandra, Dhyan; Guru, Khurshid; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2598-2617</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The in vitro and in vivo anticancer activity of iodinated photosensitizers (PSs) with and without an erlotinib moiety was investigated in UMUC3 [epidermal growth factor (EGFR)-pos.] and T24 (EGFR-low) cell lines and tumored mice.  Both the erlotinib-conjugated PSs 3 and 5 showed EGFR target specificity, but the position-3 erlotinib-PS conjugate 3 demonstrated lower photodynamic therapy efficacy than the corresponding non-erlotinib analog 1, whereas the conjugate 5 contg. an erlotinib moiety at position-17 of the PS showed higher tumor uptake and long-term tumor cure (severe combined immunodeficient mice bearing UMUC3 tumors).  PS-erlotinib conjugates in the absence of light were ineffective in vitro and in vivo, but robust apoptotic and necrotic cell death was obsd. in bladder cancer cells after exposing them to a laser light at 665 nm.  In contrast to 18F-fluorodeoxyglucose, a positron emission tomog. agent, the position-17 erlotinib conjugate (124I-analog 6) showed enhanced UMUC3 tumor contrast even at a low imaging dose of 15 μCi/mouse.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOrPTZ88ZGOrVg90H21EOLACvtfcHk0lhVXU6QByDKJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtFGjsrg%253D&md5=2b6d6c1387d3d847f9a0be8b3f8ee1b1</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01927%26sid%3Dliteratum%253Aachs%26aulast%3DCheruku%26aufirst%3DR.%2BR.%26aulast%3DCacaccio%26aufirst%3DJ.%26aulast%3DDurrani%26aufirst%3DF.%2BA.%26aulast%3DTabaczynski%26aufirst%3DW.%2BA.%26aulast%3DWatson%26aufirst%3DR.%26aulast%3DMarko%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DEl-Khouly%26aufirst%3DM.%2BE.%26aulast%3DFukuzumi%26aufirst%3DS.%26aulast%3DMissert%26aufirst%3DJ.%2BR.%26aulast%3DYao%26aufirst%3DR.%26aulast%3DSajjad%26aufirst%3DM.%26aulast%3DChandra%26aufirst%3DD.%26aulast%3DGuru%26aufirst%3DK.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DEpidermal%2520growth%2520factor%2520receptor-targeted%2520multifunctional%2520photosensitizers%2520for%2520bladder%2520cancer%2520imaging%2520and%2520photodynamic%2520therapy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D2598%26epage%3D2617%26doi%3D10.1021%2Facs.jmedchem.8b01927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pera, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabaczynski, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siters, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kryman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheruku, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durrani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Missert, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohulchanskyy, T. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracy, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Highly effective dual-function near-infrared (NIR) photosensitizer for fluorescence imaging and photodynamic therapy (PDT) of cancer</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">9774</span>– <span class="NLM_lpage">9787</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00890</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00890" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1ylu7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9774-9787&author=N.+Patelauthor=P.+Peraauthor=P.+Joshiauthor=M.+Dukhauthor=W.+A.+Tabaczynskiauthor=K.+E.+Sitersauthor=M.+Krymanauthor=R.+R.+Cherukuauthor=F.+Durraniauthor=J.+R.+Missertauthor=R.+Watsonauthor=T.+Y.+Ohulchanskyyauthor=E.+C.+Tracyauthor=H.+Baumannauthor=R.+K.+Pandey&title=Highly+effective+dual-function+near-infrared+%28NIR%29+photosensitizer+for+fluorescence+imaging+and+photodynamic+therapy+%28PDT%29+of+cancer&doi=10.1021%2Facs.jmedchem.6b00890"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Effective Dual-Function Near-Infrared (NIR) Photosensitizer for Fluorescence Imaging and Photodynamic Therapy (PDT) of Cancer</span></div><div class="casAuthors">Patel, Nayan; Pera, Paula; Joshi, Penny; Dukh, Mykhaylo; Tabaczynski, Walter A.; Siters, Kevin E.; Kryman, Mark; Cheruku, Ravindra R.; Durrani, Farukh; Missert, Joseph R.; Watson, Ramona; Ohulchanskyy, Tymish Y.; Tracy, Erin C.; Baumann, Heinz; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9774-9787</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report herein the synthesis and biol. efficacy of near-IR (NIR), bacteriochlorin analogs: 3-(1'-butyloxy)ethyl-3-deacetyl-bacteriopurpurin-18-N-butylimide Me ester (3) and the corresponding carboxylic acid 10.  In in vitro assays, compared to its Me ester analog 3, the corresponding carboxylic acid deriv. 10 showed higher photosensitizing efficacy.  However, due to drastically different pharmacokinetics in vivo, the PS 3 (HPLC purity >99%) showed higher tumor uptake and long-term tumor cure than 10 (HPLC purity >96.5%) in BALB/c mice bearing Colon 26 tumors.  Isomerically pure R- and S- isomers of 3 (3a and 3b, purity by HPLC > 99%) under similar treatment parameters showed identical efficacy in vitro and in vivo.  In addn., photosensitizer (PS) 3 showed limited skin phototoxicity and provides an addnl. advantage over the clin. approved chem. complex hematoporphyrin deriv. as well as other porphyrin-based PDT agents, which makes 3 a promising dual-function agent for fluorescence-guided surgery with an option of phototherapy of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCI6Ows2GCs7Vg90H21EOLACvtfcHk0lhVXU6QByDKJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1ylu7nF&md5=8bf2b0ce63bffd5f2ecb1e2032bea519</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00890%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DPera%26aufirst%3DP.%26aulast%3DJoshi%26aufirst%3DP.%26aulast%3DDukh%26aufirst%3DM.%26aulast%3DTabaczynski%26aufirst%3DW.%2BA.%26aulast%3DSiters%26aufirst%3DK.%2BE.%26aulast%3DKryman%26aufirst%3DM.%26aulast%3DCheruku%26aufirst%3DR.%2BR.%26aulast%3DDurrani%26aufirst%3DF.%26aulast%3DMissert%26aufirst%3DJ.%2BR.%26aulast%3DWatson%26aufirst%3DR.%26aulast%3DOhulchanskyy%26aufirst%3DT.%2BY.%26aulast%3DTracy%26aufirst%3DE.%2BC.%26aulast%3DBaumann%26aufirst%3DH.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DHighly%2520effective%2520dual-function%2520near-infrared%2520%2528NIR%2529%2520photosensitizer%2520for%2520fluorescence%2520imaging%2520and%2520photodynamic%2520therapy%2520%2528PDT%2529%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D9774%26epage%3D9787%26doi%3D10.1021%2Facs.jmedchem.6b00890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ethirajan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">William, W. H.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohkubo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuzumi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Remarkable Regioselective Position-10 Bromination of Bacteriopyropheophorbide-a and Ring-B Reduced Pyropheophorbide-a</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1956</span>– <span class="NLM_lpage">1959</span>, <span class="refDoi"> DOI: 10.1021/ol200314v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol200314v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFKnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=1956-1959&author=M.+Ethirajanauthor=P.+Joshiauthor=W.+H.+Williamauthor=K.+Ohkuboauthor=S.+Fukuzumiauthor=R.+K.+Pandey&title=Remarkable+Regioselective+Position-10+Bromination+of+Bacteriopyropheophorbide-a+and+Ring-B+Reduced+Pyropheophorbide-a&doi=10.1021%2Fol200314v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Remarkable Regioselective Position-10 Bromination of Bacteriopyropheophorbide-a and Ring-B Reduced Pyropheophorbide-a</span></div><div class="casAuthors">Ethirajan, Manivannan; Joshi, Penny; William, White H.; Ohkubo, Kei; Fukuzumi, Shunichi; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1956-1959</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Both bacteriopyropheophorbide-a and ring-B reduced pyropheophorbide-a on reacting with NBS (N-bromosuccinimide) undergo electrophilic bromination to provide 10-bromo analogs, e.g., I.  The electronic nature of the substituents present at position-3 did not make any difference in the regioselective outcome of the brominated products.  These relatively stable brominated chlorins and bacteriochlorins provide an easy way of introducing a wide variety of functionalities, which could be extremely useful in developing improved agents for biomedical applications and supramol. chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyGVJ4wzHIUbVg90H21EOLACvtfcHk0liQWqu90LhpOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFKnsbg%253D&md5=920d9a2332653d5891b12a1d745dc340</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fol200314v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol200314v%26sid%3Dliteratum%253Aachs%26aulast%3DEthirajan%26aufirst%3DM.%26aulast%3DJoshi%26aufirst%3DP.%26aulast%3DWilliam%26aufirst%3DW.%2BH.%26aulast%3DOhkubo%26aufirst%3DK.%26aulast%3DFukuzumi%26aufirst%3DS.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DRemarkable%2520Regioselective%2520Position-10%2520Bromination%2520of%2520Bacteriopyropheophorbide-a%2520and%2520Ring-B%2520Reduced%2520Pyropheophorbide-a%26jtitle%3DOrg.%2520Lett.%26date%3D2011%26volume%3D13%26spage%3D1956%26epage%3D1959%26doi%3D10.1021%2Fol200314v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jinadasa, R. G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicente, M. G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, K. M.</span></span> <span> </span><span class="NLM_article-title">Syntheses and cellular investigations of 17<sup>3</sup>–, 15<sup>2</sup>–, and 13<sup>1</sup>–amino acid derivatives of chlorin e<sub>6</sub></span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">7464</span>– <span class="NLM_lpage">7476</span>, <span class="refDoi"> DOI: 10.1021/jm2005139</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2005139" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1OrsbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7464-7476&author=R.+G.+W.+Jinadasaauthor=X.+Huauthor=M.+G.+H.+Vicenteauthor=K.+M.+Smith&title=Syntheses+and+cellular+investigations+of+173%E2%80%93%2C+152%E2%80%93%2C+and+131%E2%80%93amino+acid+derivatives+of+chlorin+e6&doi=10.1021%2Fjm2005139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Syntheses and Cellular Investigations of 173-, 152-, and 131-Amino Acid Derivatives of Chlorin e6</span></div><div class="casAuthors">Jinadasa, R. G. Waruna; Hu, Xiaoke; Vicente, M. Graca H.; Smith, Kevin M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7464-7476</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of amino acid conjugates of chlorin e6, contg. lysine or aspartic acid residues in positions 173, 152, or 131 of the macrocycle were synthesized and investigated as photosensitizers for photodynamic therapy of tumors.  All three regioisomers were synthesized in good yields and in five steps or less from pheophytin a.  In vitro investigations using human carcinoma HEp2 cells show that the 152-lysyl regioisomers accumulate the most within cells, and the most phototoxic are the 131 regioisomers.  The main determinant of biol. efficacy appears to be the conjugation site, probably because of mol. conformation.  Mol. modeling investigations reveal that the 173-substituted chlorin e6 conjugates are L-shaped, the 152 and 131 regioisomers assume extended conformations, and the 131 derivs. are nearly linear.  It is hypothesized that the 131-aspartylchlorin e6 conjugate may be a more efficient photosensitizer for PDT than the com. currently used 152 deriv.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqno9Qefi9hr7Vg90H21EOLACvtfcHk0liQWqu90LhpOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1OrsbnF&md5=7e41a50d85c88fafbd6936c21ca23a5f</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm2005139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2005139%26sid%3Dliteratum%253Aachs%26aulast%3DJinadasa%26aufirst%3DR.%2BG.%2BW.%26aulast%3DHu%26aufirst%3DX.%26aulast%3DVicente%26aufirst%3DM.%2BG.%2BH.%26aulast%3DSmith%26aufirst%3DK.%2BM.%26atitle%3DSyntheses%2520and%2520cellular%2520investigations%2520of%2520173%25E2%2580%2593%252C%2520152%25E2%2580%2593%252C%2520and%2520131%25E2%2580%2593amino%2520acid%2520derivatives%2520of%2520chlorin%2520e6%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7464%26epage%3D7476%26doi%3D10.1021%2Fjm2005139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumlin, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Constantine, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoudia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellnier, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodgers, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougherty, T. J.</span></span> <span> </span><span class="NLM_article-title">Alkyl ether analogs of chlorophyll-α derivatives: Part 1. Synthesis, photophysical properties, and photodynamic efficacy</span>. <i>Photochem. Photobiol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">194</span>– <span class="NLM_lpage">204</span>, <span class="refDoi"> DOI: 10.1111/j.1751-1097.1996.tb02442.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1111%2Fj.1751-1097.1996.tb02442.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=8787014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADyaK28XjvF2js74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1996&pages=194-204&author=R.+K.+Pandeyauthor=A.+B.+Sumlinauthor=S.+Constantineauthor=M.+Aoudiaauthor=W.+R.+Potterauthor=D.+A.+Bellnierauthor=B.+W.+Hendersonauthor=M.+A.+Rodgersauthor=K.+M.+Smithauthor=T.+J.+Dougherty&title=Alkyl+ether+analogs+of+chlorophyll-%CE%B1+derivatives%3A+Part+1.+Synthesis%2C+photophysical+properties%2C+and+photodynamic+efficacy&doi=10.1111%2Fj.1751-1097.1996.tb02442.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Alkyl ether analogs of chlorophyll-a derivatives: part 1. synthesis, photophysical properties and photodynamic efficacy</span></div><div class="casAuthors">Pandey, Ravindra K.; Sumlin, Adam B.; Constantine, Scott; Aoudia, Mohamed; Potter, William R.; Bellnier, David A.; Henderson, Barbara W.; Rodgers, Michael A.; Smith, Kevin M.; Dougherty, Thomas J.</div><div class="citationInfo"><span class="NLM_cas:title">Photochemistry and Photobiology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">194-204</span>CODEN:
                <span class="NLM_cas:coden">PHCBAP</span>;
        ISSN:<span class="NLM_cas:issn">0031-8655</span>.
    
            (<span class="NLM_cas:orgname">American Society for Photobiology</span>)
        </div><div class="casAbstract">The synthesis, preliminary in vivo biol. activity, singlet oxygen and fluorescence yields of a series of alkyl ether derivs. of chlorophyll-a analogs are described.  For short-chain carbon ethers (1-7 carbon units), it was obsd. that the biol. activity increased by increasing the length of the carbon chain, being max. in compds. with n-hexyl and n-heptyl chains.  Related sensitizers prepd. by reacting 2-(1-bromoethyl)-2-devinylpyropheophorbide-a with (sec)alcs. were found to be less effective.  Under similar treatment conditions, photosensitizers contg. cis- and trans- 3-hexenyl side chains were ineffective.  Thus, both stereochem. and steric factors caused differences in sensitizing activity.  In general, pyropheophorbide-a analogs were found to be more active than related chlorin e6 derivs., in which the isocyclic ring (ring "E") was cleaved.  Related photosensitizers in the 9-deoxy- series were found to be as effective as the corresponding pyropheophorbide-a analogs.  The photosensitizers prepd. from pyropheophorbide-a Me ester and chlorin e6 tri-Me ester have long wavelength absorption at 660 nm (ε 45 000 to 50 000).  Redn. of the carbonyl group in the pyropheophorbide-a to methylene (ring E) resulted in a blue shift to 648 nm (ε 38 000).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDDQ0hvF51IbVg90H21EOLACvtfcHk0liQWqu90LhpOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjvF2js74%253D&md5=04400c1a6d5e6bde846e9a0dcb4c33b9</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1111%2Fj.1751-1097.1996.tb02442.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1751-1097.1996.tb02442.x%26sid%3Dliteratum%253Aachs%26aulast%3DPandey%26aufirst%3DR.%2BK.%26aulast%3DSumlin%26aufirst%3DA.%2BB.%26aulast%3DConstantine%26aufirst%3DS.%26aulast%3DAoudia%26aufirst%3DM.%26aulast%3DPotter%26aufirst%3DW.%2BR.%26aulast%3DBellnier%26aufirst%3DD.%2BA.%26aulast%3DHenderson%26aufirst%3DB.%2BW.%26aulast%3DRodgers%26aufirst%3DM.%2BA.%26aulast%3DSmith%26aufirst%3DK.%2BM.%26aulast%3DDougherty%26aufirst%3DT.%2BJ.%26atitle%3DAlkyl%2520ether%2520analogs%2520of%2520chlorophyll-%25CE%25B1%2520derivatives%253A%2520Part%25201.%2520Synthesis%252C%2520photophysical%2520properties%252C%2520and%2520photodynamic%2520efficacy%26jtitle%3DPhotochem.%2520Photobiol.%26date%3D1996%26volume%3D64%26spage%3D194%26epage%3D204%26doi%3D10.1111%2Fj.1751-1097.1996.tb02442.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tracy, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, H.</span></span> <span> </span><span class="NLM_article-title">Cell-type selective phototoxicity achieved with chlorophyll-a derived photosensitizers in a co-culture system of primary human tumor and normal lung cells</span>. <i>Photochem. Photobiol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">1405</span>– <span class="NLM_lpage">1418</span>, <span class="refDoi"> DOI: 10.1111/j.1751-1097.2011.00992.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1111%2Fj.1751-1097.2011.00992.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=21883244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFehs7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2011&pages=1405-1418&author=E.+C.+Tracyauthor=M.+J.+Bowmanauthor=R.+K.+Pandeyauthor=B.+W.+Hendersonauthor=H.+Baumann&title=Cell-type+selective+phototoxicity+achieved+with+chlorophyll-a+derived+photosensitizers+in+a+co-culture+system+of+primary+human+tumor+and+normal+lung+cells&doi=10.1111%2Fj.1751-1097.2011.00992.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-type selective phototoxicity achieved with chlorophyll-a derived photosensitizers in a co-culture system of primary human tumor and normal lung cells</span></div><div class="casAuthors">Tracy, Erin C.; Bowman, Mary J.; Pandey, Ravindra K.; Henderson, Barbara W.; Baumann, Heinz</div><div class="citationInfo"><span class="NLM_cas:title">Photochemistry and Photobiology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1405-1418</span>CODEN:
                <span class="NLM_cas:coden">PHCBAP</span>;
        ISSN:<span class="NLM_cas:issn">0031-8655</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The ATP-dependent transporter ABCG2 exports certain photosensitizers (PS) from cells, implying that the enhanced expression of ABCG2 by cancer cells may confer resistance to photodynamic therapy (PDT) mediated by those PS.  In 35 patient-derived primary cultures of lung epithelial and stromal cells, PS with different subcellular localization and affinity for ABCG2 displayed cell-type specific retention both independent and dependent on ABCG2.  In the majority of cases, the ABCG2 substrate 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) was lost from fibroblastic cells more rapidly than from their epithelial counterparts, even in the absence of detectable ABCG2 expression, facilitating selective eradication by PDT of epithelial over fibroblastic cells in tumor/stroma co-cultures.  Pairwise comparison of normal and transformed epithelial cells also identified tumor cells with elevated or reduced retention of HPPH, depending on ABCG2.  Enhanced ABCG2 expression led to the selective PDT survival of tumor cells in tumor/stroma co-cultures.  This survival pattern was reversible through HPPH derivs. that are not ABCG2 substrates or the ABCG2 inhibitor imatinib mesylate.  PS retention, not differences in subcellular distribution or cell signaling responses, was detg. cell type selective death by PDT.  These data suggest that up-front knowledge of tumor characteristics, specifically ABCG2 status, could be helpful in individualized PDT treatment design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuy85WXtaX0LVg90H21EOLACvtfcHk0liCQ72TkFtAEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFehs7nJ&md5=b53520002604260ce9204fe31d83a67c</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1111%2Fj.1751-1097.2011.00992.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1751-1097.2011.00992.x%26sid%3Dliteratum%253Aachs%26aulast%3DTracy%26aufirst%3DE.%2BC.%26aulast%3DBowman%26aufirst%3DM.%2BJ.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26aulast%3DHenderson%26aufirst%3DB.%2BW.%26aulast%3DBaumann%26aufirst%3DH.%26atitle%3DCell-type%2520selective%2520phototoxicity%2520achieved%2520with%2520chlorophyll-a%2520derived%2520photosensitizers%2520in%2520a%2520co-culture%2520system%2520of%2520primary%2520human%2520tumor%2520and%2520normal%2520lung%2520cells%26jtitle%3DPhotochem.%2520Photobiol.%26date%3D2011%26volume%3D87%26spage%3D1405%26epage%3D1418%26doi%3D10.1111%2Fj.1751-1097.2011.00992.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tracy, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, H.</span></span> <span> </span><span class="NLM_article-title">Interleukin-1α is the major alarmin of lung epithelial cells released during photodynamic therapy to induce inflammatory mediators in fibroblasts</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">1534</span>– <span class="NLM_lpage">1546</span>, <span class="refDoi"> DOI: 10.1038/bjc.2012.429</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1038%2Fbjc.2012.429" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=22996613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFOntLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2012&pages=1534-1546&author=E.+C.+Tracyauthor=M.+J.+Bowmanauthor=B.+W.+Hendersonauthor=H.+Baumann&title=Interleukin-1%CE%B1+is+the+major+alarmin+of+lung+epithelial+cells+released+during+photodynamic+therapy+to+induce+inflammatory+mediators+in+fibroblasts&doi=10.1038%2Fbjc.2012.429"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Interleukin-1α is the major alarmin of lung epithelial cells released during photodynamic therapy to induce inflammatory mediators in fibroblasts</span></div><div class="casAuthors">Tracy, E. C.; Bowman, M. J.; Henderson, B. W.; Baumann, H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1534-1546</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: Photodynamic therapy (PDT) causes tissue damage that initiates a local inflammatory response.  Post-PDT reactions are considered to assist in mobilising the immune system thereby affecting tumor recurrence.  The initiating process of the PDT-dependent tissue reaction remains to be detd.  Methods: Primary cultures of human lung cells were established.  The photoreaction mediated by pyropheophorbide-a, at specific subcellular sites and levels resulting in the release of alarmins by epithelial cells (Eps), was defined by immunoblot analyses and expression profiling.  The activity of Ep-derived factors to stimulate expression of proinflammatory mediators, including IL-6, and to enhance neutrophil binding by fibroblasts (Fbs) was detd. by functional bioassays.  Results: Epithelial cells release IL-1β as the primary Fb-stimulatory activity under basal conditions.  Intracellular IL-1α, externalized following photoreaction, accounts for most of the PDT-mediated Fb activation.  Expression of IL-1 is subject to increase or loss during oncogenic transformation resulting in altered alarmin functions mobilisable by PDT.  Photoreaction by a cell surface-bound photosensitizer (PS) is 10-fold more effective than PSs localized to mitochondria or lysosomes.  High-dose intracellular, but not cell surface, photoreaction inactivates IL-1 and reduces Fb stimulation.  Conclusion: These in vitro data suggest that the subcellular site and intensity of photoreaction influence the magnitude of the stromal cell response to the local damage and, in part, support the relationship of PDT dose and level of post-PDT inflammatory response obsd. in vivo.  British Journal of Cancer (2012) 107, 1534-1546; doi:10.1038/bjc.2012.429 www.bjcancer.com Published online 20 Sept. 2012.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZlyBtcytZrLVg90H21EOLACvtfcHk0liCQ72TkFtAEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFOntLnN&md5=a7b145009c8e52455b46d5709e955ce3</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2Fbjc.2012.429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.2012.429%26sid%3Dliteratum%253Aachs%26aulast%3DTracy%26aufirst%3DE.%2BC.%26aulast%3DBowman%26aufirst%3DM.%2BJ.%26aulast%3DHenderson%26aufirst%3DB.%2BW.%26aulast%3DBaumann%26aufirst%3DH.%26atitle%3DInterleukin-1%25CE%25B1%2520is%2520the%2520major%2520alarmin%2520of%2520lung%2520epithelial%2520cells%2520released%2520during%2520photodynamic%2520therapy%2520to%2520induce%2520inflammatory%2520mediators%2520in%2520fibroblasts%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2012%26volume%3D107%26spage%3D1534%26epage%3D1546%26doi%3D10.1038%2Fbjc.2012.429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tracy, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowman, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, H.</span></span> <span> </span><span class="NLM_article-title">Cell-specific retention and action of pheophorbide-based photosensitizers in human lung cancer cells</span>. <i>Photochem. Photobiol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">846</span>– <span class="NLM_lpage">859</span>, <span class="refDoi"> DOI: 10.1111/php.13043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1111%2Fphp.13043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=30378688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlalu7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2019&pages=846-859&author=E.+C.+Tracyauthor=M.-J.+Bowmanauthor=R.+K.+Pandeyauthor=H.+Baumann&title=Cell-specific+retention+and+action+of+pheophorbide-based+photosensitizers+in+human+lung+cancer+cells&doi=10.1111%2Fphp.13043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-specific Retention and Action of Pheophorbide-based Photosensitizers in Human Lung Cancer Cells</span></div><div class="casAuthors">Tracy, Erin C.; Bowman, Mary-Jo; Pandey, Ravendra K.; Baumann, Heinz</div><div class="citationInfo"><span class="NLM_cas:title">Photochemistry and Photobiology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">846-859</span>CODEN:
                <span class="NLM_cas:coden">PHCBAP</span>;
        ISSN:<span class="NLM_cas:issn">0031-8655</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">This study detd. in primary cultures of human lung cancer cells the cell specificity of chlorin-based photosensitizers.  Epithelial cells (ECs) preferentially retained 3-[1-hexyloxyethyl]-2-devinylpyropheophorbide-a (HPPH) and related structural variants.  Tumor-assocd. fibroblasts (Fb) differ from EC by a higher efflux rate of HPPH.  Immunoblot analyses indicated dimerization of STAT3 as a reliable biomarker of the photoreaction.  Compared to mitochondria/ER-localized photoreaction by HPPH, the photoreaction by lysosomally targeted HPPH-lactose showed a trend toward lower STAT3 crosslinking.  Lethal consequence of the photoreaction differed between EC and Fb with the latter cells being more resistant.  A survey of lung tumor cases indicated a large quant. range by which EC retains HPPH.  The specificity of HPPH retention defined in vitro could be confirmed in vivo in selected cases grown as xenografts.  HPPH retention as a function of the tetrapyrrole structure was evaluated by altering side groups on the porphyrin macrocycle.  The presence or absence of a carboxylic acid at position 172 proved to be crit.  A benzyl group at position 20 enhanced retention in a subset of cancer cells with low HPPH binding.  This study indicated exptl. tools that are potentially effective in defining the photosensitizer preference and application for individual patient's cancer lesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZZPJcoCyWl7Vg90H21EOLACvtfcHk0liCQ72TkFtAEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlalu7bM&md5=86fd09f02fc57101933e5c994680aa75</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1111%2Fphp.13043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fphp.13043%26sid%3Dliteratum%253Aachs%26aulast%3DTracy%26aufirst%3DE.%2BC.%26aulast%3DBowman%26aufirst%3DM.-J.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26aulast%3DBaumann%26aufirst%3DH.%26atitle%3DCell-specific%2520retention%2520and%2520action%2520of%2520pheophorbide-based%2520photosensitizers%2520in%2520human%2520lung%2520cancer%2520cells%26jtitle%3DPhotochem.%2520Photobiol.%26date%3D2019%26volume%3D95%26spage%3D846%26epage%3D859%26doi%3D10.1111%2Fphp.13043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oseroff, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, H.</span></span> <span> </span><span class="NLM_article-title">Photodynamic therapy causes cross-linking of signal transducer and activator of transcription proteins and attenuation of interleukin-6 cytokine responsiveness in epithelial cells</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">6579</span>– <span class="NLM_lpage">6587</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-04-1580</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1158%2F0008-5472.CAN-04-1580" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=15374971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnsFOlurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=6579-6587&author=W.+Liuauthor=A.+R.+Oseroffauthor=H.+Baumann&title=Photodynamic+therapy+causes+cross-linking+of+signal+transducer+and+activator+of+transcription+proteins+and+attenuation+of+interleukin-6+cytokine+responsiveness+in+epithelial+cells&doi=10.1158%2F0008-5472.CAN-04-1580"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Photodynamic Therapy Causes Cross-linking of Signal Transducer and Activator of Transcription Proteins and Attenuation of Interleukin-6 Cytokine Responsiveness in Epithelial Cells</span></div><div class="casAuthors">Liu, Weiguo; Oseroff, Allan R.; Baumann, Heinz</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6579-6587</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Photodynamic therapy (PDT) is a local treatment of cancers.  The principle of PDT is the prodn. of reactive oxygen species, in particular singlet oxygen, by light activation of a photosensitizer introduced into the target cells.  The direct photochem. and subsequent redox reactions can lead to cell death.  This study sought to identify effects occurring during PDT and some of their consequences in surviving cells.  Using epithelial cells in tissue culture and in tumors, several distinct PDT-mediated reactions were found, including global dephosphorylation of proteins, induced phosphorylation of a 71-kDa protein, initiation of cellular stress responses, structural modification and loss of epidermal growth factor receptor, and crosslinking of proteins.  Specific covalent crosslinking of nonactivated signal transducer and activator of transcription (STAT)-3, and to a lesser extent of STAT1 and STAT4, correlated with PDT dose.  Cross-linked STAT3 was primarily localized to the cytoplasm and failed to bind to DNA.  The combination of STAT crosslinking and inactivation of receptor functions rendered PDT-treated cells refractory for at least 24 h to interleukin-6 and oncostatin M, cytokines known to be elevated at site of tissue damage and inflammation.  It is suggested that the loss of responsiveness to these inflammatory cytokines in the PDT-treated field assists tumor cells in evading the growth-suppressive activity of these mediators expected to be present at tissue sites after PDT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJmC1378qh6bVg90H21EOLACvtfcHk0liCQ72TkFtAEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnsFOlurg%253D&md5=6376c4186014f50bb462abaeda094cf4</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-1580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-1580%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DOseroff%26aufirst%3DA.%2BR.%26aulast%3DBaumann%26aufirst%3DH.%26atitle%3DPhotodynamic%2520therapy%2520causes%2520cross-linking%2520of%2520signal%2520transducer%2520and%2520activator%2520of%2520transcription%2520proteins%2520and%2520attenuation%2520of%2520interleukin-6%2520cytokine%2520responsiveness%2520in%2520epithelial%2520cells%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D6579%26epage%3D6587%26doi%3D10.1158%2F0008-5472.CAN-04-1580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Srivatsan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pera, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Missert, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tracy, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabaczynski, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sajjad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumann, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Effect of chirality on cellular uptake, imaging and photodynamic therapy of photosensitizers derived from chlorophyll-a</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3603</span>– <span class="NLM_lpage">3617</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2015.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=10.1016%2Fj.bmc.2015.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=25936263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsVeqtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=3603-3617&author=A.+Srivatsanauthor=P.+Peraauthor=P.+Joshiauthor=Y.+Wangauthor=J.+R.+Missertauthor=E.+C.+Tracyauthor=W.+A.+Tabaczynskiauthor=R.+Yaoauthor=M.+Sajjadauthor=H.+Baumannauthor=R.+K.+Pandey&title=Effect+of+chirality+on+cellular+uptake%2C+imaging+and+photodynamic+therapy+of+photosensitizers+derived+from+chlorophyll-a&doi=10.1016%2Fj.bmc.2015.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of chirality on cellular uptake, imaging and photodynamic therapy of photosensitizers derived from chlorophyll-a</span></div><div class="casAuthors">Srivatsan, Avinash; Pera, Paula; Joshi, Penny; Wang, Yanfang; Missert, Joseph R.; Tracy, Erin C.; Tabaczynski, Walter A.; Yao, Rutao; Sajjad, Munawwar; Baumann, Heinz; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3603-3617</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We have previously shown that the 124I-analog of Me 3-(1'-m-iodobenzyloxy) ethyl-3-devinyl-pyropheophorbide-a derived as racemic mixt. from chlorophyll-a can be used for PET (positron emission tomog.)-imaging in animal tumor models.  On the other hand, as a non-radioactive analog, it showed excellent fluorescence and photodynamic therapy (PDT) efficacy.  Thus, a single agent in a mixt. of radioactive (124I-) and non-radioactive (127I) material can be used for both dual-imaging and PDT of cancer.  Before advancing to Phase I human clin. trials, we evaluated the activity of the individual isomers as well as the impact of a chiral center at position-31 in directing in vitro/in vivo cellular uptake, intracellular localization, epithelial tumor cell-specific retention, fluorescence/PET imaging, and photosensitizing ability.  The results indicate that both isomers (racemates), either as Me ester or carboxylic acid, were equally effective.  However, the Me ester analogs, due to subcellular deposition into vesicular structures, were preferentially retained.  All derivs. contg. carboxylic acid at the position-172 were noted to be substrate for the ABCG2 (a member of the ATP binding cassette transporters) protein explaining their low retention in lung tumor cells expressing this transporter.  The compds. in which the chirality at position-3 has been substituted by a non-chiral functionality showed reduced cellular uptake, retention and lower PDT efficacy in mice bearing murine Colon26 tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc4VikWQsT3LVg90H21EOLACvtfcHk0lg4chlBksa6Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsVeqtr8%253D&md5=ce58e5a8ae06afe14296a0de6b87d24f</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DSrivatsan%26aufirst%3DA.%26aulast%3DPera%26aufirst%3DP.%26aulast%3DJoshi%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DMissert%26aufirst%3DJ.%2BR.%26aulast%3DTracy%26aufirst%3DE.%2BC.%26aulast%3DTabaczynski%26aufirst%3DW.%2BA.%26aulast%3DYao%26aufirst%3DR.%26aulast%3DSajjad%26aufirst%3DM.%26aulast%3DBaumann%26aufirst%3DH.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DEffect%2520of%2520chirality%2520on%2520cellular%2520uptake%252C%2520imaging%2520and%2520photodynamic%2520therapy%2520of%2520photosensitizers%2520derived%2520from%2520chlorophyll-a%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D3603%26epage%3D3617%26doi%3D10.1016%2Fj.bmc.2015.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spernyak, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, W. H.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ethirajan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goswami, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turowski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Missert, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazurchuk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, R. K.</span></span> <span> </span><span class="NLM_article-title">Hexylether derivative of pyropheophorbide-a (HPPH) on conjugating with 3gadolinium(III) aminobenzyldiethylenetriaminepentaacetic acid shows potential for in vivo tumor imaging (MR, fluorescence) and photodynamic therapy</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">828</span>– <span class="NLM_lpage">835</span>, <span class="refDoi"> DOI: 10.1021/bc9005317</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc9005317" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksF2lsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=828-835&author=J.+A.+Spernyakauthor=W.+H.+Whiteauthor=M.+Ethirajanauthor=N.+J.+Patelauthor=L.+Goswamiauthor=Y.+Chenauthor=S.+Turowskiauthor=J.+R.+Missertauthor=C.+Battauthor=R.+Mazurchukauthor=R.+K.+Pandey&title=Hexylether+derivative+of+pyropheophorbide-a+%28HPPH%29+on+conjugating+with+3gadolinium%28III%29+aminobenzyldiethylenetriaminepentaacetic+acid+shows+potential+for+in+vivo+tumor+imaging+%28MR%2C+fluorescence%29+and+photodynamic+therapy&doi=10.1021%2Fbc9005317"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Hexylether Derivative of Pyropheophorbide-a (HPPH) on Conjugating with 3Gadolinium(III) Aminobenzyldiethylenetriaminepentaacetic Acid Shows Potential for in Vivo Tumor Imaging (MR, Fluorescence) and Photodynamic Therapy</span></div><div class="casAuthors">Spernyak, Joseph A.; White, William H., III; Ethirajan, Manivannan; Patel, Nayan J.; Goswami, Lalit; Chen, Yihui; Turowski, Steven; Missert, Joseph R.; Batt, Carrie; Mazurchuk, Richard; Pandey, Ravindra K.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">828-835</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Conjugates of 3-(1'-hexyloxyethyl)-3-devinyl pyropheophorbide-a (HPPH) with multiple Gd(III)aminobenzyl diethylenetriamine pentacetic acid (ADTPA) moieties were evaluated for tumor imaging and photodynamic therapy (PDT).  In vivo studies performed in both mice and rat tumor models resulted in a significant MR signal enhancement of tumors relative to surrounding tissues at 24 h postinjection.  The water-sol. (pH: 7.4) HPPH-3Gd(III) ADTPA conjugate demonstrated high potential for tumor imaging by MR and fluorescence.  This agent also produced long-term tumor cures via PDT.  An in vivo biodistribution study with the corresponding 14C-analog also showed significant tumor uptake 24 h postinjection.  Toxicol. evaluations of HPHH-3Gd(III)ADTPA administered at and above imaging/therapeutic doses did not show any evidence of organ toxicity.  Our present study illustrates a novel approach for the development of water-sol. "multifunctional agents", demonstrating efficacy for tumor imaging (MR and fluorescence) and phototherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBKHMDEWcLLbVg90H21EOLACvtfcHk0lg4chlBksa6Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksF2lsL0%253D&md5=8a8ac3bdad4a8fccb17ee993184d3e2a</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fbc9005317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc9005317%26sid%3Dliteratum%253Aachs%26aulast%3DSpernyak%26aufirst%3DJ.%2BA.%26aulast%3DWhite%26aufirst%3DW.%2BH.%26aulast%3DEthirajan%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DN.%2BJ.%26aulast%3DGoswami%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DTurowski%26aufirst%3DS.%26aulast%3DMissert%26aufirst%3DJ.%2BR.%26aulast%3DBatt%26aufirst%3DC.%26aulast%3DMazurchuk%26aufirst%3DR.%26aulast%3DPandey%26aufirst%3DR.%2BK.%26atitle%3DHexylether%2520derivative%2520of%2520pyropheophorbide-a%2520%2528HPPH%2529%2520on%2520conjugating%2520with%25203gadolinium%2528III%2529%2520aminobenzyldiethylenetriaminepentaacetic%2520acid%2520shows%2520potential%2520for%2520in%2520vivo%2520tumor%2520imaging%2520%2528MR%252C%2520fluorescence%2529%2520and%2520photodynamic%2520therapy%26jtitle%3DBioconjugate%2520Chem.%26date%3D2010%26volume%3D21%26spage%3D828%26epage%3D835%26doi%3D10.1021%2Fbc9005317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i56"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01735">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_14674"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01735?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01735</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">(i) NMR (<sup>1</sup>H and <sup>13</sup>C) details and spectra of new compounds, (ii) (Table S1) a summary of NMR analysis (chemical shifts) of compounds, (iii) magnification (100×) of <a id="rightTab-" class=" internalNav" href="#fig4">Figure <a id="rightTab-" class=" internalNav" href="#fig4">4</a></a> of the main manuscript, (iv) (Table S2) molecular formula strings, and (v) (Table S3) analysis (including HPLC) of PS-Erlotinib conjugates (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01735/suppl_file/jm0c01735_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Erlotinib spreadsheet new (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01735/suppl_file/jm0c01735_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01735/suppl_file/jm0c01735_si_001.pdf">jm0c01735_si_001.pdf (5.39 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01735/suppl_file/jm0c01735_si_002.csv">jm0c01735_si_002.csv (8.72 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01735&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01735%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-1%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01735" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66e0c44e1f193291","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
